FeatureID,Name,Formula,MW,KEGG Pathways,Metabolika Pathways,name4plot,C,H,O,N,S,P,H_to_C,O_to_C,NOSC,GFE,DBE,DBE_O,AI,AI_mod,DBE_AI,Class,control_means,treatment_means,ratio,log2FC,pval,pval.adj,Comment
Feature1694,α-Lactose,C12 H22 O11,342.11629,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak2,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,8131293898.098034,395990232.35218596,0.04869953506966595,-4.359948190688649,5.2645579159850445e-9,4.246743385561269e-8,Downregulated
Feature1693,Phenacetin,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak6,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,16361774.24904201,2761642091.698802,168.78622389381135,7.399053347782305,8.318804624988213e-5,2.5030293134511604e-4,Upregulated
Feature1692,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21535,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,3230123.4741757535,5628291.934045383,1.7424386340158657,0.8011078475083565,0.2904921830417624,0.3658689651098479,Upregulated
Feature1691,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak5",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,2188515.598676284,2436198232.7488317,1113.1738033863492,10.12046314751961,1.4380157159247419e-4,4.0532423007928666e-4,Upregulated
Feature1690,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak13",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,2792059.5799075994,4438968.0276587065,1.5898543353453833,0.6688945898482116,0.33294489522141535,0.40989000908799245,Upregulated
Feature1689,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak4",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,7198560.62396615,1255803754.211845,174.45206337929565,7.446686851276474,0.0012350124100012547,0.0027491603449962226,Upregulated
Feature1688,Betaine,C5 H11 N O2,117.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak2,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,2298395794.2817845,1566913903.183372,0.6817424166376053,-0.5527013474771767,0.02528843081722604,0.04079866838512468,Downregulated
Feature1687,NA,C30 H32 O10,552.19968,NA,NA,Feature1687,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,2818014.6936661494,4390118.85081742,1.5578764939319787,0.6395808632746466,0.43748338435255874,0.5038636297487575,Upregulated
Feature1686,Phenacetin,C10 H13 N O2,179.09467,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak5,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,7166201.177267223,309741146.5759429,43.222502259427266,5.433710690749031,0.030517464367065886,0.04833030027722983,Upregulated
Feature1685,Choline O-Sulfate,C5 H13 N O4 S,183.05656,ABC transporters,NA,Choline O-Sulfate,5,13,4,1,1,0,2.6,0.8,0,60.3,0,-4,6,-4,-6,Other,140906649.61557323,385188683.63451,2.7336444708989682,1.4508256228181937,3.136814160932778e-4,8.125020166085819e-4,Upregulated
Feature1684,NA,C30 H32 O10,552.19968,NA,NA,Feature1684,30,32,10,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,15,5,0.25,0.4,5,Lignin,1332375.463898358,2180300.176443496,1.6364007260117355,0.7105260824102775,0.35618376165050836,0.4292241263699788,Upregulated
Feature1683,NA,C9 H16 O7,236.0896,NA,NA,Feature1683,9,16,7,0,0,0,1.7777777777777777,0.7777777777777778,-0.22222222222222232,66.63333333333333,2,-5,-2.5,-0.2727272727272727,-5,Carbohydrate,1931598369.8936346,419034154.2243462,0.21693648159758014,-2.204655407510223,1.55107194411638e-12,5.83892416296255e-11,Downregulated
Feature1682,Citric acid,C6 H8 O7,192.02697,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,Citric acid,6,8,7,0,0,0,1.3333333333333333,1.1666666666666667,1,31.799999999999997,3,-4,4,-0.2,-4,Other,1596156490.2010484,157849338.7462351,0.09889339780609653,-3.3379819809272724,1.2438993414192046e-13,7.023884947880442e-12,Downregulated
Feature1681,L-Phenylalanine,C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak2,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,1168061853.265524,658582995.1695818,0.5638254458258322,-0.826679505701375,1.859623751951166e-4,5.080971993234316e-4,Downregulated
Feature1680,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.10283,NA,NA,L-alpha-Glycerylphosphorylcholine-peak2,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,1099154295.8847184,874573141.1445962,0.795678226814048,-0.3297429737072327,0.0033045219040138494,0.006517249344823401,Downregulated
Feature1679,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak12",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1336563.759228302,2252831.414687651,1.6855398024471193,0.7532106956194096,0.3246767597180714,0.4014616284397175,Upregulated
Feature1678,L-Glutamic acid,C5 H9 N O4,147.05318,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,L-Glutamic acid,5,9,4,1,0,0,1.8,0.8,0.3999999999999999,48.9,2,-2,-Inf,-0.5,-3,Carbohydrate,1241105584.511483,445079102.2575461,0.35861501858662226,-1.479492186193821,3.518349118657327e-6,1.4090031695048493e-5,Downregulated
Feature1677,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak5,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1693497932.4058816,58464157.91878844,0.034522721758349514,-4.856309979241611,1.2871052757326813e-9,1.2978311530304536e-8,Downregulated
Feature1676,Adenosine,C10 H13 N5 O4,267.09675,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Adenosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,231476021.65124536,642622577.9220111,2.776195017254193,1.4731089153741626,9.499849456264555e-8,5.400249992923542e-7,Upregulated
Feature1675,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08991,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak2,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,788023907.8695444,91528078.75557144,0.11614886025859474,-3.105953097497773,1.6315698303043304e-11,3.543434990430174e-10,Downregulated
Feature1674,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak3,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,1549303.8269771638,5354431.7942972705,3.456024377571097,1.789113393796779,7.425922275163298e-5,2.2463414882368976e-4,Upregulated
Feature1673,Choline,C5 H13 N O,103.09967,NA,NA,Choline,5,13,1,1,0,0,2.6,0.2,-1.5999999999999996,105.89999999999998,0,-1,-0.6666666666666666,-0.42857142857142855,-2,Other,1446371602.5138485,589032152.2342664,0.4072481450897586,-1.2960199672253379,1.3591750903008521e-9,1.3543780017468491e-8,Downregulated
Feature1672,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak3,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,647661146.853201,80690976.27938809,0.124588261425658,-3.004759949324587,7.584453935167101e-10,8.397428082466059e-9,Downregulated
Feature1671,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11614,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak2,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,339867372.0744788,12779939.809432441,0.0376027264147964,-4.73301892035835,5.586188568591862e-4,0.0013674860455483548,Downregulated
Feature1670,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak11",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1022295.0121176715,1626306.5861141854,1.5908388154465425,0.6697876685186883,0.3124927576718216,0.38981055338443726,Upregulated
Feature1669,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak4,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1282035335.8523962,77113899.98747413,0.060149590132945005,-4.055301283049721,7.954844631874876e-12,2.0417434555145515e-10,Downregulated
Feature1668,DL-Carbidopa,C10 H14 N2 O4,226.09535,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,DL-Carbidopa,10,14,4,2,0,0,1.4,0.4,0,60.3,5,1,-0.25,0.16666666666666666,-1,Lignin,395487548.53826416,730703696.5450556,1.8476022803897674,0.8856542319366183,7.323752565220201e-8,4.191363799149669e-7,Upregulated
Feature1667,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.1057,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak3",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,1474278642.4073918,12868162.038027216,0.008728446351915147,-6.84005940513288,7.353337675488765e-10,8.195101330446033e-9,Downregulated
Feature1666,Maltotriose,C18 H32 O16,504.16909,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak2,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,1411198602.8475955,74938278.58073947,0.053102574243997135,-4.2350743897805225,2.6451798822152547e-10,3.4735928065679392e-9,Downregulated
Feature1665,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak3,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,1053921338.2527419,87447387.87811857,0.08297335361203943,-3.5912080916755613,2.0887230707585457e-5,7.148074508818134e-5,Downregulated
Feature1664,L-Iditol,C6 H14 O6,182.07905,Metabolic pathways;ABC transporters;Other,Other,L-Iditol,6,14,6,0,0,0,2.3333333333333335,1,-0.33333333333333304,69.79999999999998,0,-6,-Inf,-1,-6,Carbohydrate,133553979.98913445,578680430.1910194,4.332932872821155,2.115343886090928,1.6876532865377688e-4,4.671380175481994e-4,Upregulated
Feature1663,NA,C32 H36 O10,580.23111,NA,NA,Feature1663,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,1960852.0631026013,3032257.650299648,1.5463979702282034,0.6289116490096737,0.43672219219259534,0.5037070059920523,Upregulated
Feature1662,Maltotriose,C18 H32 O16,504.16908,Metabolic pathways;ABC transporters;Other,NA,Maltotriose-peak1,18,32,16,0,0,0,1.7777777777777777,0.8888888888888888,0,60.3,3,-13,-6.5,-0.5,-13,Carbohydrate,1104831896.5374293,23441740.053953733,0.021217472203165687,-5.558603402380969,1.3072777509965836e-9,1.3103718995196523e-8,Downregulated
Feature1661,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,655099022.636628,426177915.912904,0.6505549561005795,-0.6202571600890205,0.0024644175749961306,0.005029787195233067,Downregulated
Feature1660,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak2,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,26967855.480036512,579071688.1617252,21.47266357869629,4.424429256434784,1.8596492944585773e-8,1.2561374927619832e-7,Upregulated
Feature1659,Dambonitol,C8 H16 O6,208.09467,NA,NA,Dambonitol,8,16,6,0,0,0,2,0.75,-0.5,74.55,1,-5,-2.5,-0.4,-5,Carbohydrate,138700902.26174927,331547005.4980782,2.390373819431972,1.2572362522096245,0.0427925837163014,0.06608079928478995,Upregulated
Feature1658,NA,C6 H11 N O7,209.05352,NA,NA,Feature1658,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,798451996.2502561,80869829.64385767,0.10128327065827877,-3.3035321964787303,2.1450204693532924e-13,1.0687249044366109e-11,Downregulated
Feature1657,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07864,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak2",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,1633665.6972180998,52099348.35323193,31.89107076310025,4.995080632699576,0.008488679926837312,0.015168590502175536,Upregulated
Feature1656,D-Gluconic acid,C6 H12 O7,196.05831,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Gluconic acid,6,12,7,0,0,0,2,1.1666666666666667,0.3333333333333335,50.8,1,-6,6,-1,-6,Carbohydrate,136592841.59368172,8289423.226524697,0.06068709845851933,-4.042466344928899,0.02216530246471087,0.03634852117639904,Downregulated
Feature1655,Proline,C5 H9 N O2,115.06328,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;ABC transporters;Other,Other,Proline,5,9,2,1,0,0,1.8,0.4,-0.4000000000000003,71.7,2,0,-0.5,0,-1,Protein,799702649.3926418,208444612.53740686,0.2606526472004518,-1.939799582800855,1.1924242769613796e-7,6.558333523287588e-7,Downregulated
Feature1654,N-Acetylneuraminic acid,C11 H19 N O9,309.10605,Metabolic pathways;Other,Other,N-Acetylneuraminic acid,11,19,9,1,0,0,1.7272727272727273,0.8181818181818182,0.18181818181818168,55.11818181818182,3,-6,-7,-0.4545454545454546,-7,Carbohydrate,822212173.1771971,30366574.948173564,0.03693277226829526,-4.758954630789009,6.877950148181652e-11,1.128480220591891e-9,Downregulated
Feature1653,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16789,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak3",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,1170621.1395478968,2011667.9041616535,1.7184619653618896,0.7811179209618695,0.2971803986064367,0.3731827985465558,Upregulated
Feature1652,L-Pyroglutamic acid,C5 H7 N O3,129.04257,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak2,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,538634245.8782972,17391860.134618025,0.03228881243200356,-4.9528218095216845,3.1841882848754358e-9,2.7537816556033712e-8,Downregulated
Feature1651,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak10",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1025909.776448662,1466751.9459828609,1.4297085178973916,0.5157210472499553,0.4514384170918776,0.5156686976086585,Upregulated
Feature1650,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14748,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak2",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,626794792.8922465,30653448.178536505,0.0489050779077008,-4.353871919036577,2.7162545954112257e-12,8.681764687974748e-11,Downregulated
Feature1649,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak3,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,463796041.2460991,5213734.396418537,0.011241437901045018,-6.475029606170614,2.3869308369012716e-10,3.209095902945043e-9,Downregulated
Feature1648,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13223,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak8,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,734467626.9738655,2928449.192260111,0.003987172592379369,-7.970418228165431,3.7439621138809415e-10,4.5958491455900836e-9,Downregulated
Feature1647,NA,C16 H29 N O12,427.16894,NA,NA,Feature1647,16,29,12,1,0,0,1.8125,0.75,-0.125,63.8625,3,-9,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,801771163.8224287,4427710.642177426,0.00552241193243768,-7.50048577798937,4.140129096854641e-12,1.188708252554536e-10,Downregulated
Feature1646,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13226,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak7,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,559449181.8144828,5736395.446215864,0.010253648825816126,-6.607718796516239,9.148202060522424e-7,4.0781721817171014e-6,Downregulated
Feature1645,NP-019445,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,NP-019445,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,2844517.527250963,55948421.9124144,19.66886172309328,4.297841563232534,0.0012677987908087955,0.0028074238335145637,Upregulated
Feature1644,DL-Tryptophan,C11 H12 N2 O2,204.08987,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,DL-Tryptophan,11,12,2,2,0,0,1.0909090909090908,0.18181818181818185,-0.18181818181818168,65.48181818181817,7,5,0.42857142857142855,0.5,3,Lignin,336528712.61259204,265180236.5572258,0.7879869580771797,-0.3437563429634302,0.09247450157784683,0.1319177955737673,Downregulated
Feature1643,Beauvericin,C45 H57 N3 O9,783.40966,NA,NA,Beauvericin,45,57,9,3,0,0,1.2666666666666666,0.2,-0.666666666666667,79.30000000000001,19,10,0.21212121212121213,0.30666666666666664,7,Lignin,881902.0462354217,252772626.63579616,286.6221115086506,8.163006100607769,9.337365401775292e-4,0.002137499593325317,Upregulated
Feature1642,NA,C11 H15 N O7,273.08486,NA,NA,Feature1642,11,15,7,1,0,0,1.3636363636363635,0.6363636363636364,0.18181818181818168,55.11818181818182,5,-2,-1,0.07692307692307693,-3,Lignin,250200629.87008688,409804427.2573383,1.6379032597564738,0.711850148925714,6.689850285473171e-8,3.8943664548424575e-7,Upregulated
Feature1641,1-Linoleoyl glycerol,C21 H38 O4,354.27701,NA,NA,1-Linoleoyl glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,9272589.388755668,119830418.62003483,12.923080446692294,3.6918780980038735,0.022047157202626257,0.03624516699076189,Upregulated
Feature1640,α-Lactose,C12 H22 O11,342.11628,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,α-Lactose-peak1,12,22,11,0,0,0,1.8333333333333333,0.9166666666666666,0,60.3,2,-9,-9,-0.5384615384615384,-9,Carbohydrate,667099209.2530346,45240282.12932493,0.067816422957511,-3.882221499742809,1.8512002364646493e-7,9.769262307075126e-7,Downregulated
Feature1639,g-Butyrobetaine,C7 H15 N O2,145.1103,NA,NA,g-Butyrobetaine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,22604220.604389887,10067419.498935446,0.4453778643878696,-1.1668982379997144,0.5663875957548327,0.617016454796583,Downregulated
Feature1638,NA,C12 H21 N O9,323.12168,NA,NA,Feature1638,12,21,9,1,0,0,1.75,0.75,0,60.3,3,-6,-3.5,-0.38461538461538464,-7,Carbohydrate,591943121.7267867,1211624.5461130904,0.0020468597431770137,-8.932372036602448,1.1620782588584687e-12,4.5780478383866185e-11,Downregulated
Feature1637,DL-Stachydrine,C7 H13 N O2,143.09464,ABC transporters,NA,DL-Stachydrine,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,13625156.643903406,296087526.0821888,21.73094473850864,4.441678990986578,0.004327838602054104,0.008219011874304544,Upregulated
Feature1636,trans-3-Indoleacrylic acid,C11 H9 N O2,187.06331,Microbial metabolism in diverse environments;Other,NA,trans-3-Indoleacrylic acid,11,9,2,1,0,0,0.8181818181818182,0.18181818181818185,-0.18181818181818168,65.48181818181817,8,6,0.625,0.6666666666666666,5,Lignin,303622412.0003101,241527440.8453301,0.795486206878178,-0.3300911793416856,0.1038118354595534,0.1465477077237362,Downregulated
Feature1635,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08956,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak3",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,6218117.303834733,187250716.99015483,30.11373183241119,4.912349599446156,0.0032810773169672605,0.006500754356657941,Upregulated
Feature1634,Υ-Aminobutyric acid (GABA),C4 H9 N O2,103.06332,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Υ-Aminobutyric acid (GABA),4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,248180073.2978816,145639641.91400442,0.5868305218009925,-0.7689841855226376,0.005227005487035762,0.00973027175278965,Downregulated
Feature1633,Isoleucine,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,Isoleucine-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,289053568.28789216,199431204.1778192,0.6899454843580733,-0.5354457222043771,0.022080880953049747,0.03624516699076189,Downregulated
Feature1632,Crotonic acid,C4 H6 O2,86.03675,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak7,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,228543002.14890024,133579883.9191008,0.5844846819333847,-0.7747628795202111,0.004901393608473495,0.009154311767093828,Downregulated
Feature1631,L-Glutathione oxidized,C20 H32 N6 O12 S2,612.15209,Metabolic pathways;Biosynthesis of cofactors;Other,Other,L-Glutathione oxidized,20,32,12,6,2,0,1.6,0.6,0.7000000000000002,40.349999999999994,8,-4,-Inf,-1,-12,Amino Sugar,1509170.9612858524,3087215.014537263,2.045636375024654,1.0325497195840168,0.03305263019770481,0.05213329195056978,Upregulated
Feature1630,4-Hydroxy-3-nitrosobenzamide,C7 H6 N2 O3,166.03787,NA,NA,4-Hydroxy-3-nitrosobenzamide,7,6,3,2,0,0,0.8571428571428571,0.42857142857142855,0.8571428571428572,35.87142857142857,6,3,0.5,0.7142857142857143,1,Lignin,49703005.5916338,879474.4425841038,0.017694592753806027,-5.820547631675075,0.32372778438742866,0.4006147289934124,Downregulated
Feature1629,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak9",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,2191723.899474722,4143173.8466572026,1.8903721621369252,0.9186702892684951,0.25903746186749377,0.330554964570031,Upregulated
Feature1628,L-Saccharopine,C11 H20 N2 O6,276.13215,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Lysine degradation;Other,Superpathway of L-lysine degradation,L-Saccharopine,11,20,6,2,0,0,1.818181818181818,0.5454545454545454,-0.18181818181818168,65.48181818181817,3,-3,-1.6666666666666667,-0.3333333333333333,-5,Protein,17084911.579799067,128110806.02280967,7.498476385109647,2.9065974842820537,3.5067032048693e-4,8.94631811603704e-4,Upregulated
Feature1627,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",C20 H34 O4,338.24575,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"4-[(1E,3Z)-5-Hydroxy-3-methyl-1,3-pentadien-1-yl]-3,4a,8,8-tetramethyldecahydro-1,2,3-naphthalenetriol",20,34,4,0,0,0,1.7,0.2,-1.2999999999999998,97.35,4,0,0,0.1111111111111111,0,Lipid,4380955.806303562,148692622.60471475,33.940680796361285,5.08494359823829,0.0012579910578650881,0.0027929709725078105,Upregulated
Feature1626,L-Tyrosine,C9 H11 N O3,181.07392,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,L-Tyrosine,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,383490639.8246841,216676265.59554622,0.5650105715607597,-0.8236502337390049,1.5013033974398148e-4,4.2106091974553745e-4,Downregulated
Feature1625,NA,C9 H17 N O6,235.10555,NA,NA,Feature1625,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,31655432.675104,139055873.18668956,4.392796478692664,2.1351396599172454,4.0877055344635556e-4,0.0010213234771948765,Upregulated
Feature1624,NA,C74 H117 N10 O14 P3,1462.79612,Other,NA,Feature1624,74,117,14,10,0,3,1.5810810810810811,0.1891891891891892,-1,88.8,23,9,-0.0851063829787234,0.05555555555555555,-4,Lipid,46164163.73573868,338941.1234336938,0.007342083035965351,-7.089594853839717,0.3353202318202817,0.41179896517327086,Downregulated
Feature1623,Homovanillic acid,C9 H10 O4,182.05795,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Other,Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Homovanillic acid,9,10,4,0,0,0,1.1111111111111112,0.4444444444444444,-0.22222222222222232,66.63333333333333,5,1,0.2,0.42857142857142855,1,Lignin,11854677.378035987,14063701.930239704,1.186342021951313,0.24651999828009843,0.7228506892234774,0.7544726232560509,Upregulated
Feature1622,L-Glutamine,C5 H10 N2 O3,146.06916,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Glutamine,5,10,3,2,0,0,2,0.6,0.3999999999999999,48.9,2,-1,-Inf,-1,-3,Amino Sugar,54107736.64691482,305406507.8282036,5.644414768652454,2.496824005421342,1.8570020079384494e-4,5.080971993234316e-4,Upregulated
Feature1621,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak3,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,5998630.817579357,76283438.55159673,12.716808363675828,3.6686647265418846,0.013617345953245484,0.023324351915872447,Upregulated
Feature1620,Acetylagmatine,C7 H16 N4 O,172.13243,NA,NA,Acetylagmatine,7,16,1,4,0,0,2.2857142857142856,0.14285714285714285,-0.2857142857142856,68.44285714285714,2,1,-1.5,-1,-3,Lipid,6503248.87520529,3997102.1197737516,0.6146315782275169,-0.7022062040028633,0.11223612701210715,0.1569388130234165,Downregulated
Feature1619,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.16788,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak2",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,616813.1925083523,1764495.3401472,2.8606640739502454,1.5163500928025164,0.21719632662208427,0.2825041685669988,Upregulated
Feature1618,NA,C29 H30 O10,538.18407,NA,NA,Feature1618,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,941411.0289491422,1332075.6663743819,1.414977757230359,0.500779374763397,0.5463288504934216,0.6001822780388173,Upregulated
Feature1617,Tris(hydroxymethyl)aminomethane,C4 H11 N O3,121.07387,NA,NA,Tris(hydroxymethyl)aminomethane,4,11,3,1,0,0,2.75,0.75,-0.5,74.55,0,-3,-Inf,-1.6666666666666667,-4,Other,202111423.3723794,135523802.436208,0.6705400425908273,-0.5766046068705503,0.032722804822115835,0.051661166233610646,Downregulated
Feature1616,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak3,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,372678032.0110197,25838353.460549023,0.06933157106449733,-3.8503437371770795,5.759278164917129e-17,1.626036201894936e-14,Downregulated
Feature1615,L-Pyroglutamic acid,C5 H7 N O3,129.0426,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,L-Pyroglutamic acid-peak1,5,7,3,1,0,0,1.4,0.6,0.3999999999999999,48.9,3,0,-1,0.2,-1,Lignin,69136007.62850411,281471565.7506724,4.071273066028539,2.025479988314938,3.484430791312373e-4,8.902904616113362e-4,Upregulated
Feature1614,2-Hydroxy-N-(2-hydroxyethyl)propionamide,C5 H11 N O3,133.07387,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Hydroxy-N-(2-hydroxyethyl)propionamide,5,11,3,1,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-2,-3,-0.6,-3,Amino Sugar,303633234.8197003,39152143.47351169,0.12894551380964778,-2.9551665142159216,7.049274702910629e-7,3.2014668489894384e-6,Downregulated
Feature1613,Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,348271600.41897327,184770115.3298348,0.5305345457612822,-0.9144813995893261,2.9611221675677582e-5,9.83557049384271e-5,Downregulated
Feature1612,Diethylpyrocarbonate,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Diethylpyrocarbonate,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,56673987.70181506,219567067.0923626,3.8742124208304243,1.9539030582460222,1.1319270749492612e-5,4.132509622767346e-5,Upregulated
Feature1611,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak7",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,348562721.5223801,17939440.785024293,0.05146689441335584,-4.280211458903586,3.324458200032994e-7,1.6700406426007725e-6,Downregulated
Feature1610,Ectoine,C6 H10 N2 O2,142.07426,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak2,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,302571858.0777986,6013153.103280916,0.01987347118625549,-5.653012307835162,1.7800148508118956e-8,1.2257500639330696e-7,Downregulated
Feature1609,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10046,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak3,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,282013999.25233626,3751244.1292447564,0.013301623817221478,-6.2322538139690025,5.371768445436625e-7,2.499938391914737e-6,Downregulated
Feature1608,NA,C9 H19 N O7,253.11617,NA,NA,Feature1608,9,19,7,1,0,0,2.111111111111111,0.7777777777777778,-0.22222222222222232,66.63333333333333,1,-6,-7,-0.7777777777777778,-7,Carbohydrate,295766111.07746905,61471914.2053049,0.20783961347486413,-2.26645744200671,9.035307811672544e-12,2.1865444904247556e-10,Downregulated
Feature1607,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak8,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,379827844.84035575,9687198.00306507,0.02550418073518719,-5.2931224316497945,4.0713026797716105e-8,2.54493975628528e-7,Downregulated
Feature1606,hercynine,C9 H15 N3 O2,197.1165,NA,NA,hercynine,9,15,2,3,0,0,1.6666666666666667,0.2222222222222222,-0.22222222222222232,66.63333333333333,4,2,-0.25,0,-1,Lipid,30133860.837788086,140511832.83536017,4.662921674449272,2.221234196173054,1.5413373385239366e-5,5.4170652519907646e-5,Upregulated
Feature1605,Meglutol,C6 H10 O5,162.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak2,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,426247676.83137524,24117611.09361478,0.05658121417317606,-4.143533053994516,1.1491334939453177e-9,1.1726699630984147e-8,Downregulated
Feature1604,NA,C6 H14 O4,150.08923,NA,NA,Feature1604,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,6523778.866040735,123251004.98467986,18.89257859831178,4.239747719700456,6.783737992362367e-9,5.271400072964151e-8,Upregulated
Feature1603,NA,C75 H119 N10 O14 P3,1476.81198,NA,NA,Feature1603,75,119,14,10,0,3,1.586666666666667,0.18666666666666668,-1.0133333333333336,89.18,23,9,-0.08333333333333333,0.05454545454545454,-4,Lipid,36075162.56234759,387807.9835373883,0.010749999611703807,-6.539519582070966,0.336031163738576,0.4118934814566916,Downregulated
Feature1602,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C15 H21 N O7,327.13187,NA,NA,"(2S)-3-Phenyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",15,21,7,1,0,0,1.4,0.4666666666666667,-0.2666666666666666,67.89999999999999,6,-1,-0.2857142857142857,0.14285714285714285,-2,Lignin,144392293.0184985,40746754.05450932,0.2821947986468304,-1.8252366981484256,9.765018663411432e-4,0.0022263716844978416,Downregulated
Feature1601,NA,C23 H33 N3 O5,431.24199,NA,NA,Feature1601,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,1493082.967344308,188895628.67178407,126.51381926067096,6.983151170662126,1.0176898635753674e-4,2.982641226464831e-4,Upregulated
Feature1600,8-hydroxy-deoxyguanosine,C10 H13 N5 O5,283.09171,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,8-hydroxy-deoxyguanosine,10,13,5,5,0,0,1.3,0.5,1.2000000000000002,26.09999999999999,7,2,-Inf,-0.2,-3,Lignin,219841474.9567102,221416175.20283,1.007162889743302,0.010297031130601677,0.947869033008079,0.9529318349647986,Upregulated
Feature1599,L-glycero-Î±-D-manno-Heptopyranose,C7 H14 O7,210.07395,Metabolic pathways;Other,NA,L-glycero-Î±-D-manno-Heptopyranose,7,14,7,0,0,0,2,1,0,60.3,1,-6,-Inf,-0.7142857142857143,-6,Carbohydrate,31741605.26392197,1639802.0405290187,0.05166096758165047,-4.274781525177189,0.15479910108255795,0.208947949987134,Downregulated
Feature1598,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",C9 H12 N2 O6,244.06954,Metabolic pathways;ABC transporters;Other,Other,"1-Pentofuranosyl-2,4(1H,3H)-pyrimidinedione",9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,279865377.5746472,82760033.31542599,0.2957137250510803,-1.757726889631337,3.792922625137159e-7,1.8623799788354629e-6,Downregulated
Feature1597,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10013,NA,NA,N-(Carboxymethyl)norleucine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,2559908.23151649,1618666.1011521579,0.6323141123669342,-0.6612866760798851,0.5121898059210882,0.5711978480778956,Downregulated
Feature1596,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak4,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,201904456.07903072,18522695.14052079,0.09173990262637155,-3.4463068136446418,2.633677862754884e-6,1.0750482649413914e-5,Downregulated
Feature1595,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",C12 H12 O5,236.06846,NA,NA,"7,8-Dihydroxy-3,7-dimethyl-6-oxo-7,8-dihydro-6H-isochromene-5-carbaldehyde",12,12,5,0,0,0,1,0.4166666666666667,-0.16666666666666696,65.05000000000001,7,2,0.2857142857142857,0.47368421052631576,2,Lignin,37397316.47391521,1033171.8330788342,0.027626897609069785,-5.177782627454506,0.3371432451927582,0.4122820930085693,Downregulated
Feature1594,2-Acetamido-2-deoxy-D-gluconolactone,C8 H13 N O6,219.07432,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,2-Acetamido-2-deoxy-D-gluconolactone,8,13,6,1,0,0,1.625,0.75,0.25,53.175,3,-3,-4,-0.25,-4,Carbohydrate,248579976.1770808,27664336.716931846,0.1112894817289089,-3.1676108487898644,5.353178331084564e-14,3.3586237380952782e-12,Downregulated
Feature1593,NA,C6 H15 N O7,213.0849,NA,NA,Feature1593,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,55870634.5625966,4366045.984036999,0.07814563085273979,-3.677690975836964,0.009556398703452701,0.016863061878800913,Downregulated
Feature1592,NA,C6 H15 N O7,213.08492,NA,NA,Feature1592,6,15,7,1,0,0,2.5,1.1666666666666667,0.3333333333333335,50.8,0,-7,4,-3,-8,Carbohydrate,53489356.31506128,4307708.914432466,0.08053394565190387,-3.6342591717533885,0.012643534398264248,0.02183297377233398,Downregulated
Feature1591,NA,C10 H20 O7,252.12091,NA,NA,Feature1591,10,20,7,0,0,0,2,0.7,-0.5999999999999996,77.39999999999999,1,-6,-2,-0.38461538461538464,-6,Amino Sugar,57526102.9974941,4863733.606129651,0.08454828943204305,-3.564080623227849,0.004912979924332699,0.009165845805968714,Downregulated
Feature1590,"pentane-1,2,3,4,5-pentol",C5 H12 O5,152.06848,Metabolic pathways;ABC transporters;Other,Other,"pentane-1,2,3,4,5-pentol",5,12,5,0,0,0,2.4,1,-0.4000000000000003,71.7,0,-5,-Inf,-1,-5,Carbohydrate,9417873.578371627,99364584.576712,10.550639032244513,3.399258477775257,0.004273012338055608,0.008123998766179799,Upregulated
Feature1589,NA,C12 H18 O9,306.09515,NA,NA,Feature1589,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,203482473.72971073,1709315.3679476196,0.008400307587267357,-6.895342129806301,8.38478535663648e-9,6.284265516142993e-8,Downregulated
Feature1588,Cyclo(leucylprolyl),C11 H18 N2 O2,210.13681,NA,NA,Cyclo(leucylprolyl),11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,251493983.07640973,183975786.52637112,0.7315315630055252,-0.45100798198063596,2.5096957910630214e-7,1.2961660579453533e-6,Downregulated
Feature1587,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20378,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak2,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,1455998.2863344646,49961736.10649896,34.3144195810008,5.100743046984169,0.006526001463474957,0.011848924414926664,Upregulated
Feature1586,Acetyl-L-carnitine,C9 H17 N O4,203.11568,NA,NA,Acetyl-L-carnitine,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,13435754.049588416,731921.4280567899,0.05447564947642155,-4.198244698051222,0.3114607531681196,0.38880951795637037,Downregulated
Feature1585,3-Deoxy-D-glycero-hexitol,C6 H14 O5,166.08414,NA,NA,3-Deoxy-D-glycero-hexitol,6,14,5,0,0,0,2.3333333333333335,0.8333333333333334,-0.666666666666667,79.30000000000001,0,-5,-5,-0.7142857142857143,-5,Carbohydrate,5108679.048975857,255559143.5830263,50.02450557825873,5.644563098081464,1.6507561109256592e-5,5.753870065654458e-5,Upregulated
Feature1584,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",C21 H22 O6,370.14172,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"(2E)-3-[7-Methoxy-2-(7-methoxy-1,3-benzodioxol-5-yl)-3-methyl-2,3-dihydro-1-benzofuran-5-yl]-2-propen-1-ol",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,790328.5107792916,1218601.2451280388,1.541892046797673,0.6247017607123567,0.45093716391622785,0.5156686976086585,Upregulated
Feature1583,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak6",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,289665964.6142579,12976130.81223585,0.044796877774425085,-4.480458006070482,3.0139408525636566e-11,5.868523912922799e-10,Downregulated
Feature1582,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,119509103.33656465,87616737.13434225,0.7331386035722628,-0.44784212192639034,0.10323146507024183,0.1458499598240114,Downregulated
Feature1581,Cytarabine,C9 H13 N3 O5,243.08555,Metabolic pathways;ABC transporters;Other,Other,Cytarabine,9,13,5,3,0,0,1.4444444444444444,0.5555555555555556,0.6666666666666665,41.3,5,0,-3,-0.14285714285714285,-3,Lignin,197608579.67877996,11235304.464789653,0.056856359592549345,-4.136534460894883,1.944395007560396e-7,1.01975391418183e-6,Downregulated
Feature1580,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak2,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,10622990.950610807,125196159.69882202,11.78539643692565,3.558928383638119,3.247531677231179e-5,1.070295459383194e-4,Upregulated
Feature1579,(+)-Piperitol,C20 H20 O6,356.12609,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,Other,(+)-Piperitol,20,20,6,0,0,0,1,0.3,-0.4000000000000003,71.7,11,5,0.35714285714285715,0.4705882352941176,5,Lignin,707484.0479182568,1033065.8602314743,1.4601966832626527,0.5461627080480839,0.5000450865509622,0.5602356988209856,Upregulated
Feature1578,5-Aminolevulinic acid,C5 H9 N O3,131.05823,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,5-Aminolevulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,10378665.817830324,2122966.3733084383,0.20455099051953554,-2.2894675715251926,0.003521070160502318,0.00687969187069311,Downregulated
Feature1577,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12595,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak2",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,410873.4123682634,29700344.87578786,72.28587682175846,6.175641896565103,0.23183970436520926,0.30048696189339286,Upregulated
Feature1576,.alpha.-Glucoheptitol,C7 H16 O7,212.08964,NA,NA,.alpha.-Glucoheptitol,7,16,7,0,0,0,2.2857142857142856,1,-0.2857142857142856,68.44285714285714,0,-7,-Inf,-1,-7,Carbohydrate,31758739.36848381,12071256.991876343,0.3800924479973348,-1.395577734104824,0.2597712481523228,0.3310460530965986,Downregulated
Feature1575,NA,C9 H17 N O6,235.10557,NA,NA,Feature1575,9,17,6,1,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,2,-4,-2.5,-0.4,-5,Amino Sugar,8430910.855163665,105683188.02597193,12.535204065316897,3.647913577427331,0.0038525883652836693,0.007433126071515417,Upregulated
Feature1574,diphthinate,C13 H22 N4 O4,298.16416,NA,NA,diphthinate,13,22,4,4,0,0,1.6923076923076923,0.3076923076923077,-0.1538461538461542,64.6846153846154,5,1,-0.6,-0.14285714285714285,-3,Protein,19647094.387211878,238541.38304603496,0.01214130590227629,-6.363932585527669,0.16950711605102675,0.22735158716582687,Downregulated
Feature1573,Linamarin,C10 H17 N O6,247.10556,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak2,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,126085372.33957131,16709543.188107392,0.13252562829497375,-2.915656714541576,1.7499019590549594e-9,1.660396803534192e-8,Downregulated
Feature1572,NA,C62 H107 N2 O15 P3,1212.68834,NA,NA,Feature1572,62,107,15,2,0,3,1.7258064516129032,0.24193548387096775,-1.387096774193548,99.83225806451613,12,-3,-0.1904761904761905,-0.0101010101010101,-8,Lipid,164018.9906373327,107004529.29792225,652.3910974097089,9.349593284806593,0.0032920788972932266,0.006507329815653122,Upregulated
Feature1571,Inosine,C10 H12 N4 O5,268.08079,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,Inosine,10,12,5,4,0,0,1.2,0.5,1,31.799999999999997,7,2,-2,0.14285714285714285,-2,Lignin,194891491.71959856,10037074.334348585,0.05150083385266245,-4.2792603985398,1.2681583879407723e-7,6.863451467002135e-7,Downregulated
Feature1570,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak7,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,210906935.86497444,38688794.99920592,0.18344012652089842,-2.4466188398112636,1.2589910598434976e-7,6.846434469686585e-7,Downregulated
Feature1569,Adenine,C5 H5 N5,135.05448,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Adenine,5,5,0,5,0,0,1,0,2,3.299999999999997,6,6,Inf,Inf,1,Unsaturated HC,254829015.95201603,6687359.901141006,0.02624253708376846,-5.251948985777852,2.057219570756961e-8,1.3829087114532906e-7,Downregulated
Feature1568,Penicillic acid,C8 H10 O4,170.05795,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak2,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,1647498.506414844,105805483.11079139,64.22189926049579,6.004993425992494,2.5379084266424143e-5,8.513300742044059e-5,Upregulated
Feature1567,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak2",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,196432418.54922694,16929993.99082033,0.08618737230778223,-3.536379680593395,6.240405027333119e-13,2.710575927257001e-11,Downregulated
Feature1566,2'-Deoxyadenosine,C10 H13 N5 O3,251.10191,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak2,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,84222950.49883835,110345457.12645929,1.3101590062198216,0.3897419137199306,0.1498113496441772,0.2028620513966716,Upregulated
Feature1565,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09473,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak2",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,28689476.045271344,995661.54972138,0.03470476589221248,-4.84872239276577,0.3376787621022801,0.4122820930085693,Downregulated
Feature1564,NA,C22 H33 N O6,407.23081,NA,NA,Feature1564,22,33,6,1,0,0,1.5,0.2727272727272727,-0.8181818181818183,83.61818181818182,7,1,0,0.16666666666666666,0,Lipid,902489.9212309611,1286861.9578604936,1.4259017498004454,0.5118745778835218,0.5302422026235709,0.5879183516401015,Upregulated
Feature1563,NA,C8 H19 N O6,225.12125,NA,NA,Feature1563,8,19,6,1,0,0,2.375,0.75,-0.5,74.55,0,-6,-7,-1,-7,Carbohydrate,17568996.939321402,78074692.77167986,4.443890168649291,2.151823160763215,0.011799581104885722,0.020501015786334783,Upregulated
Feature1562,NA,C15 H27 N O12,413.15342,NA,NA,Feature1562,15,27,12,1,0,0,1.8,0.8,0,60.3,3,-9,-5,-0.5,-10,Carbohydrate,253794242.72214046,4593543.254201567,0.018099477769598894,-5.787908118437465,3.5477714975272054e-12,1.0543727924229975e-10,Downregulated
Feature1561,N-Caffeoylputrescine,C13 H18 N2 O3,250.1317,NA,NA,N-Caffeoylputrescine,13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,423122.0013072711,69805090.09616958,164.97627133663784,7.366114725235288,9.712169944329286e-4,0.0022173067231393275,Upregulated
Feature1560,NA,C21 H31 N O12,489.18471,NA,NA,Feature1560,21,31,12,1,0,0,1.4761904761904765,0.5714285714285714,-0.1904761904761907,65.72857142857143,7,-5,-0.75,0,-6,Lignin,243813860.85442987,2103436.717080103,0.008627223693143388,-6.8568879209175755,8.741524222729074e-11,1.3687707033260623e-9,Downregulated
Feature1559,Succinyl proline,C9 H13 N O5,215.07946,Other,NA,Succinyl proline-peak2,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,76521491.11183241,7008246.64079743,0.09158533817062217,-3.4487395329545945,4.8248405965663384e-4,0.0011914402289480142,Downregulated
Feature1558,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13231,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak6,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,280562805.56564224,11996459.834481739,0.04275855386566902,-4.547643129188449,2.1002159607086032e-9,1.944134337399111e-8,Downregulated
Feature1557,2-Deoxyhexopyranose,C6 H12 O5,164.0685,Metabolic pathways;Microbial metabolism in diverse environments;ABC transporters;Other,Other,2-Deoxyhexopyranose,6,12,5,0,0,0,2,0.8333333333333334,-0.33333333333333304,69.79999999999998,1,-4,-4,-0.42857142857142855,-4,Carbohydrate,21433458.678101957,112184262.3258031,5.2340718318326775,2.3879337239116767,3.2881134735065706e-4,8.465143197750958e-4,Upregulated
Feature1556,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10572,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak2",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,273121975.26223,11462479.329152897,0.04196835248481026,-4.574554360066428,2.9315219521967634e-9,2.5767294870432837e-8,Downregulated
Feature1555,Glutarylcarnitine,C12 H21 N O6,275.13695,NA,NA,Glutarylcarnitine,12,21,6,1,0,0,1.75,0.5,-0.5,74.55,3,-3,-0.8,-0.125,-4,Protein,205973916.40292555,10593948.007480945,0.051433444547207115,-4.281149414175618,4.807269042477058e-12,1.3350022554026454e-10,Downregulated
Feature1554,NA,C10 H15 N O8,277.07983,NA,NA,Feature1554,10,15,8,1,0,0,1.5,0.8,0.3999999999999999,48.9,4,-4,-5,-0.2,-5,Carbohydrate,232149633.25329146,63301049.157006644,0.2726734833474442,-1.8747536854416473,3.1861936511113387e-9,2.7537816556033712e-8,Downregulated
Feature1553,NA,C6 H11 N3 O2,157.08515,NA,NA,Feature1553,6,11,2,3,0,0,1.8333333333333333,0.3333333333333333,0.3333333333333335,50.8,3,1,-2,-0.5,-2,Protein,152748561.1850092,124619316.99321476,0.8158460939103427,-0.29363107564945096,0.00575098617381853,0.010589315846139771,Downregulated
Feature1552,Pinolenic acid,C18 H30 O2,278.22458,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Pinolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,10421848.628482748,70622758.78508316,6.77641379208601,2.760521973484063,0.002704801189703936,0.005474233232208444,Upregulated
Feature1551,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak8",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,668278.4871259393,649426.0650048249,0.9717895720357648,-0.04128414344986968,0.9279373395135164,0.9354238905571395,Downregulated
Feature1550,NA,C22 H14 N3 O4 P,415.07208,NA,NA,Feature1550,22,14,4,3,0,1,0.6363636363636364,0.18181818181818185,-0.09090909090909084,62.89090909090909,18,14,0.7142857142857143,0.75,10,Condensed HC,1015574.5817054043,64096282.7546432,63.11331920793988,5.979872593399623,0.008991941004378879,0.016000365610733005,Upregulated
Feature1549,4-Acetamidobutanoic acid,C6 H11 N O3,145.07391,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak2,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,19461017.308987092,45430766.02491129,2.3344497003212354,1.2230825036030633,0.12513062705258896,0.1723343757943786,Upregulated
Feature1548,Valylproline,C10 H18 N2 O3,214.13174,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Valylproline,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,83590244.28012711,56666525.60558466,0.6779083623165898,-0.5608378276711288,0.05472126862813991,0.0822024160531499,Downregulated
Feature1547,D-Glucose 6-phosphate,C6 H13 O9 P,260.02974,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,D-Glucose 6-phosphate,6,13,9,0,0,1,2.1666666666666665,1.5,0,60.3,1,-8,2.25,-9,-9,Carbohydrate,135799438.74842766,33823806.596024655,0.24907177016161475,-2.0053665793534208,5.729479612283442e-15,6.791386690412996e-13,Downregulated
Feature1546,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C22 H26 O7,402.1679,NA,NA,"4-(4-hydroxy-2-methoxy-3,5,6-trimethylbenzoyloxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",22,26,7,0,0,0,1.181818181818182,0.3181818181818182,-0.5454545454545459,75.84545454545456,10,3,0.2,0.35135135135135137,3,Lignin,473554.8761206297,755614.1508854295,1.5956210969158096,0.6741181036283407,0.4081486014819664,0.4761733683956275,Upregulated
Feature1545,Leucylproline,C11 H20 N2 O3,228.14739,NA,NA,Leucylproline-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,83495140.17356634,76972643.02391951,0.921881715078409,-0.11734644186523806,0.7342532274221458,0.7654307490788401,Downregulated
Feature1544,1-linoleoyl-sn-glycerol,C21 H38 O4,354.27689,NA,NA,1-linoleoyl-sn-glycerol,21,38,4,0,0,0,1.8095238095238095,0.1904761904761905,-1.4285714285714288,101.01428571428572,3,-1,-0.0588235294117647,0.05263157894736842,-1,Lipid,4335341.9589049,33782060.76847152,7.792248244474078,2.9620396393513144,0.05070927615671879,0.07697268262498354,Upregulated
Feature1543,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak7",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,1191566.200617262,1375663.5446397432,1.154500307181518,0.2072685569744741,0.7980986493000455,0.8243775072648031,Upregulated
Feature1542,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak3,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,171476562.2920636,6179142.714205643,0.036034911311559635,-4.794460895158088,4.534855586396339e-10,5.409891100954505e-9,Downregulated
Feature1541,NA,C10 H17 N O9,295.09039,NA,NA,Feature1541,10,17,9,1,0,0,1.7,0.9,0.3999999999999999,48.9,3,-6,-Inf,-0.5555555555555556,-7,Carbohydrate,165533001.31505352,67821477.72340457,0.4097157496366672,-1.2873047432309983,1.3136279167594935e-4,3.740941703776767e-4,Downregulated
Feature1540,(5S)-5-(Carboxymethyl)-L-proline,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,(5S)-5-(Carboxymethyl)-L-proline,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,44452586.908756286,40861576.37313839,0.9192170628227142,-0.12152251685411676,0.43437848786266764,0.5015931550370546,Downregulated
Feature1539,Guanine,C5 H5 N5 O,151.04943,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak3,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,122384062.0663722,9519670.085579043,0.07778521095676877,-3.6843603032969274,3.314232164894162e-5,1.0901571431710117e-4,Downregulated
Feature1538,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak2,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,26394890.90686396,28821756.72666635,1.0919445292790084,0.12689956929188015,0.6645561647291565,0.7022820605434754,Upregulated
Feature1537,triacetic acid,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,triacetic acid,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,102378044.03721364,14358596.446493687,0.14025074010277483,-2.833919710935392,3.36225743622156e-7,1.6792096090712285e-6,Downregulated
Feature1536,N-Acetyl-α-D-glucosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-α-D-glucosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,14128546.016055776,120377551.84337021,8.5201656070322,3.090881472484226,0.0021662172606028316,0.004490538037849547,Upregulated
Feature1535,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12119,NA,NA,Cyclo(phenylalanyl-prolyl)-peak2,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,168095285.73940074,140185475.7599046,0.833964350298527,-0.2619423811776032,7.719038801051477e-4,0.00182371711701272,Downregulated
Feature1534,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13225,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak5,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,233050160.3664732,24570922.45033553,0.10543190535332635,-3.245616579623201,8.738635399704863e-14,5.1444346684372415e-12,Downregulated
Feature1533,NA,C12 H25 N O12,375.13771,NA,NA,Feature1533,12,25,12,1,0,0,2.0833333333333335,1,0.16666666666666652,55.55,1,-11,12,-1.2,-12,Carbohydrate,45949792.954507,4252571.570208514,0.09254822049837766,-3.4336509393098558,0.07851731387604104,0.113198578473203,Downregulated
Feature1532,NA,C7 H15 N O5,193.09509,NA,NA,Feature1532,7,15,5,1,0,0,2.142857142857143,0.7142857142857143,-0.2857142857142856,68.44285714285714,1,-4,-5,-0.7142857142857143,-5,Carbohydrate,84168221.61591762,64254139.18496996,0.7634014114992116,-0.38948624084498606,0.09334123311109593,0.1326510477266749,Downregulated
Feature1531,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.09546,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,126344583.27020435,25187594.562724967,0.19935634683172776,-2.326578558291016,3.8833628030921333e-11,7.1615415315561e-10,Downregulated
Feature1530,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",C7 H13 N O3,159.08956,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,"8-Azabicyclo[3.2.1]octane-1,2,7-triol",7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,23564133.457708016,52112084.98163568,2.211500162955893,1.145025348542535,0.12204570888097557,0.1687717802811205,Upregulated
Feature1529,Proacacipetalin,C11 H17 N O6,259.1056,NA,NA,Proacacipetalin-peak2,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,168554530.83809564,12821781.638300743,0.0760690417193036,-3.716546758979698,1.1161827910416372e-14,9.951650779076492e-13,Downregulated
Feature1528,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07427,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak2",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,78476544.50584935,129356382.63288546,1.6483445269846675,0.7210178174141518,2.2371515698055493e-8,1.492021558760079e-7,Upregulated
Feature1527,NA,C6 H14 O4,150.08924,NA,NA,Feature1527,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,1047815.3835789282,50834689.607437685,48.51492963751519,5.6003568751675346,4.2173433449088063e-4,0.0010506146509228704,Upregulated
Feature1526,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",C12 H16 N2 O3,236.11602,NA,Other,"3-Morpholino-4-tetrahydro-1H-pyrrol-1-ylcyclobut-3-ene-1,2-dione",12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,2196804.877837738,65240178.215818316,29.69775735386779,4.892282083939865,5.339725388451296e-4,0.0013128439489167628,Upregulated
Feature1525,Lactamide,C3 H7 N O2,89.04769,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Lactamide,3,7,2,1,0,0,2.3333333333333335,0.6666666666666666,0,60.3,1,-1,-Inf,-1,-2,Other,160600088.50807923,99011479.95976,0.6165094980927054,-0.6978049735833538,1.9309673891110954e-4,5.242081341593262e-4,Downregulated
Feature1524,cis-acetylacrylic acid,C5 H6 O3,114.03168,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak2,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,69048888.25862344,4827657.636918998,0.06991651507605667,-3.838222912942348,4.3380889954000855e-5,1.386551463812782e-4,Downregulated
Feature1523,Buphedrine,C11 H17 N O,179.13104,NA,NA,Buphedrine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,367204.0158795922,22138880.583664335,60.290409762086504,5.913856629532925,0.20935603818313708,0.2738603310287523,Upregulated
Feature1522,Glycerylphosphorylethanolamine,C5 H14 N O6 P,215.05587,Metabolic pathways;Other,NA,Glycerylphosphorylethanolamine,5,14,6,1,0,1,2.8,1.2,-0.7999999999999998,83.1,0,-6,2.6666666666666665,-Inf,-8,Other,10373201.015426897,59605024.00196427,5.746058898629306,2.5225727809534364,2.2417993348293193e-4,6.008873533545675e-4,Upregulated
Feature1521,NA,C8 H9 N,119.07346,NA,NA,Feature1521,8,9,0,1,0,0,1.125,0,-0.75,81.675,5,5,0.5714285714285714,0.5714285714285714,4,Unsaturated HC,141233612.22887707,78196685.20253691,0.5536690874677535,-0.8529041195278728,9.105349347067992e-5,2.705551915504167e-4,Downregulated
Feature1520,Linolenelaidic acid,C18 H30 O2,278.22466,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,Linolenelaidic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,6521778.480599573,60728270.261732034,9.311611923401152,3.219030932832606,0.0020230484512057828,0.004210127857914737,Upregulated
Feature1519,Glutaric acid,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Glutaric acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,98782537.19855353,21272477.004068404,0.21534653398616993,-2.215267991373553,4.973069858568148e-7,2.353178866037554e-6,Downregulated
Feature1518,"DL-2,6-Diaminopimelic acid",C7 H14 N2 O4,190.09538,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,"DL-2,6-Diaminopimelic acid",7,14,4,2,0,0,2,0.5714285714285714,0,60.3,2,-2,-4,-0.6666666666666666,-4,Amino Sugar,37920641.539470606,42148757.14203405,1.1114990525189956,0.15250671856127818,0.3182621330359795,0.39613229490297525,Upregulated
Feature1517,NA,C17 H31 N O12,441.1847,NA,NA,Feature1517,17,31,12,1,0,0,1.8235294117647056,0.7058823529411765,-0.23529411764705888,67.00588235294117,3,-9,-2.5,-0.4,-10,Carbohydrate,129704388.2736128,787475.4429270612,0.006071309177804172,-7.363776641216915,1.754492490157145e-9,1.660396803534192e-8,Downregulated
Feature1516,fructosylglycine,C8 H15 N O7,237.08487,NA,NA,fructosylglycine-peak2,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,115636049.26678288,25058971.09530366,0.21670552785395092,-2.206192139860182,8.735449832571149e-10,9.31188094807279e-9,Downregulated
Feature1515,Methionine,C5 H11 N O2 S,149.05106,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of butirocin biosynthesis;Other,Methionine,5,11,2,1,1,0,2.2,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Protein,38865431.670073174,70551594.41579469,1.8152788064906589,0.8601911470368044,0.010058662534763393,0.017657382729418847,Upregulated
Feature1514,L-Aspartic acid,C4 H7 N O4,133.03749,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various plant secondary metabolites;Other,Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of purine nucleotide salvage;Other,L-Aspartic acid,4,7,4,1,0,0,1.75,1,1,31.799999999999997,2,-2,3,-1,-3,Carbohydrate,119244864.87443581,80359563.2384102,0.6739037636801248,-0.5693855117508697,0.0034499027797259365,0.006764045496360806,Downregulated
Feature1513,3-Butynoic acid,C4 H4 O2,84.0211,Metabolic pathways;Other,NA,3-Butynoic acid-peak6,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,141707272.64691934,5528949.160962185,0.03901669305807772,-4.679764685300114,1.0884615973201289e-9,1.124301186500182e-8,Downregulated
Feature1512,UQ1000000,C6 H6 O3,126.03168,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,UQ1000000,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,146341762.35306203,10098551.280320395,0.06900662611918514,-3.8571212915025153,9.002133864794129e-7,4.0236450572457134e-6,Downregulated
Feature1511,Hordenine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Hordenine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,181044753.78834265,734224.0569891263,0.004055483749877111,-7.945910271101634,1.1091727515378432e-12,4.4736634312026344e-11,Downregulated
Feature1510,Pyrogallol,C6 H6 O3,126.03165,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak3,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,154707361.10239124,4681455.459578946,0.03026006924441417,-5.0464409008830415,1.181092948896119e-6,5.14337135071986e-6,Downregulated
Feature1509,Methylhippuric acid,C10 H11 N O3,193.07397,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak5,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1817358.8908124366,63354062.61986431,34.860512659413324,5.123521880809792,0.0018282669240336654,0.0038565361075728033,Upregulated
Feature1508,L-alpha-Glycerylphosphorylcholine,C8 H20 N O6 P,257.1028,NA,NA,L-alpha-Glycerylphosphorylcholine-peak1,8,20,6,1,0,1,2.5,0.75,-1.25,95.925,0,-6,-Inf,-1.6666666666666667,-8,Carbohydrate,38971849.64895,60978007.54192257,1.5646680383712674,0.6458566059144633,0.09260988529486419,0.13193104752943804,Upregulated
Feature1507,Muramic acid,C9 H17 N O7,251.10051,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak2,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,63107999.85247932,24970027.23123156,0.39567134578185437,-1.337625504672183,4.141098955302925e-6,1.6155751656601253e-5,Downregulated
Feature1506,Thymidine,C10 H14 N2 O5,242.09029,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Thymidine,10,14,5,2,0,0,1.4,0.5,0.20000000000000015,54.599999999999994,5,0,-0.6666666666666666,0.09090909090909093,-2,Lignin,173459383.1693197,35967679.99762122,0.2073550553475215,-2.2698248740920417,2.558920565802199e-9,2.293551025644934e-8,Downregulated
Feature1505,(Z)-dehydrobutyrine,C4 H7 N O2,101.04767,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak2,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,80676628.78164646,35312924.51499568,0.437709471110538,-1.1919544936922746,0.0011304544165135317,0.002539774246119261,Downregulated
Feature1504,Pyrogallol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,122685727.20942456,2805233.518702129,0.022865198605487295,-5.450702739429007,6.165505140281288e-7,2.830451411283605e-6,Downregulated
Feature1503,Î²-Glycerophosphate,C3 H9 O6 P,172.01368,Metabolic pathways;Biosynthesis of secondary metabolites;ABC transporters;Other,Other,Î²-Glycerophosphate,3,9,6,0,0,1,3,2,-0.666666666666667,79.30000000000001,0,-6,1.75,4,-7,Other,19034257.804288894,69454375.26119363,3.6489142878764533,1.8674672627590883,4.2285309148330276e-4,0.0010518548266853374,Upregulated
Feature1502,"6-Methoxy-1,2,4-benzenetriol",C7 H8 O4,156.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"6-Methoxy-1,2,4-benzenetriol",7,8,4,0,0,0,1.1428571428571428,0.5714285714285714,0,60.3,4,0,0,0.4,0,Lignin,661534.8480369656,1073706.7705369575,1.623053983812143,0.6987109856424137,0.1559452663645366,0.21032745320185112,Upregulated
Feature1501,N-Acetylglucosaminitol,C8 H17 N O6,223.10558,NA,NA,N-Acetylglucosaminitol-peak2,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,58468593.66663196,12805902.98797413,0.21902190877018582,-2.190852905000695,1.1705433099308414e-7,6.458958850237281e-7,Downregulated
Feature1500,pseudouridine,C9 H12 N2 O6,244.06948,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak2,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,29859945.193132166,11376035.559328921,0.3809797869938967,-1.39221363779142,0.040344895907581634,0.06270115015361769,Downregulated
Feature1499,NA,C18 H31 N O11,437.18971,NA,NA,Feature1499,18,31,11,1,0,0,1.7222222222222223,0.6111111111111112,-0.33333333333333304,69.79999999999998,4,-7,-1.3333333333333333,-0.21739130434782608,-8,Amino Sugar,168137264.96949616,1358958.7646610693,0.008082436483712367,-6.95099401976736,8.378888399942863e-13,3.548459237375803e-11,Downregulated
Feature1498,3-Hydroxy-5-methyl-L-tyrosine,C10 H13 N O4,211.08446,NA,NA,3-Hydroxy-5-methyl-L-tyrosine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,63446792.2318683,65263428.18632666,1.0286324318465054,0.0407275463846732,0.7017898969310437,0.7370316710484737,Upregulated
Feature1497,Mephedrone,C11 H15 N O,177.11538,NA,NA,Mephedrone,11,15,1,1,0,0,1.3636363636363635,0.09090909090909093,-0.9090909090909092,86.2090909090909,5,4,0.3333333333333333,0.3684210526315789,3,Unsaturated HC,381928.7232239344,17875358.406299055,46.80286482621597,5.548524935466952,0.2163510977635749,0.28170542629630735,Upregulated
Feature1496,2908,C5 H11 N,85.08916,Other,NA,2908-peak2,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,102535088.30442275,67219861.72529101,0.6555791079607579,-0.6091582156203211,0.0027608481538236324,0.005561090098189338,Downregulated
Feature1495,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak2,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,130900703.2627611,108026870.50715657,0.8252581370041292,-0.2770826364681719,5.0899953517008056e-5,1.5967503936631784e-4,Downregulated
Feature1494,Anhydroecgonine,C9 H13 N O2,167.09466,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak3,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,8537648.227978125,79407056.98580942,9.300811519217921,3.2173566004866125,7.690580183432144e-4,0.0018195311216109011,Upregulated
Feature1493,NA,C17 H31 N O13,457.17959,NA,NA,Feature1493,17,31,13,1,0,0,1.8235294117647056,0.7647058823529411,-0.117647058823529,63.65294117647058,3,-10,-3.6666666666666665,-0.47368421052631576,-11,Carbohydrate,154030357.30579138,1477484.7359773044,0.009592165867953566,-6.703927678578312,3.604552322407675e-9,3.0683978061098496e-8,Downregulated
Feature1492,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak5,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,54465024.16528228,76099995.49479112,1.3972268746976826,0.48256629735886597,0.04880645839505094,0.07435084579246069,Upregulated
Feature1491,NA,C75 H89 N10 O16 P3 S,1510.53954,NA,NA,Feature1491,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,131472991.54870676,635775.7746166848,0.004835789975777262,-7.692032696709535,1.2425403776310396e-11,2.844409999604028e-10,Downregulated
Feature1490,Linoleamide,C18 H33 N O,279.25629,NA,NA,Linoleamide,18,33,1,1,0,0,1.8333333333333333,0.05555555555555555,-1.5555555555555554,104.63333333333333,3,2,0.0625,0.09090909090909093,1,Lipid,28980751.88612654,25535467.52536693,0.8811181858118418,-0.1825925517359897,0.8234408463673022,0.8453992689370968,Downregulated
Feature1489,Acrylic acid,C3 H4 O2,72.02113,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-threonine metabolism;Other,Acrylic acid,3,4,2,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,2,0,0,0.5,0,Tannin,169299879.14999247,23144749.910302877,0.1367086026670912,-2.8708240645648364,1.5855749410442253e-14,1.2790304524423417e-12,Downregulated
Feature1488,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08921,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak3",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,1560245.040132436,1079660.8562422062,0.6919815980639573,-0.5311944222491635,0.599898940265535,0.6460450125936531,Downregulated
Feature1487,NP-011220,C11 H18 N2 O2,210.13681,NA,NA,NP-011220-peak1,11,18,2,2,0,0,1.6363636363636365,0.18181818181818185,-0.7272727272727275,81.02727272727273,4,2,0,0.125,0,Lipid,124434754.0269797,89891130.69106416,0.7223956955913952,-0.4691387983690468,0.0015076024537324748,0.003274203277721554,Downregulated
Feature1486,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak3,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,88816441.75245717,28767660.98867061,0.32390017457409265,-1.626378849177511,0.0047437605565908,0.008918901645798907,Downregulated
Feature1485,Isoferulic acid,C10 H10 O4,194.05792,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Isoferulic acid,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,1265227.5813501203,22552636.67312816,17.82496446138355,4.155827295178583,0.004139566448675669,0.007914701539567248,Upregulated
Feature1484,NA,C11 H19 N5 O2,253.15388,NA,NA,Feature1484,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,138106977.76160914,1370898.1412478078,0.009926349583973655,-6.65452102061902,6.733989768341252e-15,7.129611667231301e-13,Downregulated
Feature1483,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak3,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,110445929.97529607,4244435.691204295,0.038429987344519315,-4.701623688471647,2.368444347824591e-9,2.1570670565671276e-8,Downregulated
Feature1482,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak3,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,83913671.15553136,14568649.328717163,0.1736147296155668,-2.5260387424859685,3.9226810371580394e-4,9.894999530880913e-4,Downregulated
Feature1481,Methylhippuric acid,C10 H11 N O3,193.07394,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak4,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,1181020.4005160898,87020013.04256666,73.68205748566248,6.203241442458278,0.0010089278870130812,0.0022850494785153276,Upregulated
Feature1480,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C10 H19 N O8,281.11106,NA,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",10,19,8,1,0,0,1.9,0.8,0,60.3,2,-6,-7,-0.6,-7,Carbohydrate,95637256.40719339,29215393.420736536,0.30548130005263396,-1.710844026290323,7.820640611464936e-9,6.021893270828e-8,Downregulated
Feature1479,Methylglutaric acid,C6 H10 O4,146.05791,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Methylglutaric acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,28594863.54011546,63579899.07041859,2.2234727219880925,1.1528147055241844,0.00487317035945124,0.009123945352415588,Upregulated
Feature1478,NA,C2 H5 N2 O5 P S,199.96575,NA,NA,Feature1478,2,5,5,2,1,1,2.5,2.5,4,-53.7,2,-3,1,1,-7,Other,136042250.2170338,63679966.14773959,0.46808962690743733,-1.0951433003032414,1.4964358642910488e-10,2.130220465637846e-9,Downregulated
Feature1477,NA,C11 H20 N4 O3,256.15356,NA,NA,Feature1477,11,20,3,4,0,0,1.818181818181818,0.2727272727272727,-0.18181818181818168,65.48181818181817,4,1,-0.75,-0.2727272727272727,-3,Lipid,8016512.919678411,1166023.848240672,0.145452749833209,-2.7813775235558236,0.19528395323819817,0.2572402929902859,Downregulated
Feature1476,Mevalonolactone,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,3895230.4791201204,45520427.743190296,11.686196230799863,3.5467335147514563,3.556154722660135e-4,9.045234384664067e-4,Upregulated
Feature1475,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10595,NA,NA,α-Aspartylphenylalanine-peak3,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,120023382.21516795,18567868.61924236,0.15470209451317932,-2.692435365305837,2.2842134739326167e-9,2.091598716130731e-8,Downregulated
Feature1474,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak4,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,128202369.2476085,37403813.17267301,0.29175602129810674,-1.7771656641225984,1.4395659104282743e-8,1.0160936051106236e-7,Downregulated
Feature1473,NA,C43 H79 N O9,753.57577,NA,NA,Feature1473,43,79,9,1,0,0,1.837209302325581,0.20930232558139536,-1.348837209302325,98.74186046511628,5,-4,-0.15151515151515152,-0.01333333333333333,-5,Lipid,30914253.844482105,28361025.68045084,0.9174093550219395,-0.12436247591860443,0.8543191626336315,0.8733956919139239,Downregulated
Feature1472,NA,C77 H123 N10 O14 P3,1504.84348,NA,NA,Feature1472,77,123,14,10,0,3,1.5974025974025974,0.18181818181818185,-1.0389610389610393,89.91038961038961,23,9,-0.08,0.05263157894736842,-4,Lipid,13764852.819387525,305814.2028159356,0.02221703397984774,-5.492189962974993,0.33776272910668925,0.4122820930085693,Downregulated
Feature1471,NA,C8 H16 N2 O2,172.12119,NA,NA,Feature1471,8,16,2,2,0,0,2,0.25,-0.75,81.675,2,0,-0.5,-0.2,-2,Lipid,10574157.082162019,891155.072496961,0.08427670078783747,-3.5687223522473,0.25243995164883115,0.32371936267457985,Downregulated
Feature1470,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak6,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,60981128.433624215,39725913.06910324,0.6514460143574332,-0.6182824679679314,0.057977899874213173,0.08653265408538953,Downregulated
Feature1469,arg-leu,C12 H25 N5 O3,287.19576,NA,NA,arg-leu-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,20301684.510342687,13248087.964495089,0.6525610206259413,-0.615815281268754,0.014964751765636837,0.0253502894909888,Downregulated
Feature1468,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11167,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak2",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,125951551.72665313,3282761.0750295836,0.026063681074402396,-5.261815334082616,3.1380935270454295e-17,1.0631860869629916e-14,Downregulated
Feature1467,NA,C16 H29 N O13,443.16396,NA,NA,Feature1467,16,29,13,1,0,0,1.8125,0.8125,0,60.3,3,-10,-5.5,-0.5294117647058824,-11,Carbohydrate,134121964.67916425,981920.3998702432,0.00732110062821637,-7.093723730209298,8.740195222807401e-10,9.31188094807279e-9,Downregulated
Feature1466,DL-Mevalonic acid,C6 H12 O4,148.07354,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,DL-Mevalonic acid,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,8442418.125423176,73431711.93875572,8.697947773710267,3.1206750462547967,1.9430625665017407e-7,1.01975391418183e-6,Upregulated
Feature1465,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.1523,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,901272.2422885295,1312951.7296226278,1.456775952944865,0.542779013002948,0.5303065178902451,0.5879183516401015,Upregulated
Feature1464,NA,C12 H18 N6,246.15928,NA,NA,Feature1464,12,18,0,6,0,0,1.5,0,0,60.3,7,7,0.16666666666666666,0.16666666666666666,1,Lipid,846799.8818276379,1263755.7486990625,1.4923900862757724,0.577624681691691,0.0703626875865595,0.10266528231837364,Upregulated
Feature1463,NA,C11 H23 N O7,281.14745,NA,NA,Feature1463,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,64682685.88863558,13188254.666145133,0.2038915744601484,-2.294125935696225,5.875345964755917e-11,9.854293132966855e-10,Downregulated
Feature1462,4-Guanidinobutyric acid,C5 H11 N3 O2,145.08514,Metabolic pathways;Other,NA,4-Guanidinobutyric acid,5,11,2,3,0,0,2.2,0.4,0.3999999999999999,48.9,2,0,-Inf,-2,-3,Protein,66022944.445222214,6646268.952256058,0.10066604887290845,-3.3123508999395503,2.5966608779498635e-12,8.467914053777461e-11,Downregulated
Feature1461,Meconin,C10 H10 O4,194.05788,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak2,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,796595.1076275683,40835772.93687205,51.262896979733874,5.67984310570956,1.083496904259854e-4,3.159111455793791e-4,Upregulated
Feature1460,Phenacetin,C10 H13 N O2,179.0946,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak4,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,107496681.06276509,78539669.8084598,0.7306241367824381,-0.45279867975691807,1.9957580906745297e-4,5.390462708548209e-4,Downregulated
Feature1459,L-Threonine,C4 H9 N O3,119.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,L-Threonine,4,9,3,1,0,0,2.25,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,107771662.72606142,74262626.90382092,0.6890737790005598,-0.5372696345996847,6.138704726016361e-4,0.0014834473332199307,Downregulated
Feature1458,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C21 H24 O7,388.15227,NA,NA,"1-(3,4-Dimethoxyphenyl)-4-(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,446253.62111815275,719479.2348164248,1.6122653145394448,0.6890891734405934,0.36207386795809426,0.43438607104887517,Upregulated
Feature1457,NA,C18 H31 N O14,485.17458,NA,NA,Feature1457,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,142413014.78299102,683745.4748770362,0.004801144585829657,-7.702405901442393,1.2348710799549066e-12,4.7542536578263906e-11,Downregulated
Feature1456,4-Phenylbutyric acid,C10 H12 O2,164.08376,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,4-Phenylbutyric acid,10,12,2,0,0,0,1.2,0.2,-0.7999999999999998,83.1,5,3,0.375,0.4444444444444444,3,Lignin,2704345.0272289137,5610103.659275854,2.0744777766113707,1.0527482020423902,0.18469295218068718,0.24577365356958686,Upregulated
Feature1455,Cantharidin,C10 H12 O4,196.07357,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Other,Other,Cantharidin,10,12,4,0,0,0,1.2,0.4,-0.4000000000000003,71.7,5,1,0.16666666666666666,0.375,1,Lignin,1574210.686988937,4457814.724490581,2.8317777037946823,1.501708017461701,0.0035756743438990508,0.006959955967130505,Upregulated
Feature1454,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04228,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak5",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,124141969.77151994,7351091.886916266,0.05921520256562514,-4.077888577258965,1.861219071329739e-8,1.2561374927619832e-7,Downregulated
Feature1453,NA,C6 H14 O4,150.08923,NA,NA,Feature1453,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,919745.8296316734,35684932.07941363,38.79868864825864,5.277935986665089,0.002266736866370688,0.004682746648331641,Upregulated
Feature1452,NA,C9 H15 N O7,249.08484,NA,NA,Feature1452,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,78572327.15136957,45114249.184275016,0.5741747867205514,-0.800438114867987,3.084676733333808e-5,1.0186047536583764e-4,Downregulated
Feature1451,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,60442243.85200879,35954513.94231717,0.594857365493426,-0.749384313465084,6.364315272852968e-4,0.0015314133625302455,Downregulated
Feature1450,Furan,C4 H4 O,68.02623,Other,NA,Furan-peak3,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,61734420.73676766,33849042.15919754,0.548300960067773,-0.8669600951103882,0.005520553343693459,0.010219844577418603,Downregulated
Feature1449,NA,C23 H35 N O6,421.24649,NA,NA,Feature1449,23,35,6,1,0,0,1.5217391304347827,0.2608695652173913,-0.8695652173913047,85.08260869565218,7,1,0,0.15789473684210523,0,Lipid,4118828.0040377555,5822966.47436508,1.4137435378842547,0.4995204297792716,0.5637648671380155,0.6153464464766741,Upregulated
Feature1448,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak2,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,119066955.86461264,10328450.602110267,0.0867448951483603,-3.527077330767916,5.854349996956323e-9,4.677957025869817e-8,Downregulated
Feature1447,NA,C11 H19 N3 O2,225.14773,NA,NA,Feature1447,11,19,2,3,0,0,1.7272727272727273,0.18181818181818185,-0.5454545454545459,75.84545454545456,4,2,-0.16666666666666666,0,-1,Lipid,117459302.45863867,13634898.013590874,0.11608189158446752,-3.106785161089434,6.228404653825488e-12,1.623218074396981e-10,Downregulated
Feature1446,3-oxovaleric acid,C5 H8 O3,116.04731,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak4,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,40842100.93787673,46591081.92953242,1.14076114743461,0.1899967517630113,0.5706703871796872,0.6196895101810193,Upregulated
Feature1445,N-Acetyltyramine,C10 H13 N O2,179.09456,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,90579389.55035023,69669838.79104963,0.7691577425825149,-0.3786485914936242,7.615806168906991e-7,3.4495122059166958e-6,Downregulated
Feature1444,D-PANTOTHENIC ACID,C9 H17 N O5,219.11067,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak3,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,28712763.79662692,30402780.45237985,1.0588594211174984,0.08251106343866821,0.846065009693916,0.8660024933060384,Upregulated
Feature1443,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13229,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak4,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,110899105.20960784,17512647.891020685,0.1579151414965922,-2.662778586040432,1.770487896949002e-13,9.088504537671544e-12,Downregulated
Feature1442,3-Butynoic acid,C4 H4 O2,84.02112,Metabolic pathways;Other,NA,3-Butynoic acid-peak5,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,122110826.18307938,5727355.297897443,0.04690292807707717,-4.414178199008126,1.0823666689915807e-7,6.043836763427476e-7,Downregulated
Feature1441,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid,C18 H28 O3,292.20371,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,8-{3-Oxo-2-[(2E)-2-penten-1-yl]-1-cyclopenten-1-yl}octanoic acid-peak1,18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,2600615.2469039676,24470218.70092697,9.409395999680754,3.234102117615619,0.019549008240071504,0.03243488732485909,Upregulated
Feature1440,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",C19 H32 O2,292.24009,Other,NA,"9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester",19,32,2,0,0,0,1.6842105263157894,0.10526315789473684,-1.473684210526316,102.3,4,2,0.1176470588235294,0.16666666666666666,2,Lipid,37413198.47163567,17012878.476298355,0.4547293247113434,-1.1369200508852684,0.12905190806047023,0.1773024592493403,Downregulated
Feature1439,NA,C18 H30 O15,486.1586,Metabolic pathways;ABC transporters;Other,NA,Feature1439,18,30,15,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,4,-11,-3.6666666666666665,-0.3333333333333333,-11,Carbohydrate,137365960.60817736,3137528.535172872,0.022840655146891577,-5.452252157129312,8.55149983351649e-9,6.353614349989883e-8,Downregulated
Feature1438,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14735,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak2",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,3271087.092280193,69238803.8116796,21.166909305192164,4.4037387239120065,5.2813365935029644e-5,1.644592681873901e-4,Upregulated
Feature1437,L-Lysine,C6 H14 N2 O2,146.10554,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,L-Lysine,6,14,2,2,0,0,2.3333333333333335,0.3333333333333333,-0.666666666666667,79.30000000000001,1,-1,-1.5,-0.6666666666666666,-3,Other,42446495.311219305,56630565.60772409,1.3341635202743276,0.4159354996793566,0.014183914939847683,0.024172587432698164,Upregulated
Feature1436,Veronal,C8 H12 N2 O3,184.08481,NA,NA,Veronal-peak2,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,93039410.87684219,78306172.69822627,0.8416451905728579,-0.24871592535097906,0.004974541047413374,0.009270486836433726,Downregulated
Feature1435,NA,C22 H46 O6,406.32947,NA,NA,Feature1435,22,46,6,0,0,0,2.090909090909091,0.2727272727272727,-1.545454545454546,104.34545454545454,0,-6,-0.375,-0.15789473684210523,-6,Lipid,12885592.871857319,11061454.716170508,0.8584358380846561,-0.22021778772613726,0.8816404161324414,0.8961606149454591,Downregulated
Feature1434,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose,C10 H19 N O7,265.11624,NA,NA,1-[(3-Carboxypropyl)amino]-1-deoxy-beta-D-fructofuranose-peak1,10,19,7,1,0,0,1.9,0.7,-0.20000000000000015,66,2,-5,-3,-0.4545454545454546,-6,Amino Sugar,13099207.29912614,32945625.207609568,2.515085413588912,1.330607395525323,8.813830777004868e-4,0.0020369207825711114,Upregulated
Feature1433,NA,C75 H89 N10 O16 P3 S,1510.53964,NA,NA,Feature1433,75,89,16,10,1,3,1.1866666666666668,0.21333333333333335,-0.5333333333333332,75.5,38,22,0.17777777777777778,0.3018867924528302,8,Lignin,112049944.054094,394581.6524592269,0.003521480138077855,-8.149602339029082,1.890877705987224e-9,1.7795260188568654e-8,Downregulated
Feature1432,Misoprostol,C22 H38 O5,382.2719,NA,NA,Misoprostol,22,38,5,0,0,0,1.7272727272727273,0.2272727272727273,-1.2727272727272725,96.57272727272726,4,-1,-0.0588235294117647,0.07692307692307693,-1,Lipid,1275949.6902177958,47659680.98149878,37.352319881329805,5.223125943721248,5.58420322266444e-5,1.726211726130212e-4,Upregulated
Feature1431,NA,C15 H18 O11,374.08496,NA,NA,Feature1431,15,18,11,0,0,0,1.2,0.7333333333333333,0.2666666666666666,52.7,7,-4,-1,0.15789473684210523,-4,Tannin,7704023.118314436,217045.00173743404,0.02817294268256575,-5.149545927736723,0.11878621447416199,0.16507288541364265,Downregulated
Feature1430,"Norspermidine-2,3-dihydroxybenzoate",C13 H21 N3 O3,267.15832,NA,Other,"Norspermidine-2,3-dihydroxybenzoate",13,21,3,3,0,0,1.6153846153846154,0.2307692307692308,-0.4615384615384617,73.45384615384616,5,2,-0.14285714285714285,0.0588235294117647,-1,Lipid,523647.089164651,53294686.9890987,101.77596341482037,6.669253067918874,2.7491500031937557e-7,1.4069667992175896e-6,Upregulated
Feature1429,Mevalonolactone,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,Mevalonolactone-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,4535646.894887078,50572700.085653834,11.150052298529497,3.478978571907579,1.686495091645848e-5,5.854349764852595e-5,Upregulated
Feature1428,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak3,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,89260035.64092597,62475835.22154539,0.6999306551128022,-0.5147160992305593,0.001221438354681447,0.0027225218063557516,Downregulated
Feature1427,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride",C12 H20 O10,324.10574,NA,NA,"bis-beta-D-fructofuranose 1,2':2,3'-dianhydride-peak1",12,20,10,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,3,-7,-3.5,-0.2857142857142857,-7,Carbohydrate,71411027.02447306,2278444.6328416723,0.03190606167953352,-4.97002564903772,1.1128996548909052e-6,4.909510456732274e-6,Downregulated
Feature1426,Inosine-5'-monophosphate (IMP),C10 H13 N4 O8 P,348.04716,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Inosine-5'-monophosphate (IMP),10,13,8,4,0,1,1.3,0.8,1,31.799999999999997,7,-1,2,-2,-6,Tannin,69920041.46703033,176924.02676039012,0.0025303764564243826,-8.626432247009747,2.7800682507133466e-5,9.307185013257727e-5,Downregulated
Feature1425,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.111,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak3,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,53093472.19611163,22901671.81954318,0.431346281798093,-1.2130815748771935,0.00488570285759358,0.009135077969937665,Downregulated
Feature1424,NA,C10 H21 N O9,299.12162,NA,NA,Feature1424,10,21,9,1,0,0,2.1,0.9,0,60.3,1,-8,-Inf,-1,-9,Carbohydrate,66846889.55992886,18927444.750108592,0.28314622976047316,-1.8203807751698733,5.840432760951386e-9,4.677957025869817e-8,Downregulated
Feature1423,NA,C5 H14 N O4 P,183.06609,NA,NA,Feature1423,5,14,4,1,0,1,2.8,0.8,-1.5999999999999996,105.89999999999998,0,-4,6,-4,-6,Other,28105378.909026746,2151281.6317057884,0.07654341322595905,-3.70757795463751,3.3853427510558066e-4,8.675901089695215e-4,Downregulated
Feature1422,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak4,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,9246430.555687176,1908077.0376722896,0.2063582293924972,-2.276777121931272,0.2653899080310167,0.33726219370183214,Downregulated
Feature1421,NA,C16 H27 N O14,457.14329,NA,NA,Feature1421,16,27,14,1,0,0,1.6875,0.875,0.25,53.175,4,-10,-11,-0.5,-11,Carbohydrate,79988684.25291859,5897001.228472787,0.07372294323315638,-3.7617425210969597,5.452587277458057e-15,6.791386690412996e-13,Downregulated
Feature1420,PYRIDOXAMINE,C8 H12 N2 O2,168.08991,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak2,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,90279721.50465845,72313557.12919101,0.800994463916901,-0.32013582342345626,2.880642533688862e-5,9.624868741753318e-5,Downregulated
Feature1419,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",C10 H15 N3 O3,225.11134,Other,NA,"1-(Methylnitrosoamino)-4-(3-pyridinyl)-1,4-butanediol",10,15,3,3,0,0,1.5,0.3,0,60.3,5,2,-0.25,0.09090909090909093,-1,Lipid,106194770.36004524,80742979.67364407,0.7603291518018371,-0.39530398834292735,9.278353387785776e-5,2.743024544312235e-4,Downregulated
Feature1418,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak4",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,102470041.23206589,9574815.595875856,0.0934401458294682,-3.419813663980527,6.9215854008403e-10,7.765010376836733e-9,Downregulated
Feature1417,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak3,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,44659540.11295837,21762916.132161826,0.4873072153702523,-1.0370965107691685,1.7678341283754288e-5,6.099207766737222e-5,Downregulated
Feature1416,Pyrone,C5 H4 O2,96.02111,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak2,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,51394336.93724933,29286920.108572762,0.5698472215787326,-0.8113529163378009,2.844848030022971e-4,7.436994695769926e-4,Downregulated
Feature1415,"9S,13R-12-Oxophytodienoic acid",C18 H28 O3,292.20376,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of lipoxygenase,"9S,13R-12-Oxophytodienoic acid",18,28,3,0,0,0,1.5555555555555556,0.16666666666666666,-1.2222222222222223,95.13333333333333,5,2,0.13333333333333333,0.21212121212121213,2,Lipid,10764538.162401315,39803237.67910437,3.6976261385862568,1.886599363391646,0.034423537409461025,0.05409413021486732,Upregulated
Feature1414,NA,C14 H25 N O12,399.13775,NA,NA,Feature1414,14,25,12,1,0,0,1.7857142857142858,0.8571428571428571,0.1428571428571428,56.22857142857143,3,-9,-10,-0.5714285714285714,-10,Carbohydrate,95338185.00624444,3824904.9345128513,0.0401193386916515,-4.639558364336546,2.494801700865663e-10,3.3277118750129392e-9,Downregulated
Feature1413,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C9 H17 N O8,267.0954,Metabolic pathways;ABC transporters;Other,NA,"(2S)-3-Hydroxy-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",9,17,8,1,0,0,1.8888888888888888,0.8888888888888888,0.22222222222222232,53.96666666666666,2,-6,-Inf,-0.75,-7,Carbohydrate,17874966.161886375,43185509.7078374,2.415977144612394,1.2726068066868652,0.0020585539119025048,0.004278761137132323,Upregulated
Feature1412,NA,C23 H41 N,331.32396,NA,NA,Feature1412,23,41,0,1,0,0,1.7826086956521738,0,-1.6521739130434785,107.38695652173914,4,4,0.13636363636363635,0.13636363636363635,3,Lipid,127062541.72656202,167281932.4962087,1.3165322385585407,0.39674284978432983,0.6910243040542168,0.727529627761245,Upregulated
Feature1411,NA,C21 H31 N O13,505.17965,NA,NA,Feature1411,21,31,13,1,0,0,1.4761904761904765,0.6190476190476191,-0.0952380952380949,63.014285714285705,7,-6,-1,-0.03703703703703703,-7,Lignin,100091338.76025881,506317.3483796938,0.005058553064141117,-7.627059505613932,8.47739287975051e-11,1.3421218260090994e-9,Downregulated
Feature1410,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak3,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,34544065.946572185,37491051.66485766,1.085310910500329,0.11810839269981999,0.7143463865812993,0.7474384057249667,Upregulated
Feature1409,Caffeic acid,C9 H8 O4,180.04227,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak2,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,526303.8300812687,7325911.230036868,13.919547628801494,3.7990404207083732,0.0019362239842129847,0.004049337566983699,Upregulated
Feature1408,Isoamylamine,C5 H13 N,87.10481,NA,NA,Isoamylamine,5,13,0,1,0,0,2.6,0,-2,117.3,0,0,-0.25,-0.25,-1,Other,1680816.038006474,23507644.484227035,13.985852081771062,3.805896246927973,0.0018303748704182608,0.0038565361075728033,Upregulated
Feature1407,4-guanidinobutanal,C5 H11 N3 O,129.09017,Metabolic pathways;Other,NA,4-guanidinobutanal,5,11,1,3,0,0,2.2,0.2,0,60.3,2,1,-2,-1,-2,Lipid,97764493.86273535,7199846.4981255885,0.07364479898228099,-3.7632725483890086,2.5085517018538583e-9,2.2603652036917213e-8,Downregulated
Feature1406,NA,C9 H15 N O7,249.08488,NA,NA,Feature1406,9,15,7,1,0,0,1.6666666666666667,0.7777777777777778,0.22222222222222232,53.96666666666666,3,-4,-5,-0.3333333333333333,-5,Carbohydrate,62314228.027567424,10488081.742320834,0.168309583128928,-2.5708107724145246,5.307426961997677e-12,1.4271081386704866e-10,Downregulated
Feature1405,2'-Deoxyguanosine,C10 H13 N5 O4,267.09677,Metabolic pathways;ABC transporters;Other,Superpathway of purine nucleotide salvage;Other,2'-Deoxyguanosine,10,13,4,5,0,0,1.3,0.4,1,31.799999999999997,7,3,-2,0,-2,Lignin,16567036.93874267,50055061.30181416,3.0213647429467865,1.5952003585367946,5.880639606698031e-4,0.0014271924776141066,Upregulated
Feature1404,NP-007065,C8 H10 O3,154.063,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak3,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,2446624.074908214,5948364.117537299,2.431253815631833,1.2817005142793145,0.07690397750772728,0.11133914712862303,Upregulated
Feature1403,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak2",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,90412785.45135531,71014148.1296949,0.785443649094326,-0.3484203204352234,6.174429106428488e-5,1.9017241647799744e-4,Downregulated
Feature1402,NP-016455,C11 H18 N2 O4,242.12665,NA,NA,NP-016455-peak3,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,96925172.09854701,3045557.2462358577,0.031421736792371535,-4.992093263996475,9.560737032178728e-9,7.041690666309028e-8,Downregulated
Feature1401,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak3,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,67823879.26870413,2119436.414776084,0.03124911812223711,-5.000040713556079,6.464289479552889e-8,3.789102553066641e-7,Downregulated
Feature1400,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C10 H16 N2 O2,196.12119,NA,NA,"3-(propan-2-yl)-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,83141193.15192686,68177324.78646402,0.8200185997076223,-0.2862714614961233,1.8825262164512218e-4,5.135264751478856e-4,Downregulated
Feature1399,Isoprenaline,C11 H17 N O3,211.12084,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Isoprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,1549963.212382782,28536886.026489988,18.41133118418972,4.202522035719624,3.90441076211733e-11,7.1615415315561e-10,Upregulated
Feature1398,2908,C5 H11 N,85.08916,Other,NA,2908-peak1,5,11,0,1,0,0,2.2,0,-1.5999999999999996,105.89999999999998,1,1,0,0,0,Lipid,57188815.38914644,39127880.85121981,0.6841876437721367,-0.547536045194923,0.02075457790794796,0.03433423337506235,Downregulated
Feature1397,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak4,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,46941808.14723542,27840976.347459033,0.5930955249984058,-0.7536636084252764,2.472645520348847e-4,6.57560676840023e-4,Downregulated
Feature1396,NA,C20 H29 N5 O7,451.2068,NA,NA,Feature1396,20,29,7,5,0,0,1.45,0.35,0,60.3,9,2,-0.375,0.04347826086956521,-3,Lignin,10352895.530747272,44816138.32371354,4.328850628368961,2.113984019670319,7.23432215632785e-6,2.7254987780798264e-5,Upregulated
Feature1395,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak3,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,11829727.134629082,50176231.9961994,4.241537562546041,2.084587338315691,0.004226343068288331,0.008062415718108595,Upregulated
Feature1394,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid",C31 H34 O10,566.21537,Biosynthesis of secondary metabolites;Other,NA,"4-({4-[(2,4-Dihydroxy-3,6-dimethylbenzoyl)oxy]-2-methoxy-3,5,6-trimethylbenzoyl}oxy)-2-methoxy-3,5,6-trimethylbenzoic acid-peak1",31,34,10,0,0,0,1.096774193548387,0.3225806451612903,-0.4516129032258061,73.17096774193547,15,5,0.23809523809523808,0.38461538461538464,5,Lignin,503385.1984926471,734995.5595737904,1.4601056244297308,0.5460727378238491,0.5396593558922066,0.5940110129183873,Upregulated
Feature1393,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak6,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,7708804.6077108905,15328284.155907426,1.9884125926054728,0.991617145001457,0.04695603313569573,0.07185503173610529,Upregulated
Feature1392,Methionine sulfoxide,C5 H11 N O3 S,165.04597,Metabolic pathways;Other,Other,Methionine sulfoxide,5,11,3,1,1,0,2.2,0.6,0,60.3,1,-2,-Inf,-1.6666666666666667,-4,Amino Sugar,87652145.294917,5025948.962464024,0.057339714225516876,-4.124321475403073,1.6830882015756588e-9,1.6292293791252375e-8,Downregulated
Feature1391,3-Buten-1-amine,C4 H9 N,71.07352,NA,NA,3-Buten-1-amine-peak2,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,82182259.04618864,42503720.06959388,0.5171885095748663,-0.951237871872809,2.8909577949167183e-5,9.640319890923073e-5,Downregulated
Feature1390,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak4,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,88486812.86557719,4774409.4296534,0.0539561690045989,-4.212068272071841,5.678925643987946e-7,2.6212806650996135e-6,Downregulated
Feature1389,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",C20 H34 O3,322.2507,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1R,4aS,5R,8aS)-5-(5-hydroxy-3-methylpentyl)-1,4a-dimethyl-6-methylidene-decahydronaphthalene-1-carboxylic acid",20,34,3,0,0,0,1.7,0.15,-1.4000000000000004,100.20000000000002,4,1,0.0588235294117647,0.13513513513513514,1,Lipid,1569525.6139207785,43495325.07782929,27.712402201054303,4.792459868620345,1.3876957620056615e-5,4.9473055420434286e-5,Upregulated
Feature1388,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak4,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,26154142.05240814,12973098.230063714,0.49602461453593033,-1.0115163807514072,1.4254370314735254e-5,5.051653412795297e-5,Downregulated
Feature1387,Phloroglucinol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Phloroglucinol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,93868649.56353472,8187319.412479283,0.08722102054890776,-3.5191803186829467,1.6132463553277885e-13,8.540122893516481e-12,Downregulated
Feature1386,"4-(2-Aminopropoxy)-3,5-dimethylphenol",C11 H17 N O2,195.12596,NA,NA,"4-(2-Aminopropoxy)-3,5-dimethylphenol-peak1",11,17,2,1,0,0,1.5454545454545454,0.18181818181818185,-0.9090909090909092,86.2090909090909,4,2,0.125,0.2222222222222222,1,Lipid,432067.3978544806,9962649.759287044,23.058091882791036,4.527201226041243,0.2574217893266743,0.32911132914670665,Upregulated
Feature1385,Ne-Acetyllysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,43536007.93791764,15570157.20900851,0.35763860644300594,-1.4834256136302537,3.332194434469074e-7,1.6700406426007725e-6,Downregulated
Feature1384,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak2,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,79120956.22054589,28498246.574295208,0.36018582099611773,-1.4731867053733605,3.6482709887660676e-7,1.7965613531888718e-6,Downregulated
Feature1383,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",C9 H13 N2 O9 P,324.03593,Metabolic pathways;Biosynthesis of cofactors;Other,Other,"1,4-Anhydro-1-(2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)-5-O-phosphonopentitol",9,13,9,2,0,1,1.4444444444444444,1,0.6666666666666665,41.3,5,-4,2.3333333333333335,-1.6666666666666667,-7,Tannin,80440023.25963835,3169096.0870143436,0.03939700609962991,-4.665770190786744,1.2624323501048601e-6,5.4416295192815094e-6,Downregulated
Feature1382,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak7,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1153825.7308685435,23223836.450127434,20.127681181668283,4.331109070405352,2.303394912407435e-6,9.540222448944243e-6,Upregulated
Feature1381,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",C22 H31 N O4,373.22538,NA,NA,"(5R)-3-[(1S,2R,4aS,6R,8aR)-1,6-dimethyl-2-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalene-1-carbonyl]-4-hydroxy-5-(hydroxymethyl)-1-methyl-2,5-dihydro-1H-pyrrol-2-one",22,31,4,1,0,0,1.4090909090909092,0.18181818181818185,-0.9090909090909092,86.2090909090909,8,4,0.17647058823529413,0.2631578947368421,3,Lignin,1848466.5985400174,2669735.475273997,1.4442973854018493,0.5303678282856574,0.5325377609131563,0.5897406157723822,Upregulated
Feature1380,Anhydroecgonine,C9 H13 N O2,167.09467,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak2,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,832357.4357012992,39403284.741135955,47.3393797556898,5.564968898778807,0.00409515002657198,0.007838626152556987,Upregulated
Feature1379,NA,C5 H13 O6 P,200.04503,NA,NA,Feature1379,5,13,6,0,0,1,2.6,1.2,-1.2000000000000002,94.5,0,-6,3.5,-4,-7,Other,3318861.7688984033,27394095.006245807,8.254063264387916,3.0451044961192304,0.0025176476589212115,0.0051260758824669865,Upregulated
Feature1378,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak3,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,73771769.63530959,15580046.281262346,0.21119252470534777,-2.2433693244021,1.1596910065865645e-7,6.419988775024968e-7,Downregulated
Feature1377,"16?,17-isopropylidenedioxy-6?-methylprogesterone",C25 H36 O4,400.26153,NA,NA,"16?,17-isopropylidenedioxy-6?-methylprogesterone",25,36,4,0,0,0,1.44,0.16,-1.12,92.22,8,4,0.1904761904761905,0.2608695652173913,4,Lignin,15802367.177014457,4898326.603704736,0.3099742303690843,-1.6897798124977368,0.4138859488205744,0.4821338184332478,Downregulated
Feature1376,Acetonedicarboxylic Acid,C5 H6 O5,146.02149,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Acetonedicarboxylic Acid,5,6,5,0,0,0,1.2,1,0.7999999999999998,37.5,3,-2,-Inf,0.2,-2,Tannin,80633537.65784006,8027878.604949421,0.09956004459353973,-3.3282893132638893,9.80380131641688e-13,4.050643763417121e-11,Downregulated
Feature1375,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak6",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,18961952.66840446,11104417.131234748,0.5856156971500932,-0.7719738699930665,2.1108426048757206e-5,7.209208412619901e-5,Downregulated
Feature1374,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak6",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,760828.2637962919,1207045.2662397642,1.5864884674722661,0.6658370340314456,0.3962819888885789,0.4648903664662415,Upregulated
Feature1373,NP-021733,C7 H13 N O2,143.09463,ABC transporters,NA,NP-021733-peak2,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,10373495.293589193,569863.6735390702,0.05493458640611185,-4.186141444447854,0.2756637790337851,0.3492703378333821,Downregulated
Feature1372,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak6,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,74359278.13098994,27998967.482054994,0.37653630032196556,-1.4091391389675865,4.7304041714008515e-8,2.882483692932749e-7,Downregulated
Feature1371,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak2,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,60020407.838245556,48464100.03110455,0.8074603585119723,-0.3085366610647332,0.12990357990083745,0.1781835338882742,Downregulated
Feature1370,NA,C16 H28 N2 O13,456.15926,NA,NA,Feature1370,16,28,13,2,0,0,1.75,0.8125,0.25,53.175,4,-9,-11,-0.6,-11,Carbohydrate,80952666.05814122,2316663.7273168694,0.02861750996135214,-5.126958042612034,3.253957715760143e-12,9.843222090174432e-11,Downregulated
Feature1369,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",C19 H34 O4,326.24576,NA,NA,"1,2-dihydroxyheptadec-16-yn-4-yl acetate",19,34,4,0,0,0,1.7894736842105263,0.21052631578947367,-1.3684210526315788,99.29999999999998,3,-1,-0.06666666666666667,0.0588235294117647,-1,Lipid,9066608.183717115,25218972.459012765,2.781522257055728,1.4758746497279465,0.06153060216244485,0.09127218919718177,Upregulated
Feature1368,Glucosamine,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,57374423.79371641,19481275.17869995,0.339546332504232,-1.5583196452676296,3.6833872477866556e-5,1.1953367811782747e-4,Downregulated
Feature1367,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak2,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,633009.0580721523,4343334.020673915,6.861408956613775,2.778504857156586,4.4467330163587294e-4,0.0011028939574980509,Upregulated
Feature1366,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04225,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak3",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,71504875.54409933,6142658.73128213,0.08590545308331816,-3.5411064764952536,2.2547792178810145e-6,9.361754889927546e-6,Downregulated
Feature1365,L-Alanyl-L-proline,C8 H14 N2 O3,186.10045,NA,NA,L-Alanyl-L-proline-peak1,8,14,3,2,0,0,1.75,0.375,-0.25,67.425,3,0,-0.6666666666666666,-0.1111111111111111,-2,Protein,7380822.632127094,20048336.76682447,2.7162740206706064,1.441629027565466,0.0018793853655296345,0.003949973708693798,Upregulated
Feature1364,"5,6,7,4'-Tetramethoxyisoflavone",C19 H18 O6,342.11042,Biosynthesis of secondary metabolites;Other,NA,"5,6,7,4'-Tetramethoxyisoflavone",19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,269313.6957062305,402998.60687027423,1.4963910610393476,0.581487252829282,0.48480592629313524,0.5464146634335137,Upregulated
Feature1363,Zalcitabine,C9 H13 N3 O3,211.0957,Other,NA,Zalcitabine-peak2,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,58545963.90141701,61635557.80707063,1.0527721075846672,0.07419317155818753,0.3832637839103751,0.4530696789561587,Upregulated
Feature1362,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak3,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,9150937.513168601,35805399.57167513,3.9127575202157794,1.968185706910935,7.28667834879527e-4,0.0017312248419157344,Upregulated
Feature1361,ile-his,C12 H20 N4 O3,268.15355,NA,NA,ile-his-peak4,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,9103406.281240188,15021831.780490091,1.6501330728747412,0.7225823734620745,0.01215310215220088,0.021093601481381445,Upregulated
Feature1360,glu-thr,C9 H16 N2 O6,248.10093,NA,NA,glu-thr,9,16,6,2,0,0,1.7777777777777777,0.6666666666666666,0.22222222222222232,53.96666666666666,3,-3,-5,-0.5,-5,Amino Sugar,28174736.930952966,9604020.112793641,0.34087346179415773,-1.552691809954224,0.13689285802973958,0.1867121590196287,Downregulated
Feature1359,NA,C17 H30 N2 O8,390.20035,NA,NA,Feature1359,17,30,8,2,0,0,1.7647058823529411,0.4705882352941176,-0.47058823529411775,73.71176470588236,4,-4,-0.8571428571428571,-0.18181818181818185,-6,Protein,3854371.2085708557,49143112.33855051,12.749968718444235,3.672421802379281,6.013624578287777e-15,6.791386690412996e-13,Upregulated
Feature1358,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak2,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,9999031.14936685,1028261.7645001366,0.10283613973592305,-3.2815807344880943,0.2803196093229435,0.3549038999948178,Downregulated
Feature1357,Leu-Glu,C11 H20 N2 O5,260.13724,NA,NA,Leu-Glu-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,25157451.326108154,24631289.072317425,0.9790852321656016,-0.03049363886809817,0.8922284852248306,0.9049482593478742,Downregulated
Feature1356,mycosporine,C11 H19 N O6,261.12123,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak3,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,52548213.55851652,4384670.829144036,0.08344091135013305,-3.5831012745688047,1.0172049259227384e-7,5.743817148377063e-7,Downregulated
Feature1355,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16304,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak2,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,21177422.863766685,25053702.575207964,1.1830383109586655,0.2424967939948047,0.3473032214318119,0.42144101511854537,Upregulated
Feature1354,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",C12 H18 O8,290.10021,NA,NA,"4-(Î²-D-Glucopyranosyloxy)-2,5-dimethyl-3(2H)-furanone",12,18,8,0,0,0,1.5,0.6666666666666666,-0.16666666666666696,65.05000000000001,4,-4,-1,0,-4,Amino Sugar,83794734.58289146,3001900.583906341,0.035824453634814006,-4.802911487921082,6.114219001708954e-11,1.015439900872056e-9,Downregulated
Feature1353,NA,C12 H18 O9,306.09516,NA,NA,Feature1353,12,18,9,0,0,0,1.5,0.75,0,60.3,4,-5,-1.6666666666666667,-0.06666666666666667,-5,Carbohydrate,68513107.16028322,5639181.647046067,0.08230807039379288,-3.6028222944100308,6.841211209714069e-8,3.9552941260258134e-7,Downregulated
Feature1352,Asparagine,C4 H8 N2 O3,132.05347,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Other,Other,Asparagine,4,8,3,2,0,0,2,0.75,1,31.799999999999997,2,-1,3,-3,-3,Carbohydrate,71671179.148815915,5284707.269912365,0.07373545869727294,-3.761497624938825,6.271604846615364e-7,2.8713780027476825e-6,Downregulated
Feature1351,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",C21 H32 N4 O6,436.23229,NA,NA,"(3S,9S,14aR)-3,6-Dimethyl-9-{6-[(2S)-2-oxiranyl]-6-oxohexyl}decahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10-tetrone",21,32,6,4,0,0,1.5238095238095235,0.2857142857142857,-0.3809523809523814,71.15714285714287,8,2,-0.18181818181818185,0.07142857142857142,-2,Lipid,13536138.259921167,25079730.461496588,1.852798041798566,0.8897056336724132,0.015763826907811754,0.026607368082800894,Upregulated
Feature1350,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak5",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,773789.0420383213,795671.3499809393,1.0282794234006927,0.0402323540040499,0.9176707085785605,0.9264208464434335,Upregulated
Feature1349,Veronal,C8 H12 N2 O3,184.0848,NA,NA,Veronal-peak1,8,12,3,2,0,0,1.5,0.375,0,60.3,4,1,-0.3333333333333333,0.1111111111111111,-1,Protein,15479276.97900687,9278669.806793956,0.5994252715664801,-0.7383481862192708,0.2564261368975696,0.32808600899130125,Downregulated
Feature1348,NA,C10 H15 N O5,229.09503,NA,NA,Feature1348,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,27936113.6096494,30805070.448740825,1.1026970637068307,0.14103650378923463,0.07847039267880312,0.113198578473203,Upregulated
Feature1347,Imidazoleacetic acid riboside,C10 H14 N2 O6,258.08518,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Imidazoleacetic acid riboside,10,14,6,2,0,0,1.4,0.6,0.3999999999999999,48.9,5,-1,-1.5,0,-3,Lignin,39658068.60917334,25039780.186843965,0.6313918217654199,-0.6633925209245927,0.022629138378063834,0.036894860839692144,Downregulated
Feature1346,2-Methylhippuric Acid,C10 H11 N O3,193.07391,Phenylalanine metabolism;Other,NA,2-Methylhippuric Acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,26644830.599272687,33396558.018271513,1.2533972732100285,0.32584375963130857,0.002710345299181638,0.005478908039157153,Upregulated
Feature1345,NA,C14 H27 N O11,385.1585,NA,NA,Feature1345,14,27,11,1,0,0,1.9285714285714288,0.7857142857142857,-0.14285714285714324,64.37142857142858,2,-9,-5,-0.6,-10,Carbohydrate,83913105.64299057,1797789.576216172,0.02142441949252709,-5.544600075593238,1.4765636060867247e-11,3.291182564093305e-10,Downregulated
Feature1344,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.09574,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak2,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,5302635.973133384,25001052.77357472,4.714834829365315,2.2372072311274285,1.8921504055745728e-4,5.153219914860653e-4,Upregulated
Feature1343,AC-LYS-OH,C8 H16 N2 O3,188.1161,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,31151458.303938206,29296501.197117165,0.9404536028868178,-0.0885713244894843,0.6307340714825327,0.6719896333908241,Downregulated
Feature1342,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak2,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,2945074.019598086,34730133.569015,11.792618228914536,3.5598121598136943,1.3599714770965648e-5,4.860320004644685e-5,Upregulated
Feature1341,L-(+)-Valine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-(+)-Valine,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,6150231.563531384,4627385.070234121,0.7523920071030847,-0.4104435721479876,0.7172361705869743,0.7499988104779842,Downregulated
Feature1340,NA,C37 H71 N O5,609.53331,NA,NA,Feature1340,37,71,5,1,0,0,1.9189189189189189,0.13513513513513514,-1.5675675675675675,104.97567567567567,3,-2,-0.0967741935483871,-0.01492537313432835,-3,Lipid,8394230.48771974,14316157.447815742,1.7054758585387222,0.7701743333664626,0.39579440315752645,0.46464013787169084,Upregulated
Feature1339,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",C31 H42 O3,462.31357,NA,NA,"(3E,5E,7E,9Z,11E,13E,15Z,17E)-18-(4-Hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]hept-1-yl)-3,7,12,16-tetramethyl-3,5,7,9,11,13,15,17-octadecaoctaen-2-one",31,42,3,0,0,0,1.3548387096774193,0.0967741935483871,-1.161290322580645,93.39677419354838,11,8,0.2857142857142857,0.3220338983050847,8,Unsaturated HC,8011047.642055352,1397221.0961487743,0.1744117821511665,-2.5194305921755857,0.36710718550217636,0.43856105235591447,Downregulated
Feature1338,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak6,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,6515139.452955378,22255509.07405333,3.415968182224841,1.7722945371480359,1.836259488968773e-5,6.322405638847767e-5,Upregulated
Feature1337,Pyridoxine,C8 H11 N O3,169.07391,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak2,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,27080416.990499098,7536734.061575216,0.278309379955981,-1.8452385617552796,3.337920983897052e-8,2.1098649801200022e-7,Downregulated
Feature1336,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15318,NA,NA,4-Hydroxyprolyllysine-peak4,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,11673281.257270135,21634762.30489025,1.8533574089475562,0.8901411233482979,0.0016008094112399827,0.003428282101947574,Upregulated
Feature1335,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak4",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,963308.2778693602,909486.236900259,0.9441279160518122,-0.08294575717367073,0.7618116797256238,0.7917233039602495,Downregulated
Feature1334,ALA-GLU,C8 H14 N2 O5,218.09029,NA,NA,ALA-GLU,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,22446440.8586407,26823949.66862998,1.1950201743589193,0.25703497402350095,0.4945851669915453,0.5555883772438182,Upregulated
Feature1333,MFCD01318772,C8 H13 N3 O2,183.10077,NA,NA,MFCD01318772,8,13,2,3,0,0,1.625,0.25,0,60.3,4,2,-0.3333333333333333,0,-1,Lipid,19432693.0187913,19876030.50422893,1.0228140013846216,0.032543814997929535,0.8060308749774462,0.8305451959925754,Upregulated
Feature1332,NP-008177,C28 H41 N O5,471.29851,NA,NA,NP-008177,28,41,5,1,0,0,1.4642857142857142,0.17857142857142858,-1,88.8,9,4,0.13636363636363635,0.22448979591836735,3,Lignin,2117405.3454462592,22270440.067093372,10.517797225263786,3.394760683077751,0.009434658847839488,0.016672696521056643,Upregulated
Feature1331,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak2,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,10109531.093387367,14383081.765683072,1.4227249150152008,0.5086567426037635,0.1344511169238886,0.1838258208789889,Upregulated
Feature1330,Valylvaline,C10 H20 N2 O3,216.14739,NA,NA,Valylvaline,10,20,3,2,0,0,2,0.3,-0.7999999999999998,83.1,2,-1,-0.6,-0.2307692307692308,-3,Lipid,30898784.52159738,16896985.171435226,0.546849509877151,-0.8707842293743772,5.082377888441689e-5,1.5967503936631784e-4,Downregulated
Feature1329,NA,C6 H15 N O6,197.08997,NA,NA,Feature1329,6,15,6,1,0,0,2.5,1,0,60.3,0,-6,7,-2,-7,Carbohydrate,61973889.25147181,17148333.467347816,0.2767025544865342,-1.8535921320813686,3.794495444962453e-10,4.624370707745609e-9,Downregulated
Feature1328,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak3",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,34101373.33102457,469636.3480810807,0.013771772283839882,-6.182141958509631,8.657254746530325e-5,2.581934778278586e-4,Downregulated
Feature1327,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak3,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,56237516.24277714,8333128.164778057,0.14817738622744245,-2.7546028042400934,3.561019393282333e-9,3.0466499253637736e-8,Downregulated
Feature1326,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",C10 H16 N2 O3 S,244.08813,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;ABC transporters;Other,Other,"hexahydro-2-oxo-1h-thieno(3,4-d)imidazole-4-pentanoic acid",10,16,3,2,1,0,1.6,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,58292916.20622515,42690905.04045278,0.7323515071612385,-0.44939182900357416,4.3338194171619075e-5,1.386551463812782e-4,Downregulated
Feature1325,L-Cystathionine,C7 H14 N2 O4 S,222.06742,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;Other,Other,L-Cystathionine,7,14,4,2,1,0,2,0.5714285714285714,0.2857142857142856,52.15714285714286,2,-2,-Inf,-1.5,-5,Amino Sugar,3529001.7573596714,37156700.12694241,10.528954838135958,3.3962903285278743,6.304767591293136e-5,1.9348326629801762e-4,Upregulated
Feature1324,Leu-Leu,C12 H24 N2 O3,244.17868000000001,Microbial metabolism in diverse environments;Other,NA,Leu-Leu-peak1,12,24,3,2,0,0,2,0.25,-1,88.8,2,-1,-0.42857142857142855,-0.17647058823529413,-3,Lipid,49414882.36914781,27535236.615430284,0.5572255825629956,-0.8436666004271565,0.0013829067933748686,0.0030345130932344913,Downregulated
Feature1323,Pyrogallol,C6 H6 O3,126.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Pyrogallol-peak1,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,63331274.32705438,8030534.460600795,0.12680203494926748,-2.9793501965105214,1.629192640465353e-8,1.1404348483257471e-7,Downregulated
Feature1322,NA,C14 H25 N O9,351.15307,Biosynthesis of secondary metabolites;Other,NA,Feature1322,14,25,9,1,0,0,1.7857142857142858,0.6428571428571429,-0.2857142857142856,68.44285714285714,3,-6,-1.75,-0.29411764705882354,-7,Amino Sugar,69275978.29822382,1133197.7760406546,0.01635773039772011,-5.93388359865263,7.99476929146731e-11,1.2776546395986437e-9,Downregulated
Feature1321,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",C14 H16 N2 O3,260.11612,NA,NA,"3-[(4-hydroxyphenyl)methyl]-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",14,16,3,2,0,0,1.1428571428571428,0.21428571428571427,-0.2857142857142856,68.44285714285714,8,5,0.3333333333333333,0.42857142857142855,3,Lignin,61923809.85845836,44695319.97641688,0.7217792328763152,-0.47037046045987113,4.056492865980297e-7,1.9633425471344637e-6,Downregulated
Feature1320,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak2",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,5924880.091486788,21651021.900348265,3.6542548652516547,1.8695772579424208,0.0012678153675552781,0.0028074238335145637,Upregulated
Feature1319,afegostat,C6 H13 N O3,147.08955,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak4,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,12090195.498156471,14111582.746197155,1.1671922714855114,0.22304223565558998,0.6477887418600092,0.6871347080218257,Upregulated
Feature1318,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",C14 H19 N3 O2,261.14775,NA,NA,"8-Hydroxy-3-(methylamino)-2,3,4,4a,9,9a-hexahydro-1H-carbazole-6-carboxamide",14,19,2,3,0,0,1.3571428571428572,0.14285714285714285,-0.4285714285714288,72.51428571428572,7,5,0.2222222222222222,0.3,2,Lignin,212158.9667845064,237960.9760415856,1.1216163975915605,0.16557934625067094,0.7761043130984643,0.8046026354888608,Upregulated
Feature1317,Nojirimycin,C6 H13 N O5,179.0794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,7664927.839036213,34761675.158053316,4.5351601330175395,2.181153492105863,1.0891608664543003e-5,3.9935898436657674e-5,Upregulated
Feature1316,NA,C11 H21 N O8 S,327.09883,NA,NA,Feature1316,11,21,8,1,1,0,1.9090909090909092,0.7272727272727273,0,60.3,2,-6,-8,-0.8,-8,Carbohydrate,24243907.478284772,3472868.206514854,0.1432470491658779,-2.8034226745620896,1.03372821915513e-6,4.596156438973203e-6,Downregulated
Feature1315,Maraniol,C12 H12 O3,204.07864,NA,NA,Maraniol,12,12,3,0,0,0,1,0.25,-0.5,74.55,7,4,0.4444444444444444,0.5238095238095238,4,Lignin,5248402.267194282,1511907.7373236127,0.2880700945455265,-1.7955081972853337,0.35592383654464443,0.4292241263699788,Downregulated
Feature1314,NA,C30 H46 O11,582.30426,NA,NA,Feature1314,30,46,11,0,0,0,1.5333333333333334,0.36666666666666664,-0.7999999999999998,83.1,8,-3,-0.15789473684210523,0.1020408163265306,-3,Protein,916976.5928947864,21680762.733492788,23.643747181211236,4.5633867941650665,0.001145022117919693,0.0025623084118308586,Upregulated
Feature1313,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak2,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,56274012.5038089,2766982.2304149354,0.04916980516055528,-4.346083551404027,9.835222396258774e-16,1.851207415473596e-13,Downregulated
Feature1312,4-O-(beta-L-Araf)-cis-L-Hyp,C10 H17 N O7,263.10053,NA,Other,4-O-(beta-L-Araf)-cis-L-Hyp,10,17,7,1,0,0,1.7,0.7,0,60.3,3,-4,-2.5,-0.2727272727272727,-5,Amino Sugar,44849963.22783491,15829337.635478243,0.35293981301759897,-1.5025059138394024,3.9665328131634416e-11,7.1615415315561e-10,Downregulated
Feature1311,NA,C15 H21 N3 O5,323.14822,NA,NA,Feature1311,15,21,5,3,0,0,1.4,0.3333333333333333,-0.13333333333333375,64.10000000000001,7,2,-0.14285714285714285,0.15789473684210523,-1,Lignin,29042890.008065086,34380662.63816247,1.1837893070770542,0.24341233038945448,0.020929094272674826,0.034589156778449905,Upregulated
Feature1310,Guanosine monophosphate,C10 H14 N5 O8 P,363.05806,Metabolic pathways;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of purine nucleotide salvage;Other,Guanosine monophosphate,10,14,8,5,0,1,1.4,0.8,1.2000000000000002,26.09999999999999,7,-1,1.75,-Inf,-7,Tannin,42716743.939436786,262324.82673479803,0.006141030484596827,-7.347303519901134,1.6276655057676425e-5,5.685083230454405e-5,Downregulated
Feature1309,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26144,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak2,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,3305727.323619688,7903157.991351166,2.390747093652421,1.2574615219225715,0.13660792923334264,0.18647367616541694,Upregulated
Feature1308,dihydropyranone,C5 H6 O2,98.03676,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak2,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,26804813.358554408,22461254.315611485,0.8379560049592089,-0.25505359451089527,0.46200020300359335,0.5252792504011125,Downregulated
Feature1307,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak3",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,831264.576010421,1364947.1009719756,1.6420128324521122,0.7154654019285576,0.4567542851565012,0.5210382215859347,Upregulated
Feature1306,NA,C18 H34 N2 O12,470.2114,NA,NA,Feature1306,18,34,12,2,0,0,1.8888888888888888,0.6666666666666666,-0.22222222222222232,66.63333333333333,3,-9,-2.75,-0.5,-11,Amino Sugar,65409746.23555448,4513426.654293162,0.06900235689707995,-3.857210549251206,3.239522466557479e-11,6.236080748123147e-10,Downregulated
Feature1305,RV0540000,C5 H12 O4,136.07356,NA,NA,RV0540000,5,12,4,0,0,0,2.4,0.8,-0.7999999999999998,83.1,0,-4,-4,-0.6666666666666666,-4,Carbohydrate,2895014.3926360398,58772696.40897175,20.301348607616625,4.343503662933066,0.001713746594039088,0.0036334001630816213,Upregulated
Feature1304,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak2,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,152662.34780463576,183809.4743043089,1.2040262510539441,0.2678668471245926,0.6528620429281662,0.691649969180934,Upregulated
Feature1303,"N-Acetyl-1,6-anhydro-Î²-muramic acid",C11 H17 N O7,275.10045,Metabolic pathways;Other,NA,"N-Acetyl-1,6-anhydro-Î²-muramic acid",11,17,7,1,0,0,1.5454545454545454,0.6363636363636364,0,60.3,4,-3,-1.3333333333333333,-0.07692307692307693,-4,Amino Sugar,8947832.89602654,2160348.7817458827,0.241438212676639,-2.0502740638806953,0.2845221310280361,0.3594187098892566,Downregulated
Feature1302,(+)-castanospermine,C8 H15 N O4,189.10013,NA,NA,(+)-castanospermine-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,541946.398930956,23032273.29756756,42.49917213768934,5.40936283344399,2.317144093505067e-6,9.571736619805113e-6,Upregulated
Feature1301,Agmatine,C5 H14 N4,130.12182,Metabolic pathways;Other,Other,Agmatine,5,14,0,4,0,0,2.8,0,-0.4000000000000003,71.7,1,1,-3,-3,-3,Other,8378172.733882664,16157488.473577663,1.9285217656392077,0.9474954285710545,0.19488212494974244,0.25711084086048575,Upregulated
Feature1300,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak5,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,28787818.480134014,37693690.65378355,1.3093625235894595,0.38886459199280415,0.04956369656970485,0.0753688527729623,Upregulated
Feature1299,Val-Leu,C11 H22 N2 O3,230.16304,NA,NA,Val-Leu-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,16236755.27797564,12620869.454590797,0.7773024374956483,-0.36345205458108154,0.13898226200414202,0.1894094544127245,Downregulated
Feature1298,N-(3-Hydroxy-4-methoxybenzoyl)glycine,C10 H11 N O5,225.0637,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,N-(3-Hydroxy-4-methoxybenzoyl)glycine,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,640038.560234398,152851.04399039678,0.2388153675216364,-2.0660324193654183,0.21729807062739045,0.2825041685669988,Downregulated
Feature1297,α-Linolenic acid,C18 H30 O2,278.22444,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Linolenic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,5237313.618236322,19658918.316255555,3.7536263338905687,1.9082850398665439,0.018653447499664886,0.03104021617331269,Upregulated
Feature1296,Propionylcarnitine,C10 H19 N O4,217.13141,NA,NA,Propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,4042283.7558281366,465691.96845257794,0.11520516534277103,-3.117722691932325,0.3444568825750366,0.4185867712210272,Downregulated
Feature1295,Glu-Gly,C7 H12 N2 O5,204.07472,NA,NA,Glu-Gly,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,58326414.147551544,5862282.731566416,0.10050819713922883,-3.3146149269174185,5.613009132772957e-12,1.4856933548308423e-10,Downregulated
Feature1294,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak3,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,13676058.124473205,12031530.933773631,0.8797513745750536,-0.18483223175946542,0.4147738641304044,0.48257343807479747,Downregulated
Feature1293,NA,C15 H22 N4 O6,354.15406,NA,NA,Feature1293,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,15237001.320763033,25451290.78401604,1.6703608701099397,0.7401598208281676,5.937961356498672e-4,0.0014369866482726785,Upregulated
Feature1292,arg-leu,C12 H25 N5 O3,287.19577,NA,NA,arg-leu-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,5556722.450469854,4964913.562999656,0.8934967703092392,-0.16246558046924262,0.5495429673566243,0.6029312090039647,Downregulated
Feature1291,Tridemorph,C19 H39 N O,297.30319,NA,NA,Tridemorph,19,39,1,1,0,0,2.0526315789473686,0.05263157894736842,-1.7894736842105263,111.3,1,0,-0.0588235294117647,-0.02857142857142857,-1,Lipid,441070.2630748816,9900538.261093106,22.44662379202895,4.488426559684916,0.042118442230657645,0.06519239989999137,Upregulated
Feature1290,NA,C15 H22 N4 O6,354.15401,NA,NA,Feature1290,15,22,6,4,0,0,1.4666666666666666,0.4,0.1333333333333333,56.5,7,1,-0.6,0,-3,Lignin,53814902.60415389,307321.9834788213,0.005710722655012286,-7.452110963796487,1.167805614066782e-8,8.454114146278328e-8,Downregulated
Feature1289,ornithinoalanine,C8 H17 N3 O4,219.12181,NA,NA,ornithinoalanine,8,17,4,3,0,0,2.125,0.5,0,60.3,2,-2,-5,-1,-5,Protein,6205966.154185655,1083479.275210785,0.1745867199871893,-2.5179842709559517,0.39941975877631875,0.46792328586935267,Downregulated
Feature1288,N-Acetyl-D-galactosamine,C8 H15 N O6,221.08991,Metabolic pathways;ABC transporters;Other,Other,N-Acetyl-D-galactosamine,8,15,6,1,0,0,1.875,0.75,0,60.3,2,-4,-5,-0.5,-5,Carbohydrate,12712729.693352763,41155238.80329044,3.2373250903627495,1.694802247445362,0.0024579191253555795,0.005022575390051087,Upregulated
Feature1287,Indole-3-acetic acid,C10 H9 N O2,175.06333,Metabolic pathways;Other,Superpathway of indole-3-acetate conjugate biosynthesis,Indole-3-acetic acid,10,9,2,1,0,0,0.9,0.2,-0.20000000000000015,66,7,5,0.5714285714285714,0.625,4,Lignin,2384085.9681555643,19769485.724413987,8.292270492120108,3.05176717762382,2.2290870139575e-6,9.277821625660948e-6,Upregulated
Feature1286,NA,C11 H18 N3 O6 P S,351.06552,NA,NA,Feature1286,11,18,6,3,1,1,1.6363636363636365,0.5454545454545454,0,60.3,5,-1,-Inf,-1,-6,Protein,1263303.7004160911,18578364.788970113,14.706174598278311,3.8783501133479796,0.0026427316036004246,0.005361421959879185,Upregulated
Feature1285,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak2,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,569894.6174596692,33638732.03058292,59.02623221908828,5.883284349050932,1.263801548402264e-8,9.071524673700997e-8,Upregulated
Feature1284,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12666,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak2,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,27408756.09431502,28844552.100423805,1.0523845737897821,0.07366200625793239,0.7590622049414639,0.7893501382264211,Upregulated
Feature1283,Pyrone,C5 H4 O2,96.02112,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Pyrone-peak1,5,4,2,0,0,0,0.8,0.4,0,60.3,4,2,0.6666666666666666,0.75,2,Condensed HC,63267914.44812192,2577121.3696147185,0.04073346485488932,-4.617641652222982,4.7268996060075904e-9,3.90603313784237e-8,Downregulated
Feature1282,NA,C22 H33 N6 O10 P S,604.17155,NA,NA,Feature1282,22,33,10,6,1,1,1.5,0.4545454545454546,0.09090909090909084,57.70909090909091,10,0,-2,-0.3333333333333333,-8,Protein,284630.8213468904,421403.9863198036,1.480528300925719,0.566112068505975,0.4872167343049112,0.5482322698981118,Upregulated
Feature1281,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)",C12 H23 N O7,293.14749,NA,NA,"(2S)-4-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)pentanoic acid (non-preferred name)-peak1",12,23,7,1,0,0,1.9166666666666667,0.5833333333333334,-0.5,74.55,2,-5,-1.5,-0.3333333333333333,-6,Amino Sugar,9637600.071530044,1616436.2360966492,0.16772186271473158,-2.5758573369671027,8.806883434750886e-14,5.1444346684372415e-12,Downregulated
Feature1280,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,C19 H32 O3,308.23512,NA,NA,(3Z)-4-Hydroxy-5-methylene-3-tetradecylidenedihydro-2(3H)-furanone,19,32,3,0,0,0,1.6842105263157894,0.15789473684210523,-1.3684210526315788,99.29999999999998,4,1,0.0625,0.14285714285714285,1,Lipid,1480002.7761948912,19836089.196582135,13.402737829709354,3.7444558306369036,4.597526917929072e-5,1.4557402988732426e-4,Upregulated
Feature1279,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",C6 H6 O4,142.02662,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,5E)-6-Hydroxy-4-oxo-2,5-hexadienoic acid",6,6,4,0,0,0,1,0.6666666666666666,0.3333333333333335,50.8,4,0,0,0.5,0,Tannin,10589791.940301154,38934378.15096352,3.676595193791532,1.8783703394296531,4.492333770725598e-11,7.686882229908245e-10,Upregulated
Feature1278,N-Methyltyramine,C9 H13 N O,151.09973,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,N-Methyltyramine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,55160287.41732687,177484.96945903785,0.0032176222744496894,-8.27978931060917,3.2292495747772296e-10,4.113044195242577e-9,Downregulated
Feature1277,NP-013538,C12 H16 O8,288.08462,NA,NA,NP-013538-peak2,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,50038241.05804275,4912775.703435647,0.09818042360315954,-3.3484207984948906,2.883398590839388e-8,1.8643042797259248e-7,Downregulated
Feature1276,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11608,NA,Other,N1-Acetyl-5-methoxykynuramine-peak2,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,52043791.853701435,13807958.936048094,0.2653142371882354,-1.914225999909706,3.8596955371959586e-7,1.8842432968328397e-6,Downregulated
Feature1275,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak5,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1125965.287754916,34170919.03782156,30.348110558501872,4.923534793485845,5.6043971539275036e-8,3.3666130421110604e-7,Upregulated
Feature1274,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07398,NA,NA,Phenyl D-glucopyranosiduronic acid-peak5,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,1611485.3737735355,12069497.30921931,7.489672264884891,2.904902590223402,0.0012718824018971926,0.0028127529880076292,Upregulated
Feature1273,Ne-Acetyllysine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Ne-Acetyllysine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,9365967.422757948,164401.5277262479,0.01755307490465704,-5.832132409323504,0.25017736001598107,0.3217922914708215,Downregulated
Feature1272,α-Eleostearic acid,C18 H30 O2,278.22457000000003,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of lipoxygenase,α-Eleostearic acid,18,30,2,0,0,0,1.6666666666666667,0.1111111111111111,-1.4444444444444446,101.46666666666668,4,2,0.125,0.17647058823529413,2,Lipid,6792668.493142277,19261378.550987422,2.8356129215540653,1.5036606093518932,0.06942383289918194,0.10147020960415377,Upregulated
Feature1271,imazamethabenz-methyl,C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,imazamethabenz-methyl,16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,215759.42390916645,24351186.336417854,112.86267776961424,6.818424674126845,0.002934002516418592,0.0058818938021456746,Upregulated
Feature1270,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak2,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,7474815.378926271,6130044.417775464,0.8200930868550793,-0.28614041891018166,0.5536821596238007,0.6068511103135215,Downregulated
Feature1269,Isobutyraldehyde,C4 H8 O,72.05754,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Isobutyraldehyde,4,8,1,0,0,0,2,0.25,-1.5,103.05,1,0,0,0.14285714285714285,0,Lipid,3937585.9371263282,10933860.273878252,2.7767927985485046,1.4734195287379146,0.057915756116496006,0.08652983177873895,Upregulated
Feature1268,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,C12 H16 O5,240.09978,NA,NA,4-Hydroxy-5-(4-hydroxy-3-methoxyphenyl)pentanoic acid,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,8809646.846216049,6065697.322720747,0.6885289987902418,-0.5384106772303201,0.0015405858495315598,0.0033253127843041706,Downregulated
Feature1267,MFCD00025555,C9 H18 N2 O3,202.1317,NA,NA,MFCD00025555-peak2,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,29601950.210608013,15062558.508676637,0.5088366949309607,-0.9747253800709146,6.577753061584859e-5,2.014957266966501e-4,Downregulated
Feature1266,"3,4,5-Trimethoxyphenyl acetate",C11 H14 O5,226.08413,NA,NA,"3,4,5-Trimethoxyphenyl acetate",11,14,5,0,0,0,1.2727272727272727,0.4545454545454546,-0.3636363636363633,70.66363636363636,5,0,0,0.29411764705882354,0,Lignin,408745.688390141,511307.34111794294,1.2509180051091047,0.3229872271541484,0.4684809106260821,0.5315516829206853,Upregulated
Feature1265,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13723,NA,NA,L-gamma-Glutamyl-L-leucine-peak3,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,24912482.88589287,13503607.277098797,0.5420418084760813,-0.8835239618416375,2.3367885512833887e-4,6.233889458069386e-4,Downregulated
Feature1264,NA,C18 H33 N O15,503.18514,NA,NA,Feature1264,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,64923218.03763315,2361700.662890151,0.036376826877576776,-4.780836486467551,1.9672461765847575e-10,2.7315696910939174e-9,Downregulated
Feature1263,pentobarbital,C11 H18 N2 O3,226.13174,NA,NA,pentobarbital,11,18,3,2,0,0,1.6363636363636365,0.2727272727272727,-0.5454545454545459,75.84545454545456,4,1,-0.16666666666666666,0.06666666666666667,-1,Lipid,11630260.487587214,26472893.083732408,2.2762080962835265,1.1866324582387253,0.02552646867847502,0.04114351849794166,Upregulated
Feature1262,NA,C11 H23 N O7,281.14745,NA,NA,Feature1262,11,23,7,1,0,0,2.090909090909091,0.6363636363636364,-0.5454545454545459,75.84545454545456,1,-6,-2.3333333333333335,-0.5384615384615384,-7,Amino Sugar,44849978.165644236,12893364.293458328,0.2874776046900027,-1.798478524434328,1.9805750105505613e-5,6.791688396503342e-5,Downregulated
Feature1261,NA,C5 H16 N5 O7 P,289.07872,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of amino acids;Other,Other,Feature1261,5,16,7,5,0,1,3.2,1.4,1.6,14.699999999999996,1,-6,1.5,1.8888888888888888,-12,Other,10913315.529934742,28599175.325498976,2.6205762352469972,1.3898840790628317,0.0010911495604682014,0.0024579885045653365,Upregulated
Feature1260,5-Hydroxy-2-furoic acid,C5 H4 O4,128.01093,NA,NA,5-Hydroxy-2-furoic acid,5,4,4,0,0,0,0.8,0.8,0.7999999999999998,37.5,4,0,0,0.6666666666666666,0,Condensed HC,48384987.54720736,4819793.0143078035,0.09961339784587767,-3.3275163942094053,2.399911356848141e-12,8.188946354766004e-11,Downregulated
Feature1259,Pipecolic acid,C6 H11 N O2,129.07898,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak2,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,54536021.114683524,3915075.8466674313,0.07178880612566946,-3.8000972845284324,2.797346198726884e-12,8.775378630821002e-11,Downregulated
Feature1258,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak4,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,40827143.05545274,17236885.794383943,0.42219181907909276,-1.24402947140924,3.2462317972060345e-08,2.0751383639498197e-7,Downregulated
Feature1257,Trigonelline,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak3,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,30773039.246516675,2632989.644454913,0.08556157301729474,-3.546893183622991,2.1246790617897498e-14,1.6360028775781072e-12,Downregulated
Feature1256,NA,C7 H11 N O6,205.0586,NA,NA,Feature1256,7,11,6,1,0,0,1.5714285714285714,0.8571428571428571,0.5714285714285716,44.014285714285705,3,-3,-Inf,-0.3333333333333333,-4,Carbohydrate,48115815.38318145,11806309.75534538,0.24537274618175114,-2.026953078698082,4.659249556415413e-16,1.12753839265253e-13,Downregulated
Feature1255,DL-2-(acetylamino)-3-phenylpropanoic acid,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,DL-2-(acetylamino)-3-phenylpropanoic acid,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,4243939.766025443,9017741.868529767,2.1248515213907266,1.0873620333269163,0.18033776276149713,0.24035575933751072,Upregulated
Feature1254,NA,C16 H21 N8 O2 P,388.15237,NA,NA,Feature1254,16,21,2,8,0,1,1.3125,0.125,0.125,56.7375,11,9,0,0.16666666666666666,0,Unsaturated HC,618477.8958443684,858200.8841717812,1.3876015455655604,0.4725933526687054,0.5586965446907365,0.6109954465501017,Upregulated
Feature1253,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11068,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak3,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,2382585.6465654224,11392187.441108447,4.781438794248873,2.2574448083709235,3.833334775661387e-5,1.2392498301470208e-4,Upregulated
Feature1252,NA,C14 H31 N O,229.24056,NA,NA,Feature1252,14,31,1,1,0,0,2.2142857142857144,0.07142857142857142,-1.8571428571428568,113.2285714285714,0,-1,-0.16666666666666666,-0.12,-2,Lipid,37554335.507819176,52078420.26412223,1.386748548733581,0.4717062156482579,0.647686229157187,0.6871347080218257,Upregulated
Feature1251,11-Aminoundecanoic acid,C11 H23 N O2,201.1728,NA,NA,11-Aminoundecanoic acid,11,23,2,1,0,0,2.090909090909091,0.18181818181818185,-1.454545454545454,101.75454545454544,1,-1,-0.25,-0.1111111111111111,-2,Lipid,6813263.201460784,15946565.636250177,2.3405180696426324,1.2268279032182863,0.0467008798609551,0.07154419946682512,Upregulated
Feature1250,2-Pyrrolidone,C4 H7 N O,85.05278,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,2-Pyrrolidone-peak1,4,7,1,1,0,0,1.75,0.25,-0.5,74.55,2,1,0,0.2,0,Lipid,3746413.5831978912,11335297.493946638,3.0256396530227643,1.5972401760035733,0.0772605447380557,0.11167181125108051,Upregulated
Feature1249,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak3,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,41915237.94796413,2167023.003950877,0.0517001241085912,-4.2736884459727325,6.1998937688704954e-9,4.8849395555658695e-8,Downregulated
Feature1248,NA,C12 H19 N O7,289.11624,NA,NA,Feature1248,12,19,7,1,0,0,1.5833333333333333,0.5833333333333334,-0.16666666666666696,65.05000000000001,4,-3,-1,-0.06666666666666667,-4,Amino Sugar,34190664.60833207,2492318.6883809865,0.07289471313095279,-3.7780420064481004,3.4976441681312074e-14,2.4211381042837305e-12,Downregulated
Feature1247,"1D-myo-Inositol 1,2-cyclic phosphate",C6 H11 O8 P,242.01913,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis",Other,"1D-myo-Inositol 1,2-cyclic phosphate",6,11,8,0,0,1,1.8333333333333333,1.3333333333333333,0,60.3,2,-6,2.3333333333333335,-3,-7,Carbohydrate,8942851.796816876,10598843.098684508,1.1851748569127654,0.24509992544488082,0.6087899299172483,0.6547873912887738,Upregulated
Feature1246,APM,C7 H13 N O4,175.08447,NA,NA,APM-peak4,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,3828825.5653180378,5740531.817251453,1.4992931172550352,0.5842824629858204,0.39355993205238327,0.46265824073333606,Upregulated
Feature1245,NA,C16 H23 N5 O9,429.1496,NA,NA,Feature1245,16,23,9,5,0,0,1.4375,0.5625,0.625,42.4875,8,-1,-3,-0.2307692307692308,-6,Lignin,3840486.6310263555,1256355.1663261862,0.3271343678627596,-1.612044761817684,1.4584960569404299e-15,2.470692320457088e-13,Downregulated
Feature1244,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak3,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,360229.6180756113,9147890.23931959,25.39460882808218,4.66645034611585,0.03472738216619153,0.0545210244573943,Upregulated
Feature1243,Etilevodopa,C11 H15 N O4,225.1001,NA,NA,Etilevodopa-peak2,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,45587367.2888406,34234727.02751438,0.750969601087158,-0.4131735856144417,6.685341053617569e-6,2.5278945858991432e-5,Downregulated
Feature1242,NA,C11 H20 N2 O8,308.12197,NA,NA,Feature1242,11,20,8,2,0,0,1.818181818181818,0.7272727272727273,0.18181818181818168,55.11818181818182,3,-5,-7,-0.6,-7,Carbohydrate,3751525.2830901053,20281377.945390034,5.40616853545084,2.4346064880970095,0.0015913360628566331,0.0034123079626318183,Upregulated
Feature1241,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak2,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,808197.6219618502,4098475.2735409755,5.0711300827539905,2.3423072823590045,2.0044337328903e-6,8.383977144484366e-6,Upregulated
Feature1240,cis-4-Decenedioic acid,C10 H16 O4,200.10487,NA,NA,cis-4-Decenedioic acid,10,16,4,0,0,0,1.6,0.4,-0.7999999999999998,83.1,3,-1,-0.16666666666666666,0.125,-1,Protein,4359129.069479094,13551022.498036096,3.108653651233918,1.6362898886372463,0.024640048849539364,0.03986651647671412,Upregulated
Feature1239,EDDA,C6 H12 N2 O4,176.07974,Other,NA,EDDA,6,12,4,2,0,0,2,0.6666666666666666,0.3333333333333335,50.8,2,-2,-Inf,-1,-4,Amino Sugar,29220139.92893846,21366246.38746274,0.731216429470362,-0.45162960866926627,0.024706768086716333,0.03993632169742124,Downregulated
Feature1238,Leucylasparagine,C10 H19 N3 O4,245.13753,NA,NA,Leucylasparagine-peak4,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,24485715.415798113,6789506.689132582,0.2772843910761134,-1.8505616885744915,2.9904203091130165e-10,3.837706063361705e-9,Downregulated
Feature1237,Neolinustatin,C17 H29 N O11,423.17418,NA,NA,Neolinustatin,17,29,11,1,0,0,1.7058823529411764,0.6470588235294118,-0.23529411764705888,67.00588235294117,4,-7,-1.6,-0.23809523809523808,-8,Amino Sugar,28573518.99830184,349947.62126786634,0.012247270673544416,-6.351395911931279,1.2163965732273572e-7,6.668530081058715e-7,Downregulated
Feature1236,NA,C12 H19 N3 O4 S,301.10964,NA,NA,Feature1236,12,19,4,3,1,0,1.5833333333333333,0.3333333333333333,0,60.3,5,1,-0.75,-0.16666666666666666,-3,Protein,490588.2462662891,7788511.584770649,15.875862587509037,3.9887630752391563,0.0134792759756964,0.023181617769370257,Upregulated
Feature1235,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak2,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,7513980.500210962,5161091.56069651,0.6868651789223578,-0.5419011469183866,0.0173837099961161,0.029127601121088698,Downregulated
Feature1234,Gly-Phe,C11 H14 N2 O3,222.10044,NA,NA,Gly-Phe-peak2,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,22450791.599117145,13408043.819793558,0.5972192009621975,-0.7436675451422462,0.00019983533535822167,5.390462708548209e-4,Downregulated
Feature1233,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",C9 H16 N2 O4,216.11101,Metabolic pathways;Other,Other,"tert-Butyl 3-amino-1-methyl-2,3-dioxopropylcarbamate",9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,6251215.057091282,12607233.262965353,2.0167652444885737,1.0120431611333525,0.008864590833369886,0.015790343713699882,Upregulated
Feature1232,N-Acetyl-6-oxo-L-norleucine,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetyl-6-oxo-L-norleucine,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,6402313.582830145,1393920.9863777123,0.21772144840202112,-2.1994445560842033,0.3071295129054221,0.3839685570935683,Downregulated
Feature1231,Hymexazol N-glucoside,C10 H15 N O7,261.08485,NA,NA,Hymexazol N-glucoside,10,15,7,1,0,0,1.5,0.7,0.20000000000000015,54.599999999999994,4,-3,-2,-0.09090909090909093,-4,Amino Sugar,736964.5336533226,6729562.906138883,9.131461011805698,3.190845706415055,0.045619798227206576,0.07012698565960793,Upregulated
Feature1230,"(2Z,4E)-2,4-Pentadecadienal",C15 H26 O,222.19833,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2Z,4E)-2,4-Pentadecadienal",15,26,1,0,0,0,1.7333333333333334,0.06666666666666667,-1.5999999999999996,105.89999999999998,3,2,0.14285714285714285,0.1724137931034483,2,Lipid,918429.8299184476,1474447.2092522318,1.6053999567753106,0.6829327638732853,0.11254531165753529,0.15717374933871786,Upregulated
Feature1229,pro-his,C11 H16 N4 O3,252.12227,NA,NA,pro-his,11,16,3,4,0,0,1.4545454545454546,0.2727272727272727,0.18181818181818168,55.11818181818182,6,3,-0.25,0.09090909090909093,-1,Lignin,2669417.0437185606,15715495.417580917,5.887238734225231,2.557591131761314,4.8028935489097816e-4,0.0011877520688836744,Upregulated
Feature1228,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,C14 H16 N2 O4,276.11103,NA,NA,N-[(2S)-2-Hydroxypropanoyl]-L-tryptophan,14,16,4,2,0,0,1.1428571428571428,0.2857142857142857,-0.14285714285714324,64.37142857142858,8,4,0.25,0.4,2,Lignin,32992181.14373756,9478291.897885503,0.2872890354411937,-1.7994251622900654,3.3314162413529497e-6,1.3373031073108759e-5,Downregulated
Feature1227,NA,C21 H35 N O16,557.19585,NA,NA,Feature1227,21,35,16,1,0,0,1.6666666666666667,0.7619047619047619,0,60.3,5,-11,-3,-0.3333333333333333,-12,Carbohydrate,56187230.3070395,524228.34148234455,0.009330026388872667,-6.74390312308753,3.555078583074695e-10,4.460965273872987e-9,Downregulated
Feature1226,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,C11 H23 N3 O2,229.17901,NA,NA,N-{3-[(4-Acetamidobutyl)amino]propyl}acetamide,11,23,2,3,0,0,2.090909090909091,0.18181818181818185,-0.9090909090909092,86.2090909090909,2,0,-0.5,-0.2857142857142857,-3,Lipid,1048385.7234746306,11366229.315556448,10.841648318031005,3.4385122094636436,0.0036425883389350614,0.007068206925722788,Upregulated
Feature1225,NA,C12 H19 N O8,305.11113,NA,NA,Feature1225,12,19,8,1,0,0,1.5833333333333333,0.6666666666666666,0,60.3,4,-4,-1.6666666666666667,-0.14285714285714285,-5,Amino Sugar,386429.7440238749,14433636.66610094,37.35125696020227,5.223084888898856,3.0025418105983603e-4,7.789136029331733e-4,Upregulated
Feature1224,NA,C18 H33 N O15,503.18519,NA,NA,Feature1224,18,33,15,1,0,0,1.8333333333333333,0.8333333333333334,0,60.3,3,-12,-6.5,-0.5789473684210527,-13,Carbohydrate,52890082.6826863,9293249.789900135,0.17570874006106071,-2.5087421395732803,1.1391154312510376e-8,8.281809186863767e-8,Downregulated
Feature1223,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)",C11 H21 N O7,279.13182,NA,NA,"(2S)-3-Methyl-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)butanoic acid (non-preferred name)-peak1",11,21,7,1,0,0,1.9090909090909092,0.6363636363636364,-0.3636363636363633,70.66363636363636,2,-5,-2,-0.38461538461538464,-6,Amino Sugar,20469423.800277986,2758605.1430198736,0.13476711264253616,-2.8914596177759773,7.395594414411806e-4,0.0017526685621172399,Downregulated
Feature1222,2762577,C15 H23 N3 O4,309.16894,NA,NA,2762577-peak2,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,1675063.7163732108,4320829.490447904,2.579501572515231,1.3670923259863161,0.06717149173076026,0.09860355891846437,Upregulated
Feature1221,N-(Carboxymethyl)norleucine,C8 H15 N O4,189.10012,NA,NA,N-(Carboxymethyl)norleucine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,7164861.90065738,23075579.545547877,3.2206593602914633,1.68735607916023,2.2227380422883556e-5,7.560880007302157e-5,Upregulated
Feature1220,2'-Deoxycytidine,C9 H13 N3 O4,227.0906,Metabolic pathways;ABC transporters;Other,Other,2'-Deoxycytidine,9,13,4,3,0,0,1.4444444444444444,0.4444444444444444,0.44444444444444464,47.633333333333326,5,1,-1,0,-2,Lignin,9449070.400799459,4867296.367214317,0.5151084880056042,-0.9570517817671423,0.010298070733084511,0.018040260415558593,Downregulated
Feature1219,NA,C7 H17 N O6,211.10558,NA,NA,Feature1219,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,2551475.651042798,7770574.355583333,3.045521658185321,1.6066893641639803,0.02224985290217379,0.03641666745534532,Upregulated
Feature1218,NA,C20 H42 O5,362.30324,NA,NA,Feature1218,20,42,5,0,0,0,2.1,0.25,-1.5999999999999996,105.89999999999998,0,-5,-0.3333333333333333,-0.14285714285714285,-5,Lipid,5680361.613583823,4912220.322308123,0.8647724663446086,-0.20960750532596106,0.8764768162978781,0.8928152295902618,Downregulated
Feature1217,leu-phe,C15 H22 N2 O3,278.16307,NA,NA,leu-phe-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,13813928.29366261,18623760.23091278,1.348187122084365,0.4310207497598945,0.1415521315118819,0.19275668069222504,Upregulated
Feature1216,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak2,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,3729768.336289866,20923208.25888956,5.609787625497036,2.487946154534277,2.9650940377366984e-7,1.5038530838101697e-6,Upregulated
Feature1215,Tiglic acid,C5 H8 O2,100.05241,NA,NA,Tiglic acid-peak2,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,6113190.7775756745,28473457.1812251,4.657707933092986,2.2196201765412393,8.171039551527306e-9,6.241395267560527e-8,Upregulated
Feature1214,NP-013538,C12 H16 O8,288.08457,NA,NA,NP-013538-peak1,12,16,8,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,5,-3,-0.75,0.125,-3,Tannin,43791892.81290976,4503144.929895335,0.10283056156384766,-3.2816589931574995,5.193465492953175e-9,4.2094404521830995e-8,Downregulated
Feature1213,"(2E,4E,7E)-2,4,7-Decatrienoic acid",C10 H14 O2,166.0994,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2E,4E,7E)-2,4,7-Decatrienoic acid",10,14,2,0,0,0,1.4,0.2,-1,88.8,4,2,0.25,0.3333333333333333,2,Lignin,1486461.2884632177,14827203.686517382,9.974833385568036,3.31829274350819,0.002296131555318885,0.004731930480182714,Upregulated
Feature1212,NA,C32 H36 O10,580.23105,NA,NA,Feature1212,32,36,10,0,0,0,1.125,0.3125,-0.5,74.55,15,5,0.2272727272727273,0.3703703703703703,5,Lignin,333219.89916378027,495323.81580801704,1.4864772993780944,0.5718974314092188,0.5115413670927187,0.5708505111034687,Upregulated
Feature1211,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08922,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak2",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,2068618.0830070241,3122719.059468946,1.5095677085688235,0.5941354674350116,0.2335852802978977,0.30251793946837824,Upregulated
Feature1210,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,C14 H18 N2 O8,342.10633,Biosynthesis of secondary metabolites;Other,NA,4-Nitrophenyl 2-acetamido-2-deoxy-α-D-glucopyranoside,14,18,8,2,0,0,1.2857142857142858,0.5714285714285714,0.2857142857142856,52.15714285714286,7,-1,-0.75,0.125,-3,Lignin,775768.6383919918,5676265.756283275,7.316956983526688,2.8712437772596333,0.2675026315108995,0.3396922472109923,Upregulated
Feature1209,10-Deoxymethymycin,C25 H43 N O6,453.30918,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,10-Deoxymethymycin,25,43,6,1,0,0,1.72,0.24,-1.12,92.22,5,-1,-0.1111111111111111,0.04761904761904761,-2,Lipid,1112975.8561288752,14376794.093799097,12.917435732886519,3.6912478009395446,2.9478779520422915e-4,7.659057133066934e-4,Upregulated
Feature1208,NA,C12 H22 N4 O7,334.14893,NA,NA,Feature1208,12,22,7,4,0,0,1.8333333333333333,0.5833333333333334,0.3333333333333335,50.8,4,-3,-7,-0.7777777777777778,-7,Amino Sugar,11745225.060687799,20360609.812931158,1.733522321430837,0.7937064132988916,0.06834349674766554,0.10015041824441646,Upregulated
Feature1207,NA,C46 H84 N10 O13 P2 S,1078.54184,NA,NA,Feature1207,46,84,13,10,1,2,1.826086956521739,0.2826086956521739,-0.7826086956521738,82.60434782608695,11,-2,-0.75,-0.32075471698113206,-15,Lipid,4930378.612100697,713130.793529469,0.14464016856215103,-2.7894598307188194,0.359322641932021,0.4323100535744628,Downregulated
Feature1206,Diethyl tartrate,C8 H14 O6,206.07905,NA,NA,Diethyl tartrate,8,14,6,0,0,0,1.75,0.75,-0.25,67.425,2,-4,-2,-0.2,-4,Carbohydrate,2988014.9808356445,1335585.8141439438,0.44698096318460445,-1.1617147062170392,0.5480540804309738,0.6016873702203951,Downregulated
Feature1205,NA,C9 H19 N O3,189.13649,NA,NA,Feature1205,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,3508803.1349301627,821151.6725882888,0.23402614538664693,-2.095258378272908,0.32493562180732727,0.40148865305733944,Downregulated
Feature1204,NA,C16 H5 O13 P3,497.89406,NA,NA,Feature1204,16,5,13,0,0,3,0.3125,0.8125,0.375,49.6125,16,3,NA,1,0,Condensed HC,44352802.05086765,29327362.89405554,0.6612290889856378,-0.5967779013941463,0.0019168574825744126,0.004013790575378313,Downregulated
Feature1203,5-guanidino-2-oxopentanoic acid,C6 H11 N3 O3,173.08005,Metabolic pathways;Other,NA,5-guanidino-2-oxopentanoic acid,6,11,3,3,0,0,1.8333333333333333,0.5,0.6666666666666665,41.3,3,0,-Inf,-1,-3,Protein,3425460.68823706,416992.99932285707,0.12173340676621976,-3.038202960013417,9.002648778577227e-4,0.0020720770422431828,Downregulated
Feature1202,"(E,E)-alpha-Farnesene",C15 H24,204.18778,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,"(E,E)-alpha-Farnesene",15,24,0,0,0,0,1.6,0,-1.5999999999999996,105.89999999999998,4,4,0.26666666666666666,0.26666666666666666,4,Lipid,607825.2686992972,968349.1993328595,1.5931374511708896,0.6718707436792853,0.06316419268657024,0.09336836161522687,Upregulated
Feature1201,Nicotinamide,C6 H6 N2 O,122.04796,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Nicotinamide,6,6,1,2,0,0,1,0.16666666666666666,0.3333333333333335,50.8,5,4,0.6666666666666666,0.7142857142857143,2,Lignin,9949107.78534392,9965226.402145805,1.0016201067622996,0.002335428680193718,0.9955335884319831,0.996121617722256,Upregulated
Feature1200,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak2,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,4563551.1876390055,14386812.284563296,3.152547586960768,1.6565181478585402,0.0464810214331372,0.07132142238019422,Upregulated
Feature1199,NA,C11 H17 N O5,243.11065,NA,NA,Feature1199,11,17,5,1,0,0,1.5454545454545454,0.4545454545454546,-0.3636363636363633,70.66363636363636,4,-1,-0.4,0.06666666666666667,-2,Protein,4010134.26273922,1164327.3086888422,0.29034621596273436,-1.784153863145269,0.2978582429834303,0.3737569360103192,Downregulated
Feature1198,8722455,C11 H17 N O8,291.09546,NA,NA,8722455,11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,41258130.05892456,8573939.573680978,0.2078121223971067,-2.266648280818072,1.6784894533032508e-12,6.181219856295015e-11,Downregulated
Feature1197,Fluoranthene,C16 H10,202.07833,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak4,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,21993276.54021772,15425125.176193073,0.701356396259835,-0.5117803547088684,0.05423448005653911,0.0817377306190189,Downregulated
Feature1196,Nicotinic acid,C6 H5 N O2,123.03199,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Aminobenzoate degradation;Other,Other,Nicotinic acid,6,5,2,1,0,0,0.8333333333333334,0.3333333333333333,0.3333333333333335,50.8,5,3,0.6666666666666666,0.75,2,Lignin,39244005.57121421,11847607.894215507,0.30189598950892577,-1.727876503170025,1.5373603178329816e-10,2.1702403153408923e-9,Downregulated
Feature1195,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",C11 H15 N O2,193.11027,NA,NA,"2-oxa-4-azatetracyclo[6.3.1.1~6,10~.0~1,5~]tridecan-3-one",11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,17947587.39731472,17174970.21786925,0.9569514741819244,-0.06348232559097365,0.5659523675498366,0.6169390673291011,Downregulated
Feature1194,2-methylbutyrylcarnitine,C12 H23 N O4,245.1627,NA,NA,2-methylbutyrylcarnitine,12,23,4,1,0,0,1.9166666666666667,0.3333333333333333,-1,88.8,2,-2,-0.42857142857142855,-0.1111111111111111,-3,Protein,2767670.62453986,913745.3261649351,0.33014959152404566,-1.598808233902958,0.4772493794363929,0.5400537399901467,Downregulated
Feature1193,dihydropyranone,C5 H6 O2,98.03675,Microbial metabolism in diverse environments;Other,NA,dihydropyranone-peak1,5,6,2,0,0,0,1.2,0.4,-0.4000000000000003,71.7,3,1,0.3333333333333333,0.5,1,Lignin,30529486.843994193,28409879.097249635,0.9305717859728281,-0.10381064823292295,0.6272205747770403,0.6686668682645099,Downregulated
Feature1192,"2,5-Furandicarboxylic acid",C6 H4 O5,156.00587,Microbial metabolism in diverse environments;Other,NA,"2,5-Furandicarboxylic acid",6,4,5,0,0,0,0.6666666666666666,0.8333333333333334,1,31.799999999999997,5,0,0,0.7142857142857143,0,Condensed HC,36944344.65265616,3614621.9514251756,0.09783965544413299,-3.35343686655043,1.9320546640091e-12,6.963618299641309e-11,Downregulated
Feature1191,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak5",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,3606486.415235422,21562686.23306312,5.978862457923764,2.5798710224797112,0.0016314983050956838,0.0034851931006709812,Upregulated
Feature1190,MFCD00025555,C9 H18 N2 O3,202.13171,NA,NA,MFCD00025555-peak1,9,18,3,2,0,0,2,0.3333333333333333,-0.666666666666667,79.30000000000001,2,-1,-0.75,-0.2727272727272727,-3,Protein,21436538.081943214,8903364.447798645,0.4153359284864321,-1.2676494179062503,5.172814396154728e-7,2.4340965519683636e-6,Downregulated
Feature1189,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04732,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak2,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,1396762.7523171478,14223708.251292787,10.183338743603011,3.3481387406947114,2.112179837824377e-4,5.688446176906987e-4,Upregulated
Feature1188,UNII:74D1OHC38H,C19 H32 O4,324.23008,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak2,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,1932075.100140408,14411625.30037321,7.45914343563865,2.8990099693401117,0.01253264126357799,0.021683268862866065,Upregulated
Feature1187,Meglutol,C6 H10 O5,162.05283,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,Meglutol-peak1,6,10,5,0,0,0,1.6666666666666667,0.8333333333333334,0,60.3,2,-3,-3,-0.14285714285714285,-3,Carbohydrate,30282193.257843554,5178454.855431724,0.17100659821231493,-2.5478761029660375,8.179396395504352e-9,6.241395267560527e-8,Downregulated
Feature1186,NA,C7 H17 N O6,211.10569,NA,NA,Feature1186,7,17,6,1,0,0,2.4285714285714284,0.8571428571428571,-0.2857142857142856,68.44285714285714,0,-6,-Inf,-1.3333333333333333,-7,Carbohydrate,25448403.310354806,3737097.995665623,0.1468499988030691,-2.7675848409835786,3.973936859305038e-11,7.1615415315561e-10,Downregulated
Feature1185,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",C11 H19 N O7,277.11616,NA,NA,"1-{[(3S,4S,5R)-2,3,4-Trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}-2-pyrrolidinecarboxylic acid (non-preferred name)",11,19,7,1,0,0,1.7272727272727273,0.6363636363636364,-0.18181818181818168,65.48181818181817,3,-4,-1.6666666666666667,-0.2307692307692308,-5,Amino Sugar,13769413.117383678,2493813.29448636,0.18111253349919165,-2.4650417065702865,5.82572945250837e-10,6.709094442040902e-9,Downregulated
Feature1184,NP-019722,C8 H13 N O4,187.08445,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak2,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,40297190.88926147,11853882.839940852,0.2941615179210845,-1.7653195686741907,6.246420661612601e-9,4.8988132410980304e-8,Downregulated
Feature1183,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak2,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,16439785.025448747,19208721.883402105,1.168429018607424,0.22457009388666965,0.5019799319408897,0.5620317281611813,Upregulated
Feature1182,Thymine,C5 H6 N2 O2,126.04289,Metabolic pathways;Other,Other,Thymine,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,34950928.35357241,7133637.398447352,0.2041043753196389,-2.2926209855971416,5.7581225086697296e-8,3.4345984259459584e-7,Downregulated
Feature1181,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak2,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,9722099.814425351,5559581.080371863,0.571849825294195,-0.8062917673751827,0.5059709556192393,0.5653791548937939,Downregulated
Feature1180,1-Monopropionin,C6 H12 O4,148.07358,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,1-Monopropionin-peak1,6,12,4,0,0,0,2,0.6666666666666666,-0.666666666666667,79.30000000000001,1,-3,-1.5,-0.25,-3,Amino Sugar,947590.5012844291,10223433.768616935,10.788873204996666,3.43147229183092,0.003234674069162119,0.006423842758687725,Upregulated
Feature1179,pyroglutamine,C5 H8 N2 O2,128.05857,Metabolic pathways;Other,NA,pyroglutamine,5,8,2,2,0,0,1.6,0.4,0.3999999999999999,48.9,3,1,-1,0,-1,Protein,42487485.26910339,7820283.438763564,0.18406086849414977,-2.441745153860494,1.1885229362918507e-10,1.7862385447373162e-9,Downregulated
Feature1178,pyr-gln-OH,C10 H15 N3 O5,257.10118,NA,NA,pyr-gln-OH,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,39261166.940921776,1219341.6124329632,0.03105719232104759,-5.008928778838656,3.948470347573679e-10,4.777649120564151e-9,Downregulated
Feature1177,NA,C9 H17 N5 O2,227.1382,NA,NA,Feature1177,9,17,2,5,0,0,1.8888888888888888,0.2222222222222222,0.22222222222222232,53.96666666666666,4,2,-1.5,-0.6666666666666666,-3,Lipid,41252802.39828698,589107.2704827449,0.014280418207593274,-6.129817959904478,1.4354349263336018e-13,7.843957307126199e-12,Downregulated
Feature1176,NA,C5 H10 N6 O,170.09157,NA,NA,Feature1176,5,10,1,6,0,0,2,0.2,2,3.299999999999997,4,3,1.5,1.6666666666666667,-3,Lipid,42776816.247286215,73267464.40504657,1.7127844199881215,0.7763435776996147,0.47986453220010816,0.5423919007559919,Upregulated
Feature1175,NA,C15 H27 N O5,301.18898,NA,NA,Feature1175,15,27,5,1,0,0,1.8,0.3333333333333333,-0.9333333333333336,86.9,3,-2,-0.3333333333333333,-0.04347826086956521,-3,Protein,6175655.84216759,8715885.203047136,1.4113294888511716,0.49705483870731465,0.4406825433697218,0.5054273720164582,Upregulated
Feature1174,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak4",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,1758847.497428923,14957856.467291657,8.504350996409295,3.0882011418277546,0.007901738657502624,0.014179603057001531,Upregulated
Feature1173,Bis(4-ethylbenzylidene)sorbitol,C24 H30 O6,414.20433,NA,NA,Bis(4-ethylbenzylidene)sorbitol,24,30,6,0,0,0,1.25,0.25,-0.75,81.675,10,4,0.2222222222222222,0.3333333333333333,4,Lignin,6467200.0931006335,12811620.388992622,1.9810149994679105,0.9862398037892605,0.21926494544189412,0.2848426515173072,Upregulated
Feature1172,NA,C31 H40 O6,508.28264,NA,NA,Feature1172,31,40,6,0,0,0,1.2903225806451613,0.1935483870967742,-0.903225806451613,86.04193548387097,12,6,0.24,0.32142857142857145,6,Lignin,4700725.3669831045,273287.8526318004,0.05813737908436774,-4.1043901555763656,0.3424860200186075,0.41678973987896634,Downregulated
Feature1171,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,C14 H20 N2 O3,264.14741,Metabolic pathways;Other,NA,2-(2-amino-3-methylbutanamido)-3-phenylpropanoic acid,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,24294412.276922546,16712745.755917113,0.6879255017744422,-0.5396757567622885,0.017459811030588183,0.02922620542076718,Downregulated
Feature1170,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak4,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,10674967.220310638,13991369.30239658,1.3106709382466317,0.39030552282192804,0.12103019139341271,0.16750420279447806,Upregulated
Feature1169,N6-Acetyl-L-lysine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,N6-Acetyl-L-lysine,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,17080583.281392265,14770024.141753789,0.8647259814507846,-0.20968505789722558,0.4266934452907757,0.49406609454721395,Downregulated
Feature1168,Apocynin,C9 H10 O3,166.06303,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak2,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,1516501.0102303769,2076481.5101924683,1.3692582439341883,0.4533945664699135,0.593594170586589,0.6411004625284655,Upregulated
Feature1167,NA,C6 H9 O7 P,224.00856,NA,NA,Feature1167,6,9,7,0,0,1,1.5,1.1666666666666667,0,60.3,3,-4,2.5,-1,-5,Carbohydrate,7074003.979031638,6892764.257035198,0.9743794712960777,-0.03744435672863783,0.9301122126592691,0.9367479716080868,Downregulated
Feature1166,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.2981,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak2,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,196139.32888851414,5017654.314837703,25.58209178787261,4.677062329732688,0.09880494114780448,0.14006323874843582,Upregulated
Feature1165,Glycylproline,C7 H12 N2 O3,172.08476,NA,NA,Glycylproline,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,6867903.862426312,9081608.512153443,1.3223260974630282,0.40307800224519774,0.1740023809996912,0.23264406741395177,Upregulated
Feature1164,Phosphoric acid,H3 O4 P,97.97687,ABC transporters;Other,Superpathway of L-lysine degradation;Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of butirocin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of purine nucleotide salvage;Other,Phosphoric acid,0,3,4,0,0,1,Inf,Inf,NA,NA,0,-4,1,1,-5,Other,39763790.77937584,17205451.560767237,0.43269143166529117,-1.2085895426886537,1.1733424318236512e-11,2.7227973691907745e-10,Downregulated
Feature1163,arg-val,C11 H23 N5 O3,273.18012,NA,NA,arg-val,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,5742813.954023917,2952106.0405620793,0.5140521814211961,-0.9600132801053172,0.018527534802387717,0.030891381845713377,Downregulated
Feature1162,NA,C52 H85 N10 O8 P3,1070.57651,NA,NA,Feature1162,52,85,8,10,0,3,1.6346153846153846,0.15384615384615383,-1.0384615384615383,89.89615384615384,17,9,-0.12903225806451613,0,-4,Lipid,4032333.0260694,309181.4106403291,0.07667556440438901,-3.7050893086487005,0.3469903596955568,0.42136320381668335,Downregulated
Feature1161,Glycylglutamic acid,C7 H12 N2 O5,204.07457,NA,NA,Glycylglutamic acid,7,12,5,2,0,0,1.7142857142857142,0.7142857142857143,0.5714285714285716,44.014285714285705,3,-2,-Inf,-0.6,-4,Carbohydrate,7518696.733142274,7380532.249737625,0.9816238786709374,-0.02675775091798749,0.8790987426105545,0.8949478785951199,Downregulated
Feature1160,NA,C12 H22 N4 O6,318.15394,NA,NA,Feature1160,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,13551039.566977825,24472287.02474373,1.8059342904126416,0.8527454007808718,4.584886903536176e-6,1.773241647166731e-5,Upregulated
Feature1159,NA,C12 H22 N4 O6,318.1539,NA,NA,Feature1159,12,22,6,4,0,0,1.8333333333333333,0.5,0.16666666666666652,55.55,4,-2,-3,-0.6,-6,Protein,10673756.362314003,19556508.388878066,1.8322048700611655,0.8735808290332114,0.0063195575359025775,0.011535916450235955,Upregulated
Feature1158,AC-LYS-OH,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,AC-LYS-OH-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,22996555.850724675,14058799.644553237,0.6113437045013074,-0.7099443869151983,3.6717626837229133e-4,9.31132632668655e-4,Downregulated
Feature1157,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak2,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,34202382.38738259,1966804.3972579264,0.057504894687789035,-4.120171429521884,7.8010346871763e-7,3.523987402687107e-6,Downregulated
Feature1156,Trachelogenin,C21 H24 O7,388.1523,NA,NA,Trachelogenin,21,24,7,0,0,0,1.1428571428571428,0.3333333333333333,-0.4761904761904763,73.87142857142857,10,3,0.21428571428571427,0.37142857142857144,3,Lignin,1274353.7854222415,1827871.6395395938,1.4343517949640263,0.5203989087016966,0.5968819446183793,0.6432048436282027,Upregulated
Feature1155,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",C12 H14 N2 O5,266.0903,NA,NA,"(2R,5R)-2-Benzyl-5-(hydroxymethyl)-2,5-dihydro-2,3,5,6-pyrazinetetrol",12,14,5,2,0,0,1.1666666666666667,0.4166666666666667,0.16666666666666652,55.55,7,2,0,0.3333333333333333,0,Lignin,204113.8097104818,127483.75984868838,0.6245719485100657,-0.6790603200441113,0.042072351153442766,0.06519239989999137,Downregulated
Feature1154,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak2,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,11452516.35194932,10709537.902415821,0.9351253098706961,-0.09676839104680385,0.774183260175442,0.8031025368874457,Downregulated
Feature1153,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13724,NA,NA,L-gamma-Glutamyl-L-leucine-peak2,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,34504478.876228966,7719568.927936215,0.22372657635627782,-2.1601914513645846,1.8294539105446597e-8,1.2496350501865538e-7,Downregulated
Feature1152,Pipecolic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Pipecolic acid-peak1,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,778625.0037847565,24568909.343306337,31.554226005948017,4.979761330825329,5.1899755321461815e-5,1.619119438573781e-4,Upregulated
Feature1151,Atagabalin,C10 H19 N O2,185.14156,NA,NA,Atagabalin-peak1,10,19,2,1,0,0,1.9,0.2,-1.2000000000000002,94.5,2,0,-0.14285714285714285,0,-1,Lipid,496436.2306713492,21416229.366475,43.13994032529221,5.430952275732865,6.825392096421805e-8,3.9552941260258134e-7,Upregulated
Feature1150,NA,C11 H14 N O P S,239.05347,NA,NA,Feature1150,11,14,1,1,1,1,1.2727272727272727,0.09090909090909093,-1.0909090909090908,91.39090909090908,6,5,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,305245.0136227357,12756666.751798319,41.791564751209286,5.385139871651242,0.003017113780311263,0.006034227560622526,Upregulated
Feature1149,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",C13 H21 N O2,223.15721,NA,NA,"4-Methyl-6-[(1-methyl-2-piperidinyl)methyl]-5,6-dihydro-2H-pyran-2-one",13,21,2,1,0,0,1.6153846153846154,0.15384615384615383,-1.0769230769230766,90.99230769230768,4,2,0.1,0.18181818181818185,1,Lipid,36681192.519037955,55627298.78283983,1.5165073696545888,0.6007525089335932,0.5067360671788257,0.5658608423209827,Upregulated
Feature1148,NA,C16 H21 N5 O9,427.13398,NA,NA,Feature1148,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,19255695.827716794,24424624.617803033,1.2684363544342057,0.3430511319791209,0.001477511626072123,0.0032212415631482317,Upregulated
Feature1147,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak5",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,29597686.129559852,7259936.222952117,0.24528729006628194,-2.027455614491257,1.2933514921277707e-10,1.9051629805777767e-9,Downregulated
Feature1146,NA,C4 H11 O6 P,186.02935,NA,NA,Feature1146,4,11,6,0,0,1,2.75,1.5,-1,88.8,0,-6,2.3333333333333335,-Inf,-7,Other,1005405.2566823766,13489163.801613448,13.416643400219348,3.745951875548695,7.458831617341952e-5,2.2522746452365892e-4,Upregulated
Feature1145,NA,C13 H19 N O6,285.1213,NA,NA,Feature1145,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,5830435.742806619,517528.3208082688,0.08876323205290043,-3.4938939897724954,0.34134432428668904,0.41569898299184127,Downregulated
Feature1144,Kanosamine,C6 H13 N O5,179.07944,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak2,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,33260324.40630831,7388892.849761948,0.2221533608481743,-2.1703721275555723,1.4464360986006825e-7,7.705228776822504e-7,Downregulated
Feature1143,asn-leu,C10 H19 N3 O4,245.13755,NA,NA,asn-leu-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,16849576.855610814,16776223.7064335,0.9956465880534627,-0.006294356752846364,0.9680183416274163,0.9714591651166131,Downregulated
Feature1142,NA,C15 H29 N O12,415.16907,NA,NA,Feature1142,15,29,12,1,0,0,1.9333333333333331,0.8,-0.13333333333333375,64.10000000000001,2,-10,-5.5,-0.625,-11,Carbohydrate,38184500.399198875,174420.7967970004,0.004567842841297455,-7.774271269684002,1.5609709711899103e-9,1.546365394851291e-8,Downregulated
Feature1141,mebutamate,C10 H20 N2 O4,232.14229,Other,NA,mebutamate-peak3,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,9765010.875043241,13756075.665499179,1.4087107368877625,0.4943754006465125,0.1250017430878721,0.17229695100964632,Upregulated
Feature1140,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12155,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak4",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,16219455.391631057,7237014.101634884,0.44619340951293907,-1.1642588904339928,8.39536122195946e-9,6.284265516142993e-8,Downregulated
Feature1139,Ser-Glu,C8 H14 N2 O6,234.08519,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,Ser-Glu,8,14,6,2,0,0,1.75,0.75,0.5,46.05,3,-3,-Inf,-0.6666666666666666,-5,Carbohydrate,20154934.60598016,8800333.673142623,0.43663419629907807,-1.195502971202853,2.9367926135381264e-5,9.773922764898992e-5,Downregulated
Feature1138,Apocynin,C9 H10 O3,166.06304,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,Apocynin-peak1,9,10,3,0,0,0,1.1111111111111112,0.3333333333333333,-0.44444444444444464,72.96666666666667,5,2,0.3333333333333333,0.4666666666666667,2,Lignin,1215665.012846571,1603040.9391137527,1.318653512417958,0.3990655338207357,0.7014816767363482,0.7370316710484737,Upregulated
Feature1137,Adenosine 5'-monophosphate,C10 H14 N5 O7 P,347.06316,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Other,Superpathway of chorismate metabolism;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Superpathway of purine nucleotide salvage;Other,Adenosine 5'-monophosphate,10,14,7,5,0,1,1.4,0.7,1,31.799999999999997,7,0,2,-5,-6,Tannin,12473905.929365063,716405.6491344259,0.05743234342083032,-4.121992760339913,2.571399801412241e-4,6.795555793435781e-4,Downregulated
Feature1136,Ethyl lactate,C5 H10 O3,118.06297000000001,Metabolic pathways;Other,NA,Ethyl lactate,5,10,3,0,0,0,2,0.6,-0.7999999999999998,83.1,1,-2,-1,-0.14285714285714285,-2,Amino Sugar,1365866.8335621306,25659443.314003725,18.78619692893841,4.231601132529675,4.33301395800239e-8,2.6788779725752004e-7,Upregulated
Feature1135,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak2,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,36621111.20360473,14704636.071129272,0.4015344042777667,-1.3164044888273372,8.621151206137749e-6,3.209720910592823e-5,Downregulated
Feature1134,Glycyl-L-leucine,C8 H16 N2 O3,188.11612,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak2,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,11408282.547231458,9728507.567886595,0.8527582944768046,-0.22979121239860248,0.4380284920771682,0.5038636297487575,Downregulated
Feature1133,Acetylcholine,C7 H15 N O2,145.11029,NA,NA,Acetylcholine,7,15,2,1,0,0,2.142857142857143,0.2857142857142857,-1.1428571428571432,92.87142857142858,1,-1,-0.5,-0.2,-2,Lipid,3173805.7304931358,4483685.654925582,1.4127158483102622,0.49847131318870586,0.5950404683950951,0.6420372951982746,Upregulated
Feature1132,3-Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,3-Methylhippuric acid,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,9180605.958562018,12286036.33060197,1.3382598475587295,0.4203582687350087,0.2854823431420148,0.3600946308879919,Upregulated
Feature1131,glycidyl oleate,C21 H38 O3,338.28215,NA,NA,glycidyl oleate,21,38,3,0,0,0,1.8095238095238095,0.14285714285714285,-1.5238095238095235,103.72857142857144,3,0,0,0.07692307692307693,0,Lipid,2458151.187677383,8590565.052823856,3.4947260753887015,1.8051793783000456,0.06513303634909692,0.09611094388098448,Upregulated
Feature1130,Lys-phe,C15 H23 N3 O3,293.17394,NA,NA,Lys-phe-peak2,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,10390058.063412992,4328540.755652412,0.4166040968427991,-1.2632510681210738,1.4753380853918822e-5,5.217583959611375e-5,Downregulated
Feature1129,2805789,C9 H11 N O3,181.07391,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,2805789,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,31017327.438214332,23988863.59534094,0.7734020167638911,-0.37070956841405533,1.265857556857924e-5,4.581971584011375e-5,Downregulated
Feature1128,Muramic acid,C9 H17 N O7,251.10052,Metabolic pathways;ABC transporters;Other,NA,Muramic acid-peak1,9,17,7,1,0,0,1.8888888888888888,0.7777777777777778,0,60.3,2,-5,-6,-0.5555555555555556,-6,Carbohydrate,12163188.998012096,2455891.753691888,0.2019118303672885,-2.3082026517157543,7.240108914615831e-6,2.7254987780798264e-5,Downregulated
Feature1127,val-arg,C11 H23 N5 O3,273.18012,NA,NA,val-arg,11,23,3,5,0,0,2.090909090909091,0.2727272727272727,-0.18181818181818168,65.48181818181817,3,0,-1.6666666666666667,-0.7777777777777778,-5,Lipid,14900041.235271031,10312649.943309357,0.6921222418430287,-0.5309012273638574,0.03351959490731658,0.05272255689228811,Downregulated
Feature1126,NP-001346,C11 H15 N5 O3 S,297.08963,Metabolic pathways;Biosynthesis of plant secondary metabolites;Other,Other,NP-001346,11,15,3,5,1,0,1.3636363636363635,0.2727272727272727,0.7272727272727271,39.57272727272728,7,4,-1,-0.14285714285714285,-2,Lignin,2004290.0082570685,6470280.8967574695,3.228215911919867,1.6907370732374427,2.3611730797874105e-4,6.289036473521813e-4,Upregulated
Feature1125,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",C8 H15 N O5,205.09502,NA,NA,"8-Methyl-8-azabicyclo[3.2.1]octane-1,2,3,4,6-pentol",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,32485288.58749325,6662889.901755312,0.20510483949711647,-2.2855665619378582,5.158365804160177e-13,2.356667239518868e-11,Downregulated
Feature1124,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak2",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,3164569.681801345,7408729.988718464,2.34114926630443,1.2272169203072738,0.03517314708489934,0.05516973255724026,Upregulated
Feature1123,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,C14 H16 N2 O5,292.10594,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,4-hydroxy-4-(indol-3-ylmethyl)glutamic acid,14,16,5,2,0,0,1.1428571428571428,0.35714285714285715,0,60.3,8,3,0.14285714285714285,0.3684210526315789,1,Lignin,18003261.090591397,8254826.545781144,0.45851840420706674,-1.1249484523966102,0.0021683944008033824,0.004490538037849547,Downregulated
Feature1122,DL-Carnitine,C7 H15 N O3,161.10522,Other,NA,DL-Carnitine-peak1,7,15,3,1,0,0,2.142857142857143,0.42857142857142855,-0.8571428571428568,84.72857142857141,1,-2,-1,-0.3333333333333333,-3,Protein,422632.2474176858,17570997.347718813,41.575145898304974,5.377649421211494,1.420730407035741e-4,4.0111955158642423e-4,Upregulated
Feature1121,L-Theanine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,L-Theanine,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,17252957.012208443,6257745.356841159,0.36270567140537635,-1.4631287908682744,1.2623655496774324e-6,5.4416295192815094e-6,Downregulated
Feature1120,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08948,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak2",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,719278.6680895045,13850019.865686556,19.25542975224605,4.26719341716614,2.651670652385065e-4,6.985894378134215e-4,Upregulated
Feature1119,Fluoranthene,C16 H10,202.07831,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak3,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,35408761.06062505,9343381.858810108,0.263872035590651,-1.9220896288476261,8.789495621925746e-12,2.1578848671800312e-10,Downregulated
Feature1118,Icacine,C22 H31 N O6,405.21526,NA,NA,Icacine-peak2,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,756888.5215299628,1134105.1659321762,1.498378075069382,0.5834016946962037,0.5330285807612429,0.5897781945196248,Upregulated
Feature1117,NA,C5 H13 N O5,167.07939,NA,NA,Feature1117,5,13,5,1,0,0,2.6,1,0,60.3,0,-5,6,-2.3333333333333335,-6,Other,16649087.97314262,5284744.21657965,0.31741944214029644,-1.6555375980300817,4.938737086799474e-8,2.9986453853183905e-7,Downregulated
Feature1116,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak3,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,1323123.8713528803,15786920.445110844,11.931551373923051,3.576709733390172,1.0480136028531078e-7,5.878592858387961e-7,Upregulated
Feature1115,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,14603378.626742642,7844268.788471309,0.5371543797478743,-0.8965913122856173,9.886689848850891e-4,0.0022480607522085113,Downregulated
Feature1114,NA,C42 H55 N10 O17 P3,1064.29584,NA,NA,Feature1114,42,55,17,10,0,3,1.3095238095238095,0.4047619047619048,-0.14285714285714324,64.37142857142858,22,5,-0.6666666666666666,0.02439024390243902,-8,Lignin,34052954.38428554,1603225.906218116,0.04708037629057991,-4.408730338591568,2.5056247819666075e-7,1.2961660579453533e-6,Downregulated
Feature1113,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature1113,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,143616.27782721043,14620794.619489562,101.80457842724716,6.669658634545443,0.003557073313692286,0.0069420301767220425,Upregulated
Feature1112,Cytidine 5'-diphosphocholine,C14 H26 N4 O11 P2,488.10744,Metabolic pathways;Other,NA,Cytidine 5'-diphosphocholine,14,26,11,4,0,2,1.8571428571428572,0.7857142857142857,-0.14285714285714324,64.37142857142858,5,-6,4,-2.6,-12,Carbohydrate,2812600.292588727,6693270.7978663985,2.3797447563037437,1.2508068430449202,0.10114027867078983,0.14325387296682104,Upregulated
Feature1111,Pro-tyr,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,Pro-tyr,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,23775486.06572716,9683694.415508963,0.40729743184801603,-1.295845377211422,2.5097872047515353e-6,1.0294381416099517e-5,Downregulated
Feature1110,NA,C18 H28 O,260.21405,NA,NA,Feature1110,18,28,1,0,0,0,1.5555555555555556,0.05555555555555555,-1.4444444444444446,101.46666666666668,5,4,0.2352941176470588,0.2571428571428571,4,Lipid,1744238.450232946,10794313.713442348,6.188553928507165,2.62960233611207,0.003086908748779623,0.006159273757871239,Upregulated
Feature1109,Pogostone,C12 H16 O4,224.10484,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,Pogostone,12,16,4,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,5,1,0.125,0.3,1,Lignin,4035607.4590619197,270579.12519544875,0.06704792969590384,-3.898663404454306,0.3479730844966926,0.42195161427158007,Downregulated
Feature1108,NA,C13 H18 O9,318.09513,NA,NA,Feature1108,13,18,9,0,0,0,1.3846153846153846,0.6923076923076923,0,60.3,5,-4,-1,0.0588235294117647,-4,Tannin,177106.23468384167,213582.58980319672,1.205957487518552,0.27017905016735305,0.613693754520181,0.6579729241501181,Upregulated
Feature1107,D-lysopine,C9 H18 N2 O4,218.12664,Lysine degradation,NA,D-lysopine-peak5,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,9962913.309904354,9424935.533247948,0.9460019614823316,-0.08008491997184737,0.7634002137010089,0.7928877756036229,Downregulated
Feature1106,Acetylarginine,C8 H16 N4 O3,216.12223,NA,NA,Acetylarginine,8,16,3,4,0,0,2,0.375,0.25,53.175,3,0,-4,-1,-4,Protein,6367795.956149417,8080907.984863226,1.2690274689250127,0.3437232975895709,0.34923411606744204,0.4231778201847259,Upregulated
Feature1105,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11096,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak2,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,7796472.913300602,4448761.200988223,0.5706120255223025,-0.8094179431682664,9.668068736565458e-5,2.84829711995511e-4,Downregulated
Feature1104,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",C11 H17 N O8,291.09544,NA,NA,"(1R,2R,3S,5R,7R)-2-Acetamido-7-(1,2-dihydroxyethyl)-3-hydroxy-6,8-dioxabicyclo[3.2.1]octane-5-carboxylic acid",11,17,8,1,0,0,1.5454545454545454,0.7272727272727273,0.18181818181818168,55.11818181818182,4,-4,-2.5,-0.16666666666666666,-5,Carbohydrate,9326443.411643133,21865780.616708234,2.34449292743373,1.229275926927501,6.928095805286696e-11,1.128480220591891e-9,Upregulated
Feature1103,NA,C6 H15 N O4 S,197.07221,NA,NA,Feature1103,6,15,4,1,1,0,2.5,0.6666666666666666,-0.33333333333333304,69.79999999999998,0,-4,-Inf,-2,-6,Other,758781.8892361445,11905165.608623272,15.68983890826393,3.971758634736914,6.594250579469104e-4,0.0015800085546846764,Upregulated
Feature1102,NA,C10 H25 N10 O4 P,380.1797,NA,NA,Feature1102,10,25,4,10,0,1,2.5,0.4,0.7999999999999998,37.5,4,0,2.2,3,-11,Other,6298102.890561198,8378989.06371519,1.3303988850789594,0.41185886470915894,0.37545950404304773,0.446022720791671,Upregulated
Feature1101,4149853,C21 H41 N O4,371.30356,NA,NA,4149853,21,41,4,1,0,0,1.9523809523809523,0.1904761904761905,-1.4285714285714288,101.01428571428572,2,-2,-0.1875,-0.05555555555555555,-3,Lipid,293273.9983125977,5280017.855798954,18.003702633641044,4.1702217359901645,0.04671067568495194,0.07154419946682512,Upregulated
Feature1100,Terpendole I,C27 H35 N O5,453.2516,Biosynthesis of secondary metabolites;Other,NA,Terpendole I,27,35,5,1,0,0,1.2962962962962965,0.18518518518518515,-0.8148148148148149,83.52222222222223,11,6,0.23809523809523808,0.3191489361702128,5,Lignin,1506222.0933600944,14316150.36031917,9.504674259811557,3.248637184284953,2.1856611330447462e-6,9.119482658566011e-6,Upregulated
Feature1099,mycosporine,C11 H19 N O6,261.12118,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak2,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,32680823.483720224,741848.0443525882,0.022699796555681526,-5.461176822189135,2.4170443786204262e-12,8.188946354766004e-11,Downregulated
Feature1098,N-Benzylformamide,C8 H9 N O,135.06844,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,N-Benzylformamide,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,4867404.191399537,349357.19105836266,0.07177484698633814,-3.800377839957544,2.5993596859293268e-12,8.467914053777461e-11,Downregulated
Feature1097,Arg-Glu,C11 H21 N5 O5,303.15426,NA,NA,Arg-Glu,11,21,5,5,0,0,1.9090909090909092,0.4545454545454546,0.36363636363636376,49.93636363636363,4,-1,-6,-1,-6,Protein,4760976.499565365,10750128.771975892,2.2579671991569974,1.1750245286453473,0.0032851530847846887,0.006501225847693064,Upregulated
Feature1096,Mesalazine,C7 H7 N O3,153.04261,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,Mesalazine,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,7281250.2941476675,3984201.28893288,0.5471864210100286,-0.8698956661704361,0.049931215749983236,0.0758596228524409,Downregulated
Feature1095,Fluoranthene,C16 H10,202.07828,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak2,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,29405566.47932582,7557777.5945371315,0.2570186022381436,-1.9600553137347771,5.749046967842081e-10,6.670469564057867e-9,Downregulated
Feature1094,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak3,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1425240.1846017288,14872661.049057106,10.435196263577948,3.38338582962832,0.0017246195582639443,0.0036518819146239023,Upregulated
Feature1093,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate,C11 H22 N2 O3,230.16305,NA,NA,tert-Butyl N-[1-(aminocarbonyl)-3-methylbutyl]carbamate-peak1,11,22,3,2,0,0,2,0.2727272727272727,-0.9090909090909092,86.2090909090909,2,-1,-0.5,-0.2,-3,Lipid,12780275.315854264,14435460.71500608,1.129510934486561,0.17569823713487395,0.5832277107527002,0.6321098797281345,Upregulated
Feature1092,1726033,C6 H13 N O6,195.07432,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak2,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,9694801.052038973,6699885.154120963,0.6910802107395354,-0.5330749270808458,0.0029310613321015797,0.0058818938021456746,Downregulated
Feature1091,Hydrocotarnine,C12 H15 N O3,221.10517,NA,NA,Hydrocotarnine,12,15,3,1,0,0,1.25,0.25,-0.5,74.55,6,3,0.25,0.3684210526315789,2,Lignin,24034543.420327995,20265351.208999295,0.8431760426894241,-0.24609421888018998,0.0015240161385483143,0.0032974936297774636,Downregulated
Feature1090,Norharman,C11 H8 N2,168.06878,NA,NA,Norharman,11,8,0,2,0,0,0.7272727272727273,0,-0.18181818181818168,65.48181818181817,9,9,0.7777777777777778,0.7777777777777778,7,Condensed HC,6566483.155365994,5549685.8135135,0.8451534378761653,-0.2427148079689263,0.09726901741937019,0.13811711274804117,Downregulated
Feature1089,N1-Acetyl-5-methoxykynuramine,C12 H16 N2 O3,236.11607,NA,Other,N1-Acetyl-5-methoxykynuramine-peak1,12,16,3,2,0,0,1.3333333333333333,0.25,-0.33333333333333304,69.79999999999998,6,3,0.14285714285714285,0.29411764705882354,1,Lignin,7119287.940246665,11098844.33047941,1.558982362229735,0.6406046059910304,0.030527403362831117,0.04833030027722983,Upregulated
Feature1088,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature1088,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,1338319.0730732197,15998491.137077741,11.954168074687866,3.5794418270879325,2.7128297099359905e-9,2.4187018571745095e-8,Upregulated
Feature1087,4-Acetamidobutanoic acid,C6 H11 N O3,145.07388,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation;Other,4-Acetamidobutanoic acid-peak1,6,11,3,1,0,0,1.8333333333333333,0.5,-0.33333333333333304,69.79999999999998,2,-1,-1,-0.14285714285714285,-2,Protein,1707659.4687155636,1333760.4177521395,0.7810458947973645,-0.3565207702701909,0.5194506685176832,0.5781533721872242,Downregulated
Feature1086,Crotonic acid,C4 H6 O2,86.03679,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak4,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,18393073.705784902,20565816.556412652,1.1181283175059744,0.16108576278456604,0.33593836180200787,0.4118934814566916,Upregulated
Feature1085,NP-016455,C11 H18 N2 O4,242.12664,NA,NA,NP-016455-peak2,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,31706902.77219236,7348298.492066557,0.2317570575991791,-2.109314821588655,3.370314445597507e-7,1.6792096090712285e-6,Downregulated
Feature1084,N-Acetylglucosaminitol,C8 H17 N O6,223.10552,NA,NA,N-Acetylglucosaminitol-peak1,8,17,6,1,0,0,2.125,0.75,-0.25,67.425,1,-5,-6,-0.75,-6,Carbohydrate,665593.6990866183,16772386.262207804,25.19913617755732,4.6553023741000805,1.7293730330721924e-6,7.305630718265071e-6,Upregulated
Feature1083,D-Alanyl-D-alanine,C6 H12 N2 O3,160.08481,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,D-Alanyl-D-alanine,6,12,3,2,0,0,2,0.5,0,60.3,2,-1,-3,-0.6,-3,Protein,28240755.94549804,9573450.012006124,0.3389941129933621,-1.560667875298688,2.7342121579004207e-11,5.385762087771295e-10,Downregulated
Feature1082,3-O-beta-D-galactosyl-sn-glycerol,C9 H18 O8,254.10017,Other,NA,3-O-beta-D-galactosyl-sn-glycerol-peak1,9,18,8,0,0,0,2,0.8888888888888888,-0.22222222222222232,66.63333333333333,1,-7,-7,-0.6,-7,Carbohydrate,32360200.269314438,8491299.316572977,0.2623994674292808,-1.9301633030484209,2.0083668529939893e-9,1.8693260708636364e-8,Downregulated
Feature1081,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol",C11 H14 O4,210.08924,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Other,"5-[(5-Hydroxytetrahydro-2-furanyl)methyl]-1,3-benzenediol-peak1",11,14,4,0,0,0,1.2727272727272727,0.3636363636363637,-0.5454545454545459,75.84545454545456,5,1,0.14285714285714285,0.3333333333333333,1,Lignin,1428875.7179399827,1949618.4193751125,1.3644422638701477,0.44831134852153465,0.6324897030784544,0.6734365537491527,Upregulated
Feature1080,NA,C23 H26 N4 O5,438.1904,NA,NA,Feature1080,23,26,5,4,0,0,1.1304347826086956,0.21739130434782608,-0.17391304347826075,65.25652173913043,13,8,0.2857142857142857,0.3939393939393939,4,Lignin,7680326.11680481,15860468.722498028,2.065077508596255,1.046195931363327,8.844149884858218e-4,0.0020411430388215016,Upregulated
Feature1079,cys-val,C8 H16 N2 O3 S,220.08814,NA,NA,cys-val-peak2,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,1354912.0604149697,7347377.394442601,5.422770679443444,2.4390301623086876,0.008282524981586468,0.014831498222840885,Upregulated
Feature1078,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",C11 H11 N O5,237.06372,NA,NA,"Methyl (3,5-dihydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)acetate",11,11,5,1,0,0,1,0.4545454545454546,0.18181818181818168,55.11818181818182,7,2,0.2,0.4666666666666667,1,Lignin,23834116.644775487,20199384.63456296,0.8474987739472497,-0.23871681374339812,0.006704293026238818,0.01215960640947383,Downregulated
Feature1077,NA,C29 H30 O10,538.18408,NA,NA,Feature1077,29,30,10,0,0,0,1.0344827586206895,0.3448275862068966,-0.3448275862068968,70.12758620689655,15,5,0.2631578947368421,0.4166666666666667,5,Lignin,532506.7214777743,735650.6698123409,1.3814861674812593,0.4662211168329252,0.5684116200082022,0.6182429208194516,Upregulated
Feature1076,2'-O-Methyladenosine,C11 H15 N5 O4,281.11245,NA,NA,2'-O-Methyladenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,6229704.885598125,12189286.370216778,1.956639454686859,0.9683779384601775,0.022461228732364297,0.03665637906803961,Upregulated
Feature1075,Kanosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Kanosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,21622158.802045282,7650716.753022882,0.3538368588939966,-1.498843754677454,1.3684881016672383e-7,7.317696784366391e-7,Downregulated
Feature1074,NA,C4 H N4 O7 P3,309.90566,NA,NA,Feature1074,4,1,7,4,0,3,0.25,1.75,2.5,-10.950000000000005,8,1,0.6,0.38461538461538464,-6,Other,30455769.18584942,21711946.454126213,0.7129009391171173,-0.4882264734402839,1.6902813761648095e-5,5.855494174280547e-5,Downregulated
Feature1073,Sorbic acid,C6 H8 O2,112.05238,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,NA,Sorbic acid-peak1,6,8,2,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,3,1,0.25,0.4,1,Lignin,1022820.2766616158,20381712.067809053,19.926973030230634,4.316650671800988,3.518573710760865e-8,2.215785823802567e-7,Upregulated
Feature1072,Imidazoleacetic acid,C5 H6 N2 O2,126.04288,Metabolic pathways;Other,Other,Imidazoleacetic acid,5,6,2,2,0,0,1.2,0.4,0.7999999999999998,37.5,4,2,0,0.5,0,Lignin,7881703.621196413,17283929.67335684,2.1929179913432475,1.1328518604863507,1.6828322542801637e-4,4.665659310557443e-4,Upregulated
Feature1071,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10594,NA,NA,α-Aspartylphenylalanine-peak2,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,4185197.4365514754,3679117.6226242916,0.879078628523632,-0.18593588297963567,0.3847602633515521,0.45437705016467766,Downregulated
Feature1070,Indole-3-lactic acid,C11 H11 N O3,205.07389,Metabolic pathways;Other,Other,Indole-3-lactic acid,11,11,3,1,0,0,1,0.2727272727272727,-0.18181818181818168,65.48181818181817,7,4,0.42857142857142855,0.5294117647058824,3,Lignin,1204691.8910220407,4026969.247671946,3.3427379047563206,1.741030241484858,1.3974595117397187e-4,3.9586896536573306e-4,Upregulated
Feature1069,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10622,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak3,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,4490318.768425658,16807843.236668035,3.7431291860290354,1.9042448406042174,5.5765267824566404e-5,1.726211726130212e-4,Upregulated
Feature1068,Dicyclomine,C19 H35 N O2,309.26682,NA,NA,Dicyclomine,19,35,2,1,0,0,1.8421052631578947,0.10526315789473684,-1.473684210526316,102.3,3,1,0,0.0588235294117647,0,Lipid,8795959.015655372,3585781.046646085,0.40766231860152824,-1.2945534843426896,0.13640641503487017,0.1863487637653791,Downregulated
Feature1067,Maltol,C6 H6 O3,126.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,Maltol,6,6,3,0,0,0,1,0.5,0,60.3,4,1,0.3333333333333333,0.5555555555555556,1,Lignin,28595463.32037071,1745287.8133106404,0.06103373090189939,-4.034249406849065,4.680041915190196e-12,1.3213318340553654e-10,Downregulated
Feature1066,Proacaciberin,C16 H25 N O10,391.14794,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,Proacaciberin,16,25,10,1,0,0,1.5625,0.625,-0.125,63.8625,5,-5,-1.2,-0.1,-6,Amino Sugar,30184555.770204034,188812.24609316848,0.006255260058508133,-7.320714419883962,1.672662736526367e-9,1.6284429170549806e-8,Downregulated
Feature1065,N-Acetylvaline,C7 H13 N O3,159.08955,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-Acetylvaline,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,5602126.120216947,11426044.073972516,2.0395906534017896,1.028279631821126,0.12568925538923534,0.1729631183016772,Upregulated
Feature1064,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06372,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak2,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,14873096.10616132,20848240.232501067,1.4017417815154496,0.48722061123339583,2.409553771116254e-5,8.13104400053971e-5,Upregulated
Feature1063,N6-Me-Adenosine,C11 H15 N5 O4,281.11242,NA,NA,N6-Me-Adenosine,11,15,4,5,0,0,1.3636363636363635,0.3636363636363637,0.7272727272727271,39.57272727272728,7,3,-1,0,-2,Lignin,23943882.246321052,949752.513852064,0.03966576948890535,-4.655961653215091,2.1441424291787064e-7,1.1210423688360273e-6,Downregulated
Feature1062,Prolylglycine,C7 H12 N2 O3,172.08478,NA,NA,Prolylglycine,7,12,3,2,0,0,1.7142857142857142,0.42857142857142855,0,60.3,3,0,-1,-0.14285714285714285,-2,Protein,27040960.061955307,6613869.401708446,0.2445870777722011,-2.03157991067223,1.5356980916497442e-7,8.155086417726229e-7,Downregulated
Feature1061,NA,C10 H22 N2 O6,266.14776,NA,NA,Feature1061,10,22,6,2,0,0,2.2,0.6,-0.4000000000000003,71.7,1,-5,-3.5,-0.8,-7,Amino Sugar,342077.37037511746,17520222.734391093,51.21713463588267,5.678554637900152,8.716805847349333e-9,6.448152447777191e-8,Upregulated
Feature1060,Acetyl-L-methionine,C7 H13 N O3 S,191.06162,NA,NA,Acetyl-L-methionine-peak2,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,501866.78154232085,9126990.225419974,18.186081568043218,4.184762823620234,2.3156692228063007e-4,6.187292844532922e-4,Upregulated
Feature1059,NP-007735,C18 H24 O12,432.1269,NA,NA,NP-007735,18,24,12,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,7,-5,-0.8333333333333334,0.08333333333333333,-5,Tannin,2070968.8115478205,234955.94286820595,0.1134521879605721,-3.139843662788269,0.06432637979128936,0.09500338915993388,Downregulated
Feature1058,NA,C16 H28 N2 O8,376.18453,NA,NA,Feature1058,16,28,8,2,0,0,1.75,0.5,-0.375,70.9875,4,-4,-1,-0.2,-6,Protein,578708.6283056126,9466470.512074199,16.357921843658794,4.031917570777903,3.7523865145509757e-6,1.4782657571277565e-5,Upregulated
Feature1057,HC blue 2,C12 H19 N3 O5,285.1325,NA,NA,HC blue 2-peak2,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,3321976.769766544,6740267.5333426455,2.0289929763164256,1.0207638709836797,8.254345140917573e-4,0.0019393704117495656,Upregulated
Feature1056,Stavudine,C10 H12 N2 O4,224.07968,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Stavudine,10,12,4,2,0,0,1.2,0.4,0.20000000000000015,54.599999999999994,6,2,0,0.3333333333333333,0,Lignin,263273.53122197214,652902.6307642816,2.4799402649171136,1.310305370392088,0.001076003332687583,0.0024285629038356313,Upregulated
Feature1055,val-his,C11 H18 N4 O3,254.1379,NA,NA,val-his,11,18,3,4,0,0,1.6363636363636365,0.2727272727272727,0,60.3,5,2,-0.5,-0.09090909090909093,-2,Lipid,16074607.78327988,10362350.34583402,0.6446409446215225,-0.6334322702403918,8.454674824236325e-5,2.530427412059423e-4,Downregulated
Feature1054,NA,C23 H32 N2 O12,528.19573,NA,NA,Feature1054,23,32,12,2,0,0,1.391304347826087,0.5217391304347826,-0.08695652173913082,62.77826086956522,9,-3,-0.5555555555555556,0.06666666666666667,-5,Lignin,30669472.419197742,1311012.4314246099,0.04274649441325158,-4.5480500785479085,1.3970944808235272e-10,2.02280175257697e-9,Downregulated
Feature1053,lamifiban,C24 H28 N4 O6,468.20096,NA,NA,lamifiban-peak3,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,4230643.090776153,19332799.992097568,4.569707152618912,2.192101713860663,1.7354134727245255e-10,2.4295788618143356e-9,Upregulated
Feature1052,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak3,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,1165211.4028066227,8321155.247430954,7.141326653161774,2.836192110409483,6.544371362970661e-10,7.440379254276711e-9,Upregulated
Feature1051,NA,C6 H19 N4 O P,194.12956,NA,NA,Feature1051,6,19,1,4,0,1,3.1666666666666665,0.16666666666666666,-1.666666666666667,107.8,0,-1,-Inf,-11,-6,Other,1631634.4673671897,16227632.245105634,9.945629716495626,3.3140627194857566,4.028987828498786e-5,1.2926335949766938e-4,Upregulated
Feature1050,ascopyrone M,C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,ascopyrone M,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,19641595.448683854,3426188.8000258487,0.1744353613726135,-2.519235563341135,2.8536014078602053e-8,1.852107580427275e-7,Downregulated
Feature1049,indospicine,C7 H15 N3 O2,173.11643,NA,NA,indospicine,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,1868584.0119274403,7909453.7252453985,4.232859574286315,2.08163262783866,0.01576965617186074,0.026607368082800894,Upregulated
Feature1048,Xanthine,C5 H4 N4 O2,152.03344,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of plant secondary metabolites;Other,Other,Xanthine,5,4,2,4,0,0,0.8,0.4,2.4,-8.099999999999994,6,4,-0,Inf,0,Condensed HC,30987075.772091147,2413762.26211362,0.0778957743501438,-3.682311121942776,2.5808878172767435e-8,1.714519200967374e-7,Downregulated
Feature1047,ser-gln,C8 H15 N3 O5,233.10121,NA,NA,ser-gln,8,15,5,3,0,0,1.875,0.625,0.5,46.05,3,-2,-Inf,-1,-5,Amino Sugar,11659014.350645898,6560379.936573987,0.5626873541167353,-0.8295945543781237,1.964201521801001e-4,5.315267376886416e-4,Downregulated
Feature1046,Isovalerylglutamic acid,C10 H17 N O5,231.11068,NA,NA,Isovalerylglutamic acid-peak6,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,385193.1500073801,9868233.3974546,25.618922343934543,4.67913788509617,1.1002738765445543e-4,3.197022207318139e-4,Upregulated
Feature1045,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak2,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,444731.5688715591,4759252.925578587,10.701405653874517,3.4197284052223407,8.4710745479044e-4,0.001978773352153236,Upregulated
Feature1044,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak3",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,3350729.5653472105,16482494.050157512,4.919076197798003,2.298387402964042,5.524638170218606e-4,0.0013563387043985969,Upregulated
Feature1043,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak4,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,2080899.4407188746,15026181.777635181,7.2210033236609386,2.8521993065729028,3.3472840374388216e-5,1.0988951859343728e-4,Upregulated
Feature1042,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",C9 H12 O4,184.07358,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Tyrosine metabolism;Other,Other,"1-(3-Hydroxy-4-methoxyphenyl)-1,2-ethanediol",9,12,4,0,0,0,1.3333333333333333,0.4444444444444444,-0.44444444444444464,72.96666666666667,4,0,0,0.2857142857142857,0,Lignin,1231397.6364267983,1165320.103165239,0.9463394022313545,-0.07957039959016134,0.9072188083744445,0.9175096485888411,Downregulated
Feature1041,NA,C26 H40 O3 S2,464.24195,Other,NA,Feature1041,26,40,3,0,2,0,1.5384615384615383,0.1153846153846154,-1.1538461538461542,93.1846153846154,7,4,0.09523809523809525,0.15555555555555556,2,Lipid,12376530.266065834,7428432.617486446,0.6002031633901337,-0.7364771721603723,0.32299855382186005,0.400556039659027,Downregulated
Feature1040,3-Butynoic acid,C4 H4 O2,84.02114,Metabolic pathways;Other,NA,3-Butynoic acid-peak2,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,18841123.59250723,3357183.032284924,0.1781838018206098,-2.488561903343192,2.5330372665500294e-13,1.2259900370102142e-11,Downregulated
Feature1039,4-Oxo-4-(3-pyridyl)butyric acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Oxo-4-(3-pyridyl)butyric acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,22454277.140490405,18730197.92707256,0.8341483366346073,-0.2616241338819499,1.0212827916964162e-4,2.988001811975352e-4,Downregulated
Feature1038,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",C21 H22 O7,386.13664,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"2-(2,4-Dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-6-(3-methyl-2-buten-1-yl)-2,3-dihydro-4H-chromen-4-one",21,22,7,0,0,0,1.0476190476190477,0.3333333333333333,-0.3809523809523814,71.15714285714287,11,4,0.2857142857142857,0.42857142857142855,4,Lignin,264941.42299498175,379844.9477400582,1.4336940726224332,0.5197372088398801,0.5414186206038043,0.5955228819681266,Upregulated
Feature1037,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak4,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,17450688.39670054,11793745.118889855,0.6758326577603516,-0.5652620284185994,0.001563004808144687,0.003360063635783122,Downregulated
Feature1036,nicotianamine,C12 H21 N3 O6,303.14313,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,nicotianamine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1166937.8019318418,531543.4539814456,0.4555028152327282,-1.1344681242634507,0.002000222457124697,0.004167745193566097,Downregulated
Feature1035,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak2,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,4584843.243389916,15128136.745800266,3.2995973782987855,1.7222899954501913,9.083448289539715e-5,2.704281441560681e-4,Upregulated
Feature1034,N-(2-morpholinophenyl)-2-furamide,C15 H16 N2 O3,272.11607,NA,NA,N-(2-morpholinophenyl)-2-furamide,15,16,3,2,0,0,1.0666666666666669,0.2,-0.2666666666666666,67.89999999999999,9,6,0.4,0.4782608695652174,4,Lignin,1932003.3735598694,2157395.0136728957,1.1166621358935438,0.15919274123387198,0.6071106316083176,0.6533960673090788,Upregulated
Feature1033,17-Methyl-6Z-octadecenoic acid,C19 H36 O2,296.27159,NA,NA,17-Methyl-6Z-octadecenoic acid,19,36,2,0,0,0,1.894736842105263,0.10526315789473684,-1.6842105263157894,108.3,2,0,0,0.05555555555555555,0,Lipid,8044469.186326865,36367817.34993087,4.520847368244635,2.1765932105580887,0.3897586672508626,0.45914546754030683,Upregulated
Feature1032,NA,C23 H33 N3 O5,431.24203,NA,NA,Feature1032,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,148906.1342126404,12331747.542885236,82.81557780067877,6.37183026239394,0.0034654754635469543,0.006786723046530105,Upregulated
Feature1031,threonylphenylalanine,C13 H18 N2 O4,266.12655,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak5,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,195793.5343933997,10872546.11920257,55.53066986040928,5.795212893994778,1.676455217767124e-4,4.6555985883565704e-4,Upregulated
Feature1030,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak2",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,678759.9933813725,872131.2309778666,1.2848889732483764,0.3616437020929105,0.3712073344488518,0.4428346651805316,Upregulated
Feature1029,NA,C27 H33 N8 O7 P,612.22109,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Feature1029,27,33,7,8,0,1,1.2222222222222223,0.25925925925925924,0,60.3,16,9,0,0.2413793103448276,0,Lignin,811306.541679319,1168957.0568009699,1.440832776204851,0.5269029052979423,0.5392511963563618,0.5940110129183873,Upregulated
Feature1028,5-Ethyl-4-hydroxy-3(2H)-furanone,C6 H8 O3,128.04731,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Aminobenzoate degradation;Other,Other,5-Ethyl-4-hydroxy-3(2H)-furanone-peak1,6,8,3,0,0,0,1.3333333333333333,0.5,-0.33333333333333304,69.79999999999998,3,0,0,0.3333333333333333,0,Lignin,1223387.8139813833,10251726.091177717,8.379784377461291,3.0669131220189616,2.749752167772255e-4,7.210650421371827e-4,Upregulated
Feature1027,Quinestrol,C25 H32 O2,364.24025,NA,NA,Quinestrol-peak1,25,32,2,0,0,0,1.28,0.08,-1.12,92.22,10,8,0.34782608695652173,0.375,8,Unsaturated HC,5226283.915032497,1777075.7466409497,0.3400266375750273,-1.5562803238418526,0.4171851771229558,0.4847130933102106,Downregulated
Feature1026,Phenacetin,C10 H13 N O2,179.09465,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak3,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,2269288.8070842023,2457602.7887370815,1.0829837000319245,0.11501152913268804,0.6971085720825758,0.73302415959521,Upregulated
Feature1025,(DL)-3-O-Methyldopa,C10 H13 N O4,211.08446,NA,NA,(DL)-3-O-Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,9901133.569129586,11287405.774453325,1.1400114639040877,0.1890483321395073,0.03345622548275603,0.05267178993288914,Upregulated
Feature1024,NA,C18 H29 N3 O12,479.17524,NA,NA,Feature1024,18,29,12,3,0,0,1.6111111111111112,0.6666666666666666,0.22222222222222232,53.96666666666666,6,-6,-3,-0.3333333333333333,-9,Amino Sugar,27739592.43830525,617971.273948346,0.02227759024660353,-5.488263004102868,2.323893876631156e-10,3.1493409816105426e-9,Downregulated
Feature1023,2181,C11 H15 N O2,193.11028,NA,NA,2181,11,15,2,1,0,0,1.3636363636363635,0.18181818181818185,-0.7272727272727275,81.02727272727273,5,3,0.25,0.3333333333333333,2,Lignin,410211.26575746696,8234227.8009416405,20.073139107325346,4.327194342900293,1.34963498096646e-10,1.9709324635837788e-9,Upregulated
Feature1022,NA,C12 H23 N5 O2,269.18519,NA,NA,Feature1022,12,23,2,5,0,0,1.9166666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,2,-0.6,-0.3333333333333333,-3,Lipid,22228944.993206948,191554.30927635657,0.008617336960206369,-6.858542186564392,1.366190753732911e-14,1.1571635684117758e-12,Downregulated
Feature1021,NA,C10 H23 N O7,269.14745,NA,NA,Feature1021,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,5081389.405345011,437446.8255048118,0.08608803431688788,-3.5380434635503106,0.0067402683016436595,0.012211780217095571,Downregulated
Feature1020,N-Acetyl-L-leucine,C8 H15 N O3,173.10517,Other,NA,N-Acetyl-L-leucine-peak4,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,8734326.470079755,10045824.406137161,1.1501544441406057,0.20182760102624905,0.5251988170207046,0.5830188702706904,Upregulated
Feature1019,NA,C20 H30 N4 O6,422.21665,NA,NA,Feature1019,20,30,6,4,0,0,1.5,0.3,-0.2999999999999998,68.85,8,2,-0.2,0.07692307692307693,-2,Lipid,3355737.9934749827,11758553.715005782,3.504014240047803,1.8090086379540986,3.749530813475651e-6,1.4782657571277565e-5,Upregulated
Feature1018,MFCD03548046,C12 H16 N2 O4,252.111,NA,NA,MFCD03548046,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,14911499.452323878,7905042.814752601,0.530130644475237,-0.915580156135531,1.2993154752627712e-5,4.69304992557598e-5,Downregulated
Feature1017,1â€²-Acetoxyeugenol acetate,C14 H16 O5,264.09978,NA,NA,1â€²-Acetoxyeugenol acetate,14,16,5,0,0,0,1.1428571428571428,0.35714285714285715,-0.4285714285714288,72.51428571428572,7,2,0.2222222222222222,0.391304347826087,2,Lignin,3510087.2713251007,538923.2292697853,0.1535355641075942,-2.703355222882559,0.3642574386712105,0.43607922339860816,Downregulated
Feature1016,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak3",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,7692217.352158883,17841421.00612254,2.3194119704788636,1.2137590920753973,1.1537860029914205e-11,2.7146020681492587e-10,Upregulated
Feature1015,Guanine,C5 H5 N5 O,151.04939,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak2,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,22304350.06869148,16610884.61909961,0.7447374421555657,-0.4251962030894759,0.010704888788344137,0.01871422250511349,Downregulated
Feature1014,Val-lys,C11 H23 N3 O3,245.17392,NA,NA,Val-lys,11,23,3,3,0,0,2.090909090909091,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,5522070.700941239,3887107.9297343064,0.7039221589596358,-0.5065121931439714,0.0729731457987293,0.10592674291606463,Downregulated
Feature1013,3-Hydroxy-2-methylpyridine,C6 H7 N O,109.05272,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,3-Hydroxy-2-methylpyridine,6,7,1,1,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,4,3,0.5,0.5555555555555556,2,Lignin,20032407.5358048,15753110.935120214,0.7863813127285868,-0.34669905646691446,1.5355892893093936e-5,5.408083692495037e-5,Downregulated
Feature1012,Crotanecine,C8 H13 N O3,171.08958,Other,NA,Crotanecine-peak2,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,639010.0204770992,9958344.891956601,15.584019925887043,3.9619955220660485,3.99174491654039e-5,1.2831149693774991e-4,Upregulated
Feature1011,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,C15 H13 N O3,255.08951,NA,NA,1-Hydroxy-3-methoxy-10-methyl-9(10H)-acridinone,15,13,3,1,0,0,0.8666666666666667,0.2,-0.2666666666666666,67.89999999999999,10,7,0.5454545454545454,0.6,6,Lignin,20905853.76720403,17764562.6054107,0.8497410726788294,-0.2349047948955092,8.359364715151636e-4,0.0019559066060037115,Downregulated
Feature1010,NA,C10 H15 N O5,229.09503,NA,NA,Feature1010,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,9361360.077495996,12564591.691216463,1.34217587906065,0.4245737350424208,0.0048089606152574614,0.00902146099916516,Upregulated
Feature1009,thiodiglycol,C4 H10 O2 S,122.04011,NA,NA,thiodiglycol,4,10,2,0,1,0,2.5,0.5,-1,88.8,0,-2,-3,-1,-3,Other,1118798.980093868,8905744.440369565,7.96009345630827,2.992785368980104,0.0017024967873207988,0.0036140721274704676,Upregulated
Feature1008,lys-leu,C12 H25 N3 O3,259.18959,NA,NA,lys-leu-peak3,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,5763661.286385432,5376106.337823678,0.9327588958988252,-0.10042388052296057,0.8746494336081156,0.8914898559158531,Downregulated
Feature1007,NA,C17 H29 N O12,439.16903,NA,NA,Feature1007,17,29,12,1,0,0,1.7058823529411764,0.7058823529411765,-0.117647058823529,63.65294117647058,4,-8,-2.25,-0.3,-9,Carbohydrate,24665150.500087045,201219.19806935216,0.008158036500472277,-6.937562322649016,8.142457356023657e-12,2.0582305857660702e-10,Downregulated
Feature1006,NA,C17 H29 N3 O7,387.20043,NA,NA,Feature1006,17,29,7,3,0,0,1.7058823529411764,0.4117647058823529,-0.35294117647058787,70.35882352941175,5,-2,-0.7142857142857143,-0.14285714285714285,-5,Protein,10043111.969452059,1528757.8769837637,0.1522195392856076,-2.7157745361697496,4.098367502517744e-11,7.231910988817768e-10,Downregulated
Feature1005,Pyridoxine,C8 H11 N O3,169.07393,Metabolic pathways;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Tyrosine metabolism;Other,Other,Pyridoxine-peak1,8,11,3,1,0,0,1.375,0.375,-0.25,67.425,4,1,0,0.2727272727272727,0,Lignin,18338631.36482776,14946991.903005267,0.8150549299809022,-0.29503080297851547,0.001910152654302781,0.004004701233154592,Downregulated
Feature1004,Perillartine,C10 H15 N O,165.11539,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,Perillartine,10,15,1,1,0,0,1.5,0.1,-1,88.8,4,3,0.25,0.29411764705882354,2,Lipid,478925.6899392986,7699551.695048348,16.076714732141905,4.006900717580494,1.6579171545178817e-11,3.5550780503206223e-10,Upregulated
Feature1003,NA,C16 H22 N2 O8,370.13769,NA,NA,Feature1003,16,22,8,2,0,0,1.375,0.5,0,60.3,7,-1,-0.5,0.1,-3,Lignin,6587394.7209480265,17241996.96592115,2.6174227743012435,1.3881469718165604,4.3263072534491607e-10,5.197705310172254e-9,Upregulated
Feature1002,α-Aspartylphenylalanine,C13 H16 N2 O5,280.10596,NA,NA,α-Aspartylphenylalanine-peak1,13,16,5,2,0,0,1.2307692307692308,0.38461538461538464,0,60.3,7,2,0,0.29411764705882354,0,Lignin,10227659.36858703,5543182.652385946,0.5419795920668941,-0.8836895661462204,0.19335454454928563,0.25569289497774383,Downregulated
Feature1001,2-Mercaptoethanol,C2 H6 O S,78.01397,Metabolic pathways;Other,Other,2-Mercaptoethanol,2,6,1,0,1,0,3,0.5,-1,88.8,0,-1,-Inf,-3,-2,Other,16011262.161568753,9321354.670512712,0.5821748826826668,-0.780475497630121,0.0017814016433624017,0.0037674087189212336,Downregulated
Feature1000,N-Acetyl-L-leucine,C8 H15 N O3,173.10514,Other,NA,N-Acetyl-L-leucine-peak3,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,6876015.097181546,13306411.293203404,1.935192274178929,0.9524769148056331,0.2965123275940779,0.37262009120502076,Upregulated
Feature0999,metharbital,C9 H14 N2 O3,198.10045,NA,NA,metharbital-peak2,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,19857109.49315552,16277737.363375913,0.819743546712407,-0.2867554555885186,0.003304791727983059,0.006517249344823401,Downregulated
Feature0998,Furan,C4 H4 O,68.02622,Other,NA,Furan-peak1,4,4,1,0,0,0,1,0.25,-0.5,74.55,3,2,0.6666666666666666,0.7142857142857143,2,Lignin,15739472.064120201,19223428.35093187,1.2213515340678878,0.2884785020972955,0.06521216853188656,0.09614396300523571,Upregulated
Feature0997,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",C23 H28 O7,416.18357,NA,NA,"(6R,7R)-1,2,3,13-Tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrobenzo[3',4']cycloocta[1',2':4,5]benzo[1,2-d][1,3]dioxol-6-ol",23,28,7,0,0,0,1.2173913043478262,0.30434782608695654,-0.6086956521739131,77.64782608695651,10,3,0.1875,0.3333333333333333,3,Lignin,329454.54183290584,495442.4746485482,1.5038265124292285,0.5886381414206889,0.5024268963766492,0.5620989152479947,Upregulated
Feature0996,Benserazide,C10 H15 N3 O5,257.1012,NA,NA,Benserazide,10,15,5,3,0,0,1.5,0.5,0.3999999999999999,48.9,5,0,-1.5,-0.1111111111111111,-3,Protein,27546216.382943403,2757783.894065481,0.10011479818960178,-3.3202728570088293,1.646633029855786e-8,1.1478997335702475e-7,Downregulated
Feature0995,MFCD00672375,C5 H9 N O5,163.04806,Metabolic pathways;Other,NA,MFCD00672375,5,9,5,1,0,0,1.8,1,0.7999999999999998,37.5,2,-3,4,-1,-4,Carbohydrate,12601712.308797313,7327892.743317283,0.5814997647741607,-0.7821494867816813,1.5528405474927028e-4,4.34077869216607e-4,Downregulated
Feature0994,NA,C11 H18 N2 O4,242.12664,NA,NA,Feature0994,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,11884675.659571482,5275047.133506121,0.44385284753293136,-1.1718466420109381,2.66187231190568e-6,1.0813457305439381e-5,Downregulated
Feature0993,Phe-his,C15 H18 N4 O3,302.13799,NA,NA,Phe-his,15,18,3,4,0,0,1.2,0.2,0,60.3,9,6,0.25,0.3684210526315789,2,Lignin,1989531.269505413,5364387.674961109,2.6963072946798503,1.4309849279911118,4.362559458020678e-5,1.387741874033006e-4,Upregulated
Feature0992,Cytidine 5'-monophosphate (hydrate),C9 H14 N3 O8 P,323.05194,Metabolic pathways;Other,Other,Cytidine 5'-monophosphate (hydrate)-peak1,9,14,8,3,0,1,1.5555555555555556,0.8888888888888888,0.6666666666666665,41.3,5,-3,2.3333333333333335,-3,-7,Carbohydrate,23581656.731484972,2524844.481342825,0.10706815513821755,-3.223398646131889,6.962600054747906e-7,3.1706033582642348e-6,Downregulated
Feature0991,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",C10 H14 O4,198.08925,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Other,"4-Ethyl-2,6-dimethoxy-1,3-benzenediol",10,14,4,0,0,0,1.4,0.4,-0.5999999999999996,77.39999999999999,4,0,0,0.25,0,Lignin,2791480.933637025,3044555.5849148366,1.0906596381255165,0.12520095042451898,0.793839646399897,0.8206126965995598,Upregulated
Feature0990,lamifiban,C24 H28 N4 O6,468.20102,NA,NA,lamifiban-peak2,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,1694725.4001717835,5928210.169126657,3.4980358284154778,1.8065450660499083,0.003743959419033186,0.007240031113975134,Upregulated
Feature0989,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10008,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak3",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,2035930.3721977419,7326811.855741591,3.598753648845299,1.8474973465656044,0.006820743050971225,0.012331204619365268,Upregulated
Feature0988,NA,C14 H27 N O9,353.16869,Biosynthesis of secondary metabolites;Other,NA,Feature0988,14,27,9,1,0,0,1.9285714285714288,0.6428571428571429,-0.4285714285714288,72.51428571428572,2,-7,-2,-0.4117647058823529,-8,Amino Sugar,275965.2718590262,238281.77472938146,0.8634484082877828,-0.21181811670580974,0.7342123043503842,0.7654307490788401,Downregulated
Feature0987,"3',4'-Dimethoxyacetophenone",C10 H12 O3,180.07865,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,"3',4'-Dimethoxyacetophenone-peak1",10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,770575.5561381611,10825413.564311448,14.048477761952904,3.8123419090161925,9.945190521418878e-5,2.9197838376574664e-4,Upregulated
Feature0986,met-pro,C10 H18 N2 O3 S,246.10387,NA,NA,met-pro,10,18,3,2,1,0,1.8,0.3,-0.4000000000000003,71.7,3,0,-0.75,-0.2727272727272727,-3,Lipid,1722646.0472249282,8415995.291684054,4.88550466025315,2.2885075966336443,1.8320907874854175e-4,5.030083944895133e-4,Upregulated
Feature0985,δ-Valerolactam,C5 H9 N O,99.06839,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,δ-Valerolactam-peak1,5,9,1,1,0,0,1.8,0.2,-0.7999999999999998,83.1,2,1,0,0.14285714285714285,0,Lipid,9704089.392415944,2448143.9257311514,0.2522796139578489,-1.986904464198153,5.639391443704868e-4,0.00137851790846119,Downregulated
Feature0984,Valylglutamine,C10 H19 N3 O4,245.13752,NA,NA,Valylglutamine,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,18249270.969352443,4073864.8546817014,0.22323438900782885,-2.163368805043481,4.1974355593595113e-7,2.0142934384008533e-6,Downregulated
Feature0983,Pivagabine,C9 H17 N O3,187.12085,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak2,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,1599252.992848379,12451669.357490968,7.785928438572869,2.9608690847583414,8.859780195920666e-4,0.0020419683880121913,Upregulated
Feature0982,NA,C16 H25 N O9,375.15303,NA,NA,Feature0982,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,18700478.433234055,15368794.799329001,0.8218396579638272,-0.28307114529286553,0.022795848515812157,0.03709526165781536,Downregulated
Feature0981,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak2,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,3024914.1477141287,801402.1234111178,0.26493384085519334,-1.916295959312194,0.390242308501382,0.45939574051517795,Downregulated
Feature0980,NA,C18 H35 N5 O8,449.24869,NA,NA,Feature0980,18,35,8,5,0,0,1.9444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,-4,-1.8,-0.5555555555555556,-9,Protein,4337408.7034957195,8228586.444744882,1.8971203792976856,0.9238112259848441,0.01827888493550611,0.030506828650982608,Upregulated
Feature0979,D-lysopine,C9 H18 N2 O4,218.12662,Lysine degradation,NA,D-lysopine-peak4,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,13160506.36057376,7955640.511931329,0.6045086939636939,-0.7261650066154244,0.003864109272467711,0.00744687270484676,Downregulated
Feature0978,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12236,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak2",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,10080565.88631593,2631581.544130311,0.26105494213401303,-1.9375746237144837,9.685380711132098e-12,2.3108499893884187e-10,Downregulated
Feature0977,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07395,NA,NA,Phenyl D-glucopyranosiduronic acid-peak4,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,23825614.31495901,6623268.272903631,0.2779894018827118,-1.8468982124519149,4.003736570857375e-6,1.566357910169144e-5,Downregulated
Feature0976,gamma-Glu-gln,C10 H17 N3 O6,275.11175,NA,NA,gamma-Glu-gln,10,17,6,3,0,0,1.7,0.6,0.3999999999999999,48.9,4,-2,-5,-0.5,-5,Amino Sugar,12308495.547755508,13711577.290870644,1.1139929520769898,0.15574010517728007,0.4584288847876613,0.5225965887148709,Upregulated
Feature0975,Borrelidin,C28 H43 N O6,489.30914,NA,NA,Borrelidin,28,43,6,1,0,0,1.5357142857142858,0.21428571428571427,-1,88.8,8,2,0.04761904761904761,0.16666666666666666,1,Lipid,773054.3945532523,6293173.101356965,8.140660147199327,3.0251457911099195,0.03264528817775664,0.05158686396746245,Upregulated
Feature0974,Tolycaine,C15 H22 N2 O3,278.16307,NA,NA,Tolycaine-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,16908838.293472238,13175705.868751487,0.7792200528547281,-0.35989728992370784,0.15093021677014207,0.20421388754682163,Downregulated
Feature0973,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",C11 H12 O6,240.06344000000001,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",11,12,6,0,0,0,1.0909090909090908,0.5454545454545454,0,60.3,6,0,0,0.375,0,Lignin,13093355.245191379,11559766.533850623,0.8828727486101031,-0.17972258247100492,0.1720172114525725,0.23017152938440588,Downregulated
Feature0972,L-Ergothioneine,C9 H15 N3 O2 S,229.08852,NA,NA,L-Ergothioneine,9,15,2,3,1,0,1.6666666666666667,0.2222222222222222,0,60.3,4,2,-0.6666666666666666,-0.25,-2,Lipid,3966116.815666909,5655362.995797846,1.4259194216010218,0.5118924576996274,0.060989407689800976,0.09054869117136097,Upregulated
Feature0971,Propoxur,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Propoxur,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,11400729.092896845,15792163.064685885,1.3851888713437719,0.470082702031517,0.06661196847619903,0.09792843106752336,Upregulated
Feature0970,Nojirimycin,C6 H13 N O5,179.07941,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Nojirimycin-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,24677900.974460635,3215357.8784872727,0.1302930051390867,-2.940168460881771,9.997968111048356e-10,1.0454665419824638e-8,Downregulated
Feature0969,Glycyl-L-leucine,C8 H16 N2 O3,188.11611,Metabolic pathways;Lysine degradation,Superpathway of L-lysine degradation,Glycyl-L-leucine-peak1,8,16,3,2,0,0,2,0.375,-0.5,74.55,2,-1,-1,-0.3333333333333333,-3,Protein,14471726.293925542,6564561.30450933,0.45361287044689214,-1.1404665201572994,0.001330858011051696,0.0029316950204441787,Downregulated
Feature0968,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0968,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,339709.53551917087,2316376.663454307,6.818697802857484,2.7694962476456846,3.2343924081344874e-4,8.352226736859484e-4,Upregulated
Feature0967,Methoxyphenamine,C11 H17 N O,179.13104,NA,NA,Methoxyphenamine,11,17,1,1,0,0,1.5454545454545454,0.09090909090909093,-1.0909090909090908,91.39090909090908,4,3,0.2222222222222222,0.2631578947368421,2,Lipid,22747073.65147598,799120.8988208811,0.035130712243024234,-4.831123363596946,3.105542792637667e-18,2.630394745364104e-15,Downregulated
Feature0966,Vorinostat,C14 H20 N2 O3,264.14742,Metabolic pathways;Other,NA,Vorinostat,14,20,3,2,0,0,1.4285714285714286,0.21428571428571427,-0.5714285714285712,76.58571428571427,6,3,0.1111111111111111,0.23809523809523808,1,Lignin,6351289.678768328,7758901.805015296,1.2216261889223006,0.28880289572099327,0.19158029702968793,0.25374278590171334,Upregulated
Feature0965,NA,C5 H10 N9 O2 P,259.06957,NA,NA,Feature0965,5,10,2,9,0,1,2,0.4,3.2,-30.90000000000001,6,4,0.8571428571428571,0.8333333333333334,-6,Protein,20078388.699082565,2992278.58457625,0.14902981655659328,-2.7463270937643696,8.255965500114504e-18,3.4964013892984923e-15,Downregulated
Feature0964,NA,C11 H19 N5 O2,253.15395,NA,NA,Feature0964,11,19,2,5,0,0,1.7272727272727273,0.18181818181818185,0,60.3,5,3,-0.5,-0.2,-2,Lipid,17053748.706536047,2626860.125527025,0.15403417575399422,-2.698677615910695,6.927492415817658e-18,3.4964013892984923e-15,Downregulated
Feature0963,pyroglutamylglycine,C7 H10 N2 O4,186.06407,NA,NA,pyroglutamylglycine,7,10,4,2,0,0,1.4285714285714286,0.5714285714285714,0.5714285714285716,44.014285714285705,4,0,-2,0,-2,Lignin,14683785.159637453,15167644.664028954,1.0329519602153758,0.046773159942902716,0.6351699193308791,0.6758654794890133,Upregulated
Feature0962,NA,C16 H30 N2 O9,394.19526,NA,NA,Feature0962,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,3044917.5598003794,6938879.753714944,2.278839941456362,1.188299597803577,0.011203657483310378,0.01952035808402616,Upregulated
Feature0961,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak3,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1240867.660240073,3824807.190209364,3.0823651165744552,1.6240377640825199,1.3321185510365433e-4,3.786256418550175e-4,Upregulated
Feature0960,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak2",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,3816183.2787444233,12706082.86143803,3.329526370551706,1.7353169666495922,2.630476373160737e-7,1.3503112048891783e-6,Upregulated
Feature0959,NA,C9 H19 N O9,285.106,NA,NA,Feature0959,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,5357639.982717283,4316675.429831674,0.8057046467766479,-0.3116770188156231,0.13216938303468967,0.18099712878505236,Downregulated
Feature0958,NA,C13 H25 N3 O4,287.18454,NA,NA,Feature0958,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,14518477.463906571,12418213.753895355,0.8553385700923156,-0.2254324974528518,0.19424900225738057,0.25667535867706914,Downregulated
Feature0957,4-Methoxycinnamaldehyde,C10 H10 O2,162.0681,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Other,4-Methoxycinnamaldehyde-peak1,10,10,2,0,0,0,1,0.2,-0.5999999999999996,77.39999999999999,6,4,0.5,0.5555555555555556,4,Lignin,2609748.8872344126,4073993.1758151213,1.5610671186576839,0.6425325678557983,0.5417359864893053,0.5955228819681266,Upregulated
Feature0956,NA,C13 H12 N2 O6 S,324.04171,NA,NA,Feature0956,13,12,6,2,1,0,0.9230769230769232,0.4615384615384616,0.6153846153846154,42.76153846153846,9,3,0,0.42857142857142855,0,Lignin,142367.70078531493,3315828.6457443014,23.290596304174674,4.541675671922733,0.0034444713187676197,0.006761221800686382,Upregulated
Feature0955,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak3,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,671868.8261963878,6116564.116944003,9.103806990973752,3.1864699715156806,0.010808784433425856,0.01887637198992103,Upregulated
Feature0954,N8-Acetylspermidine,C9 H21 N3 O,187.16849,NA,NA,N8-Acetylspermidine,9,21,1,3,0,0,2.3333333333333335,0.1111111111111111,-1.1111111111111107,91.96666666666664,1,0,-0.6,-0.4545454545454546,-3,Lipid,558098.1411021834,4638642.908467493,8.311518291938182,3.055112042840503,0.025753279708153172,0.04139094480608299,Upregulated
Feature0953,NA,C7 H9 O5 P S,235.99087,NA,NA,Feature0953,7,9,5,0,1,1,1.2857142857142858,0.7142857142857143,-0.2857142857142856,68.44285714285714,4,-1,-Inf,-0.2,-3,Tannin,25311666.102999214,8795728.76375727,0.3474970287599935,-1.5249274526240193,1.956501252395194e-6,8.203745350389748e-6,Downregulated
Feature0952,NA,C19 H41 N O2,315.3138,NA,NA,Feature0952,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,179155.00483222934,1003668.9747326716,5.602237993142099,2.4860032729934036,0.08433142537888723,0.12106562253545335,Upregulated
Feature0951,Guanine,C5 H5 N5 O,151.0494,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Guanine-peak1,5,5,1,5,0,0,1,0.2,2.4,-8.099999999999994,6,5,-0,-1,0,Lignin,4912215.281057959,9764253.907436853,1.9877495892920016,0.9911360219699784,0.013602126581077767,0.02332186480601795,Upregulated
Feature0950,NA,C18 H34 N2 O8,406.23161,NA,NA,Feature0950,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,3395238.666530672,4741957.284638277,1.3966491756185468,0.48196967560939435,0.4331793822755212,0.500549709123283,Upregulated
Feature0949,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,C9 H15 N3 O3 S,245.08343,NA,NA,({5-[(2S)-2-Carboxy-2-(trimethylammonio)ethyl]-1H-imidazol-2-yl}sulfanyl)oxidanide,9,15,3,3,1,0,1.6666666666666667,0.3333333333333333,0.22222222222222232,53.96666666666666,4,1,-1.5,-0.42857142857142855,-3,Protein,1639300.8658744833,4201193.17361636,2.5627956777630554,1.3577184624654954,0.042140305720478485,0.06519239989999137,Upregulated
Feature0948,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak3,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,403017.805045269,6425165.531645147,15.942634422624181,3.994818140427769,0.00644433837633728,0.011725788624613697,Upregulated
Feature0947,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak2,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,11432884.1044381,11525173.223269118,1.0080722517597456,0.011599045107554218,0.9391242489422835,0.9447009962637934,Upregulated
Feature0946,NA,C5 H11 N3,113.09524,NA,NA,Feature0946,5,11,0,3,0,0,2.2,0,-0.4000000000000003,71.7,2,2,-0.5,-0.5,-1,Lipid,13753165.000497907,10540645.690726722,0.7664159988151904,-0.38380041746355203,0.0036560676157543744,0.0070862454703523,Downregulated
Feature0945,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10593,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak2,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,13931428.095504548,4316199.746263462,0.3098174657095084,-1.690509617699099,6.728116762883697e-10,7.59828653088332e-9,Downregulated
Feature0944,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06295,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak3,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,1543743.0739251785,11949254.94641478,7.740442790154297,2.9524160977505503,6.354984036266211e-6,2.4138380699967527e-5,Upregulated
Feature0943,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07396,NA,NA,Phenyl D-glucopyranosiduronic acid-peak3,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,5888069.765448275,9850162.6351696,1.6729018214035511,0.7423527795481455,0.00905191509920896,0.01607331674849054,Upregulated
Feature0942,Cytosine,C4 H5 N3 O,111.04321,Metabolic pathways;Other,Other,Cytosine-peak1,4,5,1,3,0,0,1.25,0.25,1.5,17.549999999999997,4,3,NA,1,0,Lignin,4776309.720427136,1152034.301778595,0.24119757076297196,-2.051712717773171,3.7370403495498693e-6,1.4782657571277565e-5,Downregulated
Feature0941,Glu-Glu,C10 H16 N2 O7,276.09576,Other,NA,Glu-Glu,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,17466062.29080503,7741767.145515301,0.4432462805077099,-1.1738195700591596,2.582933813868244e-10,3.4183514692912543e-9,Downregulated
Feature0940,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",C25 H34 O3,382.25081,NA,NA,"(3S,5R,6S)-5,6-epoxy-3-hydroxy-5,6-dihydro-12'-apo-beta-caroten-12'-al",25,34,3,0,0,0,1.36,0.12,-1.12,92.22,9,6,0.2727272727272727,0.3191489361702128,6,Unsaturated HC,3904405.7479119375,976164.3033367482,0.2500161013897691,-1.9999070854113907,0.3807688113861821,0.4507493825913295,Downregulated
Feature0939,387122,C12 H18 O,178.13575,NA,NA,387122,12,18,1,0,0,0,1.5,0.08333333333333333,-1.333333333333333,98.29999999999998,4,3,0.2727272727272727,0.30434782608695654,3,Lipid,792076.9210152115,7299280.412069131,9.215368127016733,3.2040417984564735,0.004790187682927505,0.008996206136229704,Upregulated
Feature0938,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole",C11 H12 O3,192.07866,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,"4-methoxy-6-(prop-2-en-1-yl)-2H-1,3-benzodioxole-peak1",11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,489344.58569728554,668056.330292966,1.3652063388849542,0.4491190182431291,0.5686083061609833,0.6182429208194516,Upregulated
Feature0937,NA,C19 H41 N O2,315.31381,NA,NA,Feature0937,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,263328.56971838226,435561.41678679205,1.6540606180810722,0.7260121074248065,0.2868446079734363,0.36154372463318535,Upregulated
Feature0936,NA,C12 H21 N O8,307.12685,NA,NA,Feature0936,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,2443042.471342518,1913562.8451447063,0.7832703964794978,-0.35241766180499134,0.2635979480027358,0.33523642936684267,Downregulated
Feature0935,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak2,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,5820463.737024202,9889878.2140243,1.6991564007373485,0.7648186531008676,0.009299231963134659,0.016477927767311832,Upregulated
Feature0934,NA,C62 H106 N2 O14 P2 S2,1228.65592,NA,NA,Feature0934,62,106,14,2,2,2,1.7096774193548387,0.2258064516129032,-1.258064516129032,96.1548387096774,12,-2,-0.1904761904761905,-0.02040816326530612,-8,Lipid,142056.3771655343,8700501.01284611,61.24681754137416,5.936562976773012,0.0035785842074207027,0.006959955967130505,Upregulated
Feature0933,gamma glutamyl ornithine,C10 H19 N3 O5,261.13251,NA,NA,gamma glutamyl ornithine,10,19,5,3,0,0,1.9,0.5,0,60.3,3,-2,-2.5,-0.5555555555555556,-5,Protein,4422387.609058598,2631234.1046639513,0.5949804352911677,-0.7490858657482588,0.4044478674027284,0.4725066809518772,Downregulated
Feature0932,Crotonic acid,C4 H6 O2,86.0368,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Crotonic acid-peak1,4,6,2,0,0,0,1.5,0.5,-0.5,74.55,2,0,0,0.3333333333333333,0,Protein,664492.2584233956,3339188.652079583,5.025173144984854,2.329173305964708,4.233579445676975e-6,1.6448815552699073e-5,Upregulated
Feature0931,NA,C9 H19 N O9,285.10601,NA,NA,Feature0931,9,19,9,1,0,0,2.111111111111111,1,0.22222222222222232,53.96666666666666,1,-8,9,-1.2857142857142858,-9,Carbohydrate,6115698.576844071,5090028.632592122,0.8322889966919801,-0.26484353082422313,0.4620224811674484,0.5252792504011125,Downregulated
Feature0930,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak2,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,617594.1370751013,9962294.83335429,16.130811863816067,4.011747146054555,1.0156296019522574e-7,5.743817148377063e-7,Upregulated
Feature0929,NA,C20 H28 N2 O9,440.17967,NA,NA,Feature0929,20,28,9,2,0,0,1.4,0.45,-0.20000000000000015,66,8,-1,-0.3333333333333333,0.1111111111111111,-3,Lignin,865690.4980893293,11714313.331815848,13.531756854985217,3.7582772543371514,8.807320346076789e-11,1.3687707033260623e-9,Upregulated
Feature0928,anticapsin,C9 H13 N O4,199.0845,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,anticapsin-peak1,9,13,4,1,0,0,1.4444444444444444,0.4444444444444444,-0.22222222222222232,66.63333333333333,4,0,-0.25,0.16666666666666666,-1,Lignin,17112217.10230052,12436599.362113643,0.7267672732156781,-0.46043463931159767,0.0029789737266215682,0.0059649899443226205,Downregulated
Feature0927,Anhalamine,C11 H15 N O3,209.10518,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak3,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,632631.5101330732,7335534.60410116,11.595272266090792,3.535464790880538,0.009745961495690892,0.017143986265524786,Upregulated
Feature0926,NA,C24 H40 N8 O7,552.30201,NA,NA,Feature0926,24,40,7,8,0,0,1.6666666666666667,0.2916666666666667,-0.08333333333333304,62.67499999999999,9,2,-0.6666666666666666,-0.2,-6,Lipid,5869411.03154583,129433.7375954051,0.022052253096562578,-5.502930125140359,0.0769646642784047,0.11133914712862303,Downregulated
Feature0925,NA,C4 H5 N O,83.03712,NA,NA,Feature0925,4,5,1,1,0,0,1.25,0.25,0,60.3,3,2,0.5,0.6,1,Lignin,18001906.83793859,1387532.4237591913,0.07707696947053407,-3.697556341231164,2.3701715747680727e-12,8.188946354766004e-11,Downregulated
Feature0924,MFCD02728197,C14 H20 N2 O4,280.14234,NA,NA,MFCD02728197-peak2,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,2772429.1801419035,5087598.1872014385,1.8350687633943588,0.8758341245122611,9.310547923096363e-4,0.002134244679529802,Upregulated
Feature0923,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak2,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,12882629.97343968,13663619.788500395,1.060623476469548,0.08491258741304743,0.3263739467978459,0.4026784165153321,Upregulated
Feature0922,DiisopropylSulfate,C6 H14 O4 S,182.0613,NA,NA,DiisopropylSulfate,6,14,4,0,1,0,2.3333333333333335,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,9450369.077707548,12602198.804074906,1.3335139295037906,0.4152328949458932,0.020628207134123378,0.034158536544677424,Upregulated
Feature0921,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",C24 H32 O8,448.20981,Other,NA,"3,4-Bis(3,4,5-trimethoxybenzyl)tetrahydro-2-furanol",24,32,8,0,0,0,1.3333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,9,1,0.0625,0.25,1,Lignin,472940.640966411,673032.4053514944,1.423080080358952,0.5090168482916927,0.5627818413374944,0.6147784221728998,Upregulated
Feature0920,NA,C17 H25 N3 O4,335.18462,NA,NA,Feature0920,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,1542624.1674918227,12720200.743849672,8.245819696012964,3.0436629154447656,3.920937326606428e-7,1.908640181399796e-6,Upregulated
Feature0919,NA,C7 H9 O7 P,236.00858,NA,NA,Feature0919,7,9,7,0,0,1,1.2857142857142858,1,0,60.3,4,-3,4,-0.2,-4,Tannin,2640092.154063538,2460078.1289430135,0.931815249386862,-0.1018841541868796,0.8913955083772991,0.9047477478676721,Downregulated
Feature0918,MFCD00020424,C18 H20 N2 O3,312.14738,NA,NA,MFCD00020424,18,20,3,2,0,0,1.1111111111111112,0.16666666666666666,-0.44444444444444464,72.96666666666667,10,7,0.38461538461538464,0.4482758620689655,5,Lignin,3678419.8489767206,7193665.409032362,1.9556401129777308,0.9676409025023252,0.0111039011223729,0.019371790423583616,Upregulated
Feature0917,NA,C16 H22 N2 O4,306.15784,NA,NA,Feature0917,16,22,4,2,0,0,1.375,0.25,-0.5,74.55,7,3,0.1,0.25,1,Lignin,292414.4042954892,13194795.47615375,45.123616628749275,5.495810798334583,2.345885778165479e-5,7.931997022379883e-5,Upregulated
Feature0916,Panthenol,C9 H19 N O4,205.13142,Other,NA,Panthenol,9,19,4,1,0,0,2.111111111111111,0.4444444444444444,-0.8888888888888893,85.63333333333334,1,-3,-1,-0.3333333333333333,-4,Protein,690240.2858138911,2953295.6136376453,4.278648572584099,2.097155187862793,0.2714553909123684,0.3444535072700765,Upregulated
Feature0915,leu-gln,C11 H21 N3 O4,259.15323,NA,NA,leu-gln-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,4023609.9320842093,3147889.54769079,0.7823545524603573,-0.35410552935749373,0.11550622026917243,0.16091080356577148,Downregulated
Feature0914,Erythritol,C4 H10 O4,122.05787,ABC transporters,NA,Erythritol,4,10,4,0,0,0,2.5,1,-0.5,74.55,0,-4,-Inf,-1,-4,Carbohydrate,3276025.312545508,17692925.074174874,5.400729050053424,2.433154171332006,3.543742842268422e-4,9.027218608725875e-4,Upregulated
Feature0913,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.0794,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak2",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,12525869.033798557,2436743.408274702,0.1945368741841094,-2.3618844529899747,2.5878405078426786e-11,5.218811690816069e-10,Downregulated
Feature0912,NA,C76 H121 N10 O14 P3,1490.82761,NA,NA,Feature0912,76,121,14,10,0,3,1.5921052631578947,0.18421052631578944,-1.026315789473684,89.55,23,9,-0.08163265306122448,0.05357142857142857,-4,Lipid,2349870.6174912835,369290.05889521976,0.15715335820891832,-2.6697549934819276,0.3650545681940197,0.43672488596092474,Downregulated
Feature0911,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak2,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,3673454.8604226033,6154264.14701525,1.6753340876243266,0.744448820046734,0.10292202822996376,0.1455341534403661,Upregulated
Feature0910,mebutamate,C10 H20 N2 O4,232.1423,Other,NA,mebutamate-peak2,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,5261619.460870055,5579431.372080154,1.0604019187578317,0.08461118582318863,0.74903226446086,0.7798774775640424,Upregulated
Feature0909,Methylone,C11 H13 N O3,207.08953,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak2,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,1928495.4015135004,10707262.23271295,5.552132623344497,2.4730420298679374,4.45929877124666e-4,0.0011043935845748306,Upregulated
Feature0908,N-Acetyl-L-histidine,C8 H11 N3 O3,197.08007,NA,NA,N-Acetyl-L-histidine,8,11,3,3,0,0,1.375,0.375,0.5,46.05,5,2,-0.5,0.14285714285714285,-1,Lignin,5258120.677879801,5863771.632875337,1.1151839206626482,0.1572816648954665,0.5870371523777158,0.6354255182925563,Upregulated
Feature0907,NA,C12 H18 N4 O4,282.13282,NA,NA,Feature0907,12,18,4,4,0,0,1.5,0.3333333333333333,0.16666666666666652,55.55,6,2,-0.5,0,-2,Protein,18411225.667306587,8589166.578167059,0.46651791322177544,-1.0999956165540512,9.327165732601941e-10,9.813800466476825e-9,Downregulated
Feature0906,pro-asn,C9 H15 N3 O4,229.10627,NA,NA,pro-asn,9,15,4,3,0,0,1.6666666666666667,0.4444444444444444,0.22222222222222232,53.96666666666666,4,0,-1.5,-0.25,-3,Protein,1768421.3076780762,5946558.567097345,3.3626367999971296,1.7495929611005925,0.001004893243491278,0.002281888947016387,Upregulated
Feature0905,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine",C11 H13 N O6,255.07429,NA,NA,"N-(4-Hydroxy-3,5-dimethoxybenzoyl)glycine-peak1",11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,17274245.037031148,13780501.4160739,0.797748404432863,-0.3259942768971567,1.1489875514296233e-4,3.3045584246549776e-4,Downregulated
Feature0904,NA,C15 H27 N O13,429.14831,NA,NA,Feature0904,15,27,13,1,0,0,1.8,0.8666666666666667,0.1333333333333333,56.5,3,-10,-11,-0.6,-11,Carbohydrate,20526429.33358143,1183393.042169223,0.05765216263079819,-4.116481462934824,1.2791465384391241e-6,5.49968080232456e-6,Downregulated
Feature0903,NA,C6 H2 O4,137.99529,NA,NA,Feature0903,6,2,4,0,0,0,0.3333333333333333,0.6666666666666666,1,31.799999999999997,6,2,1,1,2,Condensed HC,19122988.342770092,1713818.2606102228,0.08962083905982055,-3.4800219562348143,4.812383087433595e-13,2.264493597253475e-11,Downregulated
Feature0902,NA,C12 H12 N6 O3,288.09707,NA,NA,Feature0902,12,12,3,6,0,0,1,0.25,1,31.799999999999997,10,7,0.3333333333333333,0.5555555555555556,1,Lignin,545641.0893691842,449979.586863438,0.8246805375006848,-0.27809273458412753,0.24529056725756945,0.3164677996453333,Downregulated
Feature0901,Drospirenone,C24 H30 O3,366.21955,NA,NA,Drospirenone-peak1,24,30,3,0,0,0,1.25,0.125,-1,88.8,10,7,0.3333333333333333,0.37777777777777777,7,Unsaturated HC,2469907.9342118963,656641.2772840327,0.2658565803966111,-1.9112799189008125,0.3950803999732645,0.4641235766676214,Downregulated
Feature0900,Methyldopa,C10 H13 N O4,211.08447,NA,NA,Methyldopa,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,19788588.211334262,13697135.937125579,0.6921734785142633,-0.5307944309757037,1.8131265298153797e-4,4.997340225202186e-4,Downregulated
Feature0899,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid",C14 H16 O6,280.09471,NA,NA,"(2Z)-3-[4,5-Dihydroxy-2-(2-hydroxy-2-propanyl)-2,3-dihydro-1-benzofuran-7-yl]acrylic acid-peak1",14,16,6,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,7,1,0.125,0.3636363636363637,1,Lignin,2996081.3749192758,661583.0728811069,0.22081612282608049,-2.1790825809595145,0.3378937196674112,0.4122820930085693,Downregulated
Feature0898,N-Acetylglucosamine 1-phosphate,C8 H16 N O9 P,301.05635,Metabolic pathways;Other,Other,N-Acetylglucosamine 1-phosphate,8,16,9,1,0,1,2,1.125,0,60.3,2,-7,3,-3,-9,Carbohydrate,2009423.6838677092,5836147.7686660485,2.9043888630956696,1.5382346259582136,0.0263574869763045,0.04228180202448847,Upregulated
Feature0897,NA,C14 H27 N3 O4,301.20023,NA,NA,Feature0897,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,7156298.29556743,10007187.730107967,1.3983748743825228,0.48375116823391207,0.08099696595108385,0.1164761123269406,Upregulated
Feature0896,NA,C21 H33 N3 O2,359.25734,NA,NA,Feature0896,21,33,2,3,0,0,1.5714285714285714,0.09523809523809525,-0.9523809523809526,87.44285714285715,7,5,0.125,0.17647058823529413,2,Lipid,2531872.6663571233,237099.02879978728,0.09364571605448353,-3.4166431917646607,0.3496144074721569,0.42333581576685764,Downregulated
Feature0895,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",C18 H18 N2 O2,294.13684,Biosynthesis of secondary metabolites;Other,NA,"11-(4-Hydroxyphenyl)-3-methyl-6,7,8,9-tetrahydropyridazino[1,2-a]indazol-10-ium-1-olate",18,18,2,2,0,0,1,0.1111111111111111,-0.44444444444444464,72.96666666666667,11,9,0.5,0.5333333333333333,7,Unsaturated HC,5279180.089551729,1492186.8864182723,0.28265504512178485,-1.8228856469397727,0.20312322631068827,0.26673701191496585,Downregulated
Feature0894,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak3,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,10821435.400258517,8388695.099220509,0.7751924572797532,-0.367373561670534,0.2599121904477427,0.3310460530965986,Downregulated
Feature0893,NA,C10 H17 N3 O3,227.12699,NA,NA,Feature0893,10,17,3,3,0,0,1.7,0.3,-0.20000000000000015,66,4,1,-0.5,-0.09090909090909093,-2,Lipid,20100479.67802766,2994341.942838558,0.14896868088733964,-2.7469190439174582,3.6192203002433995e-15,5.109132657176932e-13,Downregulated
Feature0892,NA,C10 H24 N2 O6 S,300.13557,NA,NA,Feature0892,10,24,6,2,1,0,2.4,0.6,-0.4000000000000003,71.7,0,-6,-9,-1.5,-9,Other,824410.9309546539,4007957.614566024,4.861601737770358,2.2814317126843195,1.7346450682962435e-6,7.309673496750837e-6,Upregulated
Feature0891,1-alpha-linolenoyl-sn-glycerol,C21 H36 O4,352.26122,NA,NA,1-alpha-linolenoyl-sn-glycerol-peak1,21,36,4,0,0,0,1.7142857142857142,0.1904761904761905,-1.333333333333333,98.29999999999998,4,0,0,0.10526315789473684,0,Lipid,1480792.6900624714,9035093.795173474,6.10152511949009,2.609169899612264,5.4334837441756456e-5,1.6857731616544953e-4,Upregulated
Feature0890,NA,C15 H28 N2 O9,380.17959,NA,NA,Feature0890,15,28,9,2,0,0,1.8666666666666667,0.6,-0.2666666666666666,67.89999999999999,3,-6,-2,-0.4117647058823529,-8,Amino Sugar,793795.8080950872,9353590.117407529,11.783370511685899,3.5586803611335753,1.7563951307040796e-8,1.2144217760868207e-7,Upregulated
Feature0889,4-Methyleneglutamic acid,C6 H9 N O4,159.05318,Other,NA,4-Methyleneglutamic acid-peak2,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,3916026.99423183,13815435.625973934,3.527921448530254,1.818818438707938,4.314430189435311e-11,7.480561381758283e-10,Upregulated
Feature0888,threonylphenylalanine,C13 H18 N2 O4,266.12654,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak4,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,156863.3743263167,5266308.201746348,33.57258011542615,5.069211509989342,3.366807008371275e-4,8.641471321486273e-4,Upregulated
Feature0887,CI-976,C23 H39 N O4,393.28787,NA,NA,CI-976,23,39,4,1,0,0,1.6956521739130437,0.17391304347826086,-1.2173913043478262,94.99565217391304,5,1,0,0.1,0,Lipid,1055644.93747861,7143076.555391723,6.766552182263896,2.7584209125898553,2.935438458589289e-4,7.638452763210838e-4,Upregulated
Feature0886,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10623,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak2,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,14686841.86765719,3647359.2704162323,0.2483419719012778,-2.009599985057725,2.0963147264689282e-10,2.8638364085793262e-9,Downregulated
Feature0885,NA,C13 H27 N O11,373.15852,NA,NA,Feature0885,13,27,11,1,0,0,2.076923076923077,0.8461538461538461,-0.1538461538461542,64.6846153846154,1,-10,-11,-0.8461538461538461,-11,Carbohydrate,285628.4031750207,118180.69051744007,0.4137567875034615,-1.27314511597714,0.2954753656720227,0.371592627652863,Downregulated
Feature0884,leu-phe,C15 H22 N2 O3,278.16308,NA,NA,leu-phe-peak1,15,22,3,2,0,0,1.4666666666666666,0.2,-0.666666666666667,79.30000000000001,6,3,0.1,0.21739130434782608,1,Lignin,6726565.957054111,6524987.943415929,0.9700325522822253,-0.043894932919415076,0.8410585268765404,0.8619196276641619,Downregulated
Feature0883,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",C12 H12 N2 O2,216.0899,NA,NA,"2,3,4,9-Tetrahydro-1H-β-carboline-3-carboxylic acid",12,12,2,2,0,0,1,0.16666666666666666,-0.16666666666666696,65.05000000000001,8,6,0.5,0.5555555555555556,4,Lignin,16845039.702406093,13431923.66744385,0.797381538110906,-0.32665789209059326,3.5895964581875346e-4,9.116606297105972e-4,Downregulated
Feature0882,NA,C11 H17 N5 O,235.1433,NA,NA,Feature0882,11,17,1,5,0,0,1.5454545454545454,0.09090909090909093,0,60.3,6,5,0,0.09090909090909093,0,Lipid,16460861.56134164,290137.60574406554,0.01762590643648047,-5.826158737778797,1.8290221679087502e-11,3.8729544405467786e-10,Downregulated
Feature0881,Methionylleucine,C11 H22 N2 O3 S,262.13517,NA,NA,Methionylleucine-peak2,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,2425165.3398104673,5463427.036545108,2.25280600331031,1.1717230836077666,0.016797171646164892,0.028228580127582666,Upregulated
Feature0880,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak2,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,7723237.218233271,8508859.437149664,1.101721881216036,0.13976007578679334,0.12330821443487956,0.17031162820085144,Upregulated
Feature0879,2-ethyl-1H-perimidine,C13 H12 N2,196.10009,NA,NA,2-ethyl-1H-perimidine,13,12,0,2,0,0,0.9230769230769232,0,-0.4615384615384617,73.45384615384616,9,9,0.6363636363636364,0.6363636363636364,7,Unsaturated HC,168739.69039736988,168946.07240158974,1.0012230791921797,0.001763452084094871,0.9975380693635583,0.9975380693635583,Upregulated
Feature0878,NA,C12 H21 N O8,307.12682,NA,NA,Feature0878,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,19305793.483913828,14283064.853852393,0.7398330902976599,-0.4347282659843745,0.0022746014946247845,0.004693270318994378,Downregulated
Feature0877,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak3,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,346212.52983644244,336761.2858572005,0.9727010342932797,-0.039931643035723996,0.9649265456830016,0.9689303902708979,Downregulated
Feature0876,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak2,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,629679.138055134,10700834.43760225,16.994106666219736,4.086962620221574,3.6294840254302084e-7,1.792520681947164e-6,Upregulated
Feature0875,uridine 5′-diphosphate,C9 H14 N2 O12 P2,404.00229,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of scopolin and esculin biosynthesis;Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,uridine 5′-diphosphate,9,14,12,2,0,2,1.5555555555555556,1.3333333333333333,0.6666666666666665,41.3,5,-7,1.5714285714285714,5,-11,Carbohydrate,1094592.5465802723,6184488.114963134,5.650036750464564,2.4982602515173022,7.240020096298884e-8,4.157489506145868e-7,Upregulated
Feature0874,Azobenzene,C12 H10 N2,182.08443,Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Azobenzene-peak1,12,10,0,2,0,0,0.8333333333333334,0,-0.33333333333333304,69.79999999999998,9,9,0.7,0.7,7,Unsaturated HC,1950484.927598776,2153574.820247626,1.1041227695611429,0.14290059710662784,0.4385468250973217,0.5038636297487575,Upregulated
Feature0873,DH2090000,C9 H10 O5,198.05285,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak2,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,546496.2035429585,336404.4069084072,0.6155658625393606,-0.7000148685993675,0.02291174477271049,0.0372480764347136,Downregulated
Feature0872,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",C6 H11 N O5,177.06376,Other,NA,"(2S,4S)-4-Amino-2-hydroxy-2-methylpentanedioic acid",6,11,5,1,0,0,1.8333333333333333,0.8333333333333334,0.3333333333333335,50.8,2,-3,-Inf,-0.6,-4,Carbohydrate,14431139.242919372,11397766.740317,0.7898036702756718,-0.34043402276369306,0.0023269795950267343,0.0047896761044657205,Downregulated
Feature0871,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak6,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,14561137.117544627,12987738.543981235,0.8919453500875552,-0.1649727766397628,0.14856267697807973,0.20165478750069477,Downregulated
Feature0870,3-Hydroxyhexadecadienoylcarnitine,C23 H41 N O5,411.2985,NA,NA,3-Hydroxyhexadecadienoylcarnitine,23,41,5,1,0,0,1.7826086956521738,0.21739130434782608,-1.2173913043478262,94.99565217391304,4,-1,-0.1176470588235294,0.02564102564102564,-2,Lipid,279476.2463350782,6648008.356273182,23.78738244645861,4.572124621829949,2.543583268350779e-4,6.73685498918006e-4,Upregulated
Feature0869,NA,C12 H21 N O8,307.12679,NA,NA,Feature0869,12,21,8,1,0,0,1.75,0.6666666666666666,-0.16666666666666696,65.05000000000001,3,-5,-2,-0.2857142857142857,-6,Amino Sugar,7084951.195280086,1446958.985777513,0.20422991576024693,-2.2917338860771688,0.0031166867457426677,0.006211373349750682,Downregulated
Feature0868,NA,C17 H32 N2 O8,392.21597,NA,NA,Feature0868,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,1291244.1569705557,8279979.238010586,6.412404031656265,2.6808653294386575,2.642982958070094e-6,1.0762531564833508e-5,Upregulated
Feature0867,Maleic acid,C4 H4 O4,116.01093,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Tyrosine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of purine nucleotide salvage;Other,Maleic acid,4,4,4,0,0,0,1,1,1,31.799999999999997,3,-1,-Inf,0.5,-1,Tannin,813731.5495864449,2466654.08438641,3.031287266224364,1.59993057858848,0.3798214576704011,0.44994234216339823,Upregulated
Feature0866,NA,C12 H21 N3 O4,271.15326,NA,NA,Feature0866,12,21,4,3,0,0,1.75,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,0,-0.6,-0.14285714285714285,-3,Protein,4599228.60224524,7159804.467371587,1.5567402898556362,0.6385282804544276,3.277455014704734e-4,8.45054611097385e-4,Upregulated
Feature0865,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak2",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,11384521.741775906,7821351.642212929,0.6870162681944031,-0.5415838331576579,0.1075080400934017,0.15138704897607852,Downregulated
Feature0864,(Ac)2-L-Lys-D-Ala,C13 H23 N3 O5,301.16384,NA,NA,(Ac)2-L-Lys-D-Ala,13,23,5,3,0,0,1.7692307692307692,0.38461538461538464,-0.3076923076923075,69.06923076923076,4,-1,-0.8,-0.2,-4,Protein,4831613.100232932,1650350.1519236614,0.341573325033848,-1.5497327819431002,0.08037587586830779,0.11568116713756448,Downregulated
Feature0863,Pro-Hyp,C10 H16 N2 O4,228.111,NA,NA,Pro-Hyp-peak2,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,15940736.704707503,9274674.461319298,0.5818221976265606,-0.7813497558316548,3.4566261448197064e-5,1.1304101716842824e-4,Downregulated
Feature0862,6-Aminocaproic acid,C6 H13 N O2,131.09459,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak2,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,873275.4227097771,10007717.387931256,11.459978292847483,3.5185324062744185,1.8021585377396318e-8,1.2359743169760876e-7,Upregulated
Feature0861,leu-gln,C11 H21 N3 O4,259.1532,NA,NA,leu-gln-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,15423725.629881674,4142840.649255761,0.26860181182356413,-1.8964590585506929,3.133313407993984e-7,1.5844277352662116e-6,Downregulated
Feature0860,1-Naphthol,C10 H8 O,144.05749,Other,NA,1-Naphthol,10,8,1,0,0,0,0.8,0.1,-0.5999999999999996,77.39999999999999,7,6,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,1515299.8518992271,3031796.514455948,2.000789817709012,1.0005696205792953,0.384906178858508,0.45437705016467766,Upregulated
Feature0859,thr-pro,C9 H16 N2 O4,216.11107,Metabolic pathways;Other,Other,thr-pro-peak2,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,20558539.635649987,4989626.87465604,0.24270337110928192,-2.042733947466026,2.682757142941328e-10,3.4958389231866227e-9,Downregulated
Feature0858,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13227,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak2,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,13009174.80043644,12263868.9226429,0.9427092118272915,-0.0851152692154592,0.3232362938719565,0.40055763117709897,Downregulated
Feature0857,Nonivamide,C17 H27 N O3,293.199,NA,NA,Nonivamide,17,27,3,1,0,0,1.588235294117647,0.17647058823529413,-1.0588235294117645,90.47647058823529,5,2,0.07692307692307693,0.1724137931034483,1,Lipid,593714.1760960941,5190105.322379706,8.741757450540772,3.1279233495538636,0.003192705119422015,0.006355396559695526,Upregulated
Feature0856,NA,C18 H34 N2 O8,406.23163,NA,NA,Feature0856,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,1804112.3837118954,8064705.993135985,4.470179389015193,2.160332728153475,4.6616454350992445e-6,1.798821723703444e-5,Upregulated
Feature0855,NA,C11 H24 N4 O5,292.17471,NA,NA,Feature0855,11,24,5,4,0,0,2.1818181818181817,0.4545454545454546,-0.18181818181818168,65.48181818181817,2,-3,-3.5,-1,-7,Protein,18125066.94492365,7161367.165100255,0.39510845321903565,-1.3396793822424373,1.988644776927696e-9,1.8611957194008384e-8,Downregulated
Feature0854,butalbital,C11 H16 N2 O3,224.11607,NA,NA,butalbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,7834359.517692075,3377657.62214972,0.4311338552337389,-1.2137922387962452,1.3505769312370638e-4,3.8322903207966267e-4,Downregulated
Feature0853,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10734,NA,NA,N(6)-OH-Me-Adenosine-peak2,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,8394865.665750273,11076027.520610813,1.319381150528621,0.3998613989662413,1.1409027874713995e-4,3.298104645011179e-4,Upregulated
Feature0852,Arg-pro,C11 H21 N5 O3,271.16445,NA,NA,Arg-pro,11,21,3,5,0,0,1.9090909090909092,0.2727272727272727,0,60.3,4,1,-1.3333333333333333,-0.5555555555555556,-4,Lipid,3374228.011460149,5580251.515276801,1.653786139029184,0.7257726830518093,0.04515861884705068,0.06948110838047579,Upregulated
Feature0851,NA,C10 H18 N2 O7,278.11141,NA,NA,Feature0851,10,18,7,2,0,0,1.8,0.7,0.20000000000000015,54.599999999999994,3,-4,-6,-0.5555555555555556,-6,Amino Sugar,540206.5436883298,6238605.660830477,11.548556258196344,3.529640599400512,0.0014097327581263181,0.003089375539800754,Upregulated
Feature0850,Sedanolide,C12 H18 O2,194.1307,NA,NA,Sedanolide-peak1,12,18,2,0,0,0,1.5,0.16666666666666666,-1.166666666666667,93.55,4,2,0.2,0.2727272727272727,2,Lipid,1300296.0039784007,6725116.255233443,5.171988712306429,2.370719126517597,0.004184560534842275,0.007991708620093364,Upregulated
Feature0849,Paracetamol,C8 H9 N O2,151.06336,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak2,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,1320892.9383508791,4250964.6584766125,3.218250726500133,1.6862767274869455,0.25792604135346053,0.32950732583164566,Upregulated
Feature0848,N-(2-Cyanoethyl)-L-glutamine,C8 H13 N3 O3,199.0957,Other,NA,N-(2-Cyanoethyl)-L-glutamine-peak1,8,13,3,3,0,0,1.625,0.375,0.25,53.175,4,1,-1,-0.14285714285714285,-2,Protein,4537543.35263015,2728222.680472457,0.6012554522241788,-0.7339500234913852,0.07096691169094592,0.10345778692294524,Downregulated
Feature0847,1-linoleoyl-sn-glycero-3-phosphoethanolamine,C23 H44 N O7 P,477.28563,NA,NA,1-linoleoyl-sn-glycero-3-phosphoethanolamine,23,44,7,1,0,1,1.9130434782608696,0.30434782608695654,-1.391304347826087,99.95217391304348,3,-4,-0.42857142857142855,-0.14285714285714285,-6,Protein,546395.4427648325,798337.4256831307,1.4610982508262491,0.5470531947149,0.5027035753250956,0.5620989152479947,Upregulated
Feature0846,Leucylasparagine,C10 H19 N3 O4,245.13754,NA,NA,Leucylasparagine-peak3,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,14201333.230976678,5423382.991597504,0.3818925239897718,-1.3887614171590688,1.245534979939644e-6,5.396256409252576e-6,Downregulated
Feature0845,NA,C17 H29 N O14,471.15895,NA,NA,Feature0845,17,29,14,1,0,0,1.7058823529411764,0.8235294117647058,0.11764705882352944,56.94705882352941,4,-10,-5.5,-0.4444444444444444,-11,Carbohydrate,15139396.989152994,419723.1059479146,0.02772389853100727,-5.172726046445276,7.880438613556732e-10,8.612556781525874e-9,Downregulated
Feature0844,lys-leu,C12 H25 N3 O3,259.1896,NA,NA,lys-leu-peak2,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,7496586.395934538,5986066.117742256,0.7985055866212054,-0.3246255936221584,0.4870599334971665,0.5482322698981118,Downregulated
Feature0843,NA,C13 H19 N O6,285.1213,NA,NA,Feature0843,13,19,6,1,0,0,1.4615384615384617,0.4615384615384616,-0.3076923076923075,69.06923076923076,5,-1,-0.3333333333333333,0.1111111111111111,-2,Lignin,3864412.9337201915,639964.3294187001,0.1656045408176966,-2.5941858633221146,0.255867189228074,0.3276183057840948,Downregulated
Feature0842,(+)-sesamin monocatechol,C19 H18 O6,342.11045,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak2,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,962985.7376514373,1404587.2757320323,1.4585753670221409,0.5445599346213278,0.5359981119436468,0.5926767634677138,Upregulated
Feature0841,(2S)-2-Amino-4-hexynoic acid,C6 H9 N O2,127.06329,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,(2S)-2-Amino-4-hexynoic acid,6,9,2,1,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,1,0,0.25,0,Protein,846360.6018019023,2232020.591121585,2.637198123789803,1.3990059600807279,0.048804165778226966,0.07435084579246069,Upregulated
Feature0840,DL-Lactic Acid,C3 H6 O3,90.03171,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,DL-Lactic Acid,3,6,3,0,0,0,2,1,0,60.3,1,-2,-Inf,-0.3333333333333333,-2,Carbohydrate,2119945.121862688,9635580.757663636,4.54520291977999,2.1843447047219735,1.3172481577467942e-5,4.7304288751729395e-5,Upregulated
Feature0839,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",C7 H15 N O4,177.10012,NA,NA,"2-(Hydroxymethyl)-1-methyl-3,4,5-piperidinetriol",7,15,4,1,0,0,2.142857142857143,0.5714285714285714,-0.5714285714285712,76.58571428571427,1,-3,-2,-0.5,-4,Amino Sugar,1331968.302154612,9299895.413215188,6.982069616950747,2.8036547418131654,5.4064285308216684e-5,1.6804568681122762e-4,Upregulated
Feature0838,thr-pro,C9 H16 N2 O4,216.111,Metabolic pathways;Other,Other,thr-pro-peak1,9,16,4,2,0,0,1.7777777777777777,0.4444444444444444,-0.22222222222222232,66.63333333333333,3,-1,-1,-0.2,-3,Protein,7901840.74144201,4450343.715177894,0.56320341813998,-0.8282720050196916,7.676183854312649e-5,2.3137821083995776e-4,Downregulated
Feature0837,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)",C12 H19 N3 O7,317.12237,NA,NA,"(2S)-3-(1H-Imidazol-4-yl)-2-({[(3S,4S,5R)-2,3,4-trihydroxy-5-(hydroxymethyl)tetrahydro-2-furanyl]methyl}amino)propanoic acid (non-preferred name)-peak1",12,19,7,3,0,0,1.5833333333333333,0.5833333333333334,0.3333333333333335,50.8,5,-2,-2.5,-0.2727272727272727,-5,Amino Sugar,11128264.554689866,7646900.147016186,0.6871601685451931,-0.541281682258144,0.0015597741304789559,0.003357379132187232,Downregulated
Feature0836,N-(tert-Butoxycarbonyl)-L-leucine,C11 H21 N O4,231.14706,NA,NA,N-(tert-Butoxycarbonyl)-L-leucine-peak1,11,21,4,1,0,0,1.9090909090909092,0.3636363636363637,-0.9090909090909092,86.2090909090909,2,-2,-0.5,-0.125,-3,Protein,1586928.224374049,751017.933258021,0.4732526157912743,-1.0793176147826395,0.4799559971860873,0.5423919007559919,Downregulated
Feature0835,2-Aminooctanedioic acid,C8 H15 N O4,189.10017,NA,NA,2-Aminooctanedioic acid-peak3,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,13732135.832993053,1678399.3362458535,0.12222420143946609,-3.032398115461424,1.1707088751247938e-6,5.111290810467527e-6,Downregulated
Feature0834,N-acetyldopamine,C10 H13 N O3,195.08954,Other,NA,N-acetyldopamine,10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,2131062.5207411163,4319800.510640561,2.027064184460562,1.0193917706681221,0.03954701528372849,0.06163076714869923,Upregulated
Feature0833,NA,C16 H30 N2 O9,394.19522,NA,NA,Feature0833,16,30,9,2,0,0,1.875,0.5625,-0.375,70.9875,3,-6,-1.6,-0.3684210526315789,-8,Amino Sugar,922996.6896340367,8311782.978113266,9.00521428891456,3.170760607045044,1.3594507019640593e-8,9.676090290450068e-8,Upregulated
Feature0832,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",C25 H36 O3,384.26647,NA,NA,"6-[(1E,3Z,5E,7E,9E,11Z)-13-Hydroxy-3,7,12-trimethyl-1,3,5,7,9,11-tridecahexaen-1-yl]-1,5,5-trimethyl-7-oxabicyclo[4.1.0]heptan-3-ol",25,36,3,0,0,0,1.44,0.12,-1.2000000000000002,94.5,8,5,0.2272727272727273,0.2765957446808511,5,Unsaturated HC,3147493.524678854,744251.3405182456,0.23645841832007686,-2.0803415897910216,0.37903116713379714,0.449320361878693,Downregulated
Feature0831,NA,C6 H11 N O7,209.05351,NA,NA,Feature0831,6,11,7,1,0,0,1.8333333333333333,1.1666666666666667,1,31.799999999999997,2,-5,3,-1.6666666666666667,-6,Carbohydrate,4583163.825844119,2788240.6783612655,0.6083659202052922,-0.7169887572883312,7.137993067556131e-5,2.170872577457825e-4,Downregulated
Feature0830,NA,C29 H44 N4 O7,560.32104,NA,NA,Feature0830,29,44,7,4,0,0,1.5172413793103448,0.2413793103448276,-0.6206896551724137,77.98965517241379,10,3,-0.05555555555555555,0.11627906976744186,-1,Lipid,180206.47621381708,8546932.737171281,47.42855482635511,5.567684004278552,0.0015409507294443766,0.0033253127843041706,Upregulated
Feature0829,NA,C15 H5 N10 O18 P3 S2,769.84371,NA,NA,Feature0829,15,5,18,10,2,3,0.3333333333333333,1.2,3.3333333333333335,-34.7,20,2,0.7222222222222222,0.4444444444444444,-13,Other,16648233.529427571,11075729.409543386,0.6652795559340169,-0.5879673945594506,0.010439728410746717,0.018269524718806752,Downregulated
Feature0828,NA,C18 H34 N2 O8,406.23164,NA,NA,Feature0828,18,34,8,2,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,3,-5,-0.875,-0.25,-7,Protein,861710.3336185768,8279989.304323076,9.608784972501084,3.2643540142487395,1.3693682884558123e-7,7.317696784366391e-7,Upregulated
Feature0827,N-glycoloyl-beta-D-glucosamine,C8 H15 N O7,237.08484,NA,NA,N-glycoloyl-beta-D-glucosamine,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,14742432.06619334,587417.3947246417,0.0398453519804022,-4.649444748267182,9.455207574775988e-11,1.4561019665155021e-9,Downregulated
Feature0826,Pro-Hyp,C10 H16 N2 O4,228.11102,NA,NA,Pro-Hyp-peak1,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,18070546.09854965,2486949.3890290344,0.1376244732984931,-2.861191052413657,2.139968193879292e-9,1.97016636979974e-8,Downregulated
Feature0825,D-lysopine,C9 H18 N2 O4,218.12665,Lysine degradation,NA,D-lysopine-peak3,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,8844841.313596219,5162207.633187759,0.5836405029960746,-0.7768480892121403,0.003497248546540822,0.006841038149930892,Downregulated
Feature0824,Glucosamine,C6 H13 N O5,179.07942,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,Other,Glucosamine-peak1,6,13,5,1,0,0,2.1666666666666665,0.8333333333333334,0,60.3,1,-4,-Inf,-1,-5,Carbohydrate,3154227.083768557,6059338.408745095,1.9210216156997852,0.941873752573162,0.10260041199912041,0.1452005830630827,Upregulated
Feature0823,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13666,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak2",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,502894.44955722743,670591.5221177004,1.3334637570729237,0.4151786136389488,0.593793757796436,0.6411004625284655,Upregulated
Feature0822,Leu-arg,C12 H25 N5 O3,287.19576,NA,NA,Leu-arg-peak1,12,25,3,5,0,0,2.0833333333333335,0.25,-0.33333333333333304,69.79999999999998,3,0,-1.25,-0.6363636363636364,-5,Lipid,7594277.006126002,6605096.784487988,0.869746623564023,-0.20133292170548514,0.6368871991280449,0.6772673668065964,Downregulated
Feature0821,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak3,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,11265526.455424106,6852567.498739907,0.6082776092048983,-0.7171981955329251,8.270858845046751e-4,0.0019405588481314676,Downregulated
Feature0820,4-Methyleneglutamic acid,C6 H9 N O4,159.05324,Other,NA,4-Methyleneglutamic acid-peak1,6,9,4,1,0,0,1.5,0.6666666666666666,0.3333333333333335,50.8,3,-1,-2,0,-2,Amino Sugar,10571609.92107949,8323414.4551043175,0.7873365095043533,-0.3449477160407808,0.009836689549455751,0.017285634955163942,Downregulated
Feature0819,9-Nitrooleate,C18 H33 N O4,327.24099,NA,NA,9-Nitrooleate,18,33,4,1,0,0,1.8333333333333333,0.2222222222222222,-1.2222222222222223,95.13333333333333,3,-1,-0.15384615384615383,0,-2,Lipid,2148527.5450590393,4774425.336205079,2.222184838721201,1.1519788233947166,0.1861323556351005,0.24734161292610415,Upregulated
Feature0818,4-Nitrosodiphenylamine,C12 H10 N2 O,198.07934,NA,NA,4-Nitrosodiphenylamine,12,10,1,2,0,0,0.8333333333333334,0.08333333333333333,-0.16666666666666696,65.05000000000001,9,8,0.6666666666666666,0.6842105263157895,6,Unsaturated HC,1774117.83477601,1360231.2620127674,0.7667085214689263,-0.38324988033309704,0.008437979648722818,0.015093915021052222,Downregulated
Feature0817,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",C17 H18 N2 O5,330.12166,NA,NA,"4-[(E)-2-{[2-(4-Hydroxyphenyl)ethyl]amino}vinyl]-2,3-dihydro-2,6-pyridinedicarboxylic acid",17,18,5,2,0,0,1.0588235294117647,0.29411764705882354,-0.117647058823529,63.65294117647058,10,5,0.3,0.44,3,Lignin,2784479.979421104,6399761.761946836,2.298368747214822,1.2006102806211096,1.5315352361686078e-4,4.2882986612721014e-4,Upregulated
Feature0816,3-(6-Amino-1H-purin-1-yl)-1-propanol,C8 H11 N5 O,193.09636,NA,NA,3-(6-Amino-1H-purin-1-yl)-1-propanol,8,11,1,5,0,0,1.375,0.125,0.75,38.925,6,5,0,0.2,0,Unsaturated HC,2697978.412158448,142761.70582803673,0.05291432473465343,-4.24019785446644,0.33196119320397555,0.40897619002729785,Downregulated
Feature0815,NA,C20 H28 N2 O8,424.18475,NA,NA,Feature0815,20,28,8,2,0,0,1.4,0.4,-0.2999999999999998,68.85,8,0,-0.2,0.14285714285714285,-2,Lignin,1348580.0735001834,11389677.622422017,8.445681384614103,3.07821382214424,1.4527942740549347e-11,3.2813780003320793e-10,Upregulated
Feature0814,NA,C17 H30 N2 O12,454.18001,NA,NA,Feature0814,17,30,12,2,0,0,1.7647058823529411,0.7058823529411765,0,60.3,4,-8,-3.3333333333333335,-0.4444444444444444,-10,Carbohydrate,1962932.1173662795,97872.5083304473,0.04986036321101392,-4.325962797502471,0.29825047902617485,0.3739721032348928,Downregulated
Feature0813,2'-Deoxyadenosine,C10 H13 N5 O3,251.10184,Metabolic pathways;ABC transporters;Other,Superpathway of butirocin biosynthesis;Other,2'-Deoxyadenosine-peak1,10,13,3,5,0,0,1.3,0.3,0.7999999999999998,37.5,7,4,-0.5,0.14285714285714285,-1,Lignin,159385.60995191787,167047.84208954734,1.0480735503031984,0.06773996395012202,0.9097048810302628,0.918926695566646,Upregulated
Feature0812,Aspartyl-L-proline,C9 H14 N2 O5,230.09027,Biosynthesis of secondary metabolites;Other,NA,Aspartyl-L-proline,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,585358.4923924208,4289106.301895462,7.327315410365775,2.8732847190179536,3.874044801613005e-6,1.5191277532250998e-5,Upregulated
Feature0811,Tyrosylalanine,C12 H16 N2 O4,252.11103,NA,NA,Tyrosylalanine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,4570368.344391788,4504578.814717531,0.9856052018750335,-0.0209182245084545,0.9033294368543006,0.9142835520258743,Downregulated
Feature0810,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one",C16 H20 N2 O3,288.14736,NA,Superpathway of indole-3-acetate conjugate biosynthesis,"5-[(Z)-(4-Ethyl-3-methyl-5-oxo-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-5-methoxy-3-methyl-4-vinyl-1,5-dihydro-2H-pyrrol-2-one-peak1",16,20,3,2,0,0,1.25,0.1875,-0.5,74.55,8,5,0.2727272727272727,0.36,3,Lignin,299448.16176272277,8965169.42547001,29.938969645683933,4.903952666562894,5.1047445972561006e-5,1.598417254667622e-4,Upregulated
Feature0809,MFCD02728197,C14 H20 N2 O4,280.14233,NA,NA,MFCD02728197-peak1,14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,16279909.551164243,7514404.964293164,0.4615753509365031,-1.1153619116993954,3.8278334995787344e-5,1.2392498301470208e-4,Downregulated
Feature0808,NA,C11 H23 N O11,345.1272,NA,NA,Feature0808,11,23,11,1,0,0,2.090909090909091,1,0.18181818181818168,55.11818181818182,1,-10,11,-1.2222222222222223,-11,Carbohydrate,5486599.97637381,8473099.183659187,1.5443260343647662,0.6269773630374835,0.014028458075085355,0.023980028233294242,Upregulated
Feature0807,NA,C11 H19 N3 O5,273.13241,Biosynthesis of secondary metabolites;Other,NA,Feature0807,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,17387881.862907134,5863975.561076803,0.33724496217024486,-1.5681312028073409,3.778585041329385e-11,7.1615415315561e-10,Downregulated
Feature0806,NA,C10 H15 N O5,229.09493,NA,NA,Feature0806,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,4296104.345604661,3177844.754329336,0.7397038104022275,-0.4349803873940038,0.19509820463259692,0.25719560984250517,Downregulated
Feature0805,Methohexital,C14 H18 N2 O3,262.13173,NA,NA,Methohexital,14,18,3,2,0,0,1.2857142857142858,0.21428571428571427,-0.4285714285714288,72.51428571428572,7,4,0.2222222222222222,0.3333333333333333,2,Lignin,14018188.734652553,5834711.421531376,0.4162243448119756,-1.2645667446330768,6.616569978202437e-4,0.0015831171671009784,Downregulated
Feature0804,NA,C9 H17 N3 O2,199.13214,NA,NA,Feature0804,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,15340470.843863526,4568119.134568917,0.29778219854289867,-1.7476705828797208,5.119908624511408e-12,1.3988911628906977e-10,Downregulated
Feature0803,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one",C6 H8 O4,144.04227,Microbial metabolism in diverse environments;Other,Other,"5-hydroxy-4-methoxy-5,6-dihydro-2H-pyran-2-one-peak1",6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,2736563.732157669,4454105.144593376,1.6276270463766964,0.7027701590738654,0.11366642495770199,0.15860866876305368,Upregulated
Feature0802,2-Aminooctanedioic acid,C8 H15 N O4,189.10014,NA,NA,2-Aminooctanedioic acid-peak2,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,11261356.105120515,2589596.1331784744,0.22995419992100155,-2.1205815473114265,3.701215469632309e-10,4.576539420114695e-9,Downregulated
Feature0801,Myristicin,C11 H12 O3,192.07871,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Phenylpropanoid biosynthesis;Other,NA,Myristicin,11,12,3,0,0,0,1.0909090909090908,0.2727272727272727,-0.5454545454545459,75.84545454545456,6,3,0.375,0.47368421052631576,3,Lignin,2523107.575743698,1740631.664776069,0.6898761200314694,-0.5355907722163092,0.532646482958527,0.5897406157723822,Downregulated
Feature0800,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",C14 H14 O6,278.07905,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,8-Dihydroxy-3-[(2S)-2-hydroxy-4-oxopentyl]-1H-isochromen-1-one",14,14,6,0,0,0,1,0.42857142857142855,-0.14285714285714324,64.37142857142858,8,2,0.25,0.4545454545454546,2,Lignin,2715626.37448063,506316.7756238543,0.18644566880843047,-2.423172811646424,0.37464261835930945,0.4456773844808078,Downregulated
Feature0799,NA,C12 H23 N3 O2,241.17901,NA,NA,Feature0799,12,23,2,3,0,0,1.9166666666666667,0.16666666666666666,-0.833333333333333,84.04999999999998,3,1,-0.2857142857142857,-0.125,-2,Lipid,15789786.546367781,656131.5321366888,0.04155417365585747,-4.588862802786065,4.327597493579172e-11,7.480561381758283e-10,Downregulated
Feature0798,b-Ala-Lys,C9 H19 N3 O3,217.14263,Metabolic pathways;Other,Other,b-Ala-Lys,9,19,3,3,0,0,2.111111111111111,0.3333333333333333,-0.44444444444444464,72.96666666666667,2,-1,-1.3333333333333333,-0.5555555555555556,-4,Protein,7399321.309686749,5932115.8049529,0.8017107997711802,-0.31884618611232834,0.15224975297805526,0.20567071893526764,Downregulated
Feature0797,6-Methoxyquinoline,C10 H9 N O,159.06843,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,6-Methoxyquinoline,10,9,1,1,0,0,0.9,0.1,-0.4000000000000003,71.7,7,6,0.625,0.6470588235294118,5,Unsaturated HC,1320694.1840029773,752973.8915078599,0.5701349340584076,-0.810624691997815,0.11134863979816227,0.15614618859113152,Downregulated
Feature0796,D-PANTOTHENIC ACID,C9 H17 N O5,219.11064,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak2,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,9959641.478339585,8200222.561193051,0.823345155448321,-0.28043074362672965,0.13147915743553135,0.18019878049821206,Downregulated
Feature0795,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.12123,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak2,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,6843807.439215325,9625417.355110502,1.4064418732701955,0.4920499288504711,0.002084152083488176,0.004326658859594327,Upregulated
Feature0794,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak2,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,777408.2370223837,9032025.523914265,11.61812429272499,3.538305264144837,2.947606298291343e-9,2.5767294870432837e-8,Upregulated
Feature0793,Aspartame,C14 H18 N2 O5,294.1216,Other,NA,Aspartame-peak2,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,6315304.011609289,6147083.712029323,0.9733630717902527,-0.038950053325883034,0.8086887316443552,0.832777332161421,Downregulated
Feature0792,mebutamate,C10 H20 N2 O4,232.14227,Other,NA,mebutamate-peak1,10,20,4,2,0,0,2,0.4,-0.5999999999999996,77.39999999999999,2,-2,-1,-0.3333333333333333,-4,Protein,7841182.410866542,6564043.620391331,0.8371242086263273,-0.25648639579811794,0.5227014390108625,0.5806270411045253,Downregulated
Feature0791,Methyl alpha-aspartylphenylalaninate,C14 H18 N2 O5,294.12162,Other,NA,Methyl alpha-aspartylphenylalaninate,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,3612576.63008931,6287677.783915649,1.7404967223519368,0.799499097226744,1.6206924927360548e-4,4.515547833379732e-4,Upregulated
Feature0790,delta-guanidinovaleric acid,C6 H13 N3 O2,159.1008,NA,NA,delta-guanidinovaleric acid-peak2,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,8309234.368962139,177982.4796774525,0.021419841079736365,-5.544908413436638,4.834786424267603e-9,3.9757903896647184e-8,Downregulated
Feature0789,Cynometrine,C16 H19 N3 O2,285.14778,NA,NA,Cynometrine,16,19,2,3,0,0,1.1875,0.125,-0.375,70.9875,9,7,0.3636363636363637,0.4166666666666667,4,Unsaturated HC,294939.0017120875,7317793.042261944,24.811208418632276,4.632920097635327,0.0023950136911238123,0.004911807739423411,Upregulated
Feature0788,2-Amino-3-methoxybenzoic acid,C8 H9 N O3,167.05827,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,2-Amino-3-methoxybenzoic acid,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,1906311.009839178,5821273.250275634,3.0536849549889205,1.610551228696598,0.0015241661818865136,0.0032974936297774636,Upregulated
Feature0787,Fluoranthene,C16 H10,202.0783,Microbial metabolism in diverse environments;Other,NA,Fluoranthene-peak1,16,10,0,0,0,0,0.625,0,-0.625,78.1125,12,12,0.75,0.75,12,Condensed HC,11967207.77299672,4607056.087061746,0.38497335171678804,-1.3771695105775432,6.385202247928178e-6,2.4198059525705445e-5,Downregulated
Feature0786,NA,C7 H11 O3 P S,206.01667,NA,NA,Feature0786,7,11,3,0,1,1,1.5714285714285714,0.42857142857142855,-1.1428571428571432,92.87142857142858,3,0,-1,-0.14285714285714285,-2,Protein,1844211.924731006,9539435.498960352,5.172635189609112,2.3708994461906343,5.2189958791573655e-6,2.0093134134755856e-5,Upregulated
Feature0785,NA,C15 H27 N3 O6,345.19012,NA,NA,Feature0785,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,8319918.004170528,6960757.625838878,0.8366377676257936,-0.2573249690825764,0.08782247016510408,0.12575761999973484,Downregulated
Feature0784,Pro-Pro,C10 H16 N2 O3,212.11603,NA,NA,Pro-Pro,10,16,3,2,0,0,1.6,0.3,-0.4000000000000003,71.7,4,1,-0.2,0.07692307692307693,-1,Lipid,6109263.38807369,9168494.711986216,1.5007528943480584,0.5856864503453293,3.4439474626166724e-4,8.812759821257769e-4,Upregulated
Feature0783,NA,C79 H121 N6 O18 P3,1534.79514,NA,NA,Feature0783,79,121,18,6,0,3,1.5316455696202531,0.2278481012658228,-1.037974683544304,89.88227848101266,24,6,-0.05769230769230769,0.09836065573770492,-3,Lipid,2016540.162042285,689549.9108212106,0.3419470258022817,-1.5481552537877072,0.41931152531216465,0.48684970793612536,Downregulated
Feature0782,NA,C13 H24 N2 O8,336.15338,NA,NA,Feature0782,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,15025854.61096156,4094195.8560927194,0.2724767384016846,-1.8757950239885897,4.363016548326064e-14,2.842673089563213e-12,Downregulated
Feature0781,Pyroquilon,C11 H11 N O,173.08408,NA,NA,Pyroquilon,11,11,1,1,0,0,1,0.09090909090909093,-0.5454545454545459,75.84545454545456,7,6,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,218832.8686058794,182405.42523960685,0.8335376052128677,-0.262680806737118,0.32623764023328694,0.4026784165153321,Downregulated
Feature0780,NA,C11 H19 N O5,245.12631,NA,NA,Feature0780,11,19,5,1,0,0,1.7272727272727273,0.4545454545454546,-0.5454545454545459,75.84545454545456,3,-2,-0.6,-0.06666666666666667,-3,Protein,303507.65055395686,560788.6968584966,1.847692128468442,0.885724387850178,0.148779711101829,0.2017876946409114,Upregulated
Feature0779,7-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,7-Methylguanine-peak2,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,6318759.503346254,3944489.0222251047,0.6242505384381545,-0.6798029343578712,0.05234748797341412,0.07917557555978885,Downregulated
Feature0778,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16888,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak5,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,7026568.208509934,8303358.487416368,1.1817089425475302,0.24087474037918247,0.4512503560204286,0.5156686976086585,Upregulated
Feature0777,Alanyltyrosine,C12 H16 N2 O4,252.11102,NA,NA,Alanyltyrosine,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,14617795.249959785,5558770.416473733,0.3802742015071682,-1.394888027652113,3.651460762887178e-6,1.4492175845794024e-5,Downregulated
Feature0776,asn-leu,C10 H19 N3 O4,245.13754,NA,NA,asn-leu-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,5196333.574705306,5308949.759191941,1.0216722392563147,0.030932442224777958,0.9077637100590534,0.9175129623150575,Upregulated
Feature0775,6-Aminocaproic acid,C6 H13 N O2,131.0946,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Superpathway of indole-3-acetate conjugate biosynthesis,6-Aminocaproic acid-peak1,6,13,2,1,0,0,2.1666666666666665,0.3333333333333333,-1,88.8,1,-1,-0.6666666666666666,-0.25,-2,Protein,316838.5485416637,5100098.857335762,16.096838218740636,4.008705433282957,0.06895188752420651,0.10095462183751586,Upregulated
Feature0774,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0774,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,6594704.14514086,9233795.527050963,1.4001834386846073,0.4856158477017631,0.0803479622255744,0.11568116713756448,Upregulated
Feature0773,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak2,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,7250044.581659952,4583415.941579196,0.6321914148188297,-0.6615666513602293,0.007135625591713287,0.012859308247193946,Downregulated
Feature0772,Betaine,C5 H11 N O2,117.07893,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,Betaine-peak1,5,11,2,1,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-1,-1,-0.3333333333333333,-2,Protein,6099376.4426763905,9516112.34914747,1.5601779031975644,0.6417105453869947,0.026847810169624592,0.04290584002579628,Upregulated
Feature0771,"3-(2,6-Dioxocyclohexyl)propanenitrile",C9 H11 N O2,165.07901,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,"3-(2,6-Dioxocyclohexyl)propanenitrile",9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,6416394.730927129,6686691.17094769,1.0421259058015442,0.059529589230918445,0.5586792086812409,0.6109954465501017,Upregulated
Feature0770,NA,C22 H40 N2 O7,444.2837,NA,NA,Feature0770,22,40,7,2,0,0,1.818181818181818,0.3181818181818182,-0.9090909090909092,86.2090909090909,4,-3,-0.38461538461538464,-0.09090909090909093,-5,Protein,2623798.415463025,699230.5706028503,0.2664955381030887,-1.907816716538689,0.3882176890599577,0.45764841006789725,Downregulated
Feature0769,NA,C20 H30 N2 O8,426.2003,NA,NA,Feature0769,20,30,8,2,0,0,1.5,0.4,-0.4000000000000003,71.7,7,-1,-0.3,0.07142857142857142,-3,Protein,1562416.5174455645,6510092.039631182,4.166681526303051,2.0588988341460874,9.240133841373368e-5,2.736501176099036e-4,Upregulated
Feature0768,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,C18 H20 N2 O4,328.14237,NA,NA,N1-(2-{2-[2-(acetylamino)phenoxy]ethoxy}phenyl)acetamide,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,4094562.5325158173,5498375.688883146,1.3428481419490705,0.4252961645983394,0.15820257208560662,0.213202193407333,Upregulated
Feature0767,N-Methylhexanamide,C7 H15 N O,129.11533,NA,NA,N-Methylhexanamide,7,15,1,1,0,0,2.142857142857143,0.14285714285714285,-1.4285714285714288,101.01428571428572,1,0,-0.2,-0.09090909090909093,-1,Lipid,534422.503112502,3347218.0762077337,6.263243139488656,2.6469098855410973,0.02823658968880551,0.045040285247492026,Upregulated
Feature0766,Alanylclavam,C8 H12 N2 O4,200.0797,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Alanylclavam-peak1,8,12,4,2,0,0,1.5,0.5,0.25,53.175,4,0,-1,0,-2,Protein,10849172.164099874,4648142.010623992,0.42843287398505725,-1.2228589114480977,1.1884579336617152e-6,5.162173691340886e-6,Downregulated
Feature0765,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0765,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,14596813.78854188,7758249.293135457,0.5315029297164482,-0.911850450777752,1.3022649293572765e-6,5.584903266661332e-6,Downregulated
Feature0764,"β,β-dimethylacrylshikonin",C21 H22 O6,370.14171,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites,NA,"β,β-dimethylacrylshikonin",21,22,6,0,0,0,1.0476190476190477,0.2857142857142857,-0.4761904761904763,73.87142857142857,11,5,0.3333333333333333,0.4444444444444444,5,Lignin,1449753.6362772577,2258266.8298506597,1.55769006080891,0.6394082037357127,0.4167794849161739,0.4845740888455721,Upregulated
Feature0763,Prolylleucine,C11 H20 N2 O3,228.14738,NA,NA,Prolylleucine-peak2,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,14898726.949506769,5530722.513656327,0.3712211474443744,-1.4296491957255026,4.252215011120421e-8,2.6444419387889067e-7,Downregulated
Feature0762,Troxipide,C15 H22 N2 O4,294.15799,NA,NA,Troxipide-peak2,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,13818856.184349278,6235693.533748172,0.4512452731659865,-1.148016275166129,4.3663897217213236e-5,1.387741874033006e-4,Downregulated
Feature0761,Troxipide,C15 H22 N2 O4,294.158,NA,NA,Troxipide-peak1,15,22,4,2,0,0,1.4666666666666666,0.26666666666666666,-0.5333333333333332,75.5,6,2,0,0.18181818181818185,0,Lignin,13968814.69510002,5354969.408029995,0.3833517392072221,-1.3832593697458482,4.37190836599826e-7,2.0862007808453667e-6,Downregulated
Feature0760,NA,C13 H24 N2 O9,352.14823,NA,NA,Feature0760,13,24,9,2,0,0,1.8461538461538465,0.6923076923076923,0,60.3,3,-6,-4,-0.5384615384615384,-8,Amino Sugar,7245661.131101892,3452199.957566827,0.47645065027238304,-1.069601304245052,0.003946784987592586,0.007580333071407983,Downregulated
Feature0759,MFCD15144952,C5 H8 O4,132.04225,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,MFCD15144952,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,16195965.019629933,7134086.678426704,0.4404854338583718,-1.1828337825469988,2.533766946013026e-11,5.171326754874779e-10,Downregulated
Feature0758,threonylphenylalanine,C13 H18 N2 O4,266.12671,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak3,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,2770362.5130660534,7135313.990444208,2.575588558100765,1.3649021460158963,5.03222425039289e-4,0.0012408424861958596,Upregulated
Feature0757,NA,C6 H14 O4,150.08923,NA,NA,Feature0757,6,14,4,0,0,0,2.3333333333333335,0.6666666666666666,-1,88.8,0,-4,-2,-0.5,-4,Other,10324492.218245447,7643985.17114257,0.7403739583080043,-0.43367394370998363,0.17149121703946557,0.2298307924563724,Downregulated
Feature0756,NA,C17 H26 N2 O8,386.16898,NA,NA,Feature0756,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,4254957.325800074,9390467.378833583,2.2069474873212416,1.1420523021673479,3.96006952939266e-9,3.320969199401567e-8,Upregulated
Feature0755,Proacacipetalin,C11 H17 N O6,259.10561,NA,NA,Proacacipetalin-peak1,11,17,6,1,0,0,1.5454545454545454,0.5454545454545454,-0.18181818181818168,65.48181818181817,4,-2,-0.75,0,-3,Protein,508202.38650722906,220061.83858059603,0.43302008102133477,-1.2074941643507557,2.587179887596446e-4,6.826608613066011e-4,Downregulated
Feature0754,NA,C17 H34 N6 O4,386.26429,NA,NA,Feature0754,17,34,4,6,0,0,2,0.2352941176470588,-0.47058823529411775,73.71176470588236,4,0,-0.8571428571428571,-0.4444444444444444,-6,Lipid,4741843.91084325,2956696.4760440825,0.6235330668061336,-0.6814620247245329,0.05212432243829012,0.07890849169835877,Downregulated
Feature0753,Ectoine,C6 H10 N2 O2,142.07423,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Ectoine-peak1,6,10,2,2,0,0,1.6666666666666667,0.3333333333333333,0,60.3,3,1,-0.5,0,-1,Protein,16032325.733104872,5520138.825722464,0.3443130408911307,-1.5382072707246197,1.6034839343073925e-11,3.527664655476263e-10,Downregulated
Feature0752,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak5,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,825149.0310524969,3484102.942067108,4.222392332719647,2.078060636044585,1.1245709370388031e-7,6.245977597848303e-7,Upregulated
Feature0751,Malonyl-L-carnitine,C10 H17 N O6,247.10558,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Malonyl-L-carnitine,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,1180713.5342137564,178977.30498833675,0.15158402085017067,-2.7218104143020763,0.28535723027648136,0.3600946308879919,Downregulated
Feature0750,NA,C12 H19 N O9,321.10608,NA,NA,Feature0750,12,19,9,1,0,0,1.5833333333333333,0.75,0.16666666666666652,55.55,4,-5,-3,-0.2307692307692308,-6,Carbohydrate,2287211.70196209,668913.9938760676,0.2924582771687632,-1.773697274003895,0.06665376683639578,0.09792843106752336,Downregulated
Feature0749,NA,C6 H15 N O4,165.10013,NA,NA,Feature0749,6,15,4,1,0,0,2.5,0.6666666666666666,-0.666666666666667,79.30000000000001,0,-4,-5,-1,-5,Other,278976.36596089054,2366053.757957618,8.481197859926647,3.0842680412661734,5.275243402401358e-7,2.4685807523944476e-6,Upregulated
Feature0748,NA,C18 H29 N O12,451.16875,NA,NA,Feature0748,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,15179379.88114613,285313.69521322876,0.01879613643292561,-5.733420044993348,1.2573940758021304e-10,1.8684434775515868e-9,Downregulated
Feature0747,Isovalerylglutamic acid,C10 H17 N O5,231.11065,NA,NA,Isovalerylglutamic acid-peak5,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,4956921.419389958,1723250.7409606464,0.34764536194175233,-1.5243117527276144,5.254672317479411e-4,0.0012938103060770526,Downregulated
Feature0746,NA,C11 H19 N3 O5,273.13243,Biosynthesis of secondary metabolites;Other,NA,Feature0746,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,14124008.136132913,6613474.320141379,0.4682434516036832,-1.0946692764039907,4.788195447106996e-10,5.672169991188288e-9,Downregulated
Feature0745,NA,C11 H20 N4 O5,288.1433,NA,NA,Feature0745,11,20,5,4,0,0,1.818181818181818,0.4545454545454546,0.18181818181818168,55.11818181818182,4,-1,-2.5,-0.5555555555555556,-5,Protein,2699440.2274889234,7994267.37089209,2.961453744922712,1.5663055527911045,8.453980905320113e-5,2.530427412059423e-4,Upregulated
Feature0744,Imazapyr,C13 H15 N3 O3,261.1114,NA,NA,Imazapyr,13,15,3,3,0,0,1.1538461538461535,0.2307692307692308,0,60.3,8,5,0.2857142857142857,0.4117647058823529,2,Lignin,4105836.419410792,5521867.639371231,1.3448825221740437,0.4274801563662142,0.07437129023431271,0.1078638404596967,Upregulated
Feature0743,NA,C17 H26 N2 O8,386.16902,NA,NA,Feature0743,17,26,8,2,0,0,1.5294117647058822,0.4705882352941176,-0.23529411764705888,67.00588235294117,6,-2,-0.5714285714285714,0,-4,Protein,1846413.1161357716,4614259.953537438,2.499039848240625,1.321373905986759,1.1547136426013708e-6,5.067577488514824e-6,Upregulated
Feature0742,Gly-Phe,C11 H14 N2 O3,222.1005,NA,NA,Gly-Phe-peak1,11,14,3,2,0,0,1.2727272727272727,0.2727272727272727,-0.18181818181818168,65.48181818181817,6,3,0.16666666666666666,0.3333333333333333,1,Lignin,5829394.078658917,6401730.867523886,1.0981811799206134,0.13511609242117217,0.6565193622320795,0.6946557149413758,Upregulated
Feature0741,NA,C14 H24 N2 O11,396.13811,NA,NA,Feature0741,14,24,11,2,0,0,1.7142857142857142,0.7857142857142857,0.2857142857142856,52.15714285714286,4,-7,-9,-0.5384615384615384,-9,Carbohydrate,3573719.861228211,8065160.077933651,2.2567969485895376,1.1742766203724753,1.2609725823743888e-7,6.846434469686585e-7,Upregulated
Feature0740,NA,C22 H32 N4 O5,432.23734,NA,NA,Feature0740,22,32,5,4,0,0,1.4545454545454546,0.2272727272727273,-0.45454545454545414,73.25454545454544,9,4,0,0.16129032258064516,0,Lignin,107398.18876237169,135611.7208229486,1.2627002595267407,0.33651221203442466,0.6099839931658693,0.655239622335436,Upregulated
Feature0739,NP-007065,C8 H10 O3,154.06301,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak2,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,525646.2800185422,530599.618758297,1.0094233307226677,0.013531337032224384,0.9705385298527396,0.9728356624677755,Upregulated
Feature0738,Adipic acid,C6 H10 O4,146.05793,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Aminobenzoate degradation;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,Adipic acid,6,10,4,0,0,0,1.6666666666666667,0.6666666666666666,-0.33333333333333304,69.79999999999998,2,-2,-1,0,-2,Amino Sugar,1519978.159907174,2999467.575613534,1.9733622855454143,0.9806558418086001,0.010192599510163913,0.017873978851157008,Upregulated
Feature0737,(-)-Caryophyllene oxide,C15 H24 O,220.1827,Biosynthesis of secondary metabolites;Other,Other,(-)-Caryophyllene oxide-peak1,15,24,1,0,0,0,1.6,0.06666666666666667,-1.4666666666666668,102.1,4,3,0.21428571428571427,0.2413793103448276,3,Lipid,510527.585722115,1937375.1968303663,3.7948491932909927,1.924042554306296,0.017167300882152656,0.02882200960789554,Upregulated
Feature0736,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15866,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak2",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,9526116.68495429,117234.10695429181,0.012306599932735798,-6.344423960668111,6.672580375694496e-5,2.0366398480047704e-4,Downregulated
Feature0735,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",C14 H24 N2 O9,364.14823,NA,NA,"(2R)-2-{[(2R)-2-{[(2S,3R,4R,5S,6R)-3-Acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}propanoyl]amino}propanoic acid",14,24,9,2,0,0,1.7142857142857142,0.6428571428571429,0,60.3,4,-5,-2.3333333333333335,-0.3333333333333333,-7,Amino Sugar,934518.5302756131,8929502.924136646,9.555190865507086,3.2562846914099906,4.114565627752308e-12,1.188708252554536e-10,Upregulated
Feature0734,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione",C11 H14 N4 O2,234.11166,NA,NA,"7-(tert-butyl)-4-imino-1,2,3,4,5,6-hexahydropyrido[3,4-d]pyridazine-1,5-dione-peak1",11,14,2,4,0,0,1.2727272727272727,0.18181818181818185,0.18181818181818168,55.11818181818182,7,5,0.2,0.3333333333333333,1,Lignin,12455379.628224572,7896372.792831595,0.6339728718455102,-0.6575069871588045,1.2598794087231433e-5,4.570097898023564e-5,Downregulated
Feature0733,Stearidonic acid,C18 H28 O2,276.20889,Biosynthesis of secondary metabolites;Other,NA,Stearidonic acid,18,28,2,0,0,0,1.5555555555555556,0.1111111111111111,-1.333333333333333,98.29999999999998,5,3,0.1875,0.2352941176470588,3,Lipid,869791.3847979339,3068454.4337038207,3.5278050430640566,1.8187708355053391,0.05968929552460021,0.08877407078022191,Upregulated
Feature0732,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,C26 H50 N O7 P,519.33266,NA,NA,1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC,26,50,7,1,0,1,1.9230769230769231,0.2692307692307692,-1.4615384615384617,101.95384615384616,3,-4,-0.35294117647058826,-0.12195121951219512,-6,Lipid,746681.9475127035,1012516.2786291174,1.3560208359154031,0.4393793463510128,0.613364366165741,0.6579729241501181,Upregulated
Feature0731,NA,C12 H22 N2 O9,338.1325,NA,NA,Feature0731,12,22,9,2,0,0,1.8333333333333333,0.75,0.16666666666666652,55.55,3,-6,-8,-0.6363636363636364,-8,Carbohydrate,2732882.722763953,5235874.548064492,1.9158797062352864,0.9380069803507073,0.006789339058149211,0.012287543124470902,Upregulated
Feature0730,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0730,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2084683.5751083074,3307592.5025751963,1.5866160898799013,0.6659530845500296,0.029633241296586423,0.04713493967738723,Upregulated
Feature0729,Pyridoxal,C8 H9 N O3,167.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak3,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,2402005.9627783573,7446196.343602036,3.0999907822831356,1.6322639257013905,6.259909814721429e-6,2.3883529788599328e-5,Upregulated
Feature0728,NA,C12 H17 N3 O7,315.10673,NA,NA,Feature0728,12,17,7,3,0,0,1.4166666666666667,0.5833333333333334,0.5,46.05,6,-1,-2,-0.09090909090909093,-4,Lignin,1705322.959657351,4705685.8210141575,2.7594103476796366,1.464360013611112,0.012186745130808762,0.021130344167441188,Upregulated
Feature0727,NS1800000,C8 H9 N O4,183.05316,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,NS1800000,8,9,4,1,0,0,1.125,0.5,0.25,53.175,5,1,0,0.4,0,Lignin,2679174.161870076,6932770.970524326,2.587652221043077,1.3716437329827846,2.2771590263260408e-5,7.730475732657942e-5,Upregulated
Feature0726,NA,C16 H23 N5 O10,445.14456,NA,NA,Feature0726,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,15529188.519754924,165297.60518102354,0.010644316988665947,-6.553772810081095,9.261372963238354e-10,9.805478624828608e-9,Downregulated
Feature0725,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak3,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,1778913.810373278,7287407.503685882,4.096548950933564,2.034409054137711,8.286886753045289e-6,3.103109915796066e-5,Upregulated
Feature0724,methoxyresorcinol,C7 H8 O3,140.04734,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak2,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,347206.7440905178,4923180.819914186,14.179392836421112,3.825723852384524,0.0015151953062205745,0.0032864799599713872,Upregulated
Feature0723,fructosylglycine,C8 H15 N O7,237.08491,NA,NA,fructosylglycine-peak1,8,15,7,1,0,0,1.875,0.875,0.25,53.175,2,-5,-Inf,-0.7142857142857143,-6,Carbohydrate,3391102.6040932285,2463356.502797814,0.7264175669071237,-0.46112900323961065,0.237484639469326,0.3070984574511742,Downregulated
Feature0722,pseudouridine,C9 H12 N2 O6,244.06949,Metabolic pathways;ABC transporters;Other,Other,pseudouridine-peak1,9,12,6,2,0,0,1.3333333333333333,0.6666666666666666,0.6666666666666665,41.3,5,-1,-3,0,-3,Tannin,7301253.8599809855,7817159.240567351,1.070659833294402,0.09850018431613311,0.3765811530654857,0.4467286227541546,Upregulated
Feature0721,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0721,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,6165535.18710594,2214125.9059901116,0.3591133354685155,-1.4774888672340647,0.0018904754660452445,0.003968358661066474,Downregulated
Feature0720,Xamoterol [USAN:BAN:INN],C16 H25 N3 O5,339.17949,NA,NA,Xamoterol [USAN:BAN:INN],16,25,5,3,0,0,1.5625,0.3125,-0.375,70.9875,6,1,-0.25,0.04761904761904761,-2,Protein,4099171.304637698,2804254.3701372105,0.6841027519305057,-0.547715061344528,0.3002994588315965,0.3761263918304703,Downregulated
Feature0719,N2-Dimethylguanosine,C12 H17 N5 O5,311.12308,NA,NA,N2-Dimethylguanosine,12,17,5,5,0,0,1.4166666666666667,0.4166666666666667,0.6666666666666665,41.3,7,2,-1.5,-0.1111111111111111,-3,Lignin,13022758.112360045,2961551.3326188726,0.22741352538891368,-2.136610034011496,4.277703638936301e-9,3.5521715511559286e-8,Downregulated
Feature0718,UNII:74D1OHC38H,C19 H32 O4,324.23009,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,UNII:74D1OHC38H-peak1,19,32,4,0,0,0,1.6842105263157894,0.21052631578947367,-1.2631578947368425,96.3,4,0,0,0.1176470588235294,0,Lipid,2166889.4877413595,5482882.687370054,2.530301022912384,1.3393090285674383,0.12012401498646881,0.1665221615278872,Upregulated
Feature0717,NA,C33 H47 N O8,585.33043,NA,NA,Feature0717,33,47,8,1,0,0,1.4242424242424243,0.24242424242424243,-0.8484848484848486,84.48181818181818,11,3,0.08333333333333333,0.21428571428571427,2,Lignin,1786249.6652575354,307090.21946852375,0.171918979435749,-2.5401992712677184,0.3670911349987197,0.43856105235591447,Downregulated
Feature0716,perlolyrine,C16 H12 N2 O2,264.0899,Other,NA,perlolyrine,16,12,2,2,0,0,0.75,0.125,-0.125,63.8625,12,10,0.6666666666666666,0.6923076923076923,8,Condensed HC,9988461.356746748,6609531.423463063,0.6617166736094572,-0.5957144625585756,5.714206294251729e-4,0.0013947932943029436,Downregulated
Feature0715,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",C16 H13 N S,251.07697,NA,NA,"4-(4-methylphenyl)-2-phenyl-1,3-thiazole",16,13,0,1,1,0,0.8125,0,-0.5,74.55,11,11,0.6428571428571429,0.6428571428571429,9,Unsaturated HC,14184295.226548664,8599851.553940816,0.60629389170105,-0.7219108072613487,1.8580849635503926e-8,1.2561374927619832e-7,Downregulated
Feature0714,N-acetyl-L-2-aminoadipic acid 6-phosphate,C8 H14 N O8 P,283.04574,NA,NA,N-acetyl-L-2-aminoadipic acid 6-phosphate,8,14,8,1,0,1,1.75,1,0,60.3,3,-5,3.5,-1.5,-7,Carbohydrate,1059318.4048608101,4011861.316206216,3.7872100567660363,1.9211354422020708,0.01409982143689914,0.02405347181682492,Upregulated
Feature0713,3-Butynoic acid,C4 H4 O2,84.02115,Metabolic pathways;Other,NA,3-Butynoic acid-peak1,4,4,2,0,0,0,1,0.5,0,60.3,3,1,0.5,0.6666666666666666,1,Lignin,2425684.321556831,4664656.115767916,1.923026864754639,0.9433789173203313,0.08590299694931629,0.12311309376661743,Upregulated
Feature0712,threonylphenylalanine,C13 H18 N2 O4,266.12668,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak2,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,13158471.17460476,5564410.777598502,0.42287669317827414,-1.2416910463738413,5.136580889657472e-8,3.1076314382427707e-7,Downregulated
Feature0711,NA,C29 H28 O9,520.17351,NA,NA,Feature0711,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,870705.9603829505,1027301.0836983183,1.179848456816001,0.23860156751914086,0.7110227630010122,0.7444206183706519,Upregulated
Feature0710,asn-phe,C13 H17 N3 O4,279.12195,NA,NA,asn-phe-peak2,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,4003533.272113638,6744918.849990362,1.6847415499133416,0.7525272897710601,4.7744567082567186e-5,1.5061321534053782e-4,Upregulated
Feature0709,N-Acetylvanilalanine,C12 H15 N O5,253.09509,NA,NA,N-Acetylvanilalanine-peak4,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,7873754.673075651,5474551.990994098,0.6952911562909573,-0.5243108555030837,0.0847149797638318,0.12151327325989082,Downregulated
Feature0708,gepefrine,C9 H13 N O,151.09965,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,gepefrine,9,13,1,1,0,0,1.4444444444444444,0.1111111111111111,-0.8888888888888893,85.63333333333334,4,3,0.2857142857142857,0.3333333333333333,2,Unsaturated HC,321552.3743510668,6091915.444219429,18.94532875558354,4.2437702698321536,2.2267157030772354e-4,5.97790237878421e-4,Upregulated
Feature0707,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak2,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,7058444.978202321,3690250.1299005356,0.5228134725561587,-0.935631775981408,8.229832826008396e-7,3.6979673228801653e-6,Downregulated
Feature0706,NA,C22 H28 N2 O9,464.17958,NA,NA,Feature0706,22,28,9,2,0,0,1.2727272727272727,0.4090909090909091,-0.18181818181818168,65.48181818181817,10,1,-0.09090909090909093,0.2258064516129032,-1,Lignin,8817121.38718453,5835390.72762178,0.6618249280432248,-0.5954784622169105,0.002346408791290989,0.004823806422872494,Downregulated
Feature0705,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol",C20 H22 O7,374.13662,NA,NA,"1,4-Bis(4-hydroxy-3-methoxyphenyl)dihydro-1H,3H-furo[3,4-c]furan-3a(4H)-ol-peak1",20,22,7,0,0,0,1.1,0.35,-0.4000000000000003,71.7,10,3,0.2307692307692308,0.3939393939393939,3,Lignin,263061.963845695,384825.4546482194,1.4628699984690585,0.5488015665390042,0.5168933607887964,0.5756853078081664,Upregulated
Feature0704,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine,C12 H18 N2 O4,254.12667,NA,NA,6-[2-Formyl-5-(hydroxymethyl)-1H-pyrrol-1-yl]norleucine-peak1,12,18,4,2,0,0,1.5,0.3333333333333333,-0.33333333333333304,69.79999999999998,5,1,-0.16666666666666666,0.125,-1,Protein,8470065.816072319,1955078.4363588495,0.23082210679508572,-2.115146691370556,4.1799157664412366e-7,2.011584462599845e-6,Downregulated
Feature0703,NA,C12 H17 N3 O5,283.11687,NA,NA,Feature0703,12,17,5,3,0,0,1.4166666666666667,0.4166666666666667,0.16666666666666652,55.55,6,1,-0.5,0.07692307692307693,-2,Lignin,11229576.268008243,1681197.1546539543,0.14971153982394594,-2.7397426657079422,3.007493902051561e-8,1.9371462623860622e-7,Downregulated
Feature0702,Isovalerylglutamic acid,C10 H17 N O5,231.11063,NA,NA,Isovalerylglutamic acid-peak4,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,3250572.4217838105,7806879.760975333,2.4016938397241328,1.2640522525991222,1.306629299774e-7,7.049140235086484e-7,Upregulated
Feature0701,NA,C20 H42 N9 O17 P,711.2437,NA,NA,Feature0701,20,42,17,9,0,1,2.1,0.85,0.7000000000000002,40.349999999999994,5,-12,3.142857142857143,-9,-22,Carbohydrate,931566.6176164016,58979.003213819735,0.06331163236047384,-3.9813855968037912,0.30163620104600775,0.37737941253466556,Downregulated
Feature0700,NA,C77 H114 N8 O16 P2,1468.7833,NA,NA,Feature0700,77,114,16,8,0,2,1.4805194805194806,0.2077922077922078,-0.883116883116883,85.46883116883116,26,10,0,0.13559322033898305,0,Lignin,1571212.399063134,354581.8118963928,0.2256740158795966,-2.1476877787931565,0.3810471353508177,0.4507638598353947,Downregulated
Feature0699,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12154,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak2",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,9529126.132378101,3338426.8379252725,0.35033924323679094,-1.513175494266463,2.1966916991722655e-7,1.1449833041224054e-6,Downregulated
Feature0698,"(2Z,4E)-2,4-Hexadienedial",C6 H6 O2,110.03674,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z,4E)-2,4-Hexadienedial-peak1",6,6,2,0,0,0,1,0.3333333333333333,-0.33333333333333304,69.79999999999998,4,2,0.5,0.6,2,Lignin,13931981.86900289,1107619.8680937225,0.07950196020266531,-3.6528657578079105,3.539389170314455e-9,3.043515357620654e-8,Downregulated
Feature0697,MFCD00056023,C12 H14 N2 O3,234.10044,NA,NA,MFCD00056023,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,10474829.023869863,6955026.974728082,0.6639752266007478,-0.5907986803136414,3.0306377396875015e-6,1.2282058208207242e-5,Downregulated
Feature0696,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak3",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,1362995.5741172237,1123205.453905015,0.8240712407540175,-0.2791590314596861,0.8054933481482116,0.8304964892045468,Downregulated
Feature0695,Linamarin,C10 H17 N O6,247.10559,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,Linamarin-peak1,10,17,6,1,0,0,1.7,0.6,-0.20000000000000015,66,3,-3,-1.3333333333333333,-0.16666666666666666,-4,Amino Sugar,314782.21854870976,2219656.207351546,7.051402768508265,2.817910288129631,5.861546501901143e-10,6.709094442040902e-9,Upregulated
Feature0694,Otonecine,C9 H15 N O3,185.10524,Other,NA,Otonecine,9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,741618.6909174708,1126413.9224198298,1.5188585943354815,0.6029875612507275,0.5372888398726994,0.5937164349278231,Upregulated
Feature0693,N-(Carboxyacetyl)phenylalanine,C12 H13 N O5,251.07938,NA,NA,N-(Carboxyacetyl)phenylalanine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,1137280.3312295715,229228.07215698782,0.20155810828905985,-2.310732273727028,2.173883009660866e-4,5.84532987042144e-4,Downregulated
Feature0692,NA,C10 H23 N O6,253.1525,NA,NA,Feature0692,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,1626645.330548281,4326512.772495262,2.6597763453677743,1.4113049378337919,0.04448517522038715,0.06856950575371777,Upregulated
Feature0691,Meconin,C10 H10 O4,194.05794,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids,Superpathway of scopolin and esculin biosynthesis;Other,Meconin-peak1,10,10,4,0,0,0,1,0.4,-0.20000000000000015,66,6,2,0.3333333333333333,0.5,2,Lignin,208837.1137417934,5593410.935501307,26.783605822176852,4.743278295713252,0.0015769671643806348,0.0033857824796714774,Upregulated
Feature0690,1581740,C12 H13 N O4,235.08444,NA,NA,1581740-peak2,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,6769885.962810351,5945164.448659238,0.8781779311082,-0.18741481535437293,0.3695861225423611,0.4412113400893303,Downregulated
Feature0689,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak2,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,1070925.6607467586,5921822.154666093,5.52962952679348,2.467182826253486,5.854365070143648e-4,0.0014228542939488291,Upregulated
Feature0688,NA,C9 H23 N10 O5 P,382.15886,NA,NA,Feature0688,9,23,5,10,0,1,2.5555555555555554,0.5555555555555556,1.3333333333333337,22.29999999999999,4,-1,1.7142857142857142,2.111111111111111,-12,Other,2536115.44407976,6662839.856433479,2.627183187574144,1.393516799858906,8.304276746590812e-9,6.284265516142993e-8,Upregulated
Feature0687,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0687,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,3497764.1606784575,5681925.802186823,1.6244450858243988,0.6999469743550631,0.005526196949772987,0.010219844577418603,Upregulated
Feature0686,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",C8 H17 N O7,239.10053,Metabolic pathways;Biosynthesis of cofactors;Other,NA,"2,3,4,5,6-Pentahydroxy-N-(2-hydroxyethyl)hexanamide",8,17,7,1,0,0,2.125,0.875,0,60.3,1,-6,-Inf,-1,-7,Carbohydrate,1354841.0848986534,249529.5845893909,0.18417627526261246,-2.440840862803385,0.1694352481997449,0.22735158716582687,Downregulated
Feature0685,ser-asn,C7 H13 N3 O5,219.08553,Biosynthesis of secondary metabolites;Other,NA,ser-asn,7,13,5,3,0,0,1.8571428571428572,0.7142857142857143,0.8571428571428572,35.87142857142857,3,-2,5,-1.6666666666666667,-5,Carbohydrate,3737952.549603565,4282313.935962503,1.1456308979675707,0.196142308105401,0.34358171927892256,0.41782299530401634,Upregulated
Feature0684,dihydroxyphenylalanine,C9 H11 N O4,197.06882,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,dihydroxyphenylalanine,9,11,4,1,0,0,1.2222222222222223,0.4444444444444444,0,60.3,5,1,0,0.3333333333333333,0,Lignin,11837849.955432963,3563979.8498517317,0.30106648278778436,-1.7318459906354455,4.081757386279062e-11,7.231910988817768e-10,Downregulated
Feature0683,D-Glucono-delta-lactone,C6 H10 O6,178.04778,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,D-Glucono-delta-lactone,6,10,6,0,0,0,1.6666666666666667,1,0.3333333333333335,50.8,2,-4,-Inf,-0.3333333333333333,-4,Carbohydrate,1281697.6939971228,163048.3210778341,0.12721277555657373,-2.9746845319176978,0.17514685841449845,0.2339895726767826,Downregulated
Feature0682,NA,C18 H29 N O12,451.16881,NA,NA,Feature0682,18,29,12,1,0,0,1.6111111111111112,0.6666666666666666,-0.11111111111111072,63.466666666666654,5,-7,-1.6,-0.18181818181818185,-8,Amino Sugar,1316651.59987195,152887.01977743278,0.11611805263617322,-3.106335812399313,0.16724223996197904,0.2248479003933274,Downregulated
Feature0681,leu-lys,C12 H25 N3 O3,259.18959,NA,NA,leu-lys,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,5943116.655012168,3285781.044256647,0.5528717060408971,-0.8549833531830477,0.03228744709962523,0.05106903397457062,Downregulated
Feature0680,lys-leu,C12 H25 N3 O3,259.18958,NA,NA,lys-leu-peak1,12,25,3,3,0,0,2.0833333333333335,0.25,-0.833333333333333,84.04999999999998,2,-1,-0.6666666666666666,-0.3333333333333333,-4,Lipid,6051236.6847844785,3329259.5807586336,0.550178377443058,-0.8620286534678008,0.029808160769856092,0.04732429647997771,Downregulated
Feature0679,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0679,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3144330.56737492,8121562.346835398,2.582922556267923,1.3690043877984748,7.212212247496076e-4,0.0017159392622553868,Upregulated
Feature0678,Zalcitabine,C9 H13 N3 O3,211.09565,Other,NA,Zalcitabine-peak1,9,13,3,3,0,0,1.4444444444444444,0.3333333333333333,0.22222222222222232,53.96666666666666,5,2,-0.3333333333333333,0.1111111111111111,-1,Lignin,5012025.000010178,3785098.1991067673,0.7552033757012546,-0.4050628814368467,0.21036797380532798,0.2749717188473963,Downregulated
Feature0677,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11578,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak2,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,367484.3700377343,547210.6993813561,1.4890720367921146,0.5744135488218699,0.052949558787783096,0.08001476591124404,Upregulated
Feature0676,2'-O-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,2'-O-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,10712067.221756063,3591491.826677124,0.3352753256983725,-1.57658178175998,1.6281167139030215e-6,6.929722897868639e-6,Downregulated
Feature0675,NA,C16 H23 N5 O10,445.14457,NA,NA,Feature0675,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,9336445.440761952,9025731.610830592,0.966720329283475,-0.04882951429920163,0.6215026599400897,0.6642432214123103,Downregulated
Feature0674,Cyclo(phenylalanyl-prolyl),C14 H16 N2 O2,244.12117,NA,NA,Cyclo(phenylalanyl-prolyl)-peak1,14,16,2,2,0,0,1.1428571428571428,0.14285714285714285,-0.4285714285714288,72.51428571428572,8,6,0.4,0.4545454545454546,4,Lignin,11277733.550392637,9494568.388147965,0.8418862128390513,-0.24830283934634387,0.001949830847810972,0.004072016479419139,Downregulated
Feature0673,NA,C14 H20 N2 O10,376.1119,NA,NA,Feature0673,14,20,10,2,0,0,1.4285714285714286,0.7142857142857143,0.4285714285714284,48.08571428571429,6,-4,-3,-0.14285714285714285,-6,Tannin,809667.5603213481,208788.01155341868,0.2578688115781161,-1.9552908006377085,0.18243405546752942,0.24295856129087642,Downregulated
Feature0672,N(6)-[(indol-3-yl)acetyl]-L-lysine,C16 H21 N3 O3,303.15835,NA,NA,N(6)-[(indol-3-yl)acetyl]-L-lysine,16,21,3,3,0,0,1.3125,0.1875,-0.375,70.9875,8,5,0.2,0.30434782608695654,2,Lignin,3372230.0078182826,7153283.253841308,2.1212323113360934,1.0849026293829775,8.67063763982605e-4,0.002012063035871963,Upregulated
Feature0671,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak5,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,636283.7326007728,6107574.336308533,9.598822071631751,3.2628573750335512,1.145593726579367e-5,4.1734102641407476e-5,Upregulated
Feature0670,Leu-Gly-Pro,C13 H23 N3 O4,285.16888,NA,NA,Leu-Gly-Pro-peak3,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,5073797.7293951465,3903317.93531309,0.7693089365189199,-0.37836502767527286,0.33546787009392787,0.41179896517327086,Downregulated
Feature0669,NA,C21 H32 N2 O8,440.21604,NA,NA,Feature0669,21,32,8,2,0,0,1.5238095238095235,0.380952380952381,-0.4761904761904763,73.87142857142857,7,-1,-0.2727272727272727,0.06666666666666667,-3,Protein,1449953.7353576447,6589990.937652646,4.544966350962338,2.1842696133457915,1.0287264864735657e-7,5.789576970386114e-7,Upregulated
Feature0668,N(6)-OH-Me-Adenosine,C11 H15 N5 O5,297.10731,NA,NA,N(6)-OH-Me-Adenosine-peak1,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,6003920.924406975,4260868.4964677505,0.7096809818308207,-0.49475744965141827,0.012732364646190009,0.021963977302083375,Downregulated
Feature0667,2762577,C15 H23 N3 O4,309.16893,NA,NA,2762577-peak1,15,23,4,3,0,0,1.5333333333333334,0.26666666666666666,-0.4000000000000003,71.7,6,2,-0.125,0.1,-1,Lipid,5739293.208604505,5184654.191797818,0.9033610940149988,-0.14662531381095686,0.5962451654916023,0.6429276322996654,Downregulated
Feature0666,NA,C19 H35 P S,326.21985,NA,NA,Feature0666,19,35,0,0,1,1,1.8421052631578947,0,-2,117.3,3,3,0.0588235294117647,0.0588235294117647,1,Lipid,4947416.981056231,3112408.5105835996,0.6290976730890241,-0.6686440689725749,0.46113835208001075,0.5249787422201198,Downregulated
Feature0665,xylometazoline,C16 H24 N2,244.19396,NA,NA,xylometazoline,16,24,0,2,0,0,1.5,0,-1.125,92.3625,6,6,0.2857142857142857,0.2857142857142857,4,Lipid,179647.9009819656,1517384.651190611,8.446436851733312,3.0783428656013023,0.003892574191498207,0.007493205318634048,Upregulated
Feature0664,Threonylglutamine,C9 H17 N3 O5,247.11681,NA,NA,Threonylglutamine,9,17,5,3,0,0,1.8888888888888888,0.5555555555555556,0.22222222222222232,53.96666666666666,3,-2,-5,-0.7142857142857143,-5,Amino Sugar,8394973.105477894,8417533.769765243,1.0026874016156917,0.0038719006349783877,0.9884049695809707,0.9895732969681823,Upregulated
Feature0663,(S)-(+)-2-Aminobutyric Acid,C4 H9 N O2,103.06328,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,(S)-(+)-2-Aminobutyric Acid,4,9,2,1,0,0,2.25,0.5,-0.5,74.55,1,-1,-2,-0.5,-2,Protein,2608286.814604938,2142177.439707532,0.8212967330557913,-0.28402453553506896,0.6399151217145316,0.6796339913381921,Downregulated
Feature0662,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14231,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak2",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,294661.4760519012,4462057.06935271,15.142994357928114,3.920578605243697,0.0014849296121192783,0.0032332529086504594,Upregulated
Feature0661,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07397,NA,NA,Phenyl D-glucopyranosiduronic acid-peak2,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,3961013.826995841,4367565.732236107,1.1026383453825526,0.14095967861795566,0.7039117219275068,0.7383445553840227,Upregulated
Feature0660,Prolylleucine,C11 H20 N2 O3,228.14739,NA,NA,Prolylleucine-peak1,11,20,3,2,0,0,1.818181818181818,0.2727272727272727,-0.7272727272727275,81.02727272727273,3,0,-0.3333333333333333,-0.06666666666666667,-2,Lipid,6025267.392344427,2259877.5429897616,0.3750667639848005,-1.4147806686214652,3.6417768524087434e-5,1.1841017251401941e-4,Downregulated
Feature0659,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime",C10 H13 N O3,195.08957,Other,NA,"1-(3,4-dimethoxyphenyl)ethan-1-one oxime-peak1",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,9797472.147810377,9159325.937869562,0.9348662389325155,-0.09716813655408385,0.7107465118769379,0.7444206183706519,Downregulated
Feature0658,2'-deamino-2'-hydroxy-6'-dehydroparomamine,C12 H22 N2 O8,322.13771,Biosynthesis of secondary metabolites;Other,Kanamycin biosynthesis,2'-deamino-2'-hydroxy-6'-dehydroparomamine,12,22,8,2,0,0,1.8333333333333333,0.6666666666666666,0,60.3,3,-5,-3.5,-0.5,-7,Amino Sugar,12818644.545159563,2473226.8431323655,0.19293981001027743,-2.3737772439900335,3.931846920126656e-11,7.1615415315561e-10,Downregulated
Feature0657,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak3,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,7116173.349761248,2723830.220051853,0.3827661421630825,-1.385464873981211,4.446821307797229e-8,2.729317136017575e-7,Downregulated
Feature0656,NA,C16 H29 N3 O9,407.19049,NA,NA,Feature0656,16,29,9,3,0,0,1.8125,0.5625,-0.125,63.8625,4,-5,-2,-0.4117647058823529,-8,Amino Sugar,3379186.6767392145,1103741.5744188067,0.3266293578914897,-1.6142736267649536,2.809902209367722e-8,1.8307593625649698e-7,Downregulated
Feature0655,butoctamide,C16 H29 N O5,315.20464,NA,NA,butoctamide,16,29,5,1,0,0,1.8125,0.3125,-1,88.8,3,-2,-0.3,-0.04,-3,Protein,4642258.181352866,7917085.898856639,1.7054385149576945,0.7701427433625747,0.4018719522657923,0.47047068910729245,Upregulated
Feature0654,NA,C23 H33 N3 O5,431.24202,NA,NA,Feature0654,23,33,5,3,0,0,1.434782608695652,0.21739130434782608,-0.6086956521739131,77.64782608695651,9,4,0.06666666666666667,0.2,1,Lignin,296435.2319574118,6498172.750111359,21.921054077151453,4.454245267059739,1.815361088921609e-4,4.997340225202186e-4,Upregulated
Feature0653,NA,C18 H31 N O14,485.17464,NA,NA,Feature0653,18,31,14,1,0,0,1.7222222222222223,0.7777777777777778,0,60.3,4,-10,-3.6666666666666665,-0.4,-11,Carbohydrate,12465889.918742334,7835744.205902693,0.6285747954601888,-0.6698436706565419,1.4471076965301465e-4,4.07209375070111e-4,Downregulated
Feature0652,NA,C29 H28 O9,520.17353,NA,NA,Feature0652,29,28,9,0,0,0,0.9655172413793104,0.3103448275862069,-0.3448275862068968,70.12758620689655,16,7,0.35,0.4693877551020408,7,Lignin,226229.30318158848,310229.4245634101,1.3713052208554826,0.45554971743816103,0.5746500111475582,0.6232119839205914,Upregulated
Feature0651,N6-acetyl-N6-hydroxy-L-lysine,C8 H16 N2 O4,204.11098,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,NA,N6-acetyl-N6-hydroxy-L-lysine-peak1,8,16,4,2,0,0,2,0.5,-0.25,67.425,2,-2,-2,-0.5,-4,Protein,9924141.820232918,3149389.190306077,0.31734624991807714,-1.655870300499092,7.172600489059414e-8,4.132784091315186e-7,Downregulated
Feature0650,1-(5-Amino-5-carboxypentyl)-5-oxoproline,C11 H18 N2 O5,258.12159,NA,NA,1-(5-Amino-5-carboxypentyl)-5-oxoproline,11,18,5,2,0,0,1.6363636363636365,0.4545454545454546,-0.18181818181818168,65.48181818181817,4,-1,-0.75,-0.07692307692307693,-3,Protein,7978210.9093921315,7731547.116091417,0.9690828186792685,-0.04530812997744454,0.7704431457014149,0.7997124318738952,Downregulated
Feature0649,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23298,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak2,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,3051148.142593507,769663.9082217328,0.25225386387417775,-1.9870517270446415,5.1537126857546784e-5,1.6107729316731413e-4,Downregulated
Feature0648,NA,C14 H29 N O2,243.2198,NA,NA,Feature0648,14,29,2,1,0,0,2.0714285714285716,0.14285714285714285,-1.5714285714285712,105.08571428571427,1,-1,-0.18181818181818185,-0.08333333333333333,-2,Lipid,226692.19356033928,441407.2385788755,1.9471655889261352,0.9613755775170502,0.11439888178572907,0.15949934629220167,Upregulated
Feature0647,Leucyltryptophan,C17 H23 N3 O3,317.17403,NA,NA,Leucyltryptophan-peak1,17,23,3,3,0,0,1.3529411764705883,0.17647058823529413,-0.47058823529411775,73.71176470588236,8,5,0.18181818181818185,0.28,2,Lignin,2698912.8969921647,6011153.947617509,2.2272500732856964,1.15526355149544,0.013591166738510446,0.02332186480601795,Upregulated
Feature0646,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak2",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,1197885.2568239183,1006140.1209056246,0.8399302981433395,-0.25165848449033146,0.8325703344092273,0.8542544800055912,Downregulated
Feature0645,NA,C32 H37 N4 O2 P3,602.213,NA,NA,Feature0645,32,37,2,4,0,3,1.15625,0.0625,-1.125,92.3625,18,16,0.391304347826087,0.4166666666666667,9,Unsaturated HC,383070.8180455904,593585.8655770296,1.5495460306934297,0.6318456121469558,0.4711781206845276,0.5342541743236879,Upregulated
Feature0644,N-Acetylserotonin,C12 H14 N2 O2,218.10552,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-Acetylserotonin,12,14,2,2,0,0,1.1666666666666667,0.16666666666666666,-0.33333333333333304,69.79999999999998,7,5,0.375,0.4444444444444444,3,Lignin,8979366.19885637,4981599.909078713,0.5547830212908768,-0.8500044591261275,1.6525399092041075e-4,4.596720207211425e-4,Downregulated
Feature0643,Homo-L-arginine,C7 H16 N4 O2,188.12733,NA,NA,Homo-L-arginine,7,16,2,4,0,0,2.2857142857142856,0.2857142857142857,0,60.3,2,0,-4,-1.5,-4,Lipid,289193.5478067063,4392100.203279344,15.187407314546917,3.9248036991776956,1.1174396721788794e-6,4.91673455758707e-6,Upregulated
Feature0642,NA,C9 H19 N O3,189.13649,NA,NA,Feature0642,9,19,3,1,0,0,2.111111111111111,0.3333333333333333,-1.1111111111111107,91.96666666666664,1,-2,-0.6,-0.2307692307692308,-3,Protein,238211.50699273933,2487365.1115442826,10.441834414070087,3.384303280703264,0.004583032536452383,0.00865513613907507,Upregulated
Feature0641,N-Aceyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Aceyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,8884770.714182802,2610368.5325489687,0.2938025770751771,-1.7670810444074918,1.0583333072619332e-8,7.761110919920843e-8,Downregulated
Feature0640,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0640,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,7719668.009626538,6512089.251676447,0.84357115403872,-0.2454183319473294,0.2828775393292595,0.3576078743460937,Downregulated
Feature0639,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak4,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,1105157.4468776728,7556853.4934335835,6.837807151174211,2.773533734563065,4.442602178950496e-8,2.729317136017575e-7,Upregulated
Feature0638,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak2,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,10619152.156280873,2846230.880211867,0.268028072140243,-1.8995439844410105,8.047709870251274e-10,8.683325172105516e-9,Downregulated
Feature0637,Leucylasparagine,C10 H19 N3 O4,245.13752,NA,NA,Leucylasparagine-peak2,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,7001321.310258813,3370687.6819841,0.4814359365345994,-1.0545842598360318,0.00144997275259718,0.0031652755707469366,Downregulated
Feature0636,Acetophenone,C8 H8 O,120.05748,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak2,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,11511758.559664952,474905.3636223771,0.0412539371079547,-4.599324378899355,2.7824900952168136e-8,1.819898927141808e-7,Downregulated
Feature0635,NA,C16 H23 N5 O10,445.14463,NA,NA,Feature0635,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,3801571.668849137,8324633.717696745,2.1897873939640573,1.1307908056423372,2.4471943508694765e-11,5.055545402893773e-10,Upregulated
Feature0634,NA,C9 H12 N2 O4,212.0797,NA,NA,Feature0634,9,12,4,2,0,0,1.3333333333333333,0.4444444444444444,0.22222222222222232,53.96666666666666,5,1,-0.3333333333333333,0.2,-1,Lignin,10851842.3848109,8338069.185079951,0.7683551685887526,-0.38015475071674276,1.6551693311297693e-5,5.757406256537637e-5,Downregulated
Feature0633,HC Blue 1,C11 H17 N3 O4,255.12193,NA,NA,HC Blue 1,11,17,4,3,0,0,1.5454545454545454,0.3636363636363637,0,60.3,5,1,-0.5,0,-2,Protein,10898337.864200655,7074601.646438776,0.6491450104219784,-0.6233873016428915,3.0754224282241254e-5,1.0175323424632165e-4,Downregulated
Feature0632,beta-Pyracin,C8 H7 N O3,165.04262,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Other,Other,beta-Pyracin,8,7,3,1,0,0,0.875,0.375,0.25,53.175,6,3,0.5,0.6363636363636364,2,Lignin,8812448.800503435,7571525.945280262,0.8591852408660483,-0.21895888405035482,0.0012094496802964295,0.002699351460371741,Downregulated
Feature0631,ET8750000,C4 H7 N,69.05786,NA,Superpathway of linamarin and lotaustralin biosynthesis;Other,ET8750000,4,7,0,1,0,0,1.75,0,-1,88.8,2,2,0.3333333333333333,0.3333333333333333,1,Lipid,11751923.84609789,750200.777786173,0.06383642266668277,-3.969476383227663,1.6679477561925778e-9,1.6284429170549806e-8,Downregulated
Feature0630,Isovalerylglutamic acid,C10 H17 N O5,231.11073,NA,NA,Isovalerylglutamic acid-peak3,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,7857890.801903943,1680534.3823554646,0.21386583559398362,-2.2252220600505734,1.8150963629161128e-7,9.608666371187172e-7,Downregulated
Feature0629,NP-021733,C7 H13 N O2,143.09464,ABC transporters,NA,NP-021733-peak1,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,385324.97996088956,357122.65553590126,0.9268089900949302,-0.1096560564005662,0.8496548566052932,0.8691517675660427,Downregulated
Feature0628,propionylcarnitine,C10 H19 N O4,217.13149,NA,NA,propionylcarnitine,10,19,4,1,0,0,1.9,0.4,-0.7999999999999998,83.1,2,-2,-0.6,-0.14285714285714285,-3,Protein,6328327.1213672785,3150791.4417174933,0.49788694251898014,-1.0061099148120445,1.8028408871977647e-6,7.578194697054625e-6,Downregulated
Feature0627,Tetrahydrothiophene,C4 H8 S,88.03465,NA,NA,Tetrahydrothiophene,4,8,0,0,1,0,2,0,-1.5,103.05,1,1,0,0,0,Lipid,247938.60330582532,3293285.2966622026,13.282664549820131,3.731472680368326,0.0014402041165855574,0.0031480074496721736,Upregulated
Feature0626,4-[(Z)-2-Aminovinyl]phenol,C8 H9 N O,135.06839,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Other,NA,4-[(Z)-2-Aminovinyl]phenol,8,9,1,1,0,0,1.125,0.125,-0.5,74.55,5,4,0.5,0.5384615384615384,3,Unsaturated HC,9415123.828886973,5332402.209540094,0.5663655950205888,-0.8201944661203402,2.5020857061116257e-4,6.643468943813627e-4,Downregulated
Feature0625,glu-asp,C9 H14 N2 O7,262.08011,NA,NA,glu-asp,9,14,7,2,0,0,1.5555555555555556,0.7777777777777778,0.6666666666666665,41.3,4,-3,-Inf,-0.42857142857142855,-5,Carbohydrate,972030.0406980342,3656562.01656349,3.761778816977343,1.9114150245573187,4.3617920634508684e-5,1.387741874033006e-4,Upregulated
Feature0624,NA,C13 H15 N O4,249.1001,NA,NA,Feature0624,13,15,4,1,0,0,1.1538461538461535,0.3076923076923077,-0.3076923076923075,69.06923076923076,7,3,0.25,0.4,2,Lignin,8812736.421977382,7695263.747165547,0.8731979919398181,-0.19561928226570985,0.011595423404273462,0.020166988959793887,Downregulated
Feature0623,NA,C10 H20 N2 O4 S,264.11437,NA,NA,Feature0623,10,20,4,2,1,0,2,0.4,-0.4000000000000003,71.7,2,-2,-1.6666666666666667,-0.6,-5,Protein,9617880.233490217,191537.5016456651,0.019914731416462893,-5.650020167102501,1.4473772145275803e-8,1.0173680503774776e-7,Downregulated
Feature0622,Succinic anhydride,C4 H4 O3,100.01602,NA,NA,Succinic anhydride,4,4,3,0,0,0,1,0.75,0.5,46.05,3,0,0,0.6,0,Tannin,1306687.243636438,1418495.5370475193,1.085566224018477,0.11844773898740613,0.9034891771495357,0.9142835520258743,Upregulated
Feature0621,dapdiamide A,C12 H20 N4 O5,300.14339,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,dapdiamide A,12,20,5,4,0,0,1.6666666666666667,0.4166666666666667,0.16666666666666652,55.55,5,0,-1.3333333333333333,-0.2727272727272727,-4,Protein,2855097.31626382,6546800.50812129,2.293021842312693,1.1972500974595348,2.522020668481165e-6,1.0319572493736942e-5,Upregulated
Feature0620,Pyridostigmine,C9 H12 N2 O2,180.08989,Metabolic pathways;Other,NA,Pyridostigmine,9,12,2,2,0,0,1.3333333333333333,0.2222222222222222,-0.22222222222222232,66.63333333333333,5,3,0.2,0.3333333333333333,1,Lignin,7734543.26712895,7204654.141985266,0.9314905732836661,-0.10238692576953384,0.3380518460383133,0.4122820930085693,Downregulated
Feature0619,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",C10 H11 N O2,177.07899,NA,NA,"1-Methyl-3,4-dihydro-6,7-isoquinolinediol",10,11,2,1,0,0,1.1,0.2,-0.4000000000000003,71.7,6,4,0.42857142857142855,0.5,3,Lignin,1240075.5742821086,2543406.5482457317,2.051009310233478,1.0363340407193653,0.04587810208074025,0.07046011325908794,Upregulated
Feature0618,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak6,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2603406.3109130682,6330923.195425511,2.4317845312455764,1.2820154041619332,1.1129948227397329e-4,3.222928597813859e-4,Upregulated
Feature0617,NA,C61 H95 N10 O14 P3,1284.62434,NA,NA,Feature0617,61,95,14,10,0,3,1.5573770491803278,0.22950819672131148,-0.8524590163934427,84.5950819672131,21,7,-0.17647058823529413,0.02439024390243902,-6,Lipid,146002.35359190305,2574717.7435503607,17.634768756858918,4.140350752844882,2.9347999032462995e-4,7.638452763210838e-4,Upregulated
Feature0616,5-Hydroxyindole-3-acetic acid,C10 H9 N O3,191.05831,Metabolic pathways;Other,NA,5-Hydroxyindole-3-acetic acid,10,9,3,1,0,0,0.9,0.3,0,60.3,7,4,0.5,0.6,3,Lignin,9037148.607643688,8060992.601363673,0.8919840705668628,-0.16491014877697857,0.050810630642159384,0.07705748281810026,Downregulated
Feature0615,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0615,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3842199.684821074,6614509.318982034,1.7215423095039015,0.7837016377544063,0.01748723717240304,0.02924321793687142,Upregulated
Feature0614,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0614,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4246536.103110414,5697471.623894675,1.3416750701169147,0.42403531871332695,0.12007748498820894,0.1665221615278872,Upregulated
Feature0613,NA,C16 H23 N5 O10,445.14459,NA,NA,Feature0613,16,23,10,5,0,0,1.4375,0.625,0.75,38.925,8,-2,-7,-0.3333333333333333,-7,Lignin,5271143.457067072,4836637.459118664,0.91756892949558,-0.12411155490847986,0.6269188558460213,0.6686668682645099,Downregulated
Feature0612,MFCD00142316,C12 H14 N2 O3,234.1004,NA,NA,MFCD00142316,12,14,3,2,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,7,4,0.2857142857142857,0.4117647058823529,2,Lignin,158945.85316818842,3335683.7495291065,20.986289878223218,4.391375233056461,9.044114094327985e-6,3.352457171945647e-5,Upregulated
Feature0611,NP-015145,C14 H13 N O2,227.09462,Other,NA,NP-015145,14,13,2,1,0,0,0.9285714285714286,0.14285714285714285,-0.4285714285714288,72.51428571428572,9,7,0.5454545454545454,0.5833333333333334,6,Lignin,9362009.13178541,7967302.29185533,0.8510248366245614,-0.2327268582144092,0.002180389092634943,0.004509864618954328,Downregulated
Feature0610,NA,C13 H25 N3 O5,303.17945,NA,NA,Feature0610,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,3228062.8265610714,2174716.195501307,0.673690789908845,-0.5698415186490938,0.001552876413366864,0.003346784534660901,Downregulated
Feature0609,2-Hexenoylcarnitine,C13 H23 N O4,257.16273,NA,NA,2-Hexenoylcarnitine,13,23,4,1,0,0,1.7692307692307692,0.3076923076923077,-0.9230769230769234,86.6076923076923,3,-1,-0.25,0,-2,Protein,1524278.2516145278,2992891.6026912816,1.9634811423184624,0.9734137421274156,0.16890755447323763,0.2269067385231281,Upregulated
Feature0608,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak3,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,5165394.253795889,4166799.9721958498,0.8066760768810235,-0.30993862348112017,0.32187668212728004,0.39945721576821425,Downregulated
Feature0607,Leonurine,C14 H21 N3 O5,311.14823,NA,NA,Leonurine-peak2,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,221920.3107375258,2278259.1399124586,10.266113688922545,3.3598182373200167,0.013346943760328025,0.022977360497963083,Upregulated
Feature0606,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak4,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1353397.667938731,3917981.6380323255,2.8949227051643587,1.5335248285721086,5.757258736079872e-4,0.0014032800430099717,Upregulated
Feature0605,ile-his,C12 H20 N4 O3,268.15359,NA,NA,ile-his-peak2,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,1467191.5772753553,3667522.4427780746,2.4996888610748695,1.3217485322796219,0.01254403983802169,0.021683268862866065,Upregulated
Feature0604,Apaxifylline,C16 H22 N4 O3,318.1693,NA,NA,Apaxifylline,16,22,3,4,0,0,1.375,0.1875,-0.25,67.425,8,5,0.1111111111111111,0.23809523809523808,1,Lignin,141173.37548258906,5040827.444615233,35.706643886523196,5.158120634417381,7.891958255963193e-7,3.5555790653195877e-6,Upregulated
Feature0603,Levetiracetam,C8 H14 N2 O2,170.10558,NA,NA,Levetiracetam-peak2,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,717198.0767533411,5701962.5741017675,7.950331657209375,2.9910150453317006,1.0350857223438676e-5,3.8118156818489384e-5,Upregulated
Feature0602,Butenylcarnitine,C11 H19 N O4,229.13142,NA,NA,Butenylcarnitine,11,19,4,1,0,0,1.7272727272727273,0.3636363636363637,-0.7272727272727275,81.02727272727273,3,-1,-0.3333333333333333,0,-2,Protein,693568.5226912335,757267.558582039,1.0918424550809138,0.1267647008815858,0.8745978894846286,0.8914898559158531,Upregulated
Feature0601,NA,C12 H24 N O13 P,421.09864,NA,NA,Feature0601,12,24,13,1,0,1,2,1.0833333333333333,0,60.3,2,-11,4.333333333333333,-1.8571428571428572,-13,Carbohydrate,532795.3382941837,266635.4238214835,0.5004462401550901,-0.9987129973093033,1.4592058931361425e-4,4.099327998296228e-4,Downregulated
Feature0600,NA,C10 H20 N2 O6,264.13219,NA,NA,Feature0600,10,20,6,2,0,0,2,0.6,-0.20000000000000015,66,2,-4,-3,-0.6,-6,Amino Sugar,3586193.7432478205,511078.212369604,0.142512716534592,-2.810837436923314,5.948737819197484e-9,4.7089541428600646e-8,Downregulated
Feature0599,NA,C16 H14 O3 S,286.0665,NA,NA,Feature0599,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,6410526.421342198,4083239.768561436,0.6369585740988977,-0.6507285479717365,9.847837762744372e-5,2.8962217309182236e-4,Downregulated
Feature0598,NA,C10 H22 N2 O4,234.15795,NA,NA,Feature0598,10,22,4,2,0,0,2.2,0.4,-0.7999999999999998,83.1,1,-3,-1.25,-0.5,-5,Protein,191388.71703068592,180616.83859263323,0.9437172754738431,-0.08357338187237656,0.7939694272294442,0.8206126965995598,Downregulated
Feature0597,NP-021030,C9 H8 O4,180.04228,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,NP-021030,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,336304.0630290381,199452.83694561088,0.5930729327180004,-0.7537185648198678,0.03676783674024185,0.05751127925943647,Downregulated
Feature0596,NA,C7 H15 N O6,209.08992,NA,NA,Feature0596,7,15,6,1,0,0,2.142857142857143,0.8571428571428571,0,60.3,1,-5,-Inf,-1,-6,Carbohydrate,2044807.833414654,2984415.640861768,1.459509100118249,0.5454832061499033,0.16169248081444976,0.21773216414918753,Upregulated
Feature0595,NA,C13 H25 N3 O4,287.18456,NA,NA,Feature0595,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,1709166.863992494,81200.44675216616,0.04750878832420587,-4.395661777405064,0.18713884963402874,0.2484429555486244,Downregulated
Feature0594,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",C10 H13 N O3,195.08955,Other,NA,"2-Methyl-1,2,3,4-tetrahydro-4,6,7-isoquinolinetriol",10,13,3,1,0,0,1.3,0.3,-0.4000000000000003,71.7,5,2,0.16666666666666666,0.3333333333333333,1,Lignin,2291518.6632623407,4056350.1376010505,1.7701580190606836,0.8238781530424604,0.0024317028565199483,0.004975005602590329,Upregulated
Feature0593,3-Methylcrotonylglycine,C7 H11 N O3,157.07391,NA,NA,3-Methylcrotonylglycine-peak1,7,11,3,1,0,0,1.5714285714285714,0.42857142857142855,-0.2857142857142856,68.44285714285714,3,0,-0.3333333333333333,0.1111111111111111,-1,Protein,885032.785096286,2367287.7748065647,2.6748023515863526,1.4194322907956276,0.00877747809163242,0.01565162935497402,Upregulated
Feature0592,7098783,C14 H18 N2 O4,278.1267,Metabolic pathways;Biosynthesis of cofactors;Other,NA,7098783,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,1292875.5553639466,6254604.981982632,4.8377471103334075,2.274335355468384,4.465453912449284e-8,2.73085881866032e-7,Upregulated
Feature0591,NA,C18 H27 N O12,449.1534,NA,NA,Feature0591,18,27,12,1,0,0,1.5,0.6666666666666666,0,60.3,6,-6,-1.4,-0.09090909090909093,-7,Amino Sugar,3254030.9386010566,4815481.371069933,1.4798511329275073,0.5654520538343851,0.06642074021136735,0.09775563329110015,Upregulated
Feature0590,5-Pentylresorcinol,C11 H16 O2,180.11499,NA,NA,5-Pentylresorcinol,11,16,2,0,0,0,1.4545454545454546,0.18181818181818185,-1.0909090909090908,91.39090909090908,4,2,0.2222222222222222,0.3,2,Lignin,2035335.3788549313,5365640.79543274,2.636244056471627,1.3984839374031013,0.06624746787907304,0.09758540051056498,Upregulated
Feature0589,NA,C16 H28 N2 O5,328.19992,NA,NA,Feature0589,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,138296.2168749863,3939820.388777389,28.48827305477787,4.832296263729831,2.470209828477975e-5,8.319155963104751e-5,Upregulated
Feature0588,NA,C16 H25 N O9,375.15307,NA,NA,Feature0588,16,25,9,1,0,0,1.5625,0.5625,-0.25,67.425,5,-4,-0.8333333333333334,-0.04761904761904761,-5,Amino Sugar,11379738.958375668,338402.7467047183,0.02973730310884227,-5.071582375199546,5.468723983696863e-10,6.38897822647068e-9,Downregulated
Feature0587,asn-phe,C13 H17 N3 O4,279.12194,NA,NA,asn-phe-peak1,13,17,4,3,0,0,1.3076923076923077,0.3076923076923077,0,60.3,7,3,0,0.25,0,Lignin,3386749.164112596,3127622.971222353,0.9234882241542859,-0.11483453006571359,0.6970592259334083,0.73302415959521,Downregulated
Feature0586,4'-Methoxyacetophenone,C9 H10 O2,150.06812,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine metabolism;Other,Other,4'-Methoxyacetophenone,9,10,2,0,0,0,1.1111111111111112,0.2222222222222222,-0.666666666666667,79.30000000000001,5,3,0.42857142857142855,0.5,3,Lignin,2505586.626637062,1488551.6580291146,0.5940930727376258,-0.7512391284094354,0.5699649391984114,0.6193204663259197,Downregulated
Feature0585,N6-Dimethyladenosine,C12 H17 N5 O4,295.1281,NA,NA,N6-Dimethyladenosine,12,17,4,5,0,0,1.4166666666666667,0.3333333333333333,0.5,46.05,7,3,-0.6666666666666666,0,-2,Lignin,10363247.226497538,1809392.1678711523,0.17459702816360115,-2.5178990919917354,1.0167875710797475e-9,1.0567105186558848e-8,Downregulated
Feature0584,NA,C20 H38 N4 O6,430.27924,NA,NA,Feature0584,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,223118.5573485624,2557912.67920878,11.464365445912835,3.5190845986617254,0.0016591687226229738,0.0035398385593492666,Upregulated
Feature0583,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0583,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,3302861.838183806,4518278.278449193,1.3679888835234253,0.4520565067217724,0.05644256458813674,0.08453908436101118,Upregulated
Feature0582,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",C14 H23 N O3,253.16772,NA,NA,"(1R,5R)-3,3,5-Trimethylcyclohexyl 5-oxo-L-prolinate",14,23,3,1,0,0,1.6428571428571428,0.21428571428571427,-1,88.8,4,1,0,0.13043478260869565,0,Lipid,1255875.749408891,3395595.218288027,2.7037668494564437,1.4349707508674239,0.006041515378085824,0.011100137798782415,Upregulated
Feature0581,NA,C22 H37 N2 O8 P3 S,582.1482,NA,NA,Feature0581,22,37,8,2,1,3,1.681818181818182,0.3636363636363637,-1.2727272727272725,96.57272727272726,7,-1,-0.875,-0.25,-7,Protein,257504.47960572588,358277.9387766206,1.391346431429824,0.4764816813313878,0.566913646305099,0.6171926200776592,Upregulated
Feature0580,NA,C16 H29 N3 O6,359.20575,NA,NA,Feature0580,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,2677285.5218784185,4512991.916284484,1.685659553082747,0.7533131894977099,0.013533163644167389,0.023250688857220644,Upregulated
Feature0579,VLK,C17 H34 N4 O4,358.25811,NA,NA,VLK,17,34,4,4,0,0,2,0.2352941176470588,-0.8235294117647056,83.7705882352941,3,-1,-0.5555555555555556,-0.2727272727272727,-5,Lipid,6011823.035358582,1986578.0482204761,0.3304451971617266,-1.5975170677499364,5.211336509169409e-7,2.445430483804149e-6,Downregulated
Feature0578,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16891,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak3,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,4613074.345153319,3924256.687615153,0.8506814315139175,-0.2333091312730952,0.42637878614385194,0.4940394416742033,Downregulated
Feature0577,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0577,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,5689376.092367734,5067886.097798467,0.8907630670781296,-0.16688635271117086,0.08300401892430075,0.11926107553669675,Downregulated
Feature0576,NA,C15 H21 N5 O2,303.16956,NA,NA,Feature0576,15,21,2,5,0,0,1.4,0.13333333333333333,-0.13333333333333375,64.10000000000001,8,6,0.125,0.2222222222222222,1,Lignin,10495244.755023405,312065.56640915823,0.029733996080443224,-5.07174282346758,9.603033333778269e-16,1.851207415473596e-13,Downregulated
Feature0575,Methionylleucine,C11 H22 N2 O3 S,262.13515,NA,NA,Methionylleucine-peak1,11,22,3,2,1,0,2,0.2727272727272727,-0.7272727272727275,81.02727272727273,2,-1,-0.8,-0.38461538461538464,-4,Lipid,1220568.5695665209,4135808.6448328933,3.388427940842116,1.7606160910640363,0.0013357619662009571,0.002938676325642106,Upregulated
Feature0574,NA,C11 H19 N3 O4,257.13761,NA,NA,Feature0574,11,19,4,3,0,0,1.7272727272727273,0.3636363636363637,-0.18181818181818168,65.48181818181817,4,0,-0.75,-0.16666666666666666,-3,Protein,6441312.073683047,189171.8174496651,0.029368522326771767,-5.0895855112917,3.9252890701015194e-4,9.894999530880913e-4,Downregulated
Feature0573,NA,C19 H23 N3 O5,373.16384,NA,NA,Feature0573,19,23,5,3,0,0,1.2105263157894737,0.2631578947368421,-0.21052631578947345,66.29999999999998,10,5,0.18181818181818185,0.3333333333333333,2,Lignin,11619878.812457446,263978.96091512876,0.0227178755627057,-5.460028260673802,2.948462971623132e-12,9.081265952599247e-11,Downregulated
Feature0572,3-Methoxy-4-hydroxyhippuric acid,C10 H11 N O5,225.06369,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Superpathway of chorismate metabolism;Other,3-Methoxy-4-hydroxyhippuric acid-peak1,10,11,5,1,0,0,1.1,0.5,0.20000000000000015,54.599999999999994,6,1,0,0.38461538461538464,0,Lignin,9337643.021701684,2194310.8598483726,0.23499622493048394,-2.089290513917577,7.595450173476945e-15,7.568642702276438e-13,Downregulated
Feature0571,NA,C11 H22 N4 O3,258.16921,NA,NA,Feature0571,11,22,3,4,0,0,2,0.2727272727272727,-0.3636363636363633,70.66363636363636,3,0,-1,-0.4545454545454546,-4,Lipid,2014673.2625485065,213279.31771746933,0.10586298120007649,-3.2397299075948127,0.1238347746634839,0.17082744973936623,Downregulated
Feature0570,glu-leu,C11 H20 N2 O5,260.13722,NA,NA,glu-leu,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,8911416.618359117,2472772.929271813,0.2774837082779249,-1.8495250249619846,4.2805571116533336e-6,1.65932808859056e-5,Downregulated
Feature0569,NA,C13 H24 N2 O10,368.14308,NA,NA,Feature0569,13,24,10,2,0,0,1.8461538461538465,0.7692307692307693,0.15384615384615374,55.91538461538462,3,-7,-9,-0.6666666666666666,-9,Carbohydrate,1205230.9189625715,1419154.954188047,1.1774963053633034,0.23572253309291843,0.6879304391945855,0.7247227388032512,Upregulated
Feature0568,6-methyltetrahydropterin,C7 H11 N5 O,181.09637,NA,NA,6-methyltetrahydropterin,7,11,1,5,0,0,1.5714285714285714,0.14285714285714285,0.8571428571428572,35.87142857142857,5,4,-1,-0.3333333333333333,-1,Lipid,5483736.519646984,1287745.7982968383,0.2348299911352665,-2.090311421963128,0.0011372651267330142,0.002551691555875134,Downregulated
Feature0567,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak3,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,421968.4499612088,5402649.005255686,12.803443019856928,3.678459917592003,5.447215513213637e-6,2.08768847949862e-5,Upregulated
Feature0566,NA,C39 H72 N2 O5,648.54423,NA,NA,Feature0566,39,72,5,2,0,0,1.8461538461538465,0.1282051282051282,-1.435897435897436,101.22307692307692,5,0,-0.0625,0.0144927536231884,-2,Lipid,296271.6681639387,410654.7214955151,1.3860748955188107,0.47100521452727845,0.5558595973285019,0.6086788350836989,Upregulated
Feature0565,NA,C13 H24 N2 O3,256.17864,NA,NA,Feature0565,13,24,3,2,0,0,1.8461538461538465,0.2307692307692308,-0.9230769230769234,86.6076923076923,3,0,-0.25,-0.05263157894736842,-2,Lipid,476937.6223405691,6158773.450392188,12.913163403147012,3.690770563152533,1.903014019470219e-4,5.174487558559472e-4,Upregulated
Feature0564,NP-004713,C15 H24 O2,236.17762,Other,Other,NP-004713,15,24,2,0,0,0,1.6,0.13333333333333333,-1.333333333333333,98.29999999999998,4,2,0.15384615384615383,0.21428571428571427,2,Lipid,435251.2215683537,1083703.8121695912,2.489835199691454,1.3160502545599557,0.03724046800899989,0.058196819932883594,Upregulated
Feature0563,NA,C16 H31 N3 O4,329.23156,NA,NA,Feature0563,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,695434.581217595,3286963.435380179,4.726488334280458,2.2407686942818343,3.984489344270871e-5,1.2831149693774991e-4,Upregulated
Feature0562,1774244,C7 H15 N3 O2,173.11643,NA,NA,1774244,7,15,2,3,0,0,2.142857142857143,0.2857142857142857,-0.2857142857142856,68.44285714285714,2,0,-1.5,-0.6666666666666666,-3,Lipid,1485601.6998568722,2191181.228029158,1.4749452886599845,0.5606614404115347,0.3562509573058974,0.4292241263699788,Upregulated
Feature0561,1-Methyl-4-(1-methyl-2-propenyl)-benzene,C13 H18,174.14087,NA,NA,1-Methyl-4-(1-methyl-2-propenyl)-benzene,13,18,0,0,0,0,1.3846153846153846,0,-1.384615384615385,99.76153846153846,5,5,0.38461538461538464,0.38461538461538464,5,Unsaturated HC,1135771.4668245632,988638.6708585792,0.8704556327890998,-0.20015732944794432,0.6224314535980067,0.6648164453940878,Downregulated
Feature0560,anthramycin,C16 H17 N3 O4,315.12196,NA,NA,anthramycin,16,17,4,3,0,0,1.0625,0.25,0,60.3,10,6,0.3333333333333333,0.4545454545454546,3,Lignin,4397694.913572584,2068094.7284262236,0.47026789467442887,-1.0884452525384376,0.004874362776821787,0.009123945352415588,Downregulated
Feature0559,"(8Z,11Z,14Z)-Heptadecatrienal",C17 H28 O,248.21402,Other,NA,"(8Z,11Z,14Z)-Heptadecatrienal",17,28,1,0,0,0,1.6470588235294117,0.0588235294117647,-1.5294117647058822,103.88823529411764,4,3,0.1875,0.21212121212121213,3,Lipid,884989.4163740493,3437582.434762458,3.8843203897813967,1.9576622032507827,0.013932559299584774,0.023840157023733946,Upregulated
Feature0558,NA,C30 H51 N4 O17 P3,832.24652,NA,NA,Feature0558,30,51,17,4,0,3,1.7,0.5666666666666667,-0.666666666666667,79.30000000000001,9,-8,-2.5,-0.4482758620689655,-15,Amino Sugar,1899768.4615121393,1264792.5522263763,0.6657614219048843,-0.5869228201421511,0.21186935789079414,0.2765074670778161,Downregulated
Feature0557,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0557,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,4517671.905474434,4474369.176295712,0.9904148131859136,-0.013895202437326261,0.9332915634864783,0.939391508345867,Downregulated
Feature0556,NA,C12 H23 N3 O5,289.16381,NA,NA,Feature0556,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,4302812.950860748,6121126.520806101,1.4225871751133434,0.508517062549553,0.0062771191520627385,0.011470969089045229,Upregulated
Feature0555,NA,C17 H31 N3 O9,421.20619,NA,NA,Feature0555,17,31,9,3,0,0,1.8235294117647056,0.5294117647058824,-0.23529411764705888,67.00588235294117,4,-5,-1.6,-0.3684210526315789,-8,Protein,5155092.077088568,2179877.2929701703,0.4228590411912284,-1.241751269521904,1.8172146273462493e-4,4.997340225202186e-4,Downregulated
Feature0554,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose",C8 H15 N O5,205.09504,NA,NA,"3,6-Dideoxy-3-[(Z)-(1-hydroxyethylidene)amino]-alpha-D-glucopyranose-peak1",8,15,5,1,0,0,1.875,0.625,-0.25,67.425,2,-3,-2,-0.3333333333333333,-4,Amino Sugar,3408420.6254509687,3456112.7721442846,1.0139924475099096,0.020046906798277454,0.8878602076392433,0.9016997552403345,Upregulated
Feature0553,Hopantenic acid,C10 H19 N O5,233.12632,NA,NA,Hopantenic acid,10,19,5,1,0,0,1.9,0.5,-0.5999999999999996,77.39999999999999,2,-3,-1,-0.2307692307692308,-4,Protein,2231235.2169178845,5945738.720616436,2.6647745049621343,1.4140134563101885,0.0012845401777811438,0.002833347735887054,Upregulated
Feature0552,4-Acetamidobenzoic acid,C9 H9 N O3,179.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of alkaloids derived from shikimate pathway;Other,Other,4-Acetamidobenzoic acid,9,9,3,1,0,0,1,0.3333333333333333,0,60.3,6,3,0.4,0.5384615384615384,2,Lignin,844521.5206976341,2499038.917320196,2.9591180995077715,1.565167276178388,0.0213800396665288,0.03523131050106983,Upregulated
Feature0551,NP-019811,C6 H7 N O2,125.04764,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak2,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,9856256.42114071,1608262.0692601,0.16317169527068456,-2.615537274306881,2.950918066625721e-9,2.5767294870432837e-8,Downregulated
Feature0550,NA,C32 H66 N3 O18 P3 S,905.32735,NA,NA,Feature0550,32,66,18,3,1,3,2.0625,0.5625,-1.0625,90.58125,3,-15,-3.142857142857143,-0.8125,-22,Amino Sugar,10232597.860574517,124276.63034206862,0.012145169001598096,-6.363473624373109,8.40428298215613e-9,6.284265516142993e-8,Downregulated
Feature0549,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.1689,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak2,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,9138336.871310059,1634910.5305518424,0.17890679163783815,-2.4827199390445167,2.811739079285928e-7,1.434664457924808e-6,Downregulated
Feature0548,1726033,C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1726033-peak1,6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,10148766.243784234,5094610.698724253,0.501993106979336,-0.9942605406615225,6.7835847147184164e-9,5.271400072964151e-8,Downregulated
Feature0547,4-Hydroxyprolylproline,C10 H16 N2 O4,228.111,NA,NA,4-Hydroxyprolylproline,10,16,4,2,0,0,1.6,0.4,-0.20000000000000015,66,4,0,-0.5,0,-2,Protein,6311760.081453324,6093588.737584411,0.9654341513217534,-0.05075023322698879,0.5908760229295444,0.6387645072384481,Downregulated
Feature0546,NA,C13 H24 N2 O8,336.15337,NA,NA,Feature0546,13,24,8,2,0,0,1.8461538461538465,0.6153846153846154,-0.1538461538461542,64.6846153846154,3,-5,-2.3333333333333335,-0.42857142857142855,-7,Amino Sugar,4055387.937727828,4373061.825452989,1.078333785226759,0.10880381608172791,0.5386698819006543,0.5940110129183873,Upregulated
Feature0545,valienone,C7 H10 O5,174.05284,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,valienone,7,10,5,0,0,0,1.4285714285714286,0.7142857142857143,0,60.3,3,-2,-1,0.1111111111111111,-2,Tannin,1562210.563518621,3445406.451439378,2.205468668499571,1.14108526524928,0.007935912479047362,0.014225857925403419,Upregulated
Feature0544,Oxepanone,C6 H10 O2,114.06804,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,Oxepanone-peak1,6,10,2,0,0,0,1.6666666666666667,0.3333333333333333,-1,88.8,2,0,0,0.2,0,Protein,405293.35713032924,1627497.733050062,4.015604263967029,2.005617099332605,0.002390531335933184,0.004908557676449471,Upregulated
Feature0543,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0543,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,776539.3672572448,3942609.16978609,5.077152989308807,2.344019733298119,1.1433076064657857e-4,3.2994260397837155e-4,Upregulated
Feature0542,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0542,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5310108.45450569,4515429.455662872,0.8503459946908384,-0.23387812039109002,0.1716442816439855,0.22985408150585887,Downregulated
Feature0541,NA,C37 H51 N3 O12,729.34763,NA,NA,Feature0541,37,51,12,3,0,0,1.3783783783783785,0.32432432432432434,-0.4864864864864869,74.16486486486487,14,2,-0.04545454545454545,0.17857142857142858,-1,Lignin,528330.3925812924,247514.44884640427,0.4684842142756723,-1.0939276582513282,0.3004126376308302,0.3761263918304703,Downregulated
Feature0540,NA,C9 H16 N2 O3,200.1161,NA,NA,Feature0540,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,7365314.714682301,5078121.2314822255,0.6894642562060931,-0.5364523346359811,3.9675795044393777e-4,9.957155082252304e-4,Downregulated
Feature0539,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak4,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3440279.246361417,6214560.062420625,1.8064115199350177,0.8531265916775633,0.025570477129661713,0.04117527400917009,Upregulated
Feature0538,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0538,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5227130.652097285,4288267.360535324,0.8203864884867073,-0.2856243636177974,0.042244629288077554,0.06529416242153593,Downregulated
Feature0537,Anhydroecgonine methyl ester,C10 H15 N O2,181.11031,NA,NA,Anhydroecgonine methyl ester,10,15,2,1,0,0,1.5,0.2,-0.7999999999999998,83.1,4,2,0.14285714285714285,0.25,1,Lipid,1012089.035739178,628804.6725721321,0.6212938292656094,-0.6866523694861234,0.5839377839768833,0.6324748120568033,Downregulated
Feature0536,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10587,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak2",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,9864951.740762733,1969154.5967373415,0.1996111738287218,-2.3247356128089733,7.723545813297905e-10,8.495900394627695e-9,Downregulated
Feature0535,NA,C14 H25 N3 O7,347.16934,NA,NA,Feature0535,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,2837905.12197406,3256599.7588260234,1.14753651685181,0.19854006374171793,0.4555647605354941,0.5200314719320264,Upregulated
Feature0534,NA,C10 H21 N O10,315.11663,NA,NA,Feature0534,10,21,10,1,0,0,2.1,1,0.20000000000000015,54.599999999999994,1,-9,10,-1.25,-10,Carbohydrate,5385489.922362964,2085756.3569912326,0.38729185033477437,-1.3685069513969343,0.02299964028252178,0.03735512045886088,Downregulated
Feature0533,NA,C16 H14 O3 S,286.06646,NA,NA,Feature0533,16,14,3,0,1,0,0.875,0.1875,-0.375,70.9875,10,7,0.5,0.5555555555555556,6,Lignin,8763024.194811743,3261313.7899297667,0.372167612165292,-1.4259755843629771,5.910391222174471e-9,4.700564662142513e-8,Downregulated
Feature0532,NA,C19 H34 N4 O5,398.25301,NA,NA,Feature0532,19,34,5,4,0,0,1.7894736842105263,0.2631578947368421,-0.6315789473684212,78.30000000000001,5,0,-0.4,-0.12,-4,Lipid,1630569.4574692186,781678.3057809072,0.47938976300594877,-1.0607289931974355,0.004335000768199406,0.008223394514367072,Downregulated
Feature0531,1-Aminocyclohexanecarboxylic acid,C7 H13 N O2,143.09463,ABC transporters,NA,1-Aminocyclohexanecarboxylic acid,7,13,2,1,0,0,1.8571428571428572,0.2857142857142857,-0.8571428571428568,84.72857142857141,2,0,-0.25,0,-1,Lipid,941978.7175416405,1084712.8171655491,1.1515258221506464,0.2035467629075609,0.7865042243872277,0.8145682598844659,Upregulated
Feature0530,ascopyrone P,C6 H8 O4,144.04226,Microbial metabolism in diverse environments;Other,Other,ascopyrone P,6,8,4,0,0,0,1.3333333333333333,0.6666666666666666,0,60.3,3,-1,-0.5,0.25,-1,Tannin,1817135.6453448408,3474844.5138302594,1.9122647903210508,0.9352823063904994,0.09251377871407057,0.1319177955737673,Upregulated
Feature0529,gln-phe,C14 H19 N3 O4,293.13766,NA,NA,gln-phe-peak2,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,3975296.574448433,3387648.6567843105,0.8521750750770947,-0.23077823955585922,0.3529661374368096,0.4264797694849896,Downregulated
Feature0528,lys-gln,C11 H22 N4 O4,274.16413,NA,NA,lys-gln,11,22,4,4,0,0,2,0.3636363636363637,-0.18181818181818168,65.48181818181817,3,-1,-1.6666666666666667,-0.6,-5,Protein,6059615.96537305,6360917.5883196,1.049722890801711,0.07000853091077876,0.6097079269418664,0.655239622335436,Upregulated
Feature0527,2-O-ETHYL ASCORBIC ACID,C8 H12 O6,204.06331,NA,NA,2-O-ETHYL ASCORBIC ACID,8,12,6,0,0,0,1.5,0.75,0,60.3,3,-3,-1.5,0,-3,Carbohydrate,1181297.1970588763,252994.91695395307,0.21416703398928297,-2.223191666901711,0.12791098214790475,0.17587760045336903,Downregulated
Feature0526,NA,C9 H16 N2 O3,200.11609,NA,NA,Feature0526,9,16,3,2,0,0,1.7777777777777777,0.3333333333333333,-0.44444444444444464,72.96666666666667,3,0,-0.5,-0.09090909090909093,-2,Protein,7926969.735685489,1948773.647643392,0.24584093450873643,-2.0242029387543714,1.3027762167211372e-8,9.311826629221968e-8,Downregulated
Feature0525,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one",C10 H16 N2 O5,244.10586,NA,NA,"1-(beta-D-Ribofuranosyl)-1,3,4,7-tetrahydro-2H-1,3-diazepin-2-one-peak1",10,16,5,2,0,0,1.6,0.5,0,60.3,4,-1,-1,-0.09090909090909093,-3,Protein,9288654.032858705,1279588.126232718,0.13775818559999783,-2.859790048514441,8.42106418042774e-9,6.284265516142993e-8,Downregulated
Feature0524,"3-Hydroxy-2,4,5-pyridinetrimethanol",C8 H11 N O4,185.06883,NA,NA,"3-Hydroxy-2,4,5-pyridinetrimethanol-peak1",8,11,4,1,0,0,1.375,0.5,0,60.3,4,0,-0.3333333333333333,0.2,-1,Lignin,213176.19524225555,1336919.944517017,6.271431681186204,2.6487948279666016,0.2520786696327887,0.32350095936207884,Upregulated
Feature0523,4-Ethoxy-m-anisaldehyde,C10 H12 O3,180.07871,Metabolic pathways;Biosynthesis of secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of various plant secondary metabolites;Other,NA,4-Ethoxy-m-anisaldehyde,10,12,3,0,0,0,1.2,0.3,-0.5999999999999996,77.39999999999999,5,2,0.2857142857142857,0.4117647058823529,2,Lignin,2674799.009704071,6071935.505456509,2.270052995917732,1.1827259785977864,0.06778898585951604,0.09942384592729019,Upregulated
Feature0522,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak2,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,3946884.796705644,4773178.314345836,1.209353340723265,0.274235823108456,0.11041480602071603,0.15509343399593115,Upregulated
Feature0521,Gabexate,C16 H23 N3 O4,321.16895,NA,NA,Gabexate,16,23,4,3,0,0,1.4375,0.25,-0.375,70.9875,7,3,0,0.18181818181818185,0,Lignin,4970187.222778144,3431056.9404256507,0.6903275041031194,-0.5346471294471764,8.767213548445299e-4,0.002031690800419471,Downregulated
Feature0520,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",C13 H12 N2 O2,228.08992,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"N1-[4-(1,3-Oxazol-5-yl)phenyl]cyclopropane-1-carboxamide",13,12,2,2,0,0,0.9230769230769232,0.15384615384615383,-0.1538461538461542,64.6846153846154,9,7,0.5555555555555556,0.6,5,Lignin,2643175.1868191957,2525341.2814415456,0.9554195628177594,-0.06579367768544613,0.6667465724427322,0.703718812285351,Downregulated
Feature0519,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak2,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,593978.603217686,4576182.49998631,7.704288462911507,2.9456617213824154,3.495043654808035e-5,1.1407714742282873e-4,Upregulated
Feature0518,NA,C13 H17 N O5,267.11069,NA,NA,Feature0518,13,17,5,1,0,0,1.3076923076923077,0.38461538461538464,-0.3076923076923075,69.06923076923076,6,1,0,0.2631578947368421,0,Lignin,2326253.4014962725,5025298.812357705,2.160254256533435,1.1112011239871094,0.0010766533298586535,0.0024285629038356313,Upregulated
Feature0517,NA,C20 H20 N6 O5,424.14931,NA,NA,Feature0517,20,20,5,6,0,0,1,0.25,0.3999999999999999,48.9,14,9,0.3333333333333333,0.4782608695652174,3,Lignin,333499.9968481309,536624.0415974798,1.609067606204049,0.6862249432684938,0.43680377320090014,0.5037070059920523,Upregulated
Feature0516,gamma-Glu-His,C11 H16 N4 O5,284.11217,NA,NA,gamma-Glu-His,11,16,5,4,0,0,1.4545454545454546,0.4545454545454546,0.5454545454545454,44.75454545454545,6,1,-1.5,-0.1111111111111111,-3,Lignin,1980556.0877064466,3744044.744229025,1.89040076545611,0.9186921185968002,0.0032056240700502467,0.006373623444442626,Upregulated
Feature0515,6-methoxymellein,C11 H12 O4,208.07356,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak2,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,755563.386108158,261346.70855065758,0.3458964705751982,-1.5315878019329154,0.421799153275082,0.489067601401772,Downregulated
Feature0514,NA,C8 H18 N2 O3,190.13174,NA,NA,Feature0514,8,18,3,2,0,0,2.25,0.375,-0.75,81.675,1,-2,-1.3333333333333333,-0.5555555555555556,-4,Protein,641045.1692699223,2359455.097130282,3.68063782434775,1.8799557951650343,0.05901698178837611,0.08792855510071163,Upregulated
Feature0513,NP-019722,C8 H13 N O4,187.08446,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,NP-019722-peak1,8,13,4,1,0,0,1.625,0.5,-0.25,67.425,3,-1,-0.6666666666666666,0,-2,Protein,1315857.6494099156,2150954.1365982285,1.6346404472875955,0.7089733378885789,0.009282626043167366,0.016465726195942953,Upregulated
Feature0512,glutaral,C5 H8 O2,100.05243,NA,NA,glutaral,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,1288025.7642998588,5919651.484590847,4.595910771869252,2.200350788795309,3.3070512023817334e-7,1.6673049812007907e-6,Upregulated
Feature0511,Pyridoxal,C8 H9 N O3,167.0583,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak2,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,7711624.60540449,4371129.709648145,0.5668234559271407,-0.8190286347090806,1.6564284016309732e-6,7.032555670082377e-6,Downregulated
Feature0510,D-lysopine,C9 H18 N2 O4,218.12663,Lysine degradation,NA,D-lysopine-peak1,9,18,4,2,0,0,2,0.4444444444444444,-0.44444444444444464,72.96666666666667,2,-2,-1.3333333333333333,-0.4,-4,Protein,7183842.759368764,3826187.4373107646,0.5326101315790724,-0.9088482224036879,0.002731945906005636,0.005515990899610902,Downregulated
Feature0509,NA,C14 H25 N3 O6,331.17445,NA,NA,Feature0509,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,5544103.678818818,5282941.99024082,0.9528937942528449,-0.06961266883525362,0.49744246989555196,0.5580579761609702,Downregulated
Feature0508,N-valeryl-Glycine,C7 H13 N O3,159.08952,Metabolic pathways;Lysine degradation;Other,Superpathway of L-lysine degradation,N-valeryl-Glycine,7,13,3,1,0,0,1.8571428571428572,0.42857142857142855,-0.5714285714285712,76.58571428571427,2,-1,-0.6666666666666666,-0.1111111111111111,-2,Protein,2171815.1383988624,2905082.494465728,1.3376288078585987,0.4196778234847802,0.4873894914206355,0.5482322698981118,Upregulated
Feature0507,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06296,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak2,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,701398.6452734687,3249233.5884879213,4.632506222222707,2.2117929140321015,1.0873748346848126e-4,3.164970738756138e-4,Upregulated
Feature0506,gamma-Glutamyl-N~5~-acetylornithine,C12 H21 N3 O6,303.14309,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various plant secondary metabolites;Other,NA,gamma-Glutamyl-N~5~-acetylornithine,12,21,6,3,0,0,1.75,0.5,0,60.3,4,-2,-1.6666666666666667,-0.3333333333333333,-5,Protein,1754888.8402015453,1846524.1197356794,1.0522171418695727,0.07343245859607794,0.6660898029516105,0.7034639190773242,Upregulated
Feature0505,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak3,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,6675508.4728259,5398575.772906909,0.8087137923475011,-0.3062988785334393,0.19480655101619704,0.25711084086048575,Downregulated
Feature0504,NA,C9 H7 N O3 S,209.01467,NA,NA,Feature0504,9,7,3,1,1,0,0.7777777777777778,0.3333333333333333,0.44444444444444464,47.633333333333326,7,4,0.5,0.6363636363636364,2,Condensed HC,219695.94221337346,1123192.9390351905,5.112488322357457,2.354025642739721,0.0012521042938263265,0.0027835494406060327,Upregulated
Feature0503,Acetylcarnitine,C9 H17 N O4,203.1157,NA,NA,Acetylcarnitine-peak2,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,303695.11852349824,3683276.1025328566,12.128203181006564,3.6002939228506277,4.083579702349859e-4,0.0010213234771948765,Upregulated
Feature0502,NA,C20 H31 N O14,509.17464,NA,NA,Feature0502,20,31,14,1,0,0,1.55,0.7,0,60.3,6,-8,-1.8,-0.16666666666666666,-9,Amino Sugar,2182219.723792266,6079499.413608347,2.7859245094913634,1.4781561655996105,3.8123709773986215e-6,1.4984121660587621e-5,Upregulated
Feature0501,NA,C16 H28 N2 O5,328.19969,NA,NA,Feature0501,16,28,5,2,0,0,1.75,0.3125,-0.75,81.675,4,-1,-0.3333333333333333,-0.04347826086956521,-3,Protein,185920.97280298453,3908740.7470918945,21.023667680751018,4.393942471288017,8.298162879903293e-6,3.103109915796066e-5,Upregulated
Feature0500,NA,C16 H29 N3 O4,327.21588,NA,NA,Feature0500,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,3402927.4924235013,5603973.58104734,1.646809576026639,0.7196737429180284,0.04934581984351031,0.0751049585039591,Upregulated
Feature0499,NA,C9 H22 N2 O2,190.16816,NA,NA,Feature0499,9,22,2,2,0,0,2.4444444444444446,0.2222222222222222,-1.333333333333333,98.29999999999998,0,-2,-0.8,-0.5,-4,Lipid,406166.3954708179,245737.79167648248,0.6050175357112677,-0.7249511371000397,0.6156322300973318,0.6589377991023181,Downregulated
Feature0498,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0498,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,4758678.180081747,4527778.575066237,0.9514782054432722,-0.07175748437757884,0.7506415037863532,0.7810729161020162,Downregulated
Feature0497,NA,C14 H27 N3 O5,317.19512,NA,NA,Feature0497,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,7389209.4524065945,4538723.174280681,0.614236638373062,-0.703133525226395,8.505946191029516e-4,0.001978773352153236,Downregulated
Feature0496,"8-Methyl-1,2-naphthalenediol",C11 H10 O2,174.0681,Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,"8-Methyl-1,2-naphthalenediol-peak1",11,10,2,0,0,0,0.9090909090909092,0.18181818181818185,-0.5454545454545459,75.84545454545456,7,5,0.5555555555555556,0.6,5,Lignin,1621162.5117582355,1248161.5290112472,0.7699175868911198,-0.37722406901061883,0.5628815423790836,0.6147784221728998,Downregulated
Feature0495,7-Methylguanosine,C11 H15 N5 O5,297.10741,NA,NA,7-Methylguanosine,11,15,5,5,0,0,1.3636363636363635,0.4545454545454546,0.9090909090909092,34.39090909090909,7,2,-3,-0.14285714285714285,-3,Lignin,9729717.928083476,2935884.793028183,0.30174408083857807,-1.7286026242503534,1.7484475588611381e-9,1.660396803534192e-8,Downregulated
Feature0494,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,C10 H12 N6 O4,280.09207,NA,NA,1-(6-Amino-9H-purin-9-yl)-1-deoxy-Î²-D-ribofuranuronamide,10,12,4,6,0,0,1.2,0.4,1.4,20.4,8,4,-Inf,0,-2,Lignin,380192.32592590764,4629253.358889141,12.176083111659901,3.6059782064408634,1.3090785965564827e-4,3.740941703776767e-4,Upregulated
Feature0493,NA,C7 H10 N2 O2,154.07425,NA,NA,Feature0493,7,10,2,2,0,0,1.4285714285714286,0.2857142857142857,0,60.3,4,2,0,0.25,0,Lignin,7055253.022138104,6347016.770524772,0.8996157544752803,-0.1526191684266591,0.02505525066325875,0.040461005360877336,Downregulated
Feature0492,tyr-his,C15 H18 N4 O4,318.13296,NA,NA,tyr-his,15,18,4,4,0,0,1.2,0.26666666666666666,0.1333333333333333,56.5,9,5,0.14285714285714285,0.3333333333333333,1,Lignin,571466.9913594708,3737722.5642387383,6.540574732666568,2.709417413634172,3.180722204027779e-6,1.2828912889578707e-5,Upregulated
Feature0491,NA,C16 H33 N O2,271.25118,NA,NA,Feature0491,16,33,2,1,0,0,2.0625,0.125,-1.625,106.6125,1,-1,-0.15384615384615383,-0.07142857142857142,-2,Lipid,238255.3006543344,866774.8874605073,3.6380088295204054,1.8631490444434522,0.060438562266277585,0.0898095828763809,Upregulated
Feature0490,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak2,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,3941748.3036996825,5429481.538827619,1.3774297901597536,0.4619787841541137,0.17579341573667287,0.2344835009904912,Upregulated
Feature0489,NA,C89 H119 N4 O11 P3,1512.80906,NA,NA,Feature0489,89,119,11,4,0,3,1.3370786516853932,0.12359550561797752,-1.1235955056179776,92.32247191011236,34,23,0.22535211267605632,0.28104575163398693,16,Unsaturated HC,1173917.896882035,369051.9529107576,0.3143762897652143,-1.6694356811332163,0.40939471940564365,0.47729845469591214,Downregulated
Feature0488,met-val,C10 H20 N2 O3 S,248.11947,NA,NA,met-val,10,20,3,2,1,0,2,0.3,-0.5999999999999996,77.39999999999999,2,-1,-1,-0.4545454545454546,-4,Lipid,2284015.916425022,3369220.0067349686,1.4751298283457348,0.5608419337747658,0.0619536177188475,0.09181927245470486,Upregulated
Feature0487,"N,N-dimethyl-9H-purin-6-amine",C7 H9 N5,163.08581,NA,NA,"N,N-dimethyl-9H-purin-6-amine",7,9,0,5,0,0,1.2857142857142858,0,0.8571428571428572,35.87142857142857,6,6,0.5,0.5,1,Unsaturated HC,2310804.47892898,1039931.411691038,0.45003003117469687,-1.1519068170424354,0.18989837657286202,0.2519090445688553,Downregulated
Feature0486,dihomomethionine,C7 H15 N O2 S,177.08241,2-Oxocarboxylic acid metabolism;Other,NA,dihomomethionine,7,15,2,1,1,0,2.142857142857143,0.2857142857142857,-0.8571428571428568,84.72857142857141,1,-1,-1,-0.5,-3,Lipid,282334.6036060375,791083.8835518982,2.8019373943115964,1.4864247209631507,0.0516711334942539,0.07829239726231316,Upregulated
Feature0485,Υ-L-Glutamyl-L-glutamic acid,C10 H16 N2 O7,276.09576,Other,NA,Υ-L-Glutamyl-L-glutamic acid,10,16,7,2,0,0,1.6,0.7,0.3999999999999999,48.9,4,-3,-5,-0.3333333333333333,-5,Amino Sugar,2101403.456159501,2644399.701191231,1.2583969505903942,0.3315870798606379,0.4595835148746995,0.5235605071941769,Upregulated
Feature0484,NA,C13 H17 N5 O7,355.11293,NA,NA,Feature0484,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,5931141.1730830725,6274126.477124276,1.0578278773059309,0.08110490083701012,0.33843069012536187,0.412447186382995,Upregulated
Feature0483,NA,C25 H34 O2,366.25594,NA,NA,Feature0483,25,34,2,0,0,0,1.36,0.08,-1.2000000000000002,94.5,9,7,0.30434782608695654,0.3333333333333333,7,Unsaturated HC,1839696.233910314,743272.5393133047,0.4040191666498457,-1.3075043589034199,0.43828059882989945,0.5038636297487575,Downregulated
Feature0482,NA,C15 H29 N3 O4,315.21585,NA,NA,Feature0482,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,8235002.046993873,1995912.9544178424,0.2423694545584765,-2.0447202052092797,1.255765945877478e-8,9.05220218006999e-8,Downregulated
Feature0481,NA,C16 H29 N3 O4,327.2159,NA,NA,Feature0481,16,29,4,3,0,0,1.8125,0.25,-0.75,81.675,4,0,-0.3333333333333333,-0.09090909090909093,-3,Lipid,6328977.686686978,3687925.657008504,0.5827047968214624,-0.779162907898624,8.37908293439347e-7,3.7550705002281847e-6,Downregulated
Feature0480,Gly-Tyr,C11 H14 N2 O4,238.09535,Other,NA,Gly-Tyr-peak2,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,4506579.961504413,2805081.6185202054,0.6224413285643325,-0.6839902400013911,0.00619509294231703,0.011349387507218582,Downregulated
Feature0479,Gly-Tyr,C11 H14 N2 O4,238.09534,Other,NA,Gly-Tyr-peak1,11,14,4,2,0,0,1.2727272727272727,0.3636363636363637,0,60.3,6,2,0,0.2857142857142857,0,Lignin,239448.1211915306,4882600.872858914,20.391059443533496,4.3498648292524065,5.486412984616064e-7,2.546296875599894e-6,Upregulated
Feature0478,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak2,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,6611435.4625987215,6413128.144615803,0.9700054066768473,-0.043935306181270534,0.6564033131435658,0.6946557149413758,Downregulated
Feature0477,metharbital,C9 H14 N2 O3,198.10047,NA,NA,metharbital-peak1,9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,2694982.8925458766,3588854.8821875085,1.33168002368921,0.41324747303050063,0.14229515219774586,0.1936128416248847,Upregulated
Feature0476,NA,C17 H31 N3 O4,341.23157,NA,NA,Feature0476,17,31,4,3,0,0,1.8235294117647056,0.2352941176470588,-0.8235294117647056,83.7705882352941,4,0,-0.3,-0.08333333333333333,-3,Lipid,959860.7587708224,3943472.2045822027,4.1083794379011085,2.0385694309011755,2.9838995671199753e-5,9.891831441685397e-5,Upregulated
Feature0475,Lys-phe,C15 H23 N3 O3,293.17398,NA,NA,Lys-phe-peak1,15,23,3,3,0,0,1.5333333333333334,0.2,-0.5333333333333332,75.5,6,3,0,0.14285714285714285,0,Lipid,1920369.8197300313,5120677.533041322,2.6665059409031926,1.4149505423100601,0.0037725187253142044,0.007286940388463241,Upregulated
Feature0474,NA,C25 H41 N5 O6,507.30589,NA,NA,Feature0474,25,41,6,5,0,0,1.64,0.24,-0.5599999999999996,76.25999999999999,8,2,-0.21428571428571427,0,-3,Lipid,137843.62533455144,153387.10978155214,1.1127617211842484,0.15414469738000713,0.7918586261826422,0.8194309790796556,Upregulated
Feature0473,NA,C14 H23 N3 O,249.18412,NA,NA,Feature0473,14,23,1,3,0,0,1.6428571428571428,0.07142857142857142,-0.8571428571428568,84.72857142857141,5,4,0.1,0.14285714285714285,1,Lipid,113295.82993139938,4290157.701250715,37.86686327156441,5.242864014393734,2.455490674971893e-6,1.009611942573395e-5,Upregulated
Feature0472,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0472,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1567048.411265868,4197973.060501286,2.6789045126628515,1.421643158424451,8.395201243780765e-5,2.521537394851882e-4,Upregulated
Feature0471,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0471,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,3159352.6953305234,5512816.196751576,1.7449195225653142,0.803160499430166,0.02223111410240785,0.03641666745534532,Upregulated
Feature0470,NA,C17 H25 N3 O4,335.18463,NA,NA,Feature0470,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,998889.1548192693,1095577.0947855166,1.0967954647417724,0.1332945106863029,0.6703657284602648,0.707098097143019,Upregulated
Feature0469,NA,C17 H25 N3 O4,335.18461,NA,NA,Feature0469,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,8679908.063040588,2845083.39639425,0.32777805660278064,-1.6092088197361385,5.4852981559803134e-8,3.3067954007938257e-7,Downregulated
Feature0468,linatine,C10 H17 N3 O5,259.11681,Other,NA,linatine,10,17,5,3,0,0,1.7,0.5,0.20000000000000015,54.599999999999994,4,-1,-2,-0.3333333333333333,-4,Protein,1608983.455661304,363891.37014107883,0.2261622820674168,-2.1445697491651754,0.022291087535548353,0.03644894042974798,Downregulated
Feature0467,NA,C6 H9 O P S,160.01125,NA,NA,Feature0467,6,9,1,0,1,1,1.5,0.16666666666666666,-1.666666666666667,107.8,3,2,0,0.14285714285714285,0,Lipid,375912.744347221,3295918.0346090444,8.76777412889383,3.1322106327735675,0.0026889155429405814,0.0054485920212217044,Upregulated
Feature0466,mycosporine,C11 H19 N O6,261.12129,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,mycosporine-peak1,11,19,6,1,0,0,1.7272727272727273,0.5454545454545454,-0.3636363636363633,70.66363636363636,3,-3,-1,-0.14285714285714285,-4,Protein,351762.1725245448,457898.6345859157,1.3017279012681928,0.38042791508122104,0.4387242348756891,0.5038636297487575,Upregulated
Feature0465,NA,C17 H32 N2 O8,392.21598,NA,NA,Feature0465,17,32,8,2,0,0,1.8823529411764703,0.4705882352941176,-0.5882352941176467,77.06470588235292,3,-5,-1,-0.2727272727272727,-7,Protein,520698.8456190921,1905510.9740556132,3.659526019862843,1.8716568034069283,0.048705847719778886,0.07433126670027516,Upregulated
Feature0464,NA,C14 H25 N3 O6,331.17446,NA,NA,Feature0464,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,6999078.935548948,4139688.5849604746,0.5914619084997922,-0.7576428361921329,9.620355622514548e-5,2.839178122742098e-4,Downregulated
Feature0463,NA,C12 H20 N2 O5,272.13725,NA,NA,Feature0463,12,20,5,2,0,0,1.6666666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,4,-1,-0.6,-0.06666666666666667,-3,Protein,1314631.1631211038,117589.56332739236,0.08944680958894934,-3.4828261649853776,0.21335839275354326,0.27802239794192485,Downregulated
Feature0462,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,C13 H14 N2 O3,246.10046,NA,Superpathway of indole-3-acetate conjugate biosynthesis,2-(acetylamino)-3-(1H-indol-3-yl)propanoic acid,13,14,3,2,0,0,1.0769230769230769,0.2307692307692308,-0.1538461538461542,64.6846153846154,8,5,0.375,0.47368421052631576,3,Lignin,477005.3507636073,1932269.8780913565,4.0508348071947395,2.0182192532049794,0.03602922648720405,0.0564602309614465,Upregulated
Feature0461,D-PANTOTHENIC ACID,C9 H17 N O5,219.11065,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Other,Other,D-PANTOTHENIC ACID-peak1,9,17,5,1,0,0,1.8888888888888888,0.5555555555555556,-0.44444444444444464,72.96666666666667,2,-3,-1.3333333333333333,-0.2727272727272727,-4,Amino Sugar,3562060.345802952,3993810.834593353,1.12120807815598,0.16505404394753584,0.6157606469769596,0.6589377991023181,Upregulated
Feature0460,(−)-trans-Methyl dihydrojasmonate,C13 H22 O3,226.15687,NA,NA,(−)-trans-Methyl dihydrojasmonate,13,22,3,0,0,0,1.6923076923076923,0.2307692307692308,-1.2307692307692308,95.37692307692308,3,0,0,0.13043478260869565,0,Lipid,1425476.1955569894,3372317.6743200044,2.365748151271167,1.2422964979163258,0.117843885007944,0.16389781708001408,Upregulated
Feature0459,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0459,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,3848039.368046985,1404161.2278017073,0.36490303073857805,-1.45441496146741,0.005471158423599313,0.010151305990774628,Downregulated
Feature0458,7-hydroxyflavanone 7-O-beta-D-glucoside,C21 H22 O8,402.13151,NA,NA,7-hydroxyflavanone 7-O-beta-D-glucoside,21,22,8,0,0,0,1.0476190476190477,0.380952380952381,-0.2857142857142856,68.44285714285714,11,3,0.2307692307692308,0.4117647058823529,3,Lignin,271014.112265397,390486.01571931294,1.4408327760324167,0.5269029051252851,0.5392511964235727,0.5940110129183873,Upregulated
Feature0457,Alpha-Methyltryptamine,C11 H14 N2,174.11571,Metabolic pathways;Other,NA,Alpha-Methyltryptamine,11,14,0,2,0,0,1.2727272727272727,0,-0.7272727272727275,81.02727272727273,6,6,0.4444444444444444,0.4444444444444444,4,Unsaturated HC,3491154.7919612364,4582329.569696543,1.3125541096739266,0.39237689870191284,0.02137909701652784,0.03523131050106983,Upregulated
Feature0456,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",C7 H9 N O3,155.05826,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(2S,3S)-2,3-dihydro-3-hydroxyanthranilic acid zwitterion",7,9,3,1,0,0,1.2857142857142858,0.42857142857142855,0,60.3,4,1,0,0.3333333333333333,0,Lignin,363310.032099276,4642450.931583503,12.778207375002884,3.6756135530351957,5.8948853763779273e-8,3.503837132485687e-7,Upregulated
Feature0455,acetoacetic acid,C4 H6 O3,102.03167,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak2,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,1978828.602124694,4249500.749442505,2.1474829830535906,1.1026466992978643,0.012829871133084174,0.022109666021815452,Upregulated
Feature0454,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak2,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,982037.5964382256,5039244.92900106,5.1314175213637565,2.3593574161928905,3.803098016133706e-4,9.615594088552981e-4,Upregulated
Feature0453,apronalide,C9 H16 N2 O2,184.12119,NA,NA,apronalide-peak1,9,16,2,2,0,0,1.7777777777777777,0.2222222222222222,-0.666666666666667,79.30000000000001,3,1,-0.2,0,-1,Lipid,7860627.291234554,3443011.131064233,0.4380071721379744,-1.190973601492026,2.1996822019013528e-5,7.497508350142639e-5,Downregulated
Feature0452,NA,C28 H40,376.313,NA,NA,Feature0452,28,40,0,0,0,0,1.4285714285714286,0,-1.4285714285714288,101.01428571428572,9,9,0.32142857142857145,0.32142857142857145,9,Unsaturated HC,295954.7519933559,8983040.498425556,30.35274966163484,4.92375531131946,0.05568681456144916,0.0834809414753052,Upregulated
Feature0451,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak2,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,1181090.0653362959,4123721.445782311,3.491453841505431,1.8038278998103963,6.427411737916428e-4,0.001544402196316373,Upregulated
Feature0450,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak2,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,3313604.7164244712,3496626.778754666,1.0552335230038192,0.07756230243820626,0.43758612576941647,0.5038636297487575,Upregulated
Feature0449,NA,C16 H29 N3 O6,359.20566,NA,NA,Feature0449,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,986857.7066296599,3592233.5394199765,3.640072439306634,1.8639671610801694,4.098363371718416e-4,0.001022478284490574,Upregulated
Feature0448,2-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,5481597.34862127,4489550.803002317,0.8190223610881467,-0.2880252537773824,0.3588102038860954,0.432000344977289,Downregulated
Feature0447,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak5,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2838254.7916088095,5713335.899944417,2.012974986190695,1.00932924502485,0.0033204842301054593,0.006540581727672847,Upregulated
Feature0446,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,8050621.802310756,6125184.453271057,0.7608337099518147,-0.3943469263664486,6.247688469608511e-5,1.920795692834268e-4,Downregulated
Feature0445,NA,C15 H29 N3 O4,315.21587,NA,NA,Feature0445,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,4869767.924222237,4007352.4307599915,0.8229041903264858,-0.28120362558574097,0.40496498371978296,0.4727847570098637,Downregulated
Feature0444,Hypoxanthine,C5 H4 N4 O,136.0385,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak2,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,1867877.400045685,2070862.7640501468,1.1086716740614224,0.1488321839538764,0.8161468333662485,0.8399469840354952,Upregulated
Feature0443,orciprenaline,C11 H17 N O3,211.12082,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,orciprenaline,11,17,3,1,0,0,1.5454545454545454,0.2727272727272727,-0.7272727272727275,81.02727272727273,4,1,0,0.17647058823529413,0,Lipid,122173.51006782455,1159647.849898304,9.491810861900639,3.246683353026949,0.19242760837037295,0.25466591295266544,Upregulated
Feature0442,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak4,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,3644425.6441336535,5126566.92247885,1.4066872048085175,0.4923015622343539,0.2034301784837979,0.2667746943285417,Upregulated
Feature0441,GLY-MET,C7 H14 N2 O3 S,206.07248,NA,NA,GLY-MET,7,14,3,2,1,0,2,0.42857142857142855,0,60.3,2,-1,-4,-1,-4,Protein,1208097.39965041,1867186.108949685,1.5455592483602705,0.6281289603605839,0.02891600056112225,0.04608062554143094,Upregulated
Feature0440,NA,C11 H21 N O12,359.10644,NA,NA,Feature0440,11,21,12,1,0,0,1.9090909090909092,1.0909090909090908,0.5454545454545454,44.75454545454545,2,-10,5.5,-1.25,-11,Carbohydrate,1316602.2982666448,1110068.5948523004,0.8431312905299849,-0.2461707929627849,0.24777832470106867,0.31919124109780256,Downregulated
Feature0439,3-Hydroxypyridine,C5 H5 N O,95.0371,NA,NA,3-Hydroxypyridine-peak1,5,5,1,1,0,0,1,0.2,0,60.3,4,3,0.6666666666666666,0.7142857142857143,2,Lignin,5314686.977114467,4853101.935613013,0.91314915751594,-0.13107755972420557,0.6112684520931887,0.6562032685968706,Downregulated
Feature0438,NA,C17 H33 N O15,491.18523,NA,NA,Feature0438,17,33,15,1,0,0,1.9411764705882353,0.8823529411764706,0,60.3,2,-13,-14,-0.7647058823529411,-14,Carbohydrate,2568066.1978233107,3399511.521331716,1.3237631974647448,0.4046450674637146,0.07117547741549213,0.10367262144612525,Upregulated
Feature0437,ARG-PHE,C15 H23 N5 O3,321.18018,NA,NA,ARG-PHE-peak1,15,23,3,5,0,0,1.5333333333333334,0.2,-0.13333333333333375,64.10000000000001,7,4,-0.14285714285714285,0.0588235294117647,-1,Lipid,1411111.7640556954,3833942.27978966,2.7169657127444498,1.4419963593156222,0.004246571856564371,0.008091892829043918,Upregulated
Feature0436,NA,C8 H19 N O4,193.13145,NA,NA,Feature0436,8,19,4,1,0,0,2.375,0.5,-1,88.8,0,-4,-1.6666666666666667,-0.6,-5,Other,424046.92268565367,4181712.142285451,9.861437304629039,3.301797934751277,1.318041575608989e-5,4.7304288751729395e-5,Upregulated
Feature0435,NA,C16 H28 N4 O5,356.20606,NA,NA,Feature0435,16,28,5,4,0,0,1.75,0.3125,-0.375,70.9875,5,0,-0.5714285714285714,-0.15789473684210523,-4,Protein,2916051.9640888427,1304881.8464790096,0.44748237087288545,-1.160097248164654,0.038650769513584905,0.06028950603684422,Downregulated
Feature0434,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak3,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,6786273.053138431,5465871.7733691065,0.8054305700006159,-0.3121678642832174,0.009321565233500884,0.016500241907576277,Downregulated
Feature0433,Chelidonic acid,C7 H4 O6,184.00082,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,Chelidonic acid,7,4,6,0,0,0,0.5714285714285714,0.8571428571428571,1.1428571428571428,27.728571428571428,6,0,0,0.75,0,Condensed HC,5978689.805920857,3032175.7406627783,0.5071639170274285,-0.9794759885610167,0.0016801323584639224,0.0035710717882533054,Downregulated
Feature0432,NA,C11 H19 N3 O7,305.12233,NA,NA,Feature0432,11,19,7,3,0,0,1.7272727272727273,0.6363636363636364,0.36363636363636376,49.93636363636363,4,-3,-6,-0.5555555555555556,-6,Amino Sugar,1700496.3913692376,360619.01615263056,0.21206691056971935,-2.2374085644532444,0.01491641161177364,0.025293694965309855,Downregulated
Feature0431,Fenspiride,C15 H20 N2 O2,260.15248,NA,NA,Fenspiride,15,20,2,2,0,0,1.3333333333333333,0.13333333333333333,-0.666666666666667,79.30000000000001,7,5,0.2727272727272727,0.3333333333333333,3,Lignin,7606492.731285534,1032583.390575165,0.13575026323605696,-2.880973099296136,1.0539201649614249e-14,9.918559774692521e-13,Downregulated
Feature0430,NA,C13 H18 N2 O6,298.11654,NA,NA,Feature0430,13,18,6,2,0,0,1.3846153846153846,0.4615384615384616,0,60.3,6,0,-0.4,0.125,-2,Lignin,3289759.087007926,4648690.997282272,1.4130794609371566,0.49884259424703575,5.93761287178518e-4,0.0014369866482726785,Upregulated
Feature0429,Gly-Lys,C8 H17 N3 O3,203.12694,NA,NA,Gly-Lys,8,17,3,3,0,0,2.125,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,2007150.5029673646,3783366.2274170257,1.8849439650009852,0.914521636164074,0.01224433981138927,0.021208498609911478,Upregulated
Feature0428,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose,C10 H19 N O6,249.1212,NA,NA,1-Deoxy-1-(4-morpholinyl)-alpha-D-fructofuranose-peak1,10,19,6,1,0,0,1.9,0.6,-0.4000000000000003,71.7,2,-4,-1.6666666666666667,-0.3333333333333333,-5,Amino Sugar,965800.8028071622,2234741.2044364684,2.313873831892715,1.2103102010637483,0.07617786835559814,0.11038948588056738,Upregulated
Feature0427,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10552,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak2",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,4499395.096099142,5759004.3071433995,1.2799507898597982,0.3560883441393485,0.016635911672448368,0.027985337014029332,Upregulated
Feature0426,eutypine,C12 H10 O2,186.06813,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,NA,eutypine,12,10,2,0,0,0,0.8333333333333334,0.16666666666666666,-0.5,74.55,8,6,0.6,0.6363636363636364,6,Lignin,808547.92911555106,680528.774472323,0.841667821988902,-0.24867713252819043,0.8374756931849092,0.8587674480963899,Downregulated
Feature0425,threonylphenylalanine,C13 H18 N2 O4,266.12661,Metabolic pathways;Biosynthesis of cofactors;Other,NA,threonylphenylalanine-peak1,13,18,4,2,0,0,1.3846153846153846,0.3076923076923077,-0.3076923076923075,69.06923076923076,6,2,0,0.2222222222222222,0,Lignin,201035.7709138632,3243624.929061239,16.134566074069568,4.012082873133286,1.313967127359608e-4,3.740941703776767e-4,Upregulated
Feature0424,NA,C19 H34 N4 O7,430.24288,NA,NA,Feature0424,19,34,7,4,0,0,1.7894736842105263,0.3684210526315789,-0.4210526315789478,72.30000000000001,5,-2,-0.75,-0.21739130434782608,-6,Protein,605802.2700502537,2878651.986534995,4.751801254056376,2.2484744961169043,7.267922540333899e-5,2.2064266636784275e-4,Upregulated
Feature0423,Methylhippuric acid,C10 H11 N O3,193.0739,Phenylalanine metabolism;Other,NA,Methylhippuric acid-peak1,10,11,3,1,0,0,1.1,0.3,-0.20000000000000015,66,6,3,0.3333333333333333,0.4666666666666667,2,Lignin,4631603.733741788,3926623.513470129,0.8477891761042091,-0.23822254755600025,0.1757302216976331,0.2344835009904912,Downregulated
Feature0422,NA,C13 H25 N3 O5,303.17947,NA,NA,Feature0422,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,1023562.9841660681,3214288.373251861,3.1402936829243115,1.650899487488153,0.007500514867769205,0.013488187033971373,Upregulated
Feature0421,1-Methylguanine,C6 H7 N5 O,165.06508,NA,NA,1-Methylguanine,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,6356560.585771151,1108191.3698144287,0.17433820615114734,-2.5200393247088693,1.5490791108104284e-5,5.433002098784401e-5,Downregulated
Feature0420,NA,C10 H23 N O7,269.14745,NA,NA,Feature0420,10,23,7,1,0,0,2.3,0.7,-0.5999999999999996,77.39999999999999,0,-7,-4,-0.8181818181818182,-8,Carbohydrate,8507392.419692077,956914.3206388843,0.11248033162592959,-3.1522553418580643,8.26208263471622e-12,2.0582305857660702e-10,Downregulated
Feature0419,N-(3-Carboxypropanoyl)-5-hydroxynorvaline,C9 H15 N O6,233.08989,NA,NA,N-(3-Carboxypropanoyl)-5-hydroxynorvaline-peak1,9,15,6,1,0,0,1.6666666666666667,0.6666666666666666,0,60.3,3,-3,-2,-0.2,-4,Amino Sugar,940252.6349912041,1674145.678464104,1.7805275052271088,0.832304722332961,0.06269046920462869,0.0927490435219572,Upregulated
Feature0418,2'-Deoxycytidine-5'-monophosphorate,C9 H14 N3 O7 P,307.05702,Metabolic pathways;Other,Other,2'-Deoxycytidine-5'-monophosphorate,9,14,7,3,0,1,1.5555555555555556,0.7777777777777778,0.44444444444444464,47.633333333333326,5,-2,3,-1.6666666666666667,-6,Carbohydrate,876047.2975528815,855922.4994704691,0.9770277265409889,-0.03352859065112476,0.9264735420571196,0.9347505540469092,Downregulated
Feature0417,NA,C12 H18 N4 O6,314.12269,NA,NA,Feature0417,12,18,6,4,0,0,1.5,0.5,0.5,46.05,6,0,-2,-0.2,-4,Protein,3078659.289031634,3505294.8653146806,1.138578366824489,0.18723359365996084,0.3354080761986985,0.41179896517327086,Upregulated
Feature0416,NA,C8 H18 N O9 P,303.07198,NA,NA,Feature0416,8,18,9,1,0,1,2.25,1.125,-0.25,67.425,1,-8,3.3333333333333335,-3.6666666666666665,-10,Carbohydrate,432926.29042386764,2722058.052699356,6.287578539141744,2.6525045159635137,0.004562767903512863,0.008626483067579007,Upregulated
Feature0415,TC2700000,C2 H7 O4 P,126.00817,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics;Other,NA,TC2700000,2,7,4,0,0,1,3.5,2,-2,117.3,0,-4,1.6666666666666667,3,-5,Other,623083.6781228567,6095101.09239075,9.782154959913662,3.290152318706397,6.103383796203208e-8,3.6150811715972846e-07,Upregulated
Feature0414,Levetiracetam,C8 H14 N2 O2,170.10556,NA,NA,Levetiracetam-peak1,8,14,2,2,0,0,1.75,0.25,-0.5,74.55,3,1,-0.25,0,-1,Lipid,6882761.246573329,3081267.43051917,0.44767896489991116,-1.1594635629928667,4.2617039509407996e-8,2.6444419387889067e-7,Downregulated
Feature0413,NP-003800,C10 H15 N O3,197.10521,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak2,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,2518888.4096287456,3253201.4441532134,1.2915226540872038,0.36907294942000435,0.11649901788773812,0.1621605064107053,Upregulated
Feature0412,dictyoquinazol B,C18 H20 N2 O4,328.14238,NA,NA,dictyoquinazol B,18,20,4,2,0,0,1.1111111111111112,0.2222222222222222,-0.33333333333333304,69.79999999999998,10,6,0.3333333333333333,0.42857142857142855,4,Lignin,1600568.4255783889,3362454.899885806,2.1007879739166624,1.0709305625751335,0.006156506689725242,0.01129915745654882,Upregulated
Feature0411,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",C20 H20 O7,372.12097,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,"2-(2,4-Dihydroxyphenyl)-5,7-dihydroxy-6-(3-hydroxy-3-methylbutyl)-4H-chromen-4-one",20,20,7,0,0,0,1,0.35,-0.2999999999999998,68.85,11,4,0.3076923076923077,0.4545454545454546,4,Lignin,268757.006142551,374301.422528425,1.392713172023848,0.47789816683560155,0.5720163728685477,0.6207531938752849,Upregulated
Feature0410,NA,C7 H16 O6,196.09463,NA,NA,Feature0410,7,16,6,0,0,0,2.2857142857142856,0.8571428571428571,-0.5714285714285712,76.58571428571427,0,-6,-6,-0.75,-6,Carbohydrate,2027769.7648050499,1919253.807888181,0.946485070050691,-0.0793483459934689,0.8809834240457595,0.8961606149454591,Downregulated
Feature0409,NA,C20 H29 N3 O4,375.21585,NA,NA,Feature0409,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,7051142.319056738,2185032.7592583545,0.309883513959573,-1.6902020904034694,3.458886819592157e-7,1.7182857103780392e-6,Downregulated
Feature0408,"4,5,7-Trihydroxycoumarin",C9 H6 O5,194.02152,Biosynthesis of various plant secondary metabolites,NA,"4,5,7-Trihydroxycoumarin",9,6,5,0,0,0,0.6666666666666666,0.5555555555555556,0.44444444444444464,47.633333333333326,7,2,0.5,0.6923076923076923,2,Condensed HC,1080065.0921744378,163301.9113171738,0.15119636075674542,-2.7255046800729676,0.353899409552192,0.4273026370501876,Downregulated
Feature0407,NA,C11 H21 N3 O2,227.16337,NA,NA,Feature0407,11,21,2,3,0,0,1.9090909090909092,0.18181818181818185,-0.7272727272727275,81.02727272727273,3,1,-0.3333333333333333,-0.14285714285714285,-2,Lipid,7748883.700646269,171887.3381724516,0.022182206471638738,-5.494453311769892,3.527153307326503e-10,4.458953509411266e-9,Downregulated
Feature0406,Clavamycin D,C13 H21 N3 O6,315.14297,NA,NA,Clavamycin D,13,21,6,3,0,0,1.6153846153846154,0.4615384615384616,0,60.3,5,-1,-1,-0.14285714285714285,-4,Protein,476691.1721467557,1128388.9482230223,2.367127847451794,1.2431376274513675,9.125044450374532e-6,3.375071025968222e-5,Upregulated
Feature0405,NA,C21 H38 N4 O7,458.27426,NA,NA,Feature0405,21,38,7,4,0,0,1.8095238095238095,0.3333333333333333,-0.5714285714285712,76.58571428571427,5,-2,-0.6,-0.18518518518518515,-6,Protein,2088658.1594833492,310950.4148017805,0.14887568527666453,-2.7478199460391473,0.06214317991004368,0.0920197087129493,Downregulated
Feature0404,pro-gln,C10 H17 N3 O4,243.1219,NA,NA,pro-gln,10,17,4,3,0,0,1.7,0.4,0,60.3,4,0,-1,-0.2,-3,Protein,5652334.268655876,295019.4574897331,0.0521942693880857,-4.259964773386372,0.0018571857876761562,0.003908164874935911,Downregulated
Feature0403,NA,C13 H25 N3 O4,287.18453,NA,NA,Feature0403,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2160330.570660693,4359597.855659103,2.018023498286102,1.0129429735837419,1.2479678222949997e-4,0.00035770854331095253,Upregulated
Feature0402,NA,C11 H15 N5 O,233.12763,NA,NA,Feature0402,11,15,1,5,0,0,1.3636363636363635,0.09090909090909093,0.18181818181818168,55.11818181818182,7,6,0.2,0.2727272727272727,1,Unsaturated HC,6857072.553947489,5506884.785416747,0.8030955983171764,-0.31635636242619536,2.9199642730623796e-4,7.621601661891636e-4,Downregulated
Feature0401,NA,C19 H36 N4 O6,416.26354,NA,NA,Feature0401,19,36,6,4,0,0,1.894736842105263,0.3157894736842105,-0.6315789473684212,78.30000000000001,4,-2,-0.6666666666666666,-0.25,-6,Protein,220115.67118677433,112878.0313274431,0.5128123350729668,-0.9634971302501917,0.0026060687208568035,0.005299736390313835,Downregulated
Feature0400,Monoethyl malonic acid,C5 H8 O4,132.04224,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Phenylalanine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Monoethyl malonic acid,5,8,4,0,0,0,1.6,0.8,0,60.3,2,-2,-2,0,-2,Carbohydrate,2596889.9249975467,1580682.7010404582,0.6086829810631852,-0.7162370666418606,0.025749025435670994,0.04139094480608299,Downregulated
Feature0399,4-Hydroxyprolylthreonine,C9 H16 N2 O5,232.10595,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;Other,Other,4-Hydroxyprolylthreonine-peak1,9,16,5,2,0,0,1.7777777777777777,0.5555555555555556,0,60.3,3,-2,-2,-0.3333333333333333,-4,Amino Sugar,997682.3978638783,1240988.9951717325,1.2438717951011204,0.31483779567480574,0.19692828007872093,0.2590034987991873,Upregulated
Feature0398,NA,C7 H7 O2 P S,185.99051,NA,NA,Feature0398,7,7,2,0,1,1,1,0.2857142857142857,-0.8571428571428568,84.72857142857141,5,3,0.3333333333333333,0.5,1,Lignin,1659149.1845352254,6091249.560644079,3.671309136887778,1.8762945994490288,1.739345479696771e-9,1.660396803534192e-8,Upregulated
Feature0397,gln-phe,C14 H19 N3 O4,293.13756,NA,NA,gln-phe-peak1,14,19,4,3,0,0,1.3571428571428572,0.2857142857142857,-0.14285714285714324,64.37142857142858,7,3,0,0.2222222222222222,0,Lignin,624885.7304787827,3454527.2261854727,5.528254299451902,2.4668239811603025,4.6225916034883335e-5,1.4609459284159026e-4,Upregulated
Feature0396,Phenacetin,C10 H13 N O2,179.09463,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Phenacetin-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,7277399.157776013,4122609.0063141226,0.5664948310426331,-0.8198653025894642,1.074972128075856e-5,3.950114500998915e-5,Downregulated
Feature0395,asn-tyr,C13 H17 N3 O5,295.11689,NA,NA,asn-tyr-peak2,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1301939.964931966,1653606.3579693616,1.270109530784526,0.34495291645088855,0.33657828623865504,0.41226581119904676,Upregulated
Feature0394,6-Hydroxymelatonin,C13 H16 N2 O3,248.11602,Other,Other,6-Hydroxymelatonin-peak2,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,155327.29000376107,2683778.991232271,17.27821937257314,4.110882641397743,3.970250672718329e-5,1.2810675503971143e-4,Upregulated
Feature0393,beta-Aspartylaspartic acid,C8 H12 N2 O7,248.0644,NA,NA,beta-Aspartylaspartic acid,8,12,7,2,0,0,1.5,0.875,1,31.799999999999997,4,-3,5,-0.6,-5,Carbohydrate,1518135.6542742436,5612246.479780748,3.6968017080553484,1.8862776611942358,2.5503377421284123e-7,1.313152624670374e-6,Upregulated
Feature0392,N-Acetyltyramine,C10 H13 N O2,179.09462,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,N-Acetyltyramine-peak1,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,4044824.351779723,5022145.41083248,1.2416226204291752,0.31222674653242555,0.4630510848164554,0.5260955987116536,Upregulated
Feature0391,Asp-Trp,C15 H17 N3 O5,319.11688,NA,NA,Asp-Trp,15,17,5,3,0,0,1.1333333333333333,0.3333333333333333,0.1333333333333333,56.5,9,4,0.14285714285714285,0.3684210526315789,1,Lignin,474675.33803408564,1180169.0945353522,2.4862658747411186,1.3139805826576805,0.0029302604843602378,0.0058818938021456746,Upregulated
Feature0390,Cyclopentanone,C5 H8 O,84.05753,Other,NA,Cyclopentanone-peak2,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,450117.7282946952,3681100.812618704,8.17808449039506,3.0317629678831453,2.486291109083462e-9,2.2522872399932537e-8,Upregulated
Feature0389,asn-val,C9 H17 N3 O4,231.12194,NA,NA,asn-val-peak2,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,1401680.1729003852,2695079.8542544083,1.9227495018907872,0.9431708188815505,0.014806928035207782,0.025133202496635254,Upregulated
Feature0388,NA,C16 H29 N3 O6,359.20577,NA,NA,Feature0388,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,5613460.216471746,4260855.564944209,0.7590426226663995,-0.39774719503984934,0.057924928711387234,0.08652983177873895,Downregulated
Feature0387,NA,C26 H43 N5 O5,505.32642,NA,NA,Feature0387,26,43,5,5,0,0,1.6538461538461535,0.19230769230769232,-0.6923076923076925,80.03076923076924,8,3,-0.125,0.02702702702702703,-2,Lipid,289339.89598266373,364556.5592286636,1.259959529571776,0.3333773944999612,0.6202443640938438,0.6633168893781385,Upregulated
Feature0386,cis-acetylacrylic acid,C5 H6 O3,114.03164,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylalanine metabolism;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,cis-acetylacrylic acid-peak1,5,6,3,0,0,0,1.2,0.6,0,60.3,3,0,0,0.42857142857142855,0,Lignin,6513440.234403655,2398249.239593256,0.3682000837170236,-1.4414381401764005,8.033900283012073e-8,4.582298679940219e-7,Downregulated
Feature0385,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,C14 H19 N O6,297.12132,NA,NA,N-(2-Phenylethyl)-beta-D-glucopyranuronosylamine,14,19,6,1,0,0,1.3571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,6,0,-0.14285714285714285,0.2,-1,Lignin,431410.8452436498,1883616.0963583167,4.366176968255164,2.1263706062906738,0.03609849494725515,0.05651649763461204,Upregulated
Feature0384,NA,C8 H19 N O7,241.11608,NA,NA,Feature0384,8,19,7,1,0,0,2.375,0.875,-0.25,67.425,0,-7,-Inf,-1.2857142857142858,-8,Carbohydrate,1296625.6920921984,533580.8832858006,0.41151497038812307,-1.2809831798860212,0.004069900435991672,0.007799107849060964,Downregulated
Feature0383,Kyotorphin,C15 H23 N5 O4,337.17513,NA,NA,Kyotorphin,15,23,4,5,0,0,1.5333333333333334,0.26666666666666666,0,60.3,7,3,-0.3333333333333333,0,-2,Lipid,995704.7993404713,4411278.800376145,4.430307861625313,2.1474069549897243,7.397627047897441e-4,0.0017526685621172399,Upregulated
Feature0382,NA,C17 H25 N3 O4,335.18464,NA,NA,Feature0382,17,25,4,3,0,0,1.4705882352941178,0.2352941176470588,-0.47058823529411775,73.71176470588236,7,3,0,0.16666666666666666,0,Lignin,2270508.9208694506,3603496.8781701727,1.5870877427736678,0.6663818903439831,0.009025313748404144,0.016042897680793936,Upregulated
Feature0381,NL8513000,C11 H13 N O2,191.09464,NA,Other,NL8513000-peak2,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,303985.56717377494,2927214.51138479,9.629452274987228,3.2674537396437464,0.0014296923771588586,0.003129068329337347,Upregulated
Feature0380,S-Allyl-L-cysteine,C6 H11 N O2 S,161.05105,NA,Other,S-Allyl-L-cysteine,6,11,2,1,1,0,1.8333333333333333,0.3333333333333333,-0.33333333333333304,69.79999999999998,2,0,-1,-0.3333333333333333,-2,Protein,634055.4638735778,746430.7717317297,1.1772326149066323,0.2353994174149442,0.8188906768805488,0.8417480622789137,Upregulated
Feature0379,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",C7 H10 N4 O,166.08548,Metabolic pathways;ABC transporters;Other,NA,"4-cyclopropyl-6-methoxy-1,3,5-triazin-2-amine",7,10,1,4,0,0,1.4285714285714286,0.14285714285714285,0.5714285714285716,44.014285714285705,5,4,0,0.2,0,Lignin,7718059.636585114,1203403.6245327734,0.15592048794601232,-2.6811175843239274,1.1984048351904648e-9,1.2156274196482919e-8,Downregulated
Feature0378,?-Ribazole,C14 H18 N2 O4,278.12667,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak2,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,3626898.0677369093,3635670.12878915,1.0024186125136167,0.003485107413873091,0.9880757070745656,0.9895732969681823,Upregulated
Feature0377,Pheneturide,C11 H14 N2 O2,206.10554,Other,NA,Pheneturide,11,14,2,2,0,0,1.2727272727272727,0.18181818181818185,-0.3636363636363633,70.66363636363636,6,4,0.2857142857142857,0.375,2,Lignin,949172.2343122892,2235396.872524218,2.355101415438945,1.2357891865474233,0.014062912709263199,0.024014691662794213,Upregulated
Feature0376,pyricarbate,C11 H15 N3 O4,253.10625,NA,NA,pyricarbate,11,15,4,3,0,0,1.3636363636363635,0.3636363636363637,0.18181818181818168,55.11818181818182,6,2,-0.25,0.16666666666666666,-1,Lignin,7295420.066579217,4883837.463906079,0.6694388286535067,-0.5789758625344801,3.528364467521253e-5,1.1494325784578852e-4,Downregulated
Feature0375,NA,C31 H37 N O11,599.23689,NA,NA,Feature0375,31,37,11,1,0,0,1.1935483870967742,0.3548387096774194,-0.387096774193548,71.33225806451611,14,3,0.10526315789473684,0.30612244897959184,2,Lignin,257643.2598517958,371220.8533677916,1.440832776224494,0.5269029053176106,0.5392511963396649,0.5940110129183873,Upregulated
Feature0374,NA,C7 H14 N2 O2,158.10555,NA,NA,Feature0374,7,14,2,2,0,0,2,0.2857142857142857,-0.5714285714285712,76.58571428571427,2,0,-0.6666666666666666,-0.25,-2,Lipid,941657.3646870785,473188.67621104163,0.5025062129347723,-0.9927866611534598,0.35240104878055856,0.4261009112307396,Downregulated
Feature0373,NA,C15 H27 N3 O6,345.19011,NA,NA,Feature0373,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,5445218.046825728,2786264.784970668,0.5116902135066771,-0.9666574539967107,5.121789106587361e-7,2.4167996508520864e-6,Downregulated
Feature0372,arg-gln,C11 H22 N6 O4,302.17037,NA,NA,arg-gln,11,22,4,6,0,0,2,0.3636363636363637,0.36363636363636376,49.93636363636363,4,0,-6,-1.3333333333333333,-6,Protein,677206.8121661365,2407164.1751179327,3.5545480817274955,1.8296661500853042,6.305344083410415e-4,0.0015215459939169863,Upregulated
Feature0371,NA,C18 H31 N6 O4 P3,488.16202,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,Feature0371,18,31,4,6,0,3,1.7222222222222223,0.2222222222222222,-1.1111111111111107,91.96666666666664,8,4,-1,-0.42857142857142855,-5,Lipid,7975673.208485434,948225.8910466054,0.11888976218807137,-3.072303607528084,3.57310818223691e-14,2.4211381042837305e-12,Downregulated
Feature0370,L-Hydroxyproline,C5 H9 N O3,131.05821,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,L-Hydroxyproline,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,4054941.8985052425,3129674.4516025335,0.77181733547309594,-0.37366864686178736,0.14335070204575265,0.19489252750040528,Downregulated
Feature0369,Penicillic acid,C8 H10 O4,170.05799,Metabolic pathways;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Tyrosine metabolism;Other,NA,Penicillic acid-peak1,8,10,4,0,0,0,1.25,0.5,-0.25,67.425,4,0,0,0.3333333333333333,0,Lignin,1029534.874191484,1284838.1134339513,1.2479792046315696,0.3195938944366465,0.7101144755954366,0.7443898030066024,Upregulated
Feature0368,NA,C11 H21 N5 O2,255.16954,NA,NA,Feature0368,11,21,2,5,0,0,1.9090909090909092,0.18181818181818185,-0.18181818181818168,65.48181818181817,4,2,-0.75,-0.4,-3,Lipid,7530982.625501599,182991.8266409484,0.024298532574128767,-5.362986999892307,2.8014875167084326e-14,2.063356457958298e-12,Downregulated
Feature0367,Marimastat,C15 H29 N3 O5,331.21084,NA,NA,Marimastat-peak3,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2262856.467202389,5357847.8622941105,2.3677365047011203,1.2435085385207167,3.3232053223292927e-4,8.542503514454964e-4,Upregulated
Feature0366,Desthiobiotin,C10 H18 N2 O3,214.13169,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak2,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,6990695.031906243,2371806.243536534,0.33928046248783117,-1.559449740239205,8.09168692609735e-6,3.0393165527292484e-5,Downregulated
Feature0365,NA,C20 H36 N4 O6,428.2636,NA,NA,Feature0365,20,36,6,4,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,5,-1,-0.5,-0.15384615384615383,-5,Lipid,5516515.244573025,196056.31816900254,0.035539885140692146,-4.814417170963609,4.259207289547491e-7,2.0381630362975847e-6,Downregulated
Feature0364,NA,C13 H17 N5 O7,355.11296,NA,NA,Feature0364,13,17,7,5,0,0,1.3076923076923077,0.5384615384615384,0.9230769230769228,33.99230769230769,8,1,-4,-0.1111111111111111,-4,Lignin,4795656.576641625,4927182.558384758,1.02742606348915,0.039034577191130786,0.5645735922292592,0.6158323665398359,Upregulated
Feature0363,Acetylcarnitine,C9 H17 N O4,203.11573,NA,NA,Acetylcarnitine-peak1,9,17,4,1,0,0,1.8888888888888888,0.4444444444444444,-0.666666666666667,79.30000000000001,2,-2,-0.75,-0.16666666666666666,-3,Protein,5715567.58603566,2473540.8874765807,0.432772572494806,-1.208319025435169,1.1715079473336259e-4,3.363617733530783e-4,Downregulated
Feature0362,NA,C8 H12 N6,192.11229,NA,NA,Feature0362,8,12,0,6,0,0,1.5,0,0.75,38.925,6,6,0,0,0,Lipid,8367468.16243639,13744851.418781783,1.6426535664020547,0.7160282497746333,0.4967474437830508,0.5576475611454526,Upregulated
Feature0361,Aniflorine,C20 H21 N3 O3,351.15844,NA,NA,Aniflorine,20,21,3,3,0,0,1.05,0.15,-0.2999999999999998,68.85,12,9,0.42857142857142855,0.4838709677419355,6,Lignin,276149.78441234794,4209952.739824544,15.24517844105294,3.9302811317234165,7.010841526948026e-5,2.1360369688219348e-4,Upregulated
Feature0360,N6-Methyladenine,C6 H7 N5,149.07016,NA,NA,N6-Methyladenine,6,7,0,5,0,0,1.1666666666666667,0,1.3333333333333337,22.29999999999999,6,6,1,1,1,Unsaturated HC,3501744.367844951,175737.41852779064,0.050185678926626856,-4.316580456857174,7.122549963191245e-4,0.0016993802306543618,Downregulated
Feature0359,afegostat,C6 H13 N O3,147.08956,Biosynthesis of secondary metabolites;Other,Superpathway of linamarin and lotaustralin biosynthesis,afegostat-peak1,6,13,3,1,0,0,2.1666666666666665,0.5,-0.666666666666667,79.30000000000001,1,-2,-1.5,-0.42857142857142855,-3,Protein,558075.72512308,2830884.206374415,5.0725807967190875,2.3427199395970377,1.313149522977186e-4,3.740941703776767e-4,Upregulated
Feature0358,NA,C43 H57 N6 O4 P3,814.36502,NA,NA,Feature0358,43,57,4,6,0,3,1.3255813953488371,0.09302325581395347,-1.0697674418604652,90.78837209302326,20,16,0.23333333333333336,0.28125,7,Unsaturated HC,290608.6519089071,406983.054717371,1.4004505786184993,0.48589107213782806,0.5538322411716081,0.6068511103135215,Upregulated
Feature0357,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",C11 H11 N O4,221.06882,NA,NA,"Methyl 2,3-dihydro-3-hydroxy-2-oxo-1H-indole-3-acetate",11,11,4,1,0,0,1,0.3636363636363637,0,60.3,7,3,0.3333333333333333,0.5,2,Lignin,352272.59279652,560535.0946591641,1.5911970051639552,0.6701124659504735,0.024121762292933262,0.039065263216280066,Upregulated
Feature0356,MFCD00037215,C8 H14 N2 O5,218.09028,NA,NA,MFCD00037215,8,14,5,2,0,0,1.75,0.625,0.25,53.175,3,-2,-4,-0.42857142857142855,-4,Amino Sugar,7064926.761712222,732590.4976227832,0.10369399745132475,-3.269595711805158,1.348506161425112e-7,7.251966468108381e-7,Downregulated
Feature0355,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid,C17 H33 N3 O4,343.24723,NA,NA,(3S)-3-{(Z)-[(3S)-3-{(Z)-[(3R)-3-Amino-1-hydroxy-4-methylpentylidene]amino}-1-hydroxybutylidene]amino}-5-methylhexanoic acid-peak1,17,33,4,3,0,0,1.9411764705882353,0.2352941176470588,-0.9411764705882356,87.12352941176471,3,-1,-0.4,-0.16666666666666666,-4,Lipid,2876868.409769326,2663394.1926382976,0.9257963219985632,-0.11123326378161696,0.7990990534221767,0.8249078589257569,Downregulated
Feature0354,NA,C13 H25 N3 O5,303.17954,NA,NA,Feature0354,13,25,5,3,0,0,1.9230769230769231,0.38461538461538464,-0.4615384615384617,73.45384615384616,3,-2,-1,-0.3333333333333333,-5,Protein,2072102.9595389627,3622811.7975684935,1.748374413969545,0.8060141707280137,0.04066501971616773,0.06314073638789014,Upregulated
Feature0353,Phosphonoacetic acid,C2 H5 O5 P,139.98747,Metabolic pathways;Microbial metabolism in diverse environments;Other,Superpathway of L-lysine degradation;Other,Phosphonoacetic acid,2,5,5,0,0,1,2.5,2.5,0,60.3,1,-4,1.25,1.6666666666666667,-5,Other,1183796.6863552176,3081342.72504741,2.602932378983533,1.380137832766879,0.05460211854452545,0.0821456383787088,Upregulated
Feature0352,"Hydroxy-1,4-benzoquinone",C6 H4 O3,124.01601,Metabolic pathways;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,NA,"Hydroxy-1,4-benzoquinone",6,4,3,0,0,0,0.6666666666666666,0.5,0.3333333333333335,50.8,5,2,0.6666666666666666,0.7777777777777778,2,Condensed HC,1342651.0156142574,4940639.0539869005,3.679764135676446,1.8796132958487912,3.62697241942046e-10,4.517714175366367e-9,Upregulated
Feature0351,Leu-Gly-Pro,C13 H23 N3 O4,285.16889,NA,NA,Leu-Gly-Pro-peak2,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,1083974.9992463945,2241833.1112542357,2.068159425090811,1.0483474007992586,0.006434794800101664,0.01172101332405615,Upregulated
Feature0350,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak3,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,354103.05913448514,3453590.2935028938,9.753065398373899,3.285855730654211,3.2733565360439442e-6,1.317117808089891e-5,Upregulated
Feature0349,NA,C22 H41 N5 O5,455.31091,NA,NA,Feature0349,22,41,5,5,0,0,1.8636363636363635,0.2272727272727273,-0.7272727272727275,81.02727272727273,5,0,-0.4166666666666667,-0.1724137931034483,-5,Lipid,797669.4112723294,1470525.9432073114,1.8435280611572362,0.8824693764991431,0.2357279330817712,0.3050596781058216,Upregulated
Feature0348,Bicine,C6 H13 N O4,163.08447,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,Bicine,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,857650.372840969,1387851.1472710508,1.6182015320226475,0.6943912932708808,0.2805997160797876,0.3549932181024348,Upregulated
Feature0347,Ethyl L-tyrosinate,C11 H15 N O3,209.1052,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Ethyl L-tyrosinate,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,212158.1639877916,1452144.8936500745,6.844633580698014,2.7749733105906356,0.023046592078583845,0.03739552392827685,Upregulated
Feature0346,Uracil,C4 H4 N2 O2,112.02723,Metabolic pathways;Other,Other,Uracil-peak1,4,4,2,2,0,0,1,0.5,1.5,17.549999999999997,4,2,NA,1,0,Lignin,4313289.056690899,2566329.3347416474,0.5949819965718929,-0.7490820799951975,0.004645295377026397,0.0087532039696137,Downregulated
Feature0345,Gly-Ser,C5 H10 N2 O4,162.06409,NA,NA,Gly-Ser,5,10,4,2,0,0,2,0.8,0.7999999999999998,37.5,2,-2,4,-2,-4,Carbohydrate,2580697.8039705954,3153418.3787096315,1.2219246956609422,0.28915537800107965,0.3138496454618086,0.39092742603845865,Upregulated
Feature0344,L-Isoleucyl-L-alanyl-D-arginine,C15 H30 N6 O4,358.23296,NA,NA,L-Isoleucyl-L-alanyl-D-arginine-peak1,15,30,4,6,0,0,2,0.26666666666666666,-0.2666666666666666,67.89999999999999,4,0,-1.2,-0.5714285714285714,-6,Lipid,4928453.150294657,513062.9452106182,0.10410222631008348,-3.263927172722921,8.319223164899308e-6,3.104133048753178e-5,Downregulated
Feature0343,Oglufanide,C16 H19 N3 O5,333.13251,NA,NA,Oglufanide,16,19,5,3,0,0,1.1875,0.3125,0,60.3,9,4,0.125,0.3333333333333333,1,Lignin,498064.2965302801,2544641.5507284557,5.1090623609350665,2.353058545301654,7.41574388883042e-5,2.2463414882368976e-4,Upregulated
Feature0342,NA,C13 H21 N3 O5,299.1482,NA,NA,Feature0342,13,21,5,3,0,0,1.6153846153846154,0.38461538461538464,-0.1538461538461542,64.6846153846154,5,0,-0.6,-0.06666666666666667,-3,Protein,7640738.939080425,363472.818733837,0.04757037527807245,-4.393792783148343,1.139759139619023e-9,1.1701527166755304e-8,Downregulated
Feature0341,NA,C19 H41 N O2,315.3138,NA,NA,Feature0341,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,182073.14596300133,370307.2506625418,2.0338378221782967,1.0242046435674135,0.16246250456284764,0.2185953000234026,Upregulated
Feature0340,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",C13 H14 N2 O4,262.09538,NA,NA,"(5-Benzyl-3,6-dioxo-2-piperazinyl)acetic acid",13,14,4,2,0,0,1.0769230769230769,0.3076923076923077,0,60.3,8,4,0.2857142857142857,0.4444444444444444,2,Lignin,2667914.7219133424,5304577.686522631,1.9882860733713255,0.9915253459052346,3.4333883075983186e-5,1.124982551851364e-4,Upregulated
Feature0339,ophthalmic acid,C11 H19 N3 O6,289.12729,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,ophthalmic acid,11,19,6,3,0,0,1.7272727272727273,0.5454545454545454,0.18181818181818168,55.11818181818182,4,-2,-2.5,-0.4,-5,Protein,559800.1933868467,434912.52066955477,0.7769066995820256,-0.36418674224208325,0.40289835940531205,0.4710212704158721,Downregulated
Feature0338,1581740,C12 H13 N O4,235.08445,NA,NA,1581740-peak1,12,13,4,1,0,0,1.0833333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,7,3,0.2857142857142857,0.4444444444444444,2,Lignin,4902088.242633633,1803763.0202309175,0.3679580886658725,-1.4423866457717698,2.7643233862445684e-8,1.819898927141808e-7,Downregulated
Feature0337,Leu-Glu,C11 H20 N2 O5,260.13726,NA,NA,Leu-Glu-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,1679615.358521252,2071754.946376122,1.2334698750314557,0.3027224812047599,0.047134064491729515,0.07206236935829403,Upregulated
Feature0336,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",C9 H15 N O3,185.10525,Other,NA,"3-[(1S,4R)-4-Hydroxy-2-cyclohexen-1-yl]-L-alanine",9,15,3,1,0,0,1.6666666666666667,0.3333333333333333,-0.666666666666667,79.30000000000001,3,0,-0.2,0.07692307692307693,-1,Protein,5923875.603663752,774463.4086437966,0.13073593378038062,-2.935272363382277,1.069218642431304e-6,4.741508848896934e-6,Downregulated
Feature0335,N-Acetyl-L-leucine,C8 H15 N O3,173.10526,Other,NA,N-Acetyl-L-leucine-peak2,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,2947430.1534325033,3050137.172741859,1.0348462945558679,0.049416500527081623,0.67467090714644,0.7111963389583504,Upregulated
Feature0334,Alanyltryptophan,C14 H17 N3 O3,275.12704,NA,NA,Alanyltryptophan-peak2,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,5194051.131163696,3987433.149392266,0.7676923173644048,-0.3813998844021511,0.07768820514351278,0.11219421953376867,Downregulated
Feature0333,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak3,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,2947031.9054847565,4367299.180501933,1.481931421364628,0.5674786862764178,0.08948486265035684,0.1279218205313962,Upregulated
Feature0332,N-Acetylvanilalanine,C12 H15 N O5,253.09505,NA,NA,N-Acetylvanilalanine-peak2,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,5276790.351552539,4726994.587727353,0.8958086777763637,-0.15873745311406054,0.02061085071549812,0.034158536544677424,Downregulated
Feature0331,tyr-thr,C13 H18 N2 O5,282.12167,NA,NA,tyr-thr-peak2,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,1199247.2214250744,2692546.0080053736,2.2451967867024125,1.1668418996468524,0.003443846344376737,0.006761221800686382,Upregulated
Feature0330,Alanyltryptophan,C14 H17 N3 O3,275.12702,NA,NA,Alanyltryptophan-peak1,14,17,3,3,0,0,1.2142857142857142,0.21428571428571427,-0.14285714285714324,64.37142857142858,8,5,0.25,0.3684210526315789,2,Lignin,982982.3427830319,4298509.272838924,4.372926232498674,2.1285990116009232,1.8865128895690365e-5,6.482257271663179e-5,Upregulated
Feature0329,NA,C17 H31 N3 O6,373.22136,NA,NA,Feature0329,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,890187.4663395297,2056770.1890236984,2.3104910671020593,1.2081995117193476,0.0595797692886636,0.08868904145430241,Upregulated
Feature0328,pre-putrebactin,C16 H30 N4 O7,390.2116,NA,NA,pre-putrebactin,16,30,7,4,0,0,1.875,0.4375,-0.25,67.425,4,-3,-1.4,-0.4117647058823529,-7,Protein,604044.9059443884,501015.31471926114,0.8294338877603039,-0.26980110297867865,0.36180320648650344,0.43438607104887517,Downregulated
Feature0327,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",C13 H10 N2 O,210.07933,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"6,7-dihydro-5H-dibenzo[d,f][1,3]diazepin-6-one",13,10,1,2,0,0,0.7692307692307693,0.07692307692307693,-0.1538461538461542,64.6846153846154,10,9,0.7,0.7142857142857143,7,Condensed HC,5070759.891526803,3957539.36645306,0.7804627809465154,-0.357598260921464,0.01718580069178281,0.028824501358297106,Downregulated
Feature0326,Brivaracetam,C11 H20 N2 O2,212.15246,NA,NA,Brivaracetam,11,20,2,2,0,0,1.818181818181818,0.18181818181818185,-0.9090909090909092,86.2090909090909,3,1,-0.14285714285714285,0,-1,Lipid,6208300.766081032,1632148.1963704245,0.26289773286881396,-1.9274263941372693,3.909947455277635e-8,2.453129996014931e-7,Downregulated
Feature0325,ile-his,C12 H20 N4 O3,268.15361,NA,NA,ile-his-peak1,12,20,3,4,0,0,1.6666666666666667,0.25,-0.16666666666666696,65.05000000000001,5,2,-0.4,-0.07692307692307693,-2,Lipid,2835723.95840703,3773430.104922024,1.330676102564564,0.4121594502206783,0.33790450600984967,0.4122820930085693,Upregulated
Feature0324,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",C18 H20 N2 S,296.13484,NA,NA,"2,3-dihydro-2-spiro[1-(benzyl)piperidin-4-yl]-1,3-benzothiazole",18,20,0,2,1,0,1.1111111111111112,0,-0.666666666666667,79.30000000000001,10,10,0.4666666666666667,0.4666666666666667,7,Unsaturated HC,846394.1273238385,130525.5529923841,0.15421367986694898,-2.6969973464902903,0.33405393232041736,0.4109566894341228,Downregulated
Feature0323,3-Buten-1-amine,C4 H9 N,71.07351,NA,NA,3-Buten-1-amine-peak1,4,9,0,1,0,0,2.25,0,-1.5,103.05,1,1,0,0,0,Lipid,1065417.010968954,2116661.7364779185,1.9866978982744976,0.9903725098311665,0.02207906025167432,0.03624516699076189,Upregulated
Feature0322,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",C9 H14 N2 O4,214.09536,NA,NA,"1-(beta-D-Ribofuranosyl)-1,2-dihydropyrimidine",9,14,4,2,0,0,1.5555555555555556,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Protein,4530461.919633561,3769820.838738531,0.832105181681661,-0.26516219212255276,0.0012822904468918655,0.0028320730339437025,Downregulated
Feature0321,NA,C14 H26 N4 O5,330.1904,NA,NA,Feature0321,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,749406.1559105457,3901958.4196009627,5.206733876985562,2.3803786705720795,1.0778484211940075e-6,4.7672982389103095e-6,Upregulated
Feature0320,Bis(methylbenzylidene)sorbitol,C22 H26 O6,386.17299,NA,NA,Bis(methylbenzylidene)sorbitol,22,26,6,0,0,0,1.181818181818182,0.2727272727272727,-0.6363636363636367,78.43636363636364,10,4,0.25,0.3684210526315789,4,Lignin,1499239.6478597168,3845595.4104189463,2.5650304912285624,1.3589759756501767,0.03319939298611256,0.052316066714860165,Upregulated
Feature0319,6-Quinolinecarboxylic acid,C10 H7 N O2,173.04768,Other,NA,6-Quinolinecarboxylic acid,10,7,2,1,0,0,0.7,0.2,0,60.3,8,6,0.7142857142857143,0.75,5,Condensed HC,562953.8998619086,1660795.7207460266,2.9501451560303895,1.5607859411636882,7.80589219454027e-4,0.001839107284777638,Upregulated
Feature0318,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one,C6 H10 O3,130.06297,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I,(4S)-4-Hydroxy-4-methyltetrahydro-2H-pyran-2-one-peak1,6,10,3,0,0,0,1.6666666666666667,0.5,-0.666666666666667,79.30000000000001,2,-1,-0.3333333333333333,0.1111111111111111,-1,Protein,665774.0388144057,2358373.474412416,3.5423031492969455,1.8246876828048437,0.030366058543573025,0.04816489061124785,Upregulated
Feature0317,CMPF,C12 H16 O5,240.09978,NA,NA,CMPF,12,16,5,0,0,0,1.3333333333333333,0.4166666666666667,-0.5,74.55,5,0,0,0.2631578947368421,0,Lignin,1030576.048428985,414448.0163573602,0.40215180334255457,-1.3141879054499164,0.468016887141003,0.5313811037646509,Downregulated
Feature0316,Asp-tyr,C13 H16 N2 O6,296.10088,NA,NA,Asp-tyr,13,16,6,2,0,0,1.2307692307692308,0.4615384615384616,0.15384615384615374,55.91538461538462,7,1,-0.2,0.25,-1,Lignin,2867108.448520732,1468247.2418188376,0.5121003506429522,-0.9655015479648295,1.4225047719502275e-5,5.051653412795297e-5,Downregulated
Feature0315,Aspartame,C14 H18 N2 O5,294.12149,Other,NA,Aspartame-peak1,14,18,5,2,0,0,1.2857142857142858,0.35714285714285715,-0.14285714285714324,64.37142857142858,7,2,0,0.2631578947368421,0,Lignin,5617742.49997778,2172858.9787214305,0.3867850793677398,-1.370395952444262,2.3302468014621684e-5,7.894876163353826e-5,Downregulated
Feature0314,4-Amino-3-hydroxybenzoic acid,C7 H7 N O3,153.04263,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Aminobenzoate degradation;Other,Other,4-Amino-3-hydroxybenzoic acid,7,7,3,1,0,0,1,0.42857142857142855,0.2857142857142856,52.15714285714286,5,2,0.3333333333333333,0.5555555555555556,1,Lignin,318058.30947594455,1285708.1456417572,4.042366155313411,2.015200006163421,0.10582395599718862,0.14913958524063023,Upregulated
Feature0313,L-gamma-Glutamyl-L-leucine,C11 H20 N2 O5,260.13725,NA,NA,L-gamma-Glutamyl-L-leucine-peak1,11,20,5,2,0,0,1.818181818181818,0.4545454545454546,-0.3636363636363633,70.66363636363636,3,-2,-1,-0.2307692307692308,-4,Protein,2616819.0485101193,1268621.8782011778,0.4847954156109744,-1.0445520386230829,0.055325603636903635,0.08301290749416719,Downregulated
Feature0312,Phenyl D-glucopyranosiduronic acid,C12 H14 O7,270.07399,NA,NA,Phenyl D-glucopyranosiduronic acid-peak1,12,14,7,0,0,0,1.1666666666666667,0.5833333333333334,0,60.3,6,-1,-0.2,0.29411764705882354,-1,Lignin,817471.4483910254,1448674.6220348706,1.772140941296727,0.8254933483759074,0.02658915624117551,0.042572807819046606,Upregulated
Feature0311,NA,C13 H23 N3 O6,317.15873,NA,NA,Feature0311,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,3120875.684870566,2251772.434428687,0.7215194265330298,-0.4708898558388583,0.024013530078805058,0.03892719612774714,Downregulated
Feature0310,NA,C15 H29 N3 O4,315.21588,NA,NA,Feature0310,15,29,4,3,0,0,1.9333333333333331,0.26666666666666666,-0.7999999999999998,83.1,3,-1,-0.5,-0.2,-4,Lipid,1997421.6433435266,4043633.1290721013,2.02442641119247,1.017513201356055,0.005806697722169376,0.010680288752828363,Upregulated
Feature0309,Leu-Gly-Pro,C13 H23 N3 O4,285.16893,NA,NA,Leu-Gly-Pro-peak1,13,23,4,3,0,0,1.7692307692307692,0.3076923076923077,-0.4615384615384617,73.45384615384616,4,0,-0.5,-0.125,-3,Protein,596220.8938485568,1488503.7834373957,2.4965642747425814,1.3199440497317754,0.0013724096828167023,0.003015385217498695,Upregulated
Feature0308,2-Methoxy-5-methylaniline,C8 H11 N O,137.08405,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of plant secondary metabolites;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,NA,2-Methoxy-5-methylaniline,8,11,1,1,0,0,1.375,0.125,-0.75,81.675,4,3,0.3333333333333333,0.38461538461538464,2,Unsaturated HC,4601724.220192014,7094255.371189092,1.541651570526552,0.6244767378376668,0.47596318486724265,0.5389583122761424,Upregulated
Feature0307,NA,C11 H14 N2 O5 S,286.06233,NA,NA,Feature0307,11,14,5,2,1,0,1.2727272727272727,0.4545454545454546,0.36363636363636376,49.93636363636363,6,1,-0.6666666666666666,0.09090909090909093,-2,Lignin,4176136.2061427915,3833190.838873849,0.9178797456930415,-0.12362294087415289,0.2507110971459091,0.3219898397006596,Downregulated
Feature0306,Salsolinol,C10 H13 N O2,179.09459,"Metabolic pathways;Biosynthesis of secondary metabolites;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",NA,Salsolinol,10,13,2,1,0,0,1.3,0.2,-0.5999999999999996,77.39999999999999,5,3,0.2857142857142857,0.375,2,Lignin,480005.8825468221,1186657.3528240358,2.4721725211529746,1.3057794255752284,0.011212106502808414,0.01952035808402616,Upregulated
Feature0305,tyr-thr,C13 H18 N2 O5,282.12161,NA,NA,tyr-thr-peak1,13,18,5,2,0,0,1.3846153846153846,0.38461538461538464,-0.1538461538461542,64.6846153846154,6,1,-0.16666666666666666,0.17647058823529413,-1,Lignin,6902980.639611085,3628725.830915064,0.5256752148618958,-0.9277563802149384,1.77712897940024e-4,4.911022008326275e-4,Downregulated
Feature0304,3-oxovaleric acid,C5 H8 O3,116.0473,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Other,3-oxovaleric acid-peak1,5,8,3,0,0,0,1.6,0.6,-0.4000000000000003,71.7,2,-1,-0.5,0.14285714285714285,-1,Amino Sugar,1306399.799636725,2898171.902612628,2.2184417843745323,1.149546694922329,2.272848422446767e-7,1.181044548351173e-6,Upregulated
Feature0303,L-Phenylalanine,C9 H11 N O2,165.079,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;ABC transporters;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Phenylalanine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of indole-3-acetate conjugate biosynthesis;Other,L-Phenylalanine-peak1,9,11,2,1,0,0,1.2222222222222223,0.2222222222222222,-0.44444444444444464,72.96666666666667,5,3,0.3333333333333333,0.42857142857142855,2,Lignin,859339.2104051262,1880274.096517223,2.18804643585481,1.1296433560768,0.08832110028452546,0.1263648174678937,Upregulated
Feature0302,(E)-5-(methylsulfanyl)pentanal oxime,C6 H13 N O S,147.0718,2-Oxocarboxylic acid metabolism;Other,NA,(E)-5-(methylsulfanyl)pentanal oxime,6,13,1,1,1,0,2.1666666666666665,0.16666666666666666,-1,88.8,1,0,-0.6666666666666666,-0.42857142857142855,-2,Lipid,139833.10227867588,1670364.4355079043,11.945414986066783,3.5783850690617682,0.039629520032533186,0.061702579903594866,Upregulated
Feature0301,NA,C16 H31 N3 O5,345.2265,NA,NA,Feature0301,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1472349.4352782844,3701960.7134734257,2.514322092821484,1.330169475514734,3.168521920183162e-4,8.19462005006149e-4,Upregulated
Feature0300,NA,C9 H15 N O5,217.09502,NA,NA,Feature0300,9,15,5,1,0,0,1.6666666666666667,0.5555555555555556,-0.22222222222222232,66.63333333333333,3,-2,-1,-0.09090909090909093,-3,Amino Sugar,1461332.4896819487,570318.2686170768,0.3902727631418115,-1.3574453132567263,1.6146250630374216e-5,5.6511877206309756e-5,Downregulated
Feature0299,ser-trp,C14 H17 N3 O4,291.12193,NA,NA,ser-trp,14,17,4,3,0,0,1.2142857142857142,0.2857142857142857,0,60.3,8,4,0.14285714285714285,0.3333333333333333,1,Lignin,2373316.0798153365,2988074.4526015427,1.2590292873396112,0.3323118431905087,0.11938652312177678,0.16577112308876218,Upregulated
Feature0298,Caffeic acid,C9 H8 O4,180.04231,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of scopolin and esculin biosynthesis;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,Caffeic acid-peak1,9,8,4,0,0,0,0.8888888888888888,0.4444444444444444,0,60.3,6,2,0.4,0.5714285714285714,2,Lignin,460870.09713003266,3716251.1097435355,8.063554422136896,3.0114159202448216,5.310744836583684e-7,2.478347590405719e-6,Upregulated
Feature0297,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak2,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,257725.68144614281,355581.7318144761,1.379690723172197,0.4643449031251267,0.5880832502300675,0.6361513575285659,Upregulated
Feature0296,Adenylsuccinic acid,C14 H18 N5 O11 P,463.07418,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of purine nucleotide salvage;Other,Adenylsuccinic acid,14,18,11,5,0,1,1.2857142857142858,0.7857142857142857,1,31.799999999999997,9,-2,2.6666666666666665,-1,-8,Tannin,223354.6742121979,1897684.3565820565,8.496282261723179,3.086831695852982,0.002401219736863221,0.00491858069437279,Upregulated
Feature0295,acetoacetic acid,C4 H6 O3,102.03166,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Tyrosine metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of branched chain amino acid biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,acetoacetic acid-peak1,4,6,3,0,0,0,1.5,0.75,0,60.3,2,-1,-1,0.2,-1,Carbohydrate,5286858.3092054995,2747628.586789361,0.5197091403045886,-0.9442236624812348,3.605054701660342e-7,1.7856615978399471e-6,Downregulated
Feature0294,NA,C16 H21 N5 O9,427.13397,NA,NA,Feature0294,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,3054320.960361211,4051226.4381478755,1.3263918529599352,0.4075070505693435,7.802640623483169e-4,0.001839107284777638,Upregulated
Feature0293,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid",C7 H13 N O5,191.07946,"Metabolic pathways;Biosynthesis of secondary metabolites;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Other,"2-amino-2,3,7-trideoxy-D-lyxo-hept-6-ulosonic acid-peak1",7,13,5,1,0,0,1.8571428571428572,0.7142857142857143,0,60.3,2,-3,-4,-0.42857142857142855,-4,Carbohydrate,395315.97471692436,193167.95048802838,0.48864190379948846,-1.0331505067396445,0.015959825121126314,0.026901436572326343,Downregulated
Feature0292,Succinyladenosine,C14 H17 N5 O8,383.10785,NA,NA,Succinyladenosine,14,17,8,5,0,0,1.2142857142857142,0.5714285714285714,1,31.799999999999997,9,1,-4,0,-4,Lignin,1749686.779961004,3695655.5437344327,2.1121812121234633,1.078733614344493,0.001609473810395162,0.003442485650011874,Upregulated
Feature0291,NA,C14 H28 N6 O4,344.21736,NA,NA,Feature0291,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,205511.88701493334,176119.3480668604,0.8569788863554294,-0.2226684342200036,0.49226974337390983,0.5533543100699424,Downregulated
Feature0290,cys-val,C8 H16 N2 O3 S,220.08817,NA,NA,cys-val-peak1,8,16,3,2,1,0,2,0.375,-0.25,67.425,2,-1,-2,-0.7142857142857143,-4,Protein,1906930.8244696206,2038573.1107697235,1.0690335929394381,0.09630718851739754,0.6612233397791791,0.6991962157215539,Upregulated
Feature0289,6-(alpha-D-glucosaminyl)-1D-myo-inositol,C12 H23 N O10,341.13214,NA,NA,6-(alpha-D-glucosaminyl)-1D-myo-inositol-peak1,12,23,10,1,0,0,1.9166666666666667,0.8333333333333334,0,60.3,2,-8,-9,-0.6666666666666666,-9,Carbohydrate,3942741.806472353,3730259.9930729214,0.9461081085627712,-0.07992305003717494,0.37504628677794605,0.4458444981065548,Downregulated
Feature0288,NA,C24 H36 N4 O6,476.26356,NA,NA,Feature0288,24,36,6,4,0,0,1.5,0.25,-0.5,74.55,9,3,-0.07142857142857142,0.1176470588235294,-1,Lipid,5610597.590332658,320454.17970520194,0.05711587305020068,-4.12996444964278,4.955460651694793e-7,2.351414662176745e-6,Downregulated
Feature0287,R-Palmitoyl-(2-methyl) ethanolamide,C19 H39 N O2,313.29814,NA,NA,R-Palmitoyl-(2-methyl) ethanolamide-peak1,19,39,2,1,0,0,2.0526315789473686,0.10526315789473684,-1.6842105263157894,108.3,1,-1,-0.125,-0.0588235294117647,-2,Lipid,186621.86700909428,328861.32369875995,1.7621800112134458,0.8173613067894925,0.24262639129778563,0.3132691363250373,Upregulated
Feature0286,Deoxyadenosine monophosphate,C10 H14 N5 O6 P,331.06822,Metabolic pathways;Other,NA,Deoxyadenosine monophosphate,10,14,6,5,0,1,1.4,0.6,0.7999999999999998,37.5,7,1,2.5,-2,-5,Lignin,1277896.9666292523,238992.16816048048,0.18701990410923142,-2.4187362738035363,0.003404645521424871,0.00669857086329121,Downregulated
Feature0285,PYRIDOXAMINE,C8 H12 N2 O2,168.08993,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,PYRIDOXAMINE-peak1,8,12,2,2,0,0,1.5,0.25,-0.25,67.425,4,2,0,0.2,0,Lipid,2552829.653762713,1684028.435923397,0.6596712919881839,-0.600180772764703,0.06999117016917476,0.1022112433332604,Downregulated
Feature0284,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,C9 H15 N O2,169.11033,NA,NA,3-[(1S)-2-Cyclohexen-1-yl]-L-alanine,9,15,2,1,0,0,1.6666666666666667,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,1,0,0.14285714285714285,0,Lipid,565650.3673088402,3621378.3702537413,6.402149772275319,2.678556427772498,2.710651611634402e-4,7.119137721098725e-4,Upregulated
Feature0283,APM,C7 H13 N O4,175.08448,NA,NA,APM-peak2,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,3374627.677947683,1017794.7634539631,0.3016020908336016,-1.7292816648722547,6.63881127936467e-8,3.8779814852564665e-7,Downregulated
Feature0282,NA,C13 H22 N2 O10,366.12745,NA,NA,Feature0282,13,22,10,2,0,0,1.6923076923076923,0.7692307692307693,0.3076923076923075,51.53076923076924,4,-6,-8,-0.5,-8,Carbohydrate,739015.7960556597,3048627.0089275646,4.125252836541473,2.0444825447756814,1.7492361209376718e-5,6.0473591609559514e-5,Upregulated
Feature0281,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0281,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,6572174.926822868,838069.17300651,0.12751778252068693,-2.971229648073567,2.6280492507831214e-8,1.7390294651666435e-7,Downregulated
Feature0280,methoxyresorcinol,C7 H8 O3,140.04735,Microbial metabolism in diverse environments;Other,NA,methoxyresorcinol-peak1,7,8,3,0,0,0,1.1428571428571428,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,1,0.25,0.4545454545454546,1,Lignin,1452389.5866861849,4984450.481877874,3.4318963228389316,1.7790059698580245,0.09844317679835514,0.13966728768543854,Upregulated
Feature0279,Acetophenone,C8 H8 O,120.05746,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Phenylalanine metabolism;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,Acetophenone-peak1,8,8,1,0,0,0,1,0.125,-0.75,81.675,5,4,0.5714285714285714,0.6,4,Unsaturated HC,7361360.658970888,112880.49128580379,0.015334188408258806,-6.027104378589762,5.286502662439019e-13,2.356667239518868e-11,Downregulated
Feature0278,NA,C19 H41 N O,299.31886,NA,NA,Feature0278,19,41,1,1,0,0,2.1578947368421053,0.05263157894736842,-1.8947368421052628,114.29999999999998,0,-1,-0.1176470588235294,-0.08571428571428572,-2,Lipid,252354.19391482315,1880500.1784945424,7.451828516585961,2.8975944749884066,0.009687565306590854,0.017058976745701566,Upregulated
Feature0277,NA,C16 H35 N O,257.27187,NA,NA,Feature0277,16,35,1,1,0,0,2.1875,0.0625,-1.875,113.7375,0,-1,-0.14285714285714285,-0.10344827586206896,-2,Lipid,8171934.402497609,11540128.507743558,1.4121660722357878,0.49790976106117174,0.6245116293121954,0.6666179584466659,Upregulated
Feature0276,NA,C19 H29 N3 O4,363.21589,NA,NA,Feature0276,19,29,4,3,0,0,1.5263157894736843,0.21052631578947367,-0.6315789473684212,78.30000000000001,7,3,0,0.14285714285714285,0,Lipid,279742.92646513414,889610.1086937124,3.1800986710725256,1.6690715296789889,9.221110265962565e-4,0.0021166071531897816,Upregulated
Feature0275,Trigonelline,C7 H7 N O2,137.04766,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak2,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,430113.84512286796,2590958.317517629,6.023889597828421,2.590695329418043,0.006197274760435177,0.011349387507218582,Upregulated
Feature0274,N-(5-acetamidopentyl)acetamide,C9 H18 N2 O2,186.13687,NA,NA,N-(5-acetamidopentyl)acetamide,9,18,2,2,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,2,0,-0.4,-0.16666666666666666,-2,Lipid,789584.5828475119,371268.35698203114,0.47020720141610484,-1.088631460261077,0.3618806722829464,0.43438607104887517,Downregulated
Feature0273,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea",C14 H20 N4 O2,276.15865,Metabolic pathways;Other,NA,"N-(3-methoxyphenyl)-N'-[2-(2-methyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]urea-peak1",14,20,2,4,0,0,1.4285714285714286,0.14285714285714285,-0.2857142857142856,68.44285714285714,7,5,0.125,0.2222222222222222,1,Lignin,4157540.891479282,123842.276160982,0.029787386196198796,-5.069154655217954,1.1635984393038476e-6,5.0933740469785995e-6,Downregulated
Feature0272,N-benzoyl-4-methoxyanthranilic acid,C15 H13 N O4,271.08448,NA,NA,N-benzoyl-4-methoxyanthranilic acid,15,13,4,1,0,0,0.8666666666666667,0.26666666666666666,-0.13333333333333375,64.10000000000001,10,6,0.5,0.5833333333333334,5,Lignin,5632818.520630949,4080122.418979378,0.7243482821318289,-0.4652445521546786,2.5193523407481183e-5,8.467823145292286e-5,Downregulated
Feature0271,Prolylaspartic acid,C9 H14 N2 O5,230.09029,Biosynthesis of secondary metabolites;Other,NA,Prolylaspartic acid,9,14,5,2,0,0,1.5555555555555556,0.5555555555555556,0.22222222222222232,53.96666666666666,4,-1,-1.5,-0.1111111111111111,-3,Amino Sugar,6871462.157400316,1773455.2487511006,0.2580899389573373,-1.9540541925072783,7.002947971148292e-11,1.1298089393452577e-9,Downregulated
Feature0270,NA,C12 H22 N4 O3,270.16921,NA,NA,Feature0270,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,578191.3525389389,130982.96075305187,0.22653912096381743,-2.1421678845851932,0.19635057170668144,0.2584443422464012,Downregulated
Feature0269,NA,C19 H29 N3 O5,379.21071,NA,NA,Feature0269,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,1564546.873088732,2193202.562155376,1.4018132661155436,0.4872941824501729,0.22786813948534568,0.2957920523281039,Upregulated
Feature0268,Enicoflavine,C10 H13 N O4,211.0845,NA,NA,Enicoflavine,10,13,4,1,0,0,1.3,0.4,-0.20000000000000015,66,5,1,0,0.2857142857142857,0,Lignin,289726.0074602904,2751278.7097592633,9.496139935371012,3.2473411947290103,6.493145603734899e-4,0.0015579870612927647,Upregulated
Feature0267,Methylone,C11 H13 N O3,207.08954,Metabolic pathways;Phenylalanine metabolism;Other,NA,Methylone-peak1,11,13,3,1,0,0,1.181818181818182,0.2727272727272727,-0.3636363636363633,70.66363636363636,6,3,0.2857142857142857,0.4117647058823529,2,Lignin,5582835.036436416,4307776.240548675,0.7716108773470719,-0.37405461378123145,2.677474767736743e-4,7.042922758611868e-4,Downregulated
Feature0266,D-ribosylnicotinate,C11 H13 N O6,255.07429,NA,NA,D-ribosylnicotinate-peak1,11,13,6,1,0,0,1.181818181818182,0.5454545454545454,0.18181818181818168,55.11818181818182,6,0,-0.25,0.2857142857142857,-1,Lignin,1742731.3680921758,2614890.402164375,1.5004552336869794,0.5854002765495149,0.1457842369192148,0.19804209891030464,Upregulated
Feature0265,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.26288,NA,NA,Leucyl-leucyl-norleucine-peak2,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,873527.0957169563,3929880.7637513992,4.4988653277273665,2.1695611808916495,7.147919337461344e-4,0.0017030345088128716,Upregulated
Feature0264,Phenethylamine,C8 H11 N,121.0891,Metabolic pathways;Phenylalanine metabolism;Other,Other,Phenethylamine,8,11,0,1,0,0,1.375,0,-1,88.8,4,4,0.42857142857142855,0.42857142857142855,3,Unsaturated HC,2785474.0262282686,1480288.4799843924,0.5314314425644848,-0.9120445063327699,0.003570250585001535,0.006959728988484005,Downregulated
Feature0263,asn-ile,C10 H19 N3 O4,245.13753,NA,NA,asn-ile,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,265102.8287944621,985253.0132477715,3.7164937761250822,1.8939421919902037,1.2530022256266387e-5,4.554905086290828e-5,Upregulated
Feature0262,NA,C14 H27 N3 O4,301.2002,NA,NA,Feature0262,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,830321.649727175,1622117.1190608505,1.9536008962235798,0.9661357672812265,0.04734993095320184,0.07232712627116675,Upregulated
Feature0261,beta-Aspartylleucine,C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,beta-Aspartylleucine,10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,2764193.2213053307,1479492.3280620438,0.5352347718164888,-0.9017562503996299,6.355205308255913e-6,2.4138380699967527e-5,Downregulated
Feature0260,.alpha.-Aminoadipic acid,C6 H11 N O4,161.06884,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Lysine degradation;Other,Superpathway of L-lysine degradation;Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,.alpha.-Aminoadipic acid,6,11,4,1,0,0,1.8333333333333333,0.6666666666666666,0,60.3,2,-2,-3,-0.3333333333333333,-3,Amino Sugar,1967229.1056164622,3354554.705476109,1.7052181140970393,0.7699562858772865,0.05422170764874625,0.0817377306190189,Upregulated
Feature0259,Norsolorinic acid,C20 H18 O7,370.10536,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,Norsolorinic acid,20,18,7,0,0,0,0.9,0.35,-0.20000000000000015,66,12,5,0.38461538461538464,0.5151515151515151,5,Lignin,173631.09370789674,292716.4813609145,1.6858528913799138,0.7534786512644611,0.31375865846089585,0.39092742603845865,Upregulated
Feature0258,NA,C7 H16 N2 O3,176.11612,NA,NA,Feature0258,7,16,3,2,0,0,2.2857142857142856,0.42857142857142855,-0.5714285714285712,76.58571428571427,1,-2,-2,-0.7142857142857143,-4,Protein,252090.96505777133,164586.55065816225,0.652885559069696,-0.615097963501316,0.36405721576710737,0.43607922339860816,Downregulated
Feature0257,1-Deoxynojirimycin,C6 H13 N O4,163.08449,Biosynthesis of secondary metabolites;Other,Superpathway of butirocin biosynthesis;Superpathway of linamarin and lotaustralin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis,1-Deoxynojirimycin-peak1,6,13,4,1,0,0,2.1666666666666665,0.6666666666666666,-0.33333333333333304,69.79999999999998,1,-3,-4,-0.6666666666666666,-4,Amino Sugar,358808.3991480187,2533661.421692984,7.061321384084369,2.8199381800809595,1.6023730314886067e-4,4.471861475027512e-4,Upregulated
Feature0256,NA,C19 H41 N O2,315.31381,NA,NA,Feature0256,19,41,2,1,0,0,2.1578947368421053,0.10526315789473684,-1.7894736842105263,111.3,0,-2,-0.1875,-0.1176470588235294,-3,Lipid,6013583.0103798015,2777539.8149292003,0.46187768758409115,-1.1144172408183775,0.014472214673159156,0.024639127292795587,Downregulated
Feature0255,NP-003800,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,NP-003800-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,420748.77758408774,250875.62595971717,0.5962599045450085,-0.7459867687892797,0.022738601617669364,0.037037683788780675,Downregulated
Feature0254,Desthiobiotin,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Desthiobiotin-peak1,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,5088207.931523816,2306616.830456711,0.4533259767483452,-1.1413792611458276,5.771222575000963e-6,2.2068738243908875e-5,Downregulated
Feature0253,asn-leu,C10 H19 N3 O4,245.13756,NA,NA,asn-leu-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,2420890.31591773,2306262.8325913427,0.9526506911227272,-0.06998077746230479,0.7181610901947562,0.7505027062245014,Downregulated
Feature0252,Isovalerylglutamic acid,C10 H17 N O5,231.11066,NA,NA,Isovalerylglutamic acid-peak2,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,343018.4627707237,888492.2387172038,2.590216956662998,1.3730729431600481,0.06934682462981077,0.10144518214412733,Upregulated
Feature0251,NA,C13 H24 N4 O6,332.1696,NA,NA,Feature0251,13,24,6,4,0,0,1.8461538461538465,0.4615384615384616,0,60.3,4,-2,-2,-0.5,-6,Protein,1385632.556661471,3668730.877786556,2.6476939071249586,1.4047363456353437,3.5470942997988394e-6,1.4171645622309514e-5,Upregulated
Feature0250,NA,C8 H10 N2 O2,166.07426,NA,NA,Feature0250,8,10,2,2,0,0,1.25,0.25,0,60.3,5,3,0.25,0.4,1,Lignin,941917.6255786634,3546409.959241371,3.7650956547953416,1.9126865180036738,1.0846082503435376e-7,6.043836763427476e-7,Upregulated
Feature0249,Isovalerylglutamic acid,C10 H17 N O5,231.11064,NA,NA,Isovalerylglutamic acid-peak1,10,17,5,1,0,0,1.7,0.5,-0.4000000000000003,71.7,3,-2,-0.75,-0.07692307692307693,-3,Protein,1930213.8149248112,2024823.6971387765,1.049015234210025,0.06903562944965645,0.8214521698569499,0.8438689968087768,Upregulated
Feature0248,Cyclopentanone,C5 H8 O,84.05754,Other,NA,Cyclopentanone-peak1,5,8,1,0,0,0,1.6,0.2,-1.2000000000000002,94.5,2,1,0.25,0.3333333333333333,1,Lipid,595823.3399067865,2196250.413913729,3.6860765042492654,1.882086014309817,0.0036993778419444185,0.007161995502004394,Upregulated
Feature0247,L-dihydroanticapsin,C9 H15 N O4,201.10006,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,L-dihydroanticapsin,9,15,4,1,0,0,1.6666666666666667,0.4444444444444444,-0.44444444444444464,72.96666666666667,3,-1,-0.5,0,-2,Protein,351339.90541309066,425140.01291387115,1.210053302695603,0.27507059943448164,0.6157544624682703,0.6589377991023181,Upregulated
Feature0246,NA,C14 H25 N3 O4,299.18456,NA,NA,Feature0246,14,25,4,3,0,0,1.7857142857142858,0.2857142857142857,-0.5714285714285712,76.58571428571427,4,0,-0.42857142857142855,-0.1111111111111111,-3,Lipid,1788464.5858701186,3151123.752068878,1.7619156548944483,0.8171448622957584,0.04494974513585666,0.06922260750921926,Upregulated
Feature0245,Methyl vinyl ketone,C4 H6 O,70.04188,Other,NA,Methyl vinyl ketone-peak1,4,6,1,0,0,0,1.5,0.25,-1,88.8,2,1,0.3333333333333333,0.42857142857142855,1,Lipid,1733563.456134538,3532607.969751872,2.037772518364459,1.0269930088418262,4.022147003603352e-4,0.0010079167195420234,Upregulated
Feature0244,SLH,C15 H25 N5 O5,355.18569,NA,NA,SLH,15,25,5,5,0,0,1.6666666666666667,0.3333333333333333,0,60.3,6,1,-0.8,-0.2,-4,Protein,977194.3976919325,273465.1018437776,0.2798471854624666,-1.8372888568545682,1.4823655780206414e-5,5.2315151857645134e-5,Downregulated
Feature0243,N~6~-(5-Oxo-D-isoleucyl)-L-lysine,C12 H23 N3 O4,273.16894,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N~6~-(5-Oxo-D-isoleucyl)-L-lysine-peak1,12,23,4,3,0,0,1.9166666666666667,0.3333333333333333,-0.5,74.55,3,-1,-0.8,-0.2857142857142857,-4,Protein,1984453.1908206814,2827477.02688232,1.4248141704531725,0.5107737699104359,0.3218352345075739,0.39945721576821425,Upregulated
Feature0242,asn-lys,C10 H20 N4 O4,260.14846,NA,NA,asn-lys,10,20,4,4,0,0,2,0.4,0,60.3,3,-1,-2.5,-0.75,-5,Protein,1201057.6935248864,3321993.4912305125,2.765890022719112,1.4677437932085455,0.0011615295515803585,0.002595819340866923,Upregulated
Feature0241,Tyrosyltyrosine,C18 H20 N2 O5,344.13731,NA,NA,Tyrosyltyrosine,18,20,5,2,0,0,1.1111111111111112,0.2777777777777778,-0.22222222222222232,66.63333333333333,10,5,0.2727272727272727,0.4074074074074074,3,Lignin,1827050.1476082755,3457348.2276071096,1.8923116216229738,0.920149688016932,0.019152372237381744,0.03180795938247517,Upregulated
Feature0240,ELK,C17 H32 N4 O6,388.23223,NA,NA,ELK,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,5869691.125703167,1238393.158507701,0.21098097531654122,-2.2448151815184914,3.3028781695141646e-8,2.103411886901126e-7,Downregulated
Feature0239,7-Methylguanine,C6 H7 N5 O,165.06507,NA,NA,7-Methylguanine-peak1,6,7,1,5,0,0,1.1666666666666667,0.16666666666666666,1.6666666666666663,12.800000000000004,6,5,NA,1,0,Lignin,2093873.365113414,451206.6338328547,0.21548897910949608,-2.214314008360254,0.07205865754287341,0.1047788548305816,Downregulated
Feature0238,Leonurine,C14 H21 N3 O5,311.14813,NA,NA,Leonurine-peak1,14,21,5,3,0,0,1.5,0.35714285714285715,-0.14285714285714324,64.37142857142858,6,1,-0.3333333333333333,0.0588235294117647,-2,Protein,2238797.1371984724,2386586.1383054615,1.0660126809398753,0.0922246000297881,0.5208090490044808,0.5792846546379451,Upregulated
Feature0237,Neostigmine,C12 H18 N2 O2,222.13678,Other,NA,Neostigmine,12,18,2,2,0,0,1.5,0.16666666666666666,-0.666666666666667,79.30000000000001,5,3,0.125,0.2222222222222222,1,Lipid,5552689.890338974,4377137.1213094285,0.7882912980472998,-0.3431992461825966,9.879350538716527e-4,0.0022480607522085113,Downregulated
Feature0236,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,C11 H9 N3 O2,215.06947,NA,NA,N'3-(2-furylmethylidene)pyridine-3-carbohydrazide,11,9,2,3,0,0,0.8181818181818182,0.18181818181818185,0.36363636363636376,49.93636363636363,9,7,0.6666666666666666,0.7142857142857143,4,Lignin,6075441.105266225,2137933.945361806,0.35189773192083673,-1.5067718793422857,3.848695695260408e-7,1.8842432968328397e-6,Downregulated
Feature0235,NA,C14 H21 N O10,363.11672,NA,NA,Feature0235,14,21,10,1,0,0,1.5,0.7142857142857143,0.1428571428571428,56.22857142857143,5,-5,-2,-0.125,-6,Carbohydrate,821080.5773049393,123382.21766434402,0.15026809922763693,-2.734389326291224,0.20346688611126082,0.2667746943285417,Downregulated
Feature0234,NA,C20 H36 N4 O7,444.25844,NA,NA,Feature0234,20,36,7,4,0,0,1.8,0.35,-0.5,74.55,5,-2,-0.6666666666666666,-0.2,-6,Protein,5295294.804121981,526326.3497789367,0.09939509871466116,-3.3306814771661415,3.334805004003621e-8,2.1098649801200022e-7,Downregulated
Feature0233,Anhalamine,C11 H15 N O3,209.10519,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak2,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,2978033.9948493093,2874396.9455558993,0.9651995076373686,-0.05110091527371855,0.6495470725793304,0.6885686739357858,Downregulated
Feature0232,NA,C19 H37 N O2,311.28246,NA,NA,Feature0232,19,37,2,1,0,0,1.9473684210526316,0.10526315789473684,-1.5789473684210522,105.29999999999998,2,0,-0.0625,0,-1,Lipid,207253.63161540873,654893.336915724,3.159864229211579,1.6598625710443975,0.07248992325115212,0.10531554887431534,Upregulated
Feature0231,NA,C13 H25 N O9,339.15309,NA,NA,Feature0231,13,25,9,1,0,0,1.9230769230769231,0.6923076923076923,-0.3076923076923075,69.06923076923076,2,-7,-2.6666666666666665,-0.4666666666666667,-8,Amino Sugar,128521.15689314458,195432.45588851723,1.520624779708482,0.6046642061618115,0.32375535064461725,0.4006147289934124,Upregulated
Feature0230,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0230,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,1687801.0113463013,2782687.9029429946,1.648706147369434,0.7213342868830243,0.004262897585388425,0.008113874729941564,Upregulated
Feature0229,NA,C16 H31 N3 O4,329.23158,NA,NA,Feature0229,16,31,4,3,0,0,1.9375,0.25,-0.875,85.2375,3,-1,-0.4444444444444444,-0.18181818181818185,-4,Lipid,1410413.814112838,2531834.938145146,1.7951007802186703,0.8440648418423354,0.00943867530324281,0.016672696521056643,Upregulated
Feature0228,NA,C47 H83 N10 O10 P3,1040.55075,NA,NA,Feature0228,47,83,10,10,0,3,1.7659574468085106,0.2127659574468085,-1.0212765957446803,89.4063829787234,13,3,-0.4166666666666667,-0.1724137931034483,-10,Lipid,200947.99565320986,1537624.1818487158,7.651851300384714,2.9358088378395375,0.017871021499504317,0.029855532958737982,Upregulated
Feature0227,NA,C13 H25 N3 O4,287.18455,NA,NA,Feature0227,13,25,4,3,0,0,1.9230769230769231,0.3076923076923077,-0.615384615384615,77.83846153846153,3,-1,-0.6666666666666666,-0.25,-4,Protein,2550114.4780287924,3131385.6501610605,1.227939246312418,0.2962391834996049,0.24189703643612925,0.31256565959023874,Upregulated
Feature0226,NA,C16 H32 N2 O10,412.20583,NA,NA,Feature0226,16,32,10,2,0,0,2,0.625,-0.375,70.9875,2,-8,-2.5,-0.5555555555555556,-10,Amino Sugar,6763489.084808986,807088.6206246471,0.11933021706760703,-3.0669686830894807,5.194161915734376e-11,8.798910285254033e-10,Downregulated
Feature0225,NA,C20 H29 N3 O4,375.2159,NA,NA,Feature0225,20,29,4,3,0,0,1.45,0.2,-0.5999999999999996,77.39999999999999,8,4,0.07692307692307693,0.2,1,Lignin,640578.4467421034,1838830.3881010567,2.8705779869009063,1.521341250797075,5.846363771178603e-4,0.0014228542939488291,Upregulated
Feature0224,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose",C10 H18 N2 O5,246.12156,Metabolic pathways;Other,NA,"2,4-Diacetamido-2,4,6-trideoxy-alpha-D-mannopyranose-peak1",10,18,5,2,0,0,1.8,0.5,-0.20000000000000015,66,3,-2,-1.3333333333333333,-0.2727272727272727,-4,Protein,3061621.087057832,4094168.474986146,1.3372551202672096,0.4192747276847888,3.9445100094899293e-4,9.913946522367863e-4,Upregulated
Feature0223,NA,C15 H27 N3 O6,345.19008,NA,NA,Feature0223,15,27,6,3,0,0,1.8,0.4,-0.4000000000000003,71.7,4,-2,-0.8333333333333334,-0.2222222222222222,-5,Protein,3510584.386981736,2650480.0232126373,0.7549968127931592,-0.4054575407505849,0.029779869560079223,0.04732373267802458,Downregulated
Feature0222,NA,C9 H21 N O7,255.13179,NA,NA,Feature0222,9,21,7,1,0,0,2.3333333333333335,0.7777777777777778,-0.44444444444444464,72.96666666666667,0,-7,-8,-1,-8,Carbohydrate,722741.98343478085,181988.48030325194,0.25180283486281563,-1.9896335694972185,0.14913412317289684,0.20210656372390978,Downregulated
Feature0221,NA,C18 H32 N4 O7,416.22724,NA,NA,Feature0221,18,32,7,4,0,0,1.7777777777777777,0.3888888888888889,-0.33333333333333304,69.79999999999998,5,-2,-0.8571428571428571,-0.23809523809523808,-6,Protein,734807.8304976337,2699519.9396066247,3.6737767720553953,1.8772639673222207,1.4591162887976007e-6,6.226052879655253e-6,Upregulated
Feature0220,Succinyl proline,C9 H13 N O5,215.07938,Other,NA,Succinyl proline-peak1,9,13,5,1,0,0,1.4444444444444444,0.5555555555555556,0,60.3,4,-1,-0.6666666666666666,0.09090909090909093,-2,Lignin,561583.4427956705,797766.7346718491,1.4205666938833037,0.5064665658998465,0.4448031243184941,0.5098081817290454,Upregulated
Feature0219,NA,C17 H31 N O9,393.19997,NA,NA,Feature0219,17,31,9,1,0,0,1.8235294117647056,0.5294117647058824,-0.5882352941176467,77.06470588235292,3,-6,-1,-0.21739130434782608,-7,Protein,400517.4442104885,451250.0768556258,1.1266677229131503,0.1720620983077676,0.80029795175542,0.825642344868259,Upregulated
Feature0218,Leucyl-leucyl-norleucine,C18 H35 N3 O4,357.2629,NA,NA,Leucyl-leucyl-norleucine-peak1,18,35,4,3,0,0,1.9444444444444444,0.2222222222222222,-1,88.8,3,-1,-0.3636363636363637,-0.15384615384615383,-4,Lipid,1745338.968055512,3525162.2097417377,2.0197579233958964,1.0141823901827463,0.014768796940657672,0.025093622886132493,Upregulated
Feature0217,NA,C10 H23 N O6,253.15257,NA,NA,Feature0217,10,23,6,1,0,0,2.3,0.6,-0.7999999999999998,83.1,0,-6,-2.3333333333333335,-0.6666666666666666,-7,Other,186133.30495045788,317089.22936015995,1.7035598730950268,0.7685526530986763,0.09095415484123562,0.12991259553208528,Upregulated
Feature0216,NP-008521,C14 H18 N2 O2,246.13679,NA,NA,NP-008521,14,18,2,2,0,0,1.2857142857142858,0.14285714285714285,-0.5714285714285712,76.58571428571427,7,5,0.3,0.3636363636363637,3,Lignin,5353818.157802863,1314685.0241563173,0.24556026846751308,-2.025850942655854,2.649078833675613e-11,5.27945828734881e-10,Downregulated
Feature0215,Tryptophyl-tyrosine,C20 H21 N3 O4,367.15331,NA,NA,Tryptophyl-tyrosine,20,21,4,3,0,0,1.05,0.2,-0.20000000000000015,66,12,8,0.38461538461538464,0.4666666666666667,5,Lignin,418871.67103675957,3072694.13470385,7.3356456097843745,2.8749239430010562,6.347575614693037e-4,0.0015295580499701286,Upregulated
Feature0214,Arachidonoyl Serinol,C23 H39 N O3,377.29295,NA,NA,Arachidonoyl Serinol,23,39,3,1,0,0,1.6956521739130437,0.13043478260869565,-1.304347826086956,97.47391304347823,5,2,0.05263157894736842,0.12195121951219512,1,Lipid,265043.3011745505,2044776.6262929325,7.714877596345274,2.9476432672890054,0.002516941717014185,0.0051260758824669865,Upregulated
Feature0213,NA,C8 H9 N5 O3,223.07054,NA,NA,Feature0213,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,3094632.424148345,3329421.292216211,1.0758697111281257,0.10550337669530209,0.26063307416205916,0.3317148216608026,Upregulated
Feature0212,Amino-levulinic acid,C5 H9 N O3,131.05828,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;ABC transporters;Other,Other,Amino-levulinic acid,5,9,3,1,0,0,1.8,0.6,0,60.3,2,-1,-2,-0.2,-2,Amino Sugar,3679176.757806443,2050035.4011525116,0.5571994867609351,-0.8437341658207641,2.839442171050034e-4,7.434335452486489e-4,Downregulated
Feature0211,N-Acetyl-L-tyrosine,C11 H13 N O4,223.08448,NA,NA,N-Acetyl-L-tyrosine,11,13,4,1,0,0,1.181818181818182,0.3636363636363637,-0.18181818181818168,65.48181818181817,6,2,0.16666666666666666,0.375,1,Lignin,1057032.7750407218,1483344.6189046593,1.4033099577707173,0.4888337011530766,0.25053864908070994,0.3219898397006596,Upregulated
Feature0210,NA,C16 H21 N5 O9,427.13399,NA,NA,Feature0210,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2541928.1938784067,3778103.923260496,1.4863141816354635,0.571739109401023,4.974012169733488e-5,1.5661666571614366e-4,Upregulated
Feature0209,NA,C20 H33 N O11,463.2054,NA,NA,Feature0209,20,33,11,1,0,0,1.65,0.55,-0.4000000000000003,71.7,5,-6,-0.875,-0.1111111111111111,-7,Protein,450399.438094654,157492.88713861245,0.3496738091078933,-1.5159183539995935,0.12336031157169108,0.17031162820085144,Downregulated
Feature0208,2-Keto-glutaramic acid,C5 H7 N O4,145.03751,Metabolic pathways;Other,Superpathway of butirocin biosynthesis;Kanamycin biosynthesis;Superpathway of neomycin biosynthesis;Other,2-Keto-glutaramic acid,5,7,4,1,0,0,1.4,0.8,0.7999999999999998,37.5,3,-1,-Inf,0,-2,Tannin,370698.06562874233,244637.7888531854,0.6599381316928492,-0.5995973147854381,0.0015070356914010609,0.003274203277721554,Downregulated
Feature0207,NA,C14 H28 N6 O4,344.21733,NA,NA,Feature0207,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,4344360.851387563,305220.50004427624,0.0702567099017087,-3.831220172560131,6.332826946308127e-8,3.737912490259919e-7,Downregulated
Feature0206,Diacetin,C7 H12 O5,176.0685,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Superpathway of branched chain amino acid biosynthesis,Diacetin,7,12,5,0,0,0,1.7142857142857142,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-3,-1.5,-0.1111111111111111,-3,Carbohydrate,4755579.410721396,2319641.3705059746,0.4877726077449934,-1.035719353112588,1.3701339162163967e-8,9.711325749249272e-8,Downregulated
Feature0205,Marimastat,C15 H29 N3 O5,331.21071,NA,NA,Marimastat-peak2,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,2495318.366543222,2008555.9466711073,0.8049297330558948,-0.31306524730783436,0.15120042935364872,0.20441622292504463,Downregulated
Feature0204,melanostatin,C13 H24 N4 O3,284.18484,NA,NA,melanostatin,13,24,3,4,0,0,1.8461538461538465,0.2307692307692308,-0.4615384615384617,73.45384615384616,4,1,-0.5,-0.2,-3,Lipid,561687.0347552542,104663.43191576705,0.18633763188315788,-2.424009031189511,0.21276669613859525,0.27746480620383396,Downregulated
Feature0203,NA,C17 H31 N5 O6,401.22757,NA,NA,Feature0203,17,31,6,5,0,0,1.8235294117647056,0.35294117647058826,-0.23529411764705888,67.00588235294117,5,-1,-1,-0.3333333333333333,-6,Protein,604331.984865806,1714827.2148958954,2.8375582591026998,1.5046500132866227,0.0026208533613211204,0.005323411983306927,Upregulated
Feature0202,NL8513000,C11 H13 N O2,191.09465,NA,Other,NL8513000-peak1,11,13,2,1,0,0,1.181818181818182,0.18181818181818185,-0.5454545454545459,75.84545454545456,6,4,0.375,0.4444444444444444,3,Lignin,6262262.171710261,1655483.2596743559,0.26435866373544586,-1.9194314864459945,9.63727981998117e-11,1.4707704518061354e-9,Downregulated
Feature0201,NA,C17 H32 N4 O5,372.2374,NA,NA,Feature0201,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,633902.498364189,3076412.9959966927,4.853132782936651,2.2789163331422015,1.3121020876109713e-5,4.729150928538267e-5,Upregulated
Feature0200,(+/-)-Metanephrine,C10 H15 N O3,197.10522,Metabolic pathways;Tyrosine metabolism,NA,(+/-)-Metanephrine-peak1,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,4631459.22453392,3228191.4483703566,0.6970138981835083,-0.5207406717340936,4.1655336125197507e-7,2.0103743417687915e-6,Downregulated
Feature0199,N-Acetyl-L-leucine,C8 H15 N O3,173.10521,Other,NA,N-Acetyl-L-leucine-peak1,8,15,3,1,0,0,1.875,0.375,-0.75,81.675,2,-1,-0.5,-0.09090909090909093,-2,Protein,1066153.639296463,1340336.1642246763,1.257169806322794,0.33017952819468466,0.37346732989280573,0.4445914665062635,Upregulated
Feature0198,NA,C15 H20 N2 O3,276.14743,NA,NA,Feature0198,15,20,3,2,0,0,1.3333333333333333,0.2,-0.5333333333333332,75.5,7,4,0.2,0.30434782608695654,2,Lignin,5364345.865128838,1453204.3344270387,0.27090056662335216,-1.884164683762181,1.4935202844973586e-10,2.130220465637846e-9,Downregulated
Feature0197,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0197,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1093982.6772645968,1367530.5486440286,1.2500477174496154,0.32198316721854375,0.25353933359476877,0.3248832307939019,Upregulated
Feature0196,Crotetamide,C12 H22 N2 O2,226.16812,Microbial metabolism in diverse environments;Other,NA,Crotetamide,12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,5202872.160457153,416289.53949059534,0.08001148724246529,-3.643649047299491,1.945006747536207e-11,4.0677054695386847e-10,Downregulated
Feature0195,NA,C14 H25 N3 O7,347.1693,NA,NA,Feature0195,14,25,7,3,0,0,1.7857142857142858,0.5,-0.14285714285714324,64.37142857142858,4,-3,-1.5,-0.3333333333333333,-6,Protein,1693732.9302759287,1747363.7655554945,1.0316642809033822,0.044973572434533406,0.8554486766512363,0.8740229543107323,Upregulated
Feature0194,Methionylphenylalanine,C14 H20 N2 O3 S,296.11939,NA,NA,Methionylphenylalanine-peak2,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,176188.23966814353,1881703.8318220526,10.680076237587167,3.416850040339456,1.9476444381139244e-4,5.278895485063981e-4,Upregulated
Feature0193,NA,C18 H26 N4 O5,378.19035,NA,NA,Feature0193,18,26,5,4,0,0,1.4444444444444444,0.2777777777777778,-0.22222222222222232,66.63333333333333,8,3,-0.1111111111111111,0.13043478260869565,-1,Lignin,649302.9396054958,670950.7599912852,1.0333400929910193,0.04731515228744486,0.8608470539030763,0.879008384154196,Upregulated
Feature0192,glu-tyr,C14 H18 N2 O6,310.11656,NA,NA,glu-tyr,14,18,6,2,0,0,1.2857142857142858,0.42857142857142855,0,60.3,7,1,-0.16666666666666666,0.2222222222222222,-1,Lignin,1641155.3968823445,2523887.420673521,1.5378722974485395,0.6209357090950454,4.3366267741533874e-4,0.0010771621342251963,Upregulated
Feature0191,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03171,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak2",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,104280.53950599582,119723.23891612541,1.1480880275772036,0.19923326229264066,0.7187514268841451,0.750656545710075,Upregulated
Feature0190,DLK,C16 H30 N4 O6,374.21636,NA,NA,DLK,16,30,6,4,0,0,1.875,0.375,-0.375,70.9875,4,-2,-1,-0.3333333333333333,-6,Protein,1042186.463406989,1104413.8466067181,1.0597084930428888,0.08366745961885758,0.8626796475109625,0.880348989688898,Upregulated
Feature0189,NP-007065,C8 H10 O3,154.06303,Microbial metabolism in diverse environments;Aminobenzoate degradation,NA,NP-007065-peak1,8,10,3,0,0,0,1.25,0.375,-0.5,74.55,4,1,0.2,0.38461538461538464,1,Lignin,402811.5541097254,542947.0878905704,1.3478935307368871,0.4307065434454169,0.32779886162447813,0.4041421190624934,Upregulated
Feature0188,NA,C16 H29 N3 O6,359.20576,NA,NA,Feature0188,16,29,6,3,0,0,1.8125,0.375,-0.5,74.55,4,-2,-0.7142857142857143,-0.2,-5,Protein,1714741.7555862393,2272947.4281262862,1.3255333759276227,0.4065729966322218,0.03834224881749401,0.059863382024732584,Upregulated
Feature0187,NA,C12 H22 N2 O3,242.16305,NA,NA,Feature0187,12,22,3,2,0,0,1.8333333333333333,0.25,-0.833333333333333,84.04999999999998,3,0,-0.2857142857142857,-0.0588235294117647,-2,Lipid,71693.28346399673,3023067.126987111,42.16667142195055,5.398031236670958,8.486821426270323e-4,0.001978773352153236,Upregulated
Feature0186,NA,C9 H9 O P S,196.01126,NA,NA,Feature0186,9,9,1,0,1,1,1,0.1111111111111111,-1.1111111111111107,91.96666666666664,6,5,0.5,0.5384615384615384,3,Unsaturated HC,1015070.8371032655,268412.2006862775,0.2644270634867735,-1.9190582540476577,0.39094921672478544,0.45990831467485177,Downregulated
Feature0185,DH2090000,C9 H10 O5,198.05286,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of various antibiotics;Tyrosine metabolism;Aminobenzoate degradation,Other,DH2090000-peak1,9,10,5,0,0,0,1.1111111111111112,0.5555555555555556,0,60.3,5,0,0,0.38461538461538464,0,Lignin,478168.9198986568,159304.84109572181,0.33315599250885003,-1.5857302511535998,0.3758022138106327,0.44611699382986114,Downregulated
Feature0184,NA,C8 H11 N O7,233.05354,NA,NA,Feature0184,8,11,7,1,0,0,1.375,0.875,0.75,38.925,4,-3,-Inf,-0.14285714285714285,-4,Tannin,870673.3493339518,2100575.4322052924,2.4125872622748723,1.2705811250022483,0.0076450386351536405,0.013733505247031036,Upregulated
Feature0183,NA,C23 H32,308.25044,NA,NA,Feature0183,23,32,0,0,0,0,1.391304347826087,0,-1.391304347826087,99.95217391304348,8,8,0.34782608695652173,0.34782608695652173,8,Unsaturated HC,406628.887496549,2906076.3708419465,7.146753367016036,2.837288002024209,0.0019518756678207445,0.004072016479419139,Upregulated
Feature0182,NA,C15 H27 N3 O5,329.19521,NA,NA,Feature0182,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,923343.7998387704,3872636.6511961394,4.194143775993687,2.068376318124484,2.5452108577775904e-4,6.73685498918006e-4,Upregulated
Feature0181,NA,C13 H26 N2 O6,306.17912,NA,NA,Feature0181,13,26,6,2,0,0,2,0.4615384615384616,-0.615384615384615,77.83846153846153,2,-4,-1.2,-0.375,-6,Protein,2454148.9067855333,406099.50802664284,0.16547468122403203,-2.5953176033343324,2.9784140132881658e-15,4.586757580463775e-13,Downregulated
Feature0180,(+)-castanospermine,C8 H15 N O4,189.10012,NA,NA,(+)-castanospermine-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,470551.22777799045,1639630.5055306398,3.4844888478417264,1.8009470375083751,0.058281669752282605,0.08690946176088621,Upregulated
Feature0179,NA,C20 H29 N3 O6,407.20564,NA,NA,Feature0179,20,29,6,3,0,0,1.45,0.3,-0.4000000000000003,71.7,8,2,-0.09090909090909093,0.14285714285714285,-1,Lignin,232439.63713082127,1451533.971124686,6.244778167106397,2.6426503239709795,0.002774672063796119,0.005582297477518558,Upregulated
Feature0178,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",C13 H18 N2 O3,250.13174,NA,NA,"(2Z)-N-(4-Aminobutyl)-3-(3,4-dihydroxyphenyl)acrylamide",13,18,3,2,0,0,1.3846153846153846,0.2307692307692308,-0.4615384615384617,73.45384615384616,6,3,0.125,0.2631578947368421,1,Lignin,462395.1556322694,2159769.7286565905,4.67083121946502,2.2236793142795794,6.687642277172747e-4,0.001597865446760315,Upregulated
Feature0177,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0177,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,333503.2661179813,1455095.4662047045,4.36306211672885,2.1253410134482515,0.005672456503168794,0.010478889112724031,Upregulated
Feature0176,NA,C16 H32 N6 O4,372.24864,NA,NA,Feature0176,16,32,4,6,0,0,2,0.25,-0.375,70.9875,4,0,-1,-0.5,-6,Lipid,915182.8594971842,960003.9654132182,1.0489750277235956,0.06898033300749204,0.8926614766058428,0.9049482593478742,Upregulated
Feature0175,Etilevodopa,C11 H15 N O4,225.10013,NA,NA,Etilevodopa-peak1,11,15,4,1,0,0,1.3636363636363635,0.3636363636363637,-0.3636363636363633,70.66363636363636,5,1,0,0.25,0,Lignin,457166.4711471742,588661.0619517025,1.2876295596975147,0.3647176017942662,0.5395065014621101,0.5940110129183873,Upregulated
Feature0174,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid",C13 H14 N2 O2,230.10555,NA,NA,"1-Methyl-1,2,3,4-tetrahydro-Î²-carboline-3-carboxylic acid-peak1",13,14,2,2,0,0,1.0769230769230769,0.15384615384615383,-0.3076923076923075,69.06923076923076,8,6,0.4444444444444444,0.5,4,Lignin,1919594.5069585547,3264987.0857010894,1.7008733218736922,0.7662756955514497,0.0010926088174435633,0.002458007087316595,Upregulated
Feature0173,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",C12 H11 N O3,217.07394,Metabolic pathways;Other,NA,"4-hydroxy-5,8-dimethylquinoline-3-carboxylic acid",12,11,3,1,0,0,0.9166666666666666,0.25,-0.16666666666666696,65.05000000000001,8,5,0.5,0.5789473684210527,4,Lignin,4103247.536874294,2088963.2325273026,0.5090999784328389,-0.9739790904029683,1.02444861661677e-4,2.9920964768082904e-4,Downregulated
Feature0172,N-(2-Acetylphenyl)formamide,C9 H9 N O2,163.06336,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,N-(2-Acetylphenyl)formamide,9,9,2,1,0,0,1,0.2222222222222222,-0.22222222222222232,66.63333333333333,6,4,0.5,0.5714285714285714,3,Lignin,3462594.326552782,3490811.3965572445,1.0081491122965462,0.011709039295010918,0.900486272866929,0.9123347764572832,Upregulated
Feature0171,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",C6 H13 N O6,195.07434,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,"(2S,3S,4R,5R)-2,3,4,5,6-Pentahydroxyhexanamide",6,13,6,1,0,0,2.1666666666666665,1,0.3333333333333335,50.8,1,-5,6,-1.5,-6,Carbohydrate,3984091.408232811,1623963.4071734352,0.40761198496039597,-1.294731623391661,2.773007812849621e-8,1.819898927141808e-7,Downregulated
Feature0170,NA,C17 H32 N4 O5,372.23738,NA,NA,Feature0170,17,32,5,4,0,0,1.8823529411764703,0.29411764705882354,-0.5882352941176467,77.06470588235292,4,-1,-0.625,-0.23809523809523808,-5,Lipid,281105.74301882874,2388928.9190446837,8.498328399091694,3.0871790944851383,0.006277206815551905,0.011470969089045229,Upregulated
Feature0169,Ser-met,C8 H16 N2 O4 S,236.08315,Microbial metabolism in diverse environments;Other,NA,Ser-met,8,16,4,2,1,0,2,0.5,0,60.3,2,-2,-5,-1,-5,Protein,676846.5113688278,1374928.148928994,2.031373621396664,1.0224556124372066,8.22648045214611e-4,0.0019355080397132653,Upregulated
Feature0168,DL-TYROSINE,C9 H11 N O3,181.07393,"Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of cofactors;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;Phenylpropanoid biosynthesis;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various plant secondary metabolites;Biosynthesis of various antibiotics;Phenylalanine metabolism;Tyrosine metabolism;Phenylalanine, tyrosine and tryptophan biosynthesis;Other",Superpathway of chorismate metabolism;Superpathway of aromatic amino acid biosynthesis;Superpathway of 4-hydroxybenzoate biosynthesis (yeast);Other,DL-TYROSINE,9,11,3,1,0,0,1.2222222222222223,0.3333333333333333,-0.22222222222222232,66.63333333333333,5,2,0.2,0.38461538461538464,1,Lignin,2223223.2668224135,1713080.02194075,0.7705389051587266,-0.37606029341978203,0.07149153302970247,0.10404351971848452,Downregulated
Feature0167,NA,C9 H19 N O8,269.11107,NA,NA,Feature0167,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,389020.913360227,690214.8845886533,1.7742359366410865,0.8271978709631047,0.24731525861240694,0.3188371751061015,Upregulated
Feature0166,LLK,C18 H36 N4 O4,372.27367,NA,NA,LLK,18,36,4,4,0,0,2,0.2222222222222222,-0.8888888888888893,85.63333333333334,3,-1,-0.5,-0.25,-5,Lipid,2959256.302281724,416457.4266032953,0.14073043496847074,-2.8289937291428187,7.987626791538463e-10,8.673743451837281e-9,Downregulated
Feature0165,NA,C14 H25 N3 O6,331.17443,NA,NA,Feature0165,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,5558731.360127128,1626524.9320085486,0.2926072203588824,-1.772962725112158,3.851639528234561e-9,3.246108139716093e-8,Downregulated
Feature0164,Paracetamol,C8 H9 N O2,151.06335,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;2-Oxocarboxylic acid metabolism;Biosynthesis of alkaloids derived from shikimate pathway;Aminobenzoate degradation;Other,Other,Paracetamol-peak1,8,9,2,1,0,0,1.125,0.25,-0.25,67.425,5,3,0.4,0.5,2,Lignin,3489512.475464681,3481964.5121447127,0.9978369576343288,-0.0031239903753030223,0.9698399079887051,0.9727109556736925,Downregulated
Feature0163,Leucylasparagine,C10 H19 N3 O4,245.13751,NA,NA,Leucylasparagine-peak1,10,19,4,3,0,0,1.9,0.4,-0.20000000000000015,66,3,-1,-1.3333333333333333,-0.4,-4,Protein,820299.1943726141,1751877.1295847557,2.1356562844422107,1.0946794763175496,0.0018260592077107179,0.0038565361075728033,Upregulated
Feature0162,2-Pentadecylfuran,C19 H34 O,278.26093,NA,NA,2-Pentadecylfuran,19,34,1,0,0,0,1.7894736842105263,0.05263157894736842,-1.6842105263157894,108.3,3,2,0.1111111111111111,0.13513513513513514,2,Lipid,753404.831610758,1652380.0209599703,2.193216650107259,1.1330483312076787,0.10922187637085774,0.15354511084832614,Upregulated
Feature0161,Maclurin,C13 H10 O6,262.04778,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,Maclurin,13,10,6,0,0,0,0.7692307692307693,0.4615384615384616,0.15384615384615374,55.91538461538462,9,3,0.42857142857142855,0.6,3,Condensed HC,961123.3945613392,240521.04964296892,0.25024991692429227,-1.9985585047588865,0.3859448422312267,0.45528590720034684,Downregulated
Feature0160,NA,C17 H32 N4 O6,388.23229,NA,NA,Feature0160,17,32,6,4,0,0,1.8823529411764703,0.35294117647058826,-0.47058823529411775,73.71176470588236,4,-2,-0.8571428571428571,-0.3,-6,Protein,294936.3247769489,719247.4953021008,2.438653481716927,1.286084774237114,0.003937544296284047,0.00757116916901836,Upregulated
Feature0159,2-Aminooctanedioic acid,C8 H15 N O4,189.10016,NA,NA,2-Aminooctanedioic acid-peak1,8,15,4,1,0,0,1.875,0.5,-0.5,74.55,2,-2,-1,-0.2,-3,Protein,709973.1826599631,347373.10910302843,0.4892763805550673,-1.0312784554406433,0.3082674891948169,0.38510702558703525,Downregulated
Feature0158,DL-Metanephrine,C10 H15 N O3,197.1052,Metabolic pathways;Tyrosine metabolism,NA,DL-Metanephrine,10,15,3,1,0,0,1.5,0.3,-0.5999999999999996,77.39999999999999,4,1,0,0.2,0,Lipid,2425594.324627615,3112633.0794881834,1.283245531985669,0.3597972373703491,0.10574405553762345,0.14913958524063023,Upregulated
Feature0157,NP-019811,C6 H7 N O2,125.04763,Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Aminobenzoate degradation;Other,Other,NP-019811-peak1,6,7,2,1,0,0,1.1666666666666667,0.3333333333333333,0,60.3,4,2,0.3333333333333333,0.5,1,Lignin,2976769.348344473,2072510.774555964,0.6962282031386101,-0.5223678382746548,0.006456335217350036,0.01173501272338086,Downregulated
Feature0156,nitrilotriacetic acid,C6 H9 N O6,191.04305,NA,NA,nitrilotriacetic acid,6,9,6,1,0,0,1.5,1,1,31.799999999999997,3,-3,4,-0.5,-4,Carbohydrate,731742.25274482,872201.5909691043,1.1919519307480344,0.25332605570798045,0.11150056349356377,0.156229904514555,Upregulated
Feature0155,NA,C9 H20 N2 O3,204.14739,NA,NA,Feature0155,9,20,3,2,0,0,2.2222222222222223,0.3333333333333333,-0.8888888888888893,85.63333333333334,1,-2,-1,-0.4545454545454546,-4,Protein,533463.3627679147,1715594.731886181,3.2159560555099587,1.6852476929188906,0.10815510618037573,0.1521717191607612,Upregulated
Feature0154,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,C9 H12 O6 S,248.0355,NA,NA,4-Ethyl-2-hydroxy-6-methoxyphenyl hydrogen sulfate,9,12,6,0,1,0,1.3333333333333333,0.6666666666666666,0.22222222222222232,53.96666666666666,4,-2,-1.5,0,-3,Tannin,164810.30653164623,1664622.7573914428,10.100234581335533,3.3363168953297158,1.1456037784339194e-4,3.3004299331072437e-4,Upregulated
Feature0153,2H-Pyran,C5 H6 O,82.04189,NA,NA,2H-Pyran,5,6,1,0,0,0,1.2,0.2,-0.7999999999999998,83.1,3,2,0.5,0.5555555555555556,2,Lignin,2668991.72188733,460963.83373256336,0.17271085179934578,-2.5335693614979693,9.58612588401107e-4,0.0021914841089763497,Downregulated
Feature0152,Pivagabine,C9 H17 N O3,187.12087,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Pivagabine-peak1,9,17,3,1,0,0,1.8888888888888888,0.3333333333333333,-0.8888888888888893,85.63333333333334,2,-1,-0.4,-0.07692307692307693,-2,Protein,4391920.015541256,3055924.400765267,0.6958060233227307,-0.5232429270243839,3.153676343222131e-6,1.275018550219162e-5,Downregulated
Feature0151,NA,C16 H32 N4 O4,344.24234,NA,NA,Feature0151,16,32,4,4,0,0,2,0.25,-0.75,81.675,3,-1,-0.625,-0.3,-5,Lipid,2208206.201559305,753005.9738461996,0.34100346847793067,-1.5521416813550368,3.968914677449302e-7,1.9264588720914376e-6,Downregulated
Feature0150,VLH,C17 H29 N5 O4,367.22207,NA,NA,VLH,17,29,4,5,0,0,1.7058823529411764,0.2352941176470588,-0.35294117647058787,70.35882352941175,6,2,-0.375,-0.1,-3,Lipid,1629627.3661977141,1268624.9081269305,0.778475456684872,-0.36127653930454756,0.19125798163413635,0.25351410085150783,Downregulated
Feature0149,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17443,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak2,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1834210.9004248132,1425526.9456548702,0.7771881332319585,-0.363664222088277,0.208509999540118,0.27296440434386393,Downregulated
Feature0148,NA,C13 H21 N O8,319.12681,NA,NA,Feature0148,13,21,8,1,0,0,1.6153846153846154,0.6153846153846154,-0.1538461538461542,64.6846153846154,4,-4,-1.25,-0.125,-5,Amino Sugar,3765049.1987125073,106485.06759021308,0.028282516899547184,-5.143945676525529,3.6529864735265927e-6,1.4492175845794024e-5,Downregulated
Feature0147,NA,C13 H23 N3 O6,317.15872,NA,NA,Feature0147,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,2728192.67643953,2062292.7855694003,0.7559190387758196,-0.40369636918618584,0.02578871398696726,0.041408608051111406,Downregulated
Feature0146,NA,C9 H13 N O4 S,231.05654,NA,NA,Feature0146,9,13,4,1,1,0,1.4444444444444444,0.4444444444444444,0,60.3,4,0,-0.6666666666666666,0,-2,Lignin,4043371.3838726673,3608049.3523181356,0.892336866880235,-0.1643396488319332,0.05473690986301835,0.0822024160531499,Downregulated
Feature0145,NA,C17 H25 N3 O5,351.17943,NA,NA,Feature0145,17,25,5,3,0,0,1.4705882352941178,0.29411764705882354,-0.35294117647058787,70.35882352941175,7,2,-0.1111111111111111,0.13043478260869565,-1,Lignin,1495978.8288822966,2766680.2001714977,1.8494113330725348,0.8870661345235816,0.005263605077991096,0.009787647642279821,Upregulated
Feature0144,Kynurenine,C10 H12 N2 O3,208.08476,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Kynurenine,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,4075548.5968253375,3477158.9281340605,0.8531756757464762,-0.2290852602217413,0.00707795292332148,0.012768958734937793,Downregulated
Feature0143,6-methoxymellein,C11 H12 O4,208.07361,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Phenylpropanoid biosynthesis;Biosynthesis of phenylpropanoids;Other,Anaerobic aromatic compound degradation (Thauera aromatica);Other,6-methoxymellein-peak1,11,12,4,0,0,0,1.0909090909090908,0.3636363636363637,-0.3636363636363633,70.66363636363636,6,2,0.2857142857142857,0.4444444444444444,2,Lignin,427408.2081535506,128218.57162551234,0.29999089671073553,-1.7370093723980116,0.3719885707556698,0.44314250271456024,Downregulated
Feature0142,NA,C14 H26 N4 O5,330.19042,NA,NA,Feature0142,14,26,5,4,0,0,1.8571428571428572,0.35714285714285715,-0.2857142857142856,68.44285714285714,4,-1,-1,-0.3333333333333333,-5,Protein,4989784.9462508885,1538245.7996530952,0.3082789771949726,-1.697691585366638,6.386160126839404e-8,3.756303907939566e-7,Downregulated
Feature0141,Isobutyric acid,C4 H8 O2,88.05244,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Other,Superpathway of L-lysine degradation;Other,Isobutyric acid,4,8,2,0,0,0,2,0.5,-1,88.8,1,-1,-0.5,0,-1,Protein,419745.4219686092,1554512.4740556248,3.703464987813207,1.888875698172008,8.794948661923781e-4,0.002035333747718427,Upregulated
Feature0140,6-Hydroxymelatonin,C13 H16 N2 O3,248.11607,Other,Other,6-Hydroxymelatonin-peak1,13,16,3,2,0,0,1.2307692307692308,0.2307692307692308,-0.3076923076923075,69.06923076923076,7,4,0.25,0.3684210526315789,2,Lignin,4028650.561436696,1720856.5392731426,0.4271545801826633,-1.2271698430605904,3.56051345194885e-6,1.4191787735532593e-5,Downregulated
Feature0139,NA,C15 H27 N3 O5,329.19515,NA,NA,Feature0139,15,27,5,3,0,0,1.8,0.3333333333333333,-0.5333333333333332,75.5,4,-1,-0.5714285714285714,-0.15789473684210523,-4,Protein,1551335.8627134417,3323979.9786903174,2.1426565701100624,1.0994006300872166,3.7082527658135843e-4,9.389805957082529e-4,Upregulated
Feature0138,Metalaxyl,C15 H21 N O4,279.14696,NA,NA,Metalaxyl,15,21,4,1,0,0,1.4,0.26666666666666666,-0.666666666666667,79.30000000000001,6,2,0.1,0.25,1,Lignin,254846.633954772,3022576.7144799153,11.860375267959538,3.5680777530561953,9.071402082957452e-4,0.0020850685384708172,Upregulated
Feature0137,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0137,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1764734.9752391512,3209973.8648802317,1.8189552028599798,0.8631100128038128,0.029507984579734782,0.046979817554577745,Upregulated
Feature0136,NA,C9 H17 N3 O2,199.13218,NA,NA,Feature0136,9,17,2,3,0,0,1.8888888888888888,0.2222222222222222,-0.44444444444444464,72.96666666666667,3,1,-0.5,-0.2,-2,Lipid,6275341.015707862,132904.66664177307,0.02117887558765304,-5.561230192851368,1.1915286632545262e-10,1.7862385447373162e-9,Downregulated
Feature0135,Icacine,C22 H31 N O6,405.21514,NA,NA,Icacine-peak1,22,31,6,1,0,0,1.4090909090909092,0.2727272727272727,-0.7272727272727275,81.02727272727273,8,2,0.06666666666666667,0.2222222222222222,1,Lignin,198304.9191145264,405629.78258879966,2.0454852274972444,1.0324431181140428,0.439130066820303,0.5039880306189657,Upregulated
Feature0134,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",C20 H34 O,290.261,Metabolic pathways;Biosynthesis of secondary metabolites;Other,NA,"(1S,4E,8E,12E)-2,2,5,9,13-Pentamethyl-4,8,12-cyclopentadecatrien-1-ol",20,34,1,0,0,0,1.7,0.05,-1.5999999999999996,105.89999999999998,4,3,0.15789473684210523,0.1794871794871795,3,Lipid,253477.30977647926,3506924.590528098,13.83526041688136,3.790277894498939,1.6090480599675966e-9,1.5847252404564585e-8,Upregulated
Feature0133,lamifiban,C24 H28 N4 O6,468.20092,NA,NA,lamifiban-peak1,24,28,6,4,0,0,1.1666666666666667,0.25,-0.16666666666666696,65.05000000000001,13,7,0.21428571428571427,0.35294117647058826,3,Lignin,538757.9620929733,2906431.0091801407,5.394687807284004,2.4315394727966475,1.7197288483462987e-6,7.2830516727465755e-6,Upregulated
Feature0132,N-Acetyl-L-aspartic acid,C6 H9 N O5,175.04806,Metabolic pathways;Other,NA,N-Acetyl-L-aspartic acid,6,9,5,1,0,0,1.5,0.8333333333333334,0.6666666666666665,41.3,3,-2,-Inf,-0.2,-3,Carbohydrate,687256.4599105653,1319347.4161048438,1.9197308327615201,0.9409040435179714,0.015428243411692409,0.026109335004402538,Upregulated
Feature0131,NA,C20 H26 O7 S,410.14012,NA,NA,Feature0131,20,26,7,0,1,0,1.3,0.35,-0.5,74.55,8,1,0,0.2258064516129032,0,Lignin,443518.09719439625,464702.9096347483,1.0477653844890722,0.0673157049217827,0.928245312884623,0.9354238905571395,Upregulated
Feature0130,Nipecotic acid,C6 H11 N O2,129.07895,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Lysine degradation;Other,Superpathway of L-lysine degradation,Nipecotic acid,6,11,2,1,0,0,1.8333333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,2,0,-0.3333333333333333,0,-1,Protein,850367.79831838,2008434.867998638,2.3618425720851137,1.2399128055304727,1.4132875822379327e-4,3.996843346095255e-4,Upregulated
Feature0129,Cyclo(leucylleucine),C12 H22 N2 O2,226.16814,Microbial metabolism in diverse environments;Other,NA,Cyclo(leucylleucine),12,22,2,2,0,0,1.8333333333333333,0.16666666666666666,-1,88.8,3,1,-0.125,0,-1,Lipid,6215801.344771197,4823348.554443132,0.7759817740154434,-0.3659053275862107,0.04441482744833126,0.06852342231099559,Downregulated
Feature0128,N-Acetylvanilalanine,C12 H15 N O5,253.09502,NA,NA,N-Acetylvanilalanine-peak1,12,15,5,1,0,0,1.25,0.4166666666666667,-0.16666666666666696,65.05000000000001,6,1,0,0.29411764705882354,0,Lignin,2695112.4610715043,3011131.0997127355,1.1172561973594195,0.15996004730611946,0.32057979107069445,0.39872405732287547,Upregulated
Feature0127,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10002,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak2",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,232744.29803590034,982901.8929462485,4.223097627915412,2.078301599183112,0.02666442704495183,0.042653011722519736,Upregulated
Feature0126,Trigonelline,C7 H7 N O2,137.04768,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Trigonelline-peak1,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,1230637.0142988362,4101868.0010642274,3.3331258148458134,1.736875775602474,0.09267883504134077,0.13193104752943804,Upregulated
Feature0125,Methyl picolinate,C7 H7 N O2,137.04767,"Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Degradation of aromatic compounds;Biosynthesis of cofactors;Biosynthesis of amino acids;Biosynthesis of plant secondary metabolites;Biosynthesis of phenylpropanoids;Biosynthesis of alkaloids derived from shikimate pathway;Biosynthesis of various antibiotics;Phenylalanine, tyrosine and tryptophan biosynthesis;Aminobenzoate degradation;Other",Superpathway of chorismate metabolism;Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic amino acid biosynthesis;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,Methyl picolinate,7,7,2,1,0,0,1,0.2857142857142857,0,60.3,5,3,0.5,0.6,2,Lignin,429811.29120758246,1723260.0923801244,4.009341140244395,2.003365176381209,0.003249485291536665,0.0064457003323924005,Upregulated
Feature0124,Pyrazinoic acid,C5 H4 N2 O2,124.02723,NA,NA,Pyrazinoic acid,5,4,2,2,0,0,0.8,0.4,1.2000000000000002,26.09999999999999,5,3,1,1,1,Condensed HC,83197.74998028939,605629.1519229669,7.27939339785569,2.8638182336152105,0.054480841442043786,0.08203604035806417,Upregulated
Feature0123,NA,C13 H23 N3 O6,317.15875,NA,NA,Feature0123,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1320598.4647684677,1201392.7729960023,0.9097335829529645,-0.13648398345196852,0.4814043590079009,0.5433037869149794,Downregulated
Feature0122,NA,C13 H24 N4 O5,316.17479,NA,NA,Feature0122,13,24,5,4,0,0,1.8461538461538465,0.38461538461538464,-0.1538461538461542,64.6846153846154,4,-1,-1.25,-0.38461538461538464,-5,Protein,4545161.390754298,1759328.0203544062,0.38707712864348576,-1.369307029745996,5.880070897599131e-7,2.7067500273187306e-6,Downregulated
Feature0121,delta-guanidinovaleric acid,C6 H13 N3 O2,159.10079,NA,NA,delta-guanidinovaleric acid-peak1,6,13,2,3,0,0,2.1666666666666665,0.3333333333333333,0,60.3,2,0,-3,-1,-3,Protein,4506962.432206577,2327681.2583128847,0.5164634259383584,-0.9532619085959275,1.1074597634890401e-8,8.08636568685532e-8,Downregulated
Feature0120,NA,C14 H28 N6 O4,344.2173,NA,NA,Feature0120,14,28,4,6,0,0,2,0.2857142857142857,-0.14285714285714324,64.37142857142858,4,0,-1.5,-0.6666666666666666,-6,Lipid,440843.8382889401,637129.5766133332,1.445250043839203,0.5313191161164923,0.12971472081257526,0.17806866860332454,Upregulated
Feature0119,NA,C27 H39 N5 O6,529.28996,NA,NA,Feature0119,27,39,6,5,0,0,1.4444444444444444,0.2222222222222222,-0.44444444444444464,72.96666666666667,11,5,0,0.15789473684210523,0,Lignin,215739.78991968368,727466.129278862,3.3719608679960498,1.7535877937308777,0.2950012876204947,0.3712720514332229,Upregulated
Feature0118,L-Glutaminyl-L-Leucine,C11 H21 N3 O4,259.15319,NA,NA,L-Glutaminyl-L-Leucine,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,2376533.680557845,2295164.3877131166,0.9657613550733989,-0.050261359642918085,0.8167934392643098,0.8401020559281971,Downregulated
Feature0117,NA,C9 H19 N O8,269.11113,NA,NA,Feature0117,9,19,8,1,0,0,2.111111111111111,0.8888888888888888,0,60.3,1,-7,-Inf,-1,-8,Carbohydrate,5716958.923945247,407410.4047199587,0.07126348293557559,-3.810693194219747,9.77761802768264e-19,1.6563284938894392e-15,Downregulated
Feature0116,Val-pro,C10 H18 N2 O3,214.13173,Metabolic pathways;Biosynthesis of cofactors;Other,Other,Val-pro,10,18,3,2,0,0,1.8,0.3,-0.5999999999999996,77.39999999999999,3,0,-0.4,-0.07692307692307693,-2,Lipid,510491.0832211827,1564540.7620285517,3.0647758863021632,1.6157815797751272,0.35079299447502643,0.424459523314782,Upregulated
Feature0115,NA,C17 H31 N3 O6,373.22139,NA,NA,Feature0115,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,1345653.109094813,2407707.651226544,1.7892483842631242,0.8393536768648591,0.01860902049155828,0.030996736197344867,Upregulated
Feature0114,Pyridoxal,C8 H9 N O3,167.05829,Metabolic pathways;Biosynthesis of secondary metabolites;Microbial metabolism in diverse environments;Biosynthesis of cofactors;Other,Other,Pyridoxal-peak1,8,9,3,1,0,0,1.125,0.375,0,60.3,5,2,0.25,0.4545454545454546,1,Lignin,381488.08032834873,2808538.519210642,7.362061002779743,2.880109704088069,2.0747504050936135e-10,2.8574204766086024e-9,Upregulated
Feature0113,Fasoracetam,C10 H16 N2 O2,196.12116,NA,NA,Fasoracetam,10,16,2,2,0,0,1.6,0.2,-0.5999999999999996,77.39999999999999,4,2,0,0.14285714285714285,0,Lipid,3235888.6835026215,2106562.0539472005,0.6509995429345226,-0.6192715644093996,8.515500435181281e-4,0.001978773352153236,Downregulated
Feature0112,NA,C22 H42 N4 O5,442.31572,NA,NA,Feature0112,22,42,5,4,0,0,1.9090909090909092,0.2272727272727273,-0.9090909090909092,86.2090909090909,4,-1,-0.38461538461538464,-0.16129032258064516,-5,Lipid,856751.9173355073,1285613.7567184097,1.5005671194955241,0.5855078512905273,0.24938637227548976,0.32101862814185383,Upregulated
Feature0111,DL-Ornithine,C5 H12 N2 O2,132.08986,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Biosynthesis of plant secondary metabolites;ABC transporters;Biosynthesis of various antibiotics;Other,Other,DL-Ornithine,5,12,2,2,0,0,2.4,0.4,-0.4000000000000003,71.7,1,-1,-3,-1,-3,Other,131159.1697135166,1558010.5925559374,11.878777488139106,3.5703144627976924,0.0055044081352109,0.010201824268104228,Upregulated
Feature0110,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,C14 H25 N3 O6 S,363.1465,Metabolic pathways;Biosynthesis of secondary metabolites;Other,Other,N-[(5S)-5-Amino-5-carboxypentanoyl]cysteinyl-D-valine,14,25,6,3,1,0,1.7857142857142858,0.42857142857142855,-0.14285714285714324,64.37142857142858,4,-2,-1.5,-0.42857142857142855,-6,Protein,143337.01219317157,550073.3668391766,3.8376226657903056,1.9402128655314181,6.547065092057106e-7,2.9894146269392825e-6,Upregulated
Feature0109,L-Alanyl-L-glutamine,C8 H15 N3 O4,217.10628,Metabolic pathways;Biosynthesis of amino acids;Other,NA,L-Alanyl-L-glutamine-peak1,8,15,4,3,0,0,1.875,0.5,0.25,53.175,3,-1,-4,-0.6666666666666666,-4,Protein,1056722.9894433068,1300315.5319516184,1.2305169329538659,0.2992645106367771,0.480624042322783,0.5427847517965296,Upregulated
Feature0108,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione",C9 H14 N2 O3,198.10045,NA,NA,"3-(1-hydroxyethyl)-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione-peak1",9,14,3,2,0,0,1.5555555555555556,0.3333333333333333,-0.22222222222222232,66.63333333333333,4,1,-0.25,0.09090909090909093,-1,Protein,3795368.3338363,3257022.7993891453,0.8581572361112569,-0.22068608472089501,0.006411311505883046,0.011690809139898686,Downregulated
Feature0107,NA,C14 H27 N3 O5,317.19514,NA,NA,Feature0107,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2476661.544612041,2942047.055458697,1.187908401072847,0.24842359505046144,0.3717210192929128,0.4431354023097778,Upregulated
Feature0106,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide",C14 H20 N2 O4,280.14221,NA,NA,"(2E)-N-(4-Aminobutyl)-3-(2,4-dihydroxy-5-methoxyphenyl)acrylamide-peak1",14,20,4,2,0,0,1.4285714285714286,0.2857142857142857,-0.4285714285714288,72.51428571428572,6,2,0,0.2,0,Lignin,137776.92906272778,1654195.3377568426,12.006330443057793,3.5857233749446835,0.0016776491701091657,0.0035710717882533054,Upregulated
Feature0105,NA,C14 H27 N3 O4,301.20018,NA,NA,Feature0105,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,4042557.670873358,2616093.0879605566,0.6471380994288631,-0.6278544783400267,0.004604241870252684,0.008685507492436578,Downregulated
Feature0104,NA,C14 H27 N O10,369.16362,NA,NA,Feature0104,14,27,10,1,0,0,1.9285714285714288,0.7142857142857143,-0.2857142857142856,68.44285714285714,2,-8,-3,-0.5,-9,Carbohydrate,1614915.19857672,1072407.4498743825,0.6640642498253356,-0.5906052623210154,0.01571669328371757,0.026570936549518528,Downregulated
Feature0103,NA,C15 H28 N4 O5,344.20609,NA,NA,Feature0103,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,1085933.7272462216,550837.1767977228,0.507247507814837,-0.9792382230710431,4.4766598071365894e-5,1.4201239163463264e-4,Downregulated
Feature0102,NP-006105,C15 H16 O5,276.09975,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of various antibiotics,NA,NP-006105,15,16,5,0,0,0,1.0666666666666669,0.3333333333333333,-0.4000000000000003,71.7,8,3,0.3,0.44,3,Lignin,868353.8768667943,261730.7929917464,0.3014102890127316,-1.7301994289327698,0.4141113965881792,0.4821338184332478,Downregulated
Feature0101,"N,N-diacetyllegionaminic acid",C13 H22 N2 O8,334.13758,Metabolic pathways;Other,NA,"N,N-diacetyllegionaminic acid",13,22,8,2,0,0,1.6923076923076923,0.6153846153846154,0,60.3,4,-4,-2,-0.2857142857142857,-6,Amino Sugar,2008665.915615314,1118275.9908092043,0.5567257263220117,-0.8449613431374962,0.003592877860788996,0.0069797420827712835,Downregulated
Feature0100,NA,C16 H31 N3 O9,409.20616,NA,NA,Feature0100,16,31,9,3,0,0,1.9375,0.5625,-0.25,67.425,3,-6,-2.25,-0.5294117647058824,-9,Amino Sugar,454516.457719795,2219337.282067514,4.882853512502982,2.287724497214459,2.9009860886856534e-7,1.4757568871572063e-6,Upregulated
Feature0099,NA,C14 H27 N3 O4,301.20024,NA,NA,Feature0099,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2783209.010495738,3693466.3660484827,1.3270531793049247,0.40822618531415966,0.18616325648216223,0.24734161292610415,Upregulated
Feature0098,NA,C20 H30 N6 O8,482.21265,NA,NA,Feature0098,20,30,8,6,0,0,1.5,0.4,0.20000000000000015,54.599999999999994,9,1,-0.8333333333333334,-0.1,-5,Protein,4824758.776176198,84270.50334540026,0.01746626251275256,-5.839285261038125,4.935247340166803e-9,4.0387966155761186e-8,Downregulated
Feature0097,imazamox,C15 H19 N3 O4,305.13767,NA,NA,imazamox,15,19,4,3,0,0,1.2666666666666666,0.26666666666666666,-0.13333333333333375,64.10000000000001,8,4,0.125,0.3,1,Lignin,184804.51026056753,2755276.4456379917,14.909140700912298,3.898125204134642,2.29245374417963e-4,6.134939403855124e-4,Upregulated
Feature0096,4-Phenyl-3-buten-2-one,C10 H10 O,146.07318,NA,NA,4-Phenyl-3-buten-2-one-peak1,10,10,1,0,0,0,1,0.1,-0.7999999999999998,83.1,6,5,0.5555555555555556,0.5789473684210527,5,Unsaturated HC,447992.0655378289,248222.3589257767,0.5540775786459025,-0.8518401068944738,0.5143948958242757,0.5732795746883703,Downregulated
Feature0095,Proglumide,C18 H26 N2 O4,334.18921,NA,NA,Proglumide,18,26,4,2,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,7,3,0.08333333333333333,0.21428571428571427,1,Lignin,207194.34788908047,2115284.027670882,10.209178238796742,3.351794839797948,8.470959823223478e-5,2.530829971876644e-4,Upregulated
Feature0094,3477,C12 H20 N2 O3,240.14735,NA,NA,3477,12,20,3,2,0,0,1.6666666666666667,0.25,-0.666666666666667,79.30000000000001,4,1,-0.14285714285714285,0.0588235294117647,-1,Lipid,189016.121076772,219292.40305349848,1.1601783054495616,0.21434654726617208,0.6386115769245257,0.6786750384630782,Upregulated
Feature0093,NA,C14 H27 N3 O5,317.19523,NA,NA,Feature0093,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,1737017.9357239688,2415682.8079404617,1.3907068880861229,0.4758183827380993,0.09293780554455758,0.13218861678629767,Upregulated
Feature0092,NA,C14 H25 N3 O5,315.17946,NA,NA,Feature0092,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,2184905.821449471,1058145.35314995,0.4842979238564956,-1.0460332766440013,0.005713126744798347,0.010531051910433515,Downregulated
Feature0091,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,C25 H30 N4 O7,498.21169,NA,NA,Methyl N-{[(2R)-1-(methoxyacetyl)-4-(3-pyridinylcarbonyl)-2-piperazinyl]carbonyl}-O-methyl-L-tyrosinate,25,30,7,4,0,0,1.2,0.28,-0.16000000000000014,64.86,13,6,0.14285714285714285,0.3142857142857143,2,Lignin,271250.0939194831,2765772.2373511028,10.196391814603702,3.349986812564198,2.7978177335324138e-9,2.4814153092167063e-8,Upregulated
Feature0090,NA,C19 H34 N4 O8,446.2376,NA,NA,Feature0090,19,34,8,4,0,0,1.7894736842105263,0.42105263157894735,-0.3157894736842106,69.3,5,-3,-1,-0.2727272727272727,-7,Protein,329509.1393194048,1587174.0351214136,4.8167830440141755,2.2680699439843077,1.1024579333954546e-4,3.197883115020377e-4,Upregulated
Feature0089,HC blue 2,C12 H19 N3 O5,285.13253,NA,NA,HC blue 2-peak1,12,19,5,3,0,0,1.5833333333333333,0.4166666666666667,0,60.3,5,0,-0.75,-0.07692307692307693,-3,Protein,3797990.52132633,2116686.804541442,0.5573175584972906,-0.8434284881106363,1.390151970491542e-5,4.9473055420434286e-5,Downregulated
Feature0088,NA,C10 H15 N O5,229.09499,NA,NA,Feature0088,10,15,5,1,0,0,1.5,0.5,-0.20000000000000015,66,4,-1,-0.5,0.07692307692307693,-2,Protein,447047.49775300786,221533.1281584283,0.49554718295465006,-1.0129056663879044,0.44600017300753003,0.5108345456894902,Downregulated
Feature0087,NA,C14 H27 N3 O4,301.20021,NA,NA,Feature0087,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,2585456.8437969107,2686889.594468119,1.0392320416852319,0.05551781787278763,0.84191451444972365,0.8622752040373833,Upregulated
Feature0086,NA,C15 H27 N3 O7,361.18494,NA,NA,Feature0086,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,1080569.5811540356,853842.0442369321,0.7901777535927291,-0.3397508651666106,0.4831595115827718,0.5449215796412886,Downregulated
Feature0085,NA,C19 H29 N3 O6,395.20574,NA,NA,Feature0085,19,29,6,3,0,0,1.5263157894736843,0.3157894736842105,-0.4210526315789478,72.30000000000001,7,1,-0.2,0.07692307692307693,-2,Protein,873772.3942541372,477885.4213439199,0.5469220869032475,-0.8705927698117156,0.4027041630348803,0.4710212704158721,Downregulated
Feature0084,(+)-sesamin monocatechol,C19 H18 O6,342.11027,Biosynthesis of secondary metabolites;Other,NA,(+)-sesamin monocatechol-peak1,19,18,6,0,0,0,0.9473684210526316,0.3157894736842105,-0.3157894736842106,69.3,11,5,0.38461538461538464,0.5,5,Lignin,354017.6081720728,544171.2651731492,1.5371305059737335,0.6202396584107049,0.47316587666570653,0.5361491605830815,Upregulated
Feature0083,S-methyl D-thioglycerate,C4 H8 O3 S,136.0194,NA,NA,S-methyl D-thioglycerate,4,8,3,0,1,0,2,0.75,0,60.3,1,-2,-Inf,-1,-3,Carbohydrate,1244761.3106621546,2221041.26676504,1.7843109741124186,0.8353670736172126,0.0027587451346939794,0.005561090098189338,Upregulated
Feature0082,NA,C15 H25 N3 O6,343.17444,NA,NA,Feature0082,15,25,6,3,0,0,1.6666666666666667,0.4,-0.2666666666666666,67.89999999999999,5,-1,-0.6666666666666666,-0.1111111111111111,-4,Protein,231433.0855038554,1614088.8620278523,6.97432200981032,2.8020529759918342,3.118657480368548e-8,2.0011385499031515e-7,Upregulated
Feature0081,Deferiprone,C7 H9 N O2,139.06334,NA,NA,Deferiprone,7,9,2,1,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,4,2,0.25,0.4,1,Lignin,3124592.0356049505,2572494.4475288,0.8233057046216086,-0.28049987244261654,0.13227535149698633,0.18099712878505236,Downregulated
Feature0080,5-Deoxy-5-aminoshikimic acid,C7 H11 N O4,173.06883,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,5-Deoxy-5-aminoshikimic acid-peak1,7,11,4,1,0,0,1.5714285714285714,0.5714285714285714,0,60.3,3,-1,-1,0,-2,Amino Sugar,3803211.0128439334,2906715.610039188,0.7642793419094641,-0.38782805933589165,1.4182757951458947e-6,6.067068679235216e-6,Downregulated
Feature0079,NA,C15 H21 N3 O7,355.13805,NA,NA,Feature0079,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,723905.4195055377,1732370.3676290761,2.393089374593118,1.258874278144477,0.003956969186811737,0.00759128629950066,Upregulated
Feature0078,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0078,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,837394.1925551974,1137463.1627655746,1.3583365789709583,0.44184100583216285,0.420597336598343,0.4880081426010911,Upregulated
Feature0077,Tiglic acid,C5 H8 O2,100.0524,NA,NA,Tiglic acid-peak1,5,8,2,0,0,0,1.6,0.4,-0.7999999999999998,83.1,2,0,0,0.25,0,Protein,888065.3381846576,2276614.589970561,2.5635665441287374,1.3581523471748476,0.057484955068900785,0.08602430555363774,Upregulated
Feature0076,Anhydroecgonine,C9 H13 N O2,167.09465,Metabolic pathways;Biosynthesis of alkaloids derived from shikimate pathway;Tyrosine metabolism;Other,Other,Anhydroecgonine-peak1,9,13,2,1,0,0,1.4444444444444444,0.2222222222222222,-0.666666666666667,79.30000000000001,4,2,0.16666666666666666,0.2857142857142857,1,Lignin,341356.9394776267,1537763.2863975666,4.504854328582809,2.1714804550223747,0.02655868861387725,0.04256425592422712,Upregulated
Feature0075,NA,C17 H30 N4 O8,418.20647,NA,NA,Feature0075,17,30,8,4,0,0,1.7647058823529411,0.4705882352941176,-0.117647058823529,63.65294117647058,5,-3,-1.4,-0.3333333333333333,-7,Protein,1754219.7407455537,1648907.0717466192,0.9399660905912642,-0.08931938258456261,0.7866786736546554,0.8145682598844659,Downregulated
Feature0074,NA,C16 H30 N4 O5,358.22175,NA,NA,Feature0074,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,434511.6819764694,2467462.2272532997,5.678701700330632,2.505561129625657,1.8358468620279888e-4,5.032240427630118e-4,Upregulated
Feature0073,NA,C18 H27 N3 O5,365.19518,NA,NA,Feature0073,18,27,5,3,0,0,1.5,0.2777777777777778,-0.44444444444444464,72.96666666666667,7,2,-0.1,0.12,-1,Lipid,1053546.3002472077,2727126.9229579405,2.588521190115743,1.3721281284170241,0.0189896727611197,0.03156870035067397,Upregulated
Feature0072,NP-016455,C11 H18 N2 O4,242.12667,NA,NA,NP-016455-peak1,11,18,4,2,0,0,1.6363636363636365,0.3636363636363637,-0.3636363636363633,70.66363636363636,4,0,-0.4,0,-2,Protein,3748429.9429917927,2624259.7970884205,0.7000957299455033,-0.5143758875800378,5.581897395357481e-7,2.5835339310752926e-6,Downregulated
Feature0071,Methionylphenylalanine,C14 H20 N2 O3 S,296.11937,NA,NA,Methionylphenylalanine-peak1,14,20,3,2,1,0,1.4285714285714286,0.21428571428571427,-0.4285714285714288,72.51428571428572,6,3,0,0.15789473684210523,0,Lignin,423419.15091268334,1274185.5220819765,3.0092770233360007,1.5894169221570744,0.005406926691850525,0.010043129184204812,Upregulated
Feature0070,NA,C14 H25 N3 O5,315.17952,NA,NA,Feature0070,14,25,5,3,0,0,1.7857142857142858,0.35714285714285715,-0.4285714285714288,72.51428571428572,4,-1,-0.6666666666666666,-0.17647058823529413,-4,Protein,403938.2957756528,1813714.3177851553,4.49007765976339,2.1667403978364903,8.906739291521977e-6,3.308775517508383e-5,Upregulated
Feature0069,NA,C19 H29 N3 O5,379.21082,NA,NA,Feature0069,19,29,5,3,0,0,1.5263157894736843,0.2631578947368421,-0.5263157894736841,75.3,7,2,-0.09090909090909093,0.1111111111111111,-1,Lipid,321239.29593688686,1892062.3006715206,5.889884346662401,2.558239305679716,5.4319259189640995e-6,2.0865493212528765e-5,Upregulated
Feature0068,NA,C11 H13 N3 O3,235.09569,NA,NA,Feature0068,11,13,3,3,0,0,1.181818181818182,0.2727272727272727,0.18181818181818168,55.11818181818182,7,4,0.2,0.38461538461538464,1,Lignin,118546.16701391882,673214.4533230201,5.678922147216926,2.5056171338804107,1.3296032200974994e-5,4.761834788256161e-5,Upregulated
Feature0067,NA,C14 H25 N3 O6,331.17449,NA,NA,Feature0067,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,495990.43347854406,2332396.7026024507,4.702503405649551,2.233428988578229,0.0030639831088241356,0.0061207398423916105,Upregulated
Feature0066,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",C16 H23 N O3,277.16771,NA,NA,"1-[2-(Hydroxyamino)phenyl]-1,3-decanedione",16,23,3,1,0,0,1.4375,0.1875,-0.875,85.2375,6,3,0.16666666666666666,0.25925925925925924,2,Lignin,356476.82261820167,587931.4689967198,1.6492838571623312,0.7218397214420528,0.43108965006862876,0.4984749946868649,Upregulated
Feature0065,allobarbital,C10 H12 N2 O3,208.08478,Metabolic pathways;Biosynthesis of cofactors;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Superpathway of aromatic compound degradation via 3-oxoadipate;Other,allobarbital,10,12,3,2,0,0,1.2,0.3,0,60.3,6,3,0.2,0.38461538461538464,1,Lignin,2532187.2144030994,502099.3388431843,0.19828681544051702,-2.334339342338019,1.666422542224857e-8,1.1569343387413556e-7,Downregulated
Feature0064,Ala-Tyr,C12 H16 N2 O4,252.11102,NA,NA,Ala-Tyr,12,16,4,2,0,0,1.3333333333333333,0.3333333333333333,-0.16666666666666696,65.05000000000001,6,2,0,0.25,0,Lignin,132227.23860736235,1971984.2250954853,14.913600600486912,3.898556705382773,6.648602332670138e-5,2.0329841789789194e-4,Upregulated
Feature0063,N-Phenyl-beta-D-glucopyranosylamine,C12 H17 N O5,255.11067,NA,NA,N-Phenyl-beta-D-glucopyranosylamine-peak1,12,17,5,1,0,0,1.4166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,5,0,-0.16666666666666666,0.17647058823529413,-1,Lignin,134080.10067143224,1509579.8254171321,11.258790960460328,3.4929800049875315,5.543212296956509e-4,0.0013589293243190053,Upregulated
Feature0062,Glu-Lys,C11 H21 N3 O5,275.14821,Metabolic pathways;Other,NA,Glu-Lys,11,21,5,3,0,0,1.9090909090909092,0.4545454545454546,-0.18181818181818168,65.48181818181817,3,-2,-1.6666666666666667,-0.4545454545454546,-5,Protein,1750834.6783861958,1946611.6612308063,1.1118192284294168,0.1529222381972458,0.32120067807770075,0.39920319050889586,Upregulated
Feature0061,N-(2-Hydroxy-7-octenoyl)glycine,C10 H17 N O4,215.11577,NA,NA,N-(2-Hydroxy-7-octenoyl)glycine-peak1,10,17,4,1,0,0,1.7,0.4,-0.5999999999999996,77.39999999999999,3,-1,-0.4,0,-2,Protein,859405.8713607236,1608172.0681060287,1.8712602760785897,0.9040102389059576,0.022319418802762236,0.03646007275976782,Upregulated
Feature0060,NA,C16 H31 N3 O5,345.22649,NA,NA,Feature0060,16,31,5,3,0,0,1.9375,0.3125,-0.75,81.675,3,-2,-0.625,-0.23809523809523808,-5,Protein,1229808.108151627,2560085.248267021,2.0816948849969528,1.057758627638533,0.02719715398220088,0.04342316573595503,Upregulated
Feature0059,Acetyl-L-methionine,C7 H13 N O3 S,191.0617,NA,NA,Acetyl-L-methionine-peak1,7,13,3,1,1,0,1.8571428571428572,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,512578.4300276436,1427878.3943146283,2.7856778800419324,1.4780284425285846,0.0210237971080384,0.03471180536161506,Upregulated
Feature0058,Ajmaline,C20 H26 N2 O2,326.19951,Biosynthesis of secondary metabolites;Other,NA,Ajmaline,20,26,2,2,0,0,1.3,0.1,-0.7999999999999998,83.1,9,7,0.3125,0.35294117647058826,5,Unsaturated HC,146566.17232020083,260487.66517760901,1.7772700279606517,0.8296628926237092,0.20717739586873501,0.27142962768881446,Upregulated
Feature0057,NA,C12 H22 N4 O3,270.16923,NA,NA,Feature0057,12,22,3,4,0,0,1.8333333333333333,0.25,-0.33333333333333304,69.79999999999998,4,1,-0.6,-0.2307692307692308,-3,Lipid,4498240.32099838,431167.3246381521,0.09585244314880334,-3.3830409850723036,4.2303145949418235e-9,3.5301245930204186e-8,Downregulated
Feature0056,Uric acid,C5 H4 N4 O3,168.02837,Metabolic pathways;Microbial metabolism in diverse environments;Other,Other,Uric acid,5,4,3,4,0,0,0.8,0.6,2.8,-19.5,6,3,0.5,-1,-1,Condensed HC,218911.95806407515,792714.0048887349,3.621154421617794,1.8564497008549385,0.11054664968458104,0.15514997892765559,Upregulated
Feature0055,NA,C21 H33 N3 O4,391.24697,NA,NA,Feature0055,21,33,4,3,0,0,1.5714285714285714,0.1904761904761905,-0.7619047619047619,82.0142857142857,7,3,0,0.125,0,Lipid,410644.10483674705,1945789.876551276,4.738385023997438,2.244395431512565,0.008516237238549077,0.0152017975575365,Upregulated
Feature0054,NA,C16 H30 N4 O5,358.22173,NA,NA,Feature0054,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,1966027.937772312,936093.4894539795,0.47613437808755577,-1.0705592960584926,0.004732671515533472,0.008907939497015224,Downregulated
Feature0053,NA,C25 H54 N2 O5 P2 S,556.32268,NA,NA,Feature0053,25,54,5,2,1,2,2.16,0.2,-1.84,112.74,1,-4,-0.6,-0.37142857142857144,-9,Lipid,182700.42936932555,711336.9077189869,3.8934605144306063,1.9610529952355553,0.004393233719504292,0.008324539061342584,Upregulated
Feature0052,NA,C19 H30 N4 O6,410.21666,NA,NA,Feature0052,19,30,6,4,0,0,1.5789473684210529,0.3157894736842105,-0.3157894736842106,69.3,7,1,-0.3333333333333333,0,-3,Protein,4300115.908372445,216787.01166608642,0.050414225170999714,-4.310025319382888,5.001456973733387e-9,4.0733019776463265e-8,Downregulated
Feature0051,NA,C15 H33 N O,243.2562,NA,NA,Feature0051,15,33,1,1,0,0,2.2,0.06666666666666667,-1.8666666666666665,113.5,0,-1,-0.15384615384615383,-0.1111111111111111,-2,Lipid,2192928.5567675014,2974854.2195662702,1.356566865977326,0.43996016065803234,0.7032729220570295,0.738131555120575,Upregulated
Feature0050,N-feruloylglycine,C12 H13 N O5,251.07936,NA,NA,N-feruloylglycine,12,13,5,1,0,0,1.0833333333333333,0.4166666666666667,0,60.3,7,2,0.16666666666666666,0.4117647058823529,1,Lignin,3854965.5584931048,2077738.2059518402,0.5389771126162856,-0.8917040839059677,9.25260006228703e-6,3.414794009915954e-5,Downregulated
Feature0049,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate",C12 H15 N O4,237.10007,NA,NA,"(1R)-6-Hydroxy-7-methoxy-1-methyl-1,2,3,4-tetrahydro-1-isoquinoliniumcarboxylate-peak1",12,15,4,1,0,0,1.25,0.3333333333333333,-0.33333333333333304,69.79999999999998,6,2,0.14285714285714285,0.3333333333333333,1,Lignin,2605470.736061121,1160561.1804285327,0.44543243735795596,-1.1667214727484496,0.0011400860523600963,0.002554637265473549,Downregulated
Feature0048,NA,C27 H42 N2 O2,426.32469,NA,NA,Feature0048,27,42,2,2,0,0,1.5555555555555556,0.07407407407407407,-1.1851851851851851,94.07777777777778,8,6,0.17391304347826086,0.20833333333333337,4,Lipid,170064.78225188254,483664.6119074766,2.844002182598406,1.5079225721383016,0.05305790006762599,0.08010702559229807,Upregulated
Feature0047,NA,C14 H27 N3 O5,317.19516,NA,NA,Feature0047,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,332804.1746351561,2072373.9037675573,6.227006935953982,2.638538886162486,5.6685107733422237e-8,3.3930944346437197e-7,Upregulated
Feature0046,asn-tyr,C13 H17 N3 O5,295.11678,NA,NA,asn-tyr-peak1,13,17,5,3,0,0,1.3076923076923077,0.38461538461538464,0.15384615384615374,55.91538461538462,7,2,-0.2,0.2,-1,Lignin,1245189.9966861415,2219035.1302894233,1.7820855742456996,0.833566615521837,0.0010329921877340702,0.002336300088146215,Upregulated
Feature0045,NA,C7 H9 N O3 S,187.03034,NA,NA,Feature0045,7,9,3,1,1,0,1.2857142857142858,0.42857142857142855,0.2857142857142856,52.15714285714286,4,1,-0.5,0.14285714285714285,-1,Lignin,2577519.1844882835,2749402.5413123486,1.0666855780777396,0.09313498235127597,0.42768246473141636,0.494873015884576,Upregulated
Feature0044,Vinylbital,C11 H16 N2 O3,224.11608,NA,NA,Vinylbital,11,16,3,2,0,0,1.4545454545454546,0.2727272727272727,-0.3636363636363633,70.66363636363636,5,2,0,0.2,0,Lignin,4584083.175435967,1188403.0913353777,0.2592455341350466,-1.9476089580637699,4.847169266126833e-10,5.702156067235317e-9,Downregulated
Feature0043,NA,C12 H17 N O4,239.11576,NA,NA,Feature0043,12,17,4,1,0,0,1.4166666666666667,0.3333333333333333,-0.5,74.55,5,1,0,0.2222222222222222,0,Lignin,1905889.825402121,1925556.8550660335,1.0103190800442847,0.01481099842074044,0.9503944234410668,0.9549040055214515,Upregulated
Feature0042,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid,C13 H25 N3 O6,319.17436,Other,NA,2-[(2Z)-2-({4-[(3-Aminopropyl)amino]butyl}imino)-2-hydroxyethyl]-2-hydroxysuccinic acid-peak1,13,25,6,3,0,0,1.9230769230769231,0.4615384615384616,-0.3076923076923075,69.06923076923076,3,-3,-1.5,-0.42857142857142855,-6,Protein,1488085.1997392634,2043282.4543644637,1.3730950719236237,0.4574315199090609,0.007366316928677827,0.013260936107524164,Upregulated
Feature0041,NA,C13 H23 N3 O6,317.15865,NA,NA,Feature0041,13,23,6,3,0,0,1.7692307692307692,0.4615384615384616,-0.1538461538461542,64.6846153846154,4,-2,-1.25,-0.2857142857142857,-5,Protein,1044614.3313055807,1123941.7789519313,1.0759394594435685,0.1055969031568593,0.7429357504760525,0.774005634259799,Upregulated
Feature0040,NA,C19 H27 N3 O6,393.19014,NA,NA,Feature0040,19,27,6,3,0,0,1.4210526315789471,0.3157894736842105,-0.3157894736842106,69.3,8,2,-0.1,0.15384615384615383,-1,Lignin,484835.54911700543,914680.6062582014,1.886579084235965,0.9157725783052564,0.016038247632844033,0.027006750984132993,Upregulated
Feature0039,NA,C26 H48 N2 O6,484.35117,NA,NA,Feature0039,26,48,6,2,0,0,1.8461538461538465,0.2307692307692308,-1.1538461538461542,93.1846153846154,4,-2,-0.2222222222222222,-0.04761904761904761,-4,Lipid,272331.48318283045,964902.3424471362,3.543117127590226,1.8250191585413231,0.04092801851336249,0.06349090051431873,Upregulated
Feature0038,NA,C14 H25 N3 O6,331.17447,NA,NA,Feature0038,14,25,6,3,0,0,1.7857142857142858,0.42857142857142855,-0.2857142857142856,68.44285714285714,4,-2,-1,-0.25,-5,Protein,1247148.9441317217,1838699.0248617115,1.4743219192169812,0.560051572295785,0.02154335517869701,0.03546593165472569,Upregulated
Feature0037,Anhalamine,C11 H15 N O3,209.10523,Biosynthesis of alkaloids derived from shikimate pathway;Other,NA,Anhalamine-peak1,11,15,3,1,0,0,1.3636363636363635,0.2727272727272727,-0.5454545454545459,75.84545454545456,5,2,0.14285714285714285,0.29411764705882354,1,Lignin,347153.1087184272,1446255.3670345577,4.166044695303601,2.05867831737831,0.00958914893880565,0.01690324485154711,Upregulated
Feature0036,Hypoxanthine,C5 H4 N4 O,136.03851,Metabolic pathways;Other,Superpathway of purine nucleotide salvage;Other,Hypoxanthine-peak1,5,4,1,4,0,0,0.8,0.2,2,3.299999999999997,6,5,Inf,3,1,Condensed HC,4074176.413469599,411974.49187854223,0.10111847158029705,-3.3058815326302637,7.646220143439926e-9,5.914473480816089e-8,Downregulated
Feature0035,NA,C8 H9 N5 O3,223.07052,NA,NA,Feature0035,8,9,3,5,0,0,1.125,0.375,1.5,17.549999999999997,7,4,-Inf,0.3333333333333333,-1,Lignin,2726982.274104198,2589426.82836906,0.9495576311436332,-0.07467253090863944,0.3598414505389701,0.43262698169837854,Downregulated
Feature0034,NA,C12 H23 N3 O5,289.16377,NA,NA,Feature0034,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,903505.983233782,1203622.2614164597,1.33216855643669,0.4137766350746659,0.1205862891551891,0.16702630730080975,Upregulated
Feature0033,Isoquinoline,C9 H7 N,129.05782,NA,NA,Isoquinoline,9,7,0,1,0,0,0.7777777777777778,0,-0.44444444444444464,72.96666666666667,7,7,0.75,0.75,6,Condensed HC,3314594.695548631,1400902.5799527895,0.42264672113128826,-1.2424758372721085,8.28280477838674e-4,0.0019406737613536845,Downregulated
Feature0032,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid",C8 H6 O3,150.03174,Metabolic pathways;Microbial metabolism in diverse environments;Phenylalanine metabolism;Aminobenzoate degradation;Other,Superpathway of aromatic compound degradation via 2-oxopent-4-enoate;Anaerobic aromatic compound degradation (Thauera aromatica);Superpathway of aromatic compound degradation via 3-oxoadipate;Other,"(2Z)-8-Hydroxy-2-octene-4,6-diynoic acid-peak1",8,6,3,0,0,0,0.75,0.375,0,60.3,6,3,0.6,0.6923076923076923,3,Condensed HC,184725.39552171447,270517.42716152285,1.4644300876850662,0.5503393201837476,0.4987125731651475,0.5591125737536464,Upregulated
Feature0031,NA,C14 H27 N3 O5,317.19507,NA,NA,Feature0031,14,27,5,3,0,0,1.9285714285714288,0.35714285714285715,-0.5714285714285712,76.58571428571427,3,-2,-0.8333333333333334,-0.29411764705882354,-5,Protein,2457728.146962803,1234331.7829519806,0.5022247006762469,-0.9935951091557058,1.0928811253129048e-5,3.9985758666955956e-5,Downregulated
Feature0030,NA,C15 H19 N3 O3 S,321.11473,NA,NA,Feature0030,15,19,3,3,1,0,1.2666666666666666,0.2,-0.13333333333333375,64.10000000000001,8,5,0.125,0.2631578947368421,1,Lignin,238053.56909278245,723843.6448009857,3.040675456198955,1.6043918398087527,0.1977403510339042,0.2598697863859067,Upregulated
Feature0029,MFCD08277025,C12 H19 N O4,241.13144,Other,NA,MFCD08277025,12,19,4,1,0,0,1.5833333333333333,0.3333333333333333,-0.666666666666667,79.30000000000001,4,0,-0.14285714285714285,0.1111111111111111,-1,Protein,301883.0303439955,550162.9309892788,1.8224374200907172,0.8658692753067412,0.3625663479005774,0.43466906818370715,Upregulated
Feature0028,NA,C12 H23 N3 O5,289.16387,NA,NA,Feature0028,12,23,5,3,0,0,1.9166666666666667,0.4166666666666667,-0.33333333333333304,69.79999999999998,3,-2,-1.25,-0.38461538461538464,-5,Protein,461171.5076756165,1860588.5127360846,4.034482793860726,2.012383737057355,0.0016798245567411912,0.0035710717882533054,Upregulated
Feature0027,asn-val,C9 H17 N3 O4,231.12192,NA,NA,asn-val-peak1,9,17,4,3,0,0,1.8888888888888888,0.4444444444444444,0,60.3,3,-1,-2,-0.5,-4,Protein,2115919.0675888467,1185206.5620440873,0.5601379467668703,-0.8361459273448905,0.0010089828866171576,0.0022850494785153276,Downregulated
Feature0026,NA,C16 H21 N5 O9,427.13396,NA,NA,Feature0026,16,21,9,5,0,0,1.3125,0.5625,0.75,38.925,9,0,-2.5,-0.07692307692307693,-5,Lignin,2683444.391802869,2711298.4882705268,1.010379979012326,0.014897957078756583,0.8818770632314524,0.8961606149454591,Upregulated
Feature0025,NA,C17 H32 N6 O6,416.23845,NA,NA,Feature0025,17,32,6,6,0,0,1.8823529411764703,0.35294117647058826,-0.117647058823529,63.65294117647058,5,-1,-1.4,-0.5,-7,Protein,731262.8391287464,1712994.0404533774,2.3425148233900437,1.2280581772606163,0.006902524056992947,0.012465752401435024,Upregulated
Feature0024,NA,C11 H19 N3 O5,273.13255,Biosynthesis of secondary metabolites;Other,NA,Feature0024,11,19,5,3,0,0,1.7272727272727273,0.4545454545454546,0,60.3,4,-1,-1.3333333333333333,-0.2727272727272727,-4,Protein,2296845.149583538,855059.3417468391,0.3722755719521961,-1.4255571426239784,4.3881161476419845e-7,2.088053020816158e-6,Downregulated
Feature0023,4-Hydroxyprolyllysine,C11 H21 N3 O4,259.15322,NA,NA,4-Hydroxyprolyllysine-peak1,11,21,4,3,0,0,1.9090909090909092,0.3636363636363637,-0.3636363636363633,70.66363636363636,3,-1,-1,-0.3333333333333333,-4,Protein,421454.25751244643,1667787.7065444607,3.957221161765598,1.9844876971191074,2.322304457343507e-6,9.571736619805113e-6,Upregulated
Feature0022,NA,C20 H38 N4 O6,430.27919,NA,NA,Feature0022,20,38,6,4,0,0,1.9,0.3,-0.7000000000000002,80.25,4,-2,-0.6,-0.2307692307692308,-6,Lipid,3412477.1626511994,269166.7414087417,0.07887722864630761,-3.6642473263001083,2.1135084627079495e-8,1.4151317532914097e-7,Downregulated
Feature0021,NA,C16 H30 N4 O5,358.22177,NA,NA,Feature0021,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,740009.8736782329,1982802.400173666,2.6794269518568847,1.4219244849686477,8.501722847820838e-4,0.001978773352153236,Upregulated
Feature0020,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",C19 H20 O7,360.12104,NA,NA,"2-(4-Hydroxyphenyl)-5,6,7,8-tetramethoxy-2,3-dihydro-4H-chromen-4-one",19,20,7,0,0,0,1.0526315789473684,0.3684210526315789,-0.3157894736842106,69.3,10,3,0.25,0.41935483870967744,3,Lignin,192961.3292253806,275709.4666506683,1.4288327498440743,0.5148370535282073,0.5219639681256458,0.580188295278769,Upregulated
Feature0019,Crotanecine,C8 H13 N O3,171.08956,Other,NA,Crotanecine-peak1,8,13,3,1,0,0,1.625,0.375,-0.5,74.55,3,0,-0.25,0.09090909090909093,-1,Protein,243131.36930975434,1999216.077269705,8.222781301094319,3.0396264584576915,9.119658463712392e-5,2.705551915504167e-4,Upregulated
Feature0018,NA,C14 H27 N3 O4,301.20015,NA,NA,Feature0018,14,27,4,3,0,0,1.9285714285714288,0.2857142857142857,-0.7142857142857144,80.65714285714286,3,-1,-0.5714285714285714,-0.2222222222222222,-4,Lipid,1388000.875628471,2122071.370045003,1.5288688986483192,0.6124647001067685,0.11172202524868217,0.15641083534815503,Upregulated
Feature0017,?-Ribazole,C14 H18 N2 O4,278.12676,Metabolic pathways;Biosynthesis of cofactors;Other,NA,?-Ribazole-peak1,14,18,4,2,0,0,1.2857142857142858,0.2857142857142857,-0.2857142857142856,68.44285714285714,7,3,0.125,0.3,1,Lignin,2890435.049292771,1867728.39163441,0.6461755271378279,-0.6300019830112279,0.014619360732421842,0.02486465570353675,Downregulated
Feature0016,NA,C15 H21 N3 O7,355.1381,NA,NA,Feature0016,15,21,7,3,0,0,1.4,0.4666666666666667,0.1333333333333333,56.5,7,0,-0.6,0.0588235294117647,-3,Lignin,4307562.240420061,237494.2755129262,0.05513426440699936,-4.180906997543976,3.675822622183086e-9,3.113421760989074e-8,Downregulated
Feature0015,NA,C17 H31 N3 O6,373.22133,NA,NA,Feature0015,17,31,6,3,0,0,1.8235294117647056,0.35294117647058826,-0.5882352941176467,77.06470588235292,4,-2,-0.625,-0.18181818181818185,-5,Protein,2761262.488378327,2421316.166985298,0.8768873575678503,-0.18953656477779668,0.450715754526652,0.5156686976086585,Downregulated
Feature0014,Marimastat,C15 H29 N3 O5,331.21086,NA,NA,Marimastat-peak1,15,29,5,3,0,0,1.9333333333333331,0.3333333333333333,-0.666666666666667,79.30000000000001,3,-2,-0.7142857142857143,-0.2631578947368421,-5,Protein,1701091.1920532894,2175100.5457503353,1.2786501722608394,0.35462160919356295,0.25913635947402663,0.330554964570031,Upregulated
Feature0013,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,C10 H14 N2 O3,210.10041,Metabolic pathways;Microbial metabolism in diverse environments;Other,NA,1-(6-hydroxy-3-pyridyl)-4-(methylamino)butan-1-one,10,14,3,2,0,0,1.4,0.3,-0.20000000000000015,66,5,2,0,0.2307692307692308,0,Lignin,489110.26582876785,2531850.607598538,5.176441355833066,2.3719606302218015,2.8058749483911127e-10,3.628360429446217e-9,Upregulated
Feature0012,Pentoxifylline,C13 H18 N4 O3,278.13793,NA,NA,Pentoxifylline,13,18,3,4,0,0,1.3846153846153846,0.2307692307692308,0,60.3,7,4,0,0.2,0,Lignin,661201.2781055311,125949.9047119236,0.19048648101950788,-2.392239482776096,0.11228444001439244,0.1569388130234165,Downregulated
Feature0011,NA,C16 H30 N4 O5,358.22167,NA,NA,Feature0011,16,30,5,4,0,0,1.875,0.3125,-0.5,74.55,4,-1,-0.7142857142857143,-0.2631578947368421,-5,Protein,388833.1945700608,784183.602325171,2.0167609485919935,1.012040088056151,0.0056993356277800205,0.010517074676970975,Upregulated
Feature0010,NA,C16 H30 N6 O6,402.22286,NA,NA,Feature0010,16,30,6,6,0,0,1.875,0.375,0,60.3,5,-1,-1.75,-0.5714285714285714,-7,Protein,378018.6566398079,1725406.4534121756,4.564342058535527,2.190406913375312,4.148613914180369e-6,1.6155751656601253e-5,Upregulated
Feature0009,APM,C7 H13 N O4,175.08446,NA,NA,APM-peak1,7,13,4,1,0,0,1.8571428571428572,0.5714285714285714,-0.2857142857142856,68.44285714285714,2,-2,-1.5,-0.25,-3,Amino Sugar,690269.5252749942,239667.52340719762,0.3472086114648003,-1.5261253649520483,0.27402212624362354,0.34745021097058254,Downregulated
Feature0008,NA,C15 H27 N3 O7,361.18502,NA,NA,Feature0008,15,27,7,3,0,0,1.8,0.4666666666666667,-0.2666666666666666,67.89999999999999,4,-3,-1.2,-0.29411764705882354,-6,Protein,400396.81424138625,1033767.0472637448,2.581856324762165,1.3684087197309416,0.004458001791895536,0.008437826855274902,Upregulated
Feature0007,(Z)-dehydrobutyrine,C4 H7 N O2,101.04765,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of plant secondary metabolites;Other,Superpathway of branched chain amino acid biosynthesis;Superpathway of jasmonoyl-amino acid conjugates biosynthesis;Superpathway of L-threonine metabolism;Superpathway of L-isoleucine biosynthesis I;Other,(Z)-dehydrobutyrine-peak1,4,7,2,1,0,0,1.75,0.5,0,60.3,2,0,-1,0,-1,Protein,3908157.856535326,1002875.4626165245,0.25661078682875854,-1.9623462784064938,1.2390141674085146e-7,6.770612901903302e-7,Downregulated
Feature0006,N~2~-Acetyl-L-ornithine,C7 H14 N2 O3,174.10045,Metabolic pathways;Biosynthesis of secondary metabolites;Biosynthesis of amino acids;2-Oxocarboxylic acid metabolism;Other,Other,N~2~-Acetyl-L-ornithine-peak1,7,14,3,2,0,0,2,0.42857142857142855,-0.2857142857142856,68.44285714285714,2,-1,-1.5,-0.42857142857142855,-3,Protein,1200337.7095618374,663192.473170376,0.5525049058172662,-0.8559408203076017,0.03999162298474746,0.06220919130960716,Downregulated
Feature0005,NA,C14 H27 N3 O6,333.19005,NA,NA,Feature0005,14,27,6,3,0,0,1.9285714285714288,0.42857142857142855,-0.4285714285714288,72.51428571428572,3,-3,-1.2,-0.375,-6,Protein,1100903.300468895,896823.8351168582,0.8146254396138921,-0.2957912264928448,0.22904973570894357,0.2970982023667308,Downregulated
Feature0004,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",C16 H19 N O5,305.12642,NA,NA,"3,4-Dihydroxy-7-methoxy-2,2,6-trimethyl-2,3,4,6-tetrahydro-5H-pyrano[3,2-c]quinolin-5-one",16,19,5,1,0,0,1.1875,0.3125,-0.375,70.9875,8,3,0.2,0.36,2,Lignin,869298.0901208668,1268206.7433729188,1.458885919324392,0.5448670730708992,0.21075830212611424,0.27526951719478604,Upregulated
Feature0003,NA,C15 H28 N4 O5,344.20604,NA,NA,Feature0003,15,28,5,4,0,0,1.8666666666666667,0.3333333333333333,-0.4000000000000003,71.7,4,-1,-0.8333333333333334,-0.29411764705882354,-5,Protein,429589.2763840283,1400621.955124936,3.260374576652281,1.7050377217676609,3.931276638992381e-4,9.895367944209648e-4,Upregulated
Feature0002,NA,C21 H21 O6 P S,432.07976,NA,NA,Feature0002,21,21,6,0,1,1,1,0.2857142857142857,-0.5714285714285712,76.58571428571427,12,6,0.3076923076923077,0.4375,4,Lignin,86693.17664541483,130466.83230393841,1.5049261931831488,0.5896927339353394,0.39696039505487024,0.4653639510193427,Upregulated
Feature0001,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,C12 H24 N4 O4,288.17983,NA,NA,N-(1-{[Methyl(2-methyl-2-propanyl)carbamoyl]amino}ethyl)-alpha-asparagine,12,24,4,4,0,0,2,0.3333333333333333,-0.33333333333333304,69.79999999999998,3,-1,-1.25,-0.5,-5,Protein,1079711.628586228,307871.4491978802,0.28514229267031826,-1.8102460573632775,5.7704006861205873e-5,1.7805207217282834e-4,Downregulated
